Explore and select your biomarker panel
Explore by Target
Explore by Pathways
Explore by Phenotypes
Explore by Therapeutic Area
Build your own experiment
Close
| Molecule | Target | Pathway | Phenotype | Area |
|---|---|---|---|---|
| (-)-Asbestinine 2 | Lipid | - | - | - |
| (-)-Fusidic acid | Lipid | - | - | - |
| (-)N-(2R-hydroxy-propyl) alpha.alpha-dimethylarachidonoyl amine | Lipid | - | - | - |
| (23R.25S)-1alpha.25-dihydroxyvitamin D3 26.23-lactone (23R.25S)-1alpha.25-dihydroxycholecalciferol 26.23-lactone |
Lipid | - | - | - |
| (24R)-1alpha.24-dihydroxy-22-oxa-20-epivitamin D3 (24R)-1alpha.24-dihydroxy-22-oxa-20-epicholecalciferol |
Lipid | - | - | - |
| (3-sulfo)Galbeta-Cer(d18:1/16:0) | Lipid | - | - | - |
| (3-sulfo)Galbeta-Cer(d18:1/18:0(2OH)) | Lipid | - | - | - |
| (3-sulfo)Galbeta-Cer(d18:1/18:0) | Lipid | - | - | - |
| (3-sulfo)Galbeta-Cer(d18:1/20:0(2OH)) | Lipid | - | - | - |
| (3-sulfo)Galbeta-Cer(d18:1/20:0) | Lipid | - | - | - |
| (3-sulfo)Galbeta-Cer(d18:1/22:0(2OH)) | Lipid | - | - | - |
| (3-sulfo)Galbeta-Cer(d18:1/22:0) | Lipid | - | - | - |
| (3-sulfo)Galbeta-Cer(d18:1/24:0(2OH)) | Lipid | - | - | - |
| (3-sulfo)Galbeta-Cer(d18:1/24:0) | Lipid | - | - | - |
| (3-sulfo)Galbeta-Cer(d18:1/24:1(15Z)(2OH)) | Lipid | - | - | - |
| (3-sulfo)Galbeta-Cer(d18:1/24:1(15Z)) | Lipid | - | - | - |
| (5E.10E)-19-fluoro-1alpha.25-dihydroxyvitamin D3 (5E.10E)-19-fluoro-1alpha.25-dihydroxycholecalciferol |
Lipid | - | - | - |
| (5E.10Z)-19-fluoro-1alpha-hydroxyvitamin-D3 (5E.10Z)-19-fluoro-1alpha-hydroxycholecalciferol |
Lipid | - | - | - |
| (6RS)-6.19-epidioxy-24.24-difluoro-25-hydroxy-6.19-dihydrovitamin D3 (6RS)-6.19-epidioxy-24.24-difluoro-25-hydroxy-6.19-dihydrocholecalciferol |
Lipid | - | - | - |
| (6S)-vitamin D2 6.19-sulfur dioxide adduct (6S)-ergocalciferol 6.19-sulfur dioxide adduct |
Lipid | - | - | - |
| (7Z.10Z.13Z.16Z.19Z)-docosapentaenoylcarnitine | Lipid | - | - | - |
| (E.E)-2.4-Decadienoic isobutylamide | Lipid | - | - | - |
| 1-(2E.6E-phytadienyl)-2-(2E.6E-phytadienyl)-sn-glycero-3-phosphocholine | Lipid | - | - | - |
| 1-(8-3-ladderane-octanoyl)-2-(8-3-ladderane-octanyl)-sn-glycerophosphocholine | Lipid | - | - | - |
| 1-(8-3-ladderane-octanoyl)-2-(8-3-ladderane-octanyl)-sn-glycerophosphoethanolamine | Lipid | - | - | - |
| 1-(8-3-ladderane-octanoyl-2-(8-3-ladderane-octanyl)-sn-glycerol | Lipid | - | - | - |
| 1-(8-3-ladderane-octanyl)-2-(8-3-ladderane-octanyl)-sn-glycerophosphoethanolamine | Lipid | - | - | - |
| 1-(8-5-ladderane-octanoyl)-2-(8-3-ladderane-octanyl)-sn-glycerophosphoethanolamine | Lipid | - | - | - |
| 1-(8-5-ladderane-octanyl)-2-(8-3-ladderane-octanyl)-sn-glycerophosphoethanolamine | Lipid | - | - | - |
| 1.2-Dihydro-5-hydroxy-2-(1-hydroxy-1-methylethyl)-4-(isobutyryl)-6-phenylfurano2.3-h1benzopyran-8-one | Lipid | - | - | - |
| 10-5-ladderane-decanoic acid | Lipid | - | - | - |
| 11.12-dihydroxy arachidic acid | Lipid | - | - | - |
| 12-hydroxyjasmonic acid 12-O-beta-D-glucoside | Lipid | - | - | - |
| 12-oxo-14.18-dihydroxy-9Z.13E.15Z-octadecatrienoic acid | Lipid | - | - | - |
| 15-methyl-15R-PGF2alpha | Lipid | - | - | - |
| 16.17-epoxy-DHA | Lipid | - | - | - |
| 16:0-Glc-Campesterol | Lipid | - | - | - |
| 17.18-dehydro-clavulone I | Lipid | - | - | - |
| 18:0-Glc-Campesterol | Lipid | - | - | - |
| 18:3-Glc-Stigmasterol | Lipid | - | - | - |
| 18-Oxocortisol | Lipid | - | - | - |
| 1alpha.22-dihydroxy-23.24.25.26.27-pentanorvitamin D3 1alpha.22-dihydroxy-23.24.25.26.27-pentanorcholecalciferol |
Lipid | - | - | - |
| 1alpha.25-dihydroxy-2beta-(3-hydroxypropyl)vitamin D3 1alpha.25-dihydroxy-2beta-(3-hydroxypropyl)cholecalciferol |
Lipid | - | - | - |
| 1alpha.25-dihydroxy-2beta-(6-hydroxyhexyl)vitamin D3 1alpha.25-dihydroxy-2beta-(6-hydroxyhexyl)cholecalciferol |
Lipid | - | - | - |
| 1-hexadecanyl-2-(8-3-ladderane-octanyl)-sn-glycerophosphocholine | Lipid | - | - | - |
| 1-Hexadecylglycerol | Lipid | - | - | - |
| 1-tetradecanyl-2-(8-3-ladderane-octanyl)-sn-glycerophosphocholine | Lipid | - | - | - |
| 20:1 Campesteryl ester | Lipid | - | - | - |
| 20-COOH-leukotriene E4 | Lipid | - | - | - |
| 22:6 Cholesteryl ester | Lipid | - | - | - |
| 24.24-difluoro-1alpha.25-dihydroxy-24a-homovitamin D3 24.24-difluoro-1alpha.25-dihydroxy-24a-homocholecalciferol |
Lipid | - | - | - |
| 26.26.26-trifluoro-25-hydroxy-27-norvitamin D3 26.26.26-trifluoro-25-hydroxy-27-norcholecalciferol |
Lipid | - | - | - |
| 2-Amino-3-methylbutanoic acid | Lipid | - | - | - |
| 2-demethylmenaquinone-8 | Lipid | - | - | - |
| 2-Methylacetophenone | Lipid | - | - | - |
| 2-Methyldocosane | Lipid | - | - | - |
| 2S-aminoheptanoic acid | Lipid | - | - | - |
| 3.17-dioxoandrost-4-en-19-al | Lipid | - | - | - |
| 3.4.17-trihydroxy-9.10-seco-androsta-1.3.5(10)-triene-9-one | Lipid | - | - | - |
| 3.4-dihydroxy-9.10-secoandrosta-1.3.5(10)-triene-9.17-dione | Lipid | - | - | - |
| 3.5.7.9.11-dodecapentaenoic acid | Lipid | - | - | - |
| 3.5-Di-O-methyl-8-prenylafzelechin-4beta-ol | Lipid | - | - | - |
| 32.35-anhydrobacteriohopan-11-ene-tetrol | Lipid | - | - | - |
| 38:5(23Z.26Z.29Z.32Z.35Z) | Lipid | - | - | - |
| 3-Deoxyvitamin D3 | Lipid | - | - | - |
| 3-MT | Amino-acid & Metabolites | - | - | - |
| 3-O-(2-O-(2E-decenoyl)-alpha-L-rhamnopyranosyl)-3-hydroxydecanoic acid | Lipid | - | - | - |
| 3-O-Methylanhydrotuberosin | Lipid | - | - | - |
| 3-oxoglycyrrhetinic acid | Lipid | - | - | - |
| 4.2.3.4.6-Pentahydroxy-5-neryldihydrochalcone | Lipid | - | - | - |
| 4.4-Diaponeurosporene | Lipid | - | - | - |
| 4.7-dioxo-octanoic acid | Lipid | - | - | - |
| 4-1BB | Protein | - | T Cell Activation | Immuno-Oncology |
| 4E.14Z-Sphingadiene | Lipid | - | - | - |
| 5alpha-Tetrahydrocorticosterone | Lipid | - | - | - |
| 5beta-scymnol sulfate | Lipid | - | - | - |
| 5-oxo-7-octenoic acid | Lipid | - | - | - |
| 6.8-Diprenylpratensein | Lipid | - | - | - |
| 6beta-Hydroxyasiatic acid | Lipid | - | - | - |
| 6-fluorovitamin D3 6-fluorocholecalciferol |
Lipid | - | - | - |
| 6Z.9Z-Docosadiene | Lipid | - | - | - |
| 7-methyl-3-oxooctanoyl-CoA | Lipid | - | - | - |
| 7-O-Methyllicoricidin | Lipid | - | - | - |
| 8.11.14-Docosatriynoic acid | Lipid | - | - | - |
| 8.8-Dimethyl-2-phenyl-4H.8H-benzo1.2-b:3.4-bdipyran-4-one | Lipid | - | - | - |
| 8.9.10.11-Tetrafluoro-8E.10E-dodecadien-1-ol | Lipid | - | - | - |
| 8-apo-beta-carotenol | Lipid | - | - | - |
| 9.11alpha-epoxy-6alpha-acetoxy-cholest-7-en-3beta.5alpha.19-triol | Lipid | - | - | - |
| 9.11alpha-epoxypregn-4-ene-3.20-dione | Lipid | - | - | - |
| 9-deoxy-9-methylene-16.16-dimethyl -PGE2 | Lipid | - | - | - |
| 9-oxo-2E-decenoic acid | Lipid | - | - | - |
| 9S.10S.11R-trihydroxy-12Z-octadecenoic acid | Lipid | - | - | - |
| 9Z.11E.13-Tetradecatrienal | Lipid | - | - | - |
| 9Z.12Z.15Z.18Z-Tetracosatetraenoic acid | Lipid | - | - | - |
| A2M | RNA | Matrix Remodeling and Metastases Signaling Affecting Cellular Metabolism |
Chemokines | CNS Metabolic Diseases Immuno-Oncology Oncology |
| AADAT | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| AAMP | RNA | Angiogenesis | - | Cardiovascular Oncology |
| AANAT | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| ABAT | RNA | Transmitter Synthesis | Transmitter Release Vesicle Trafficking |
CNS |
| ABCA1 | RNA | - | - | - |
| ABCA8 | RNA | - | - | - |
| ABCB1 | RNA | - | - | - |
| ABCB11 | RNA | - | - | - |
| ABCC1 | RNA | - | - | - |
| ABCC3 | RNA | - | Immunity and Inflammation | Inflammation |
| ABCC4 | RNA | Androgen Signaling | - | Oncology |
| ABCC8 | RNA | - | Immunity and Inflammation | Inflammation |
| ABCF1 | RNA | - | - | - |
| ABCG2 | RNA | - | - | - |
| ABI1 | - | VEGFR Signaling | - | Cardiovascular Oncology |
| ABI3BP | RNA | - | - | - |
| ABL1 | RNA | Biosynthesis and Anabolic Pathways Cell Stress Oxydative Stress RAS |
- | CNS Inflammation Oncology Metabolic Diseases |
| ACAA1 | RNA | Lipid Metabolism | - | Metabolic Diseases |
| ACAA2 | RNA | Biosynthesis and Anabolic Pathways Nutrient Capture and Catabolic Pathways |
- | CNS Metabolic Diseases |
| ACACA | RNA | Biosynthesis and Anabolic Pathways Signaling Affecting Cellular Metabolism |
- | CNS Metabolic Diseases |
| ACACB | RNA | Biosynthesis and Anabolic Pathways Signaling Affecting Cellular Metabolism |
- | CNS Metabolic Diseases |
| ACAD10 | RNA | - | - | - |
| ACAD9 | RNA | - | - | - |
| ACADL | RNA | Nutrient Capture and Catabolic Pathways | - | Metabolic Diseases |
| ACADVL | RNA | - | - | - |
| ACAP2 | RNA | Nutrient Capture and Catabolic Pathways | - | Metabolic Diseases |
| ACAT1 | RNA | Biosynthesis and Anabolic Pathways Nutrient Capture and Catabolic Pathways |
- | CNS Metabolic Diseases |
| ACAT2 | RNA | Biosynthesis and Anabolic Pathways Nutrient Capture and Catabolic Pathways |
- | CNS Metabolic Diseases |
| ACE | RNA | - | - | - |
| Acetylcholine | Neuropeptide & Neurotransmitter | - | - | - |
| ACHE | RNA | Cell Proliferation Lipid Metabolism Transmitter Synthesis |
Neural Connectivity Transmitter Release Vesicle Trafficking |
CNS Metabolic Diseases Oncology |
| ACIN1 | RNA | - | - | - |
| ACKR2 | RNA | - | - | - |
| ACKR3 | RNA | - | - | - |
| ACKR4 | RNA | - | - | - |
| ACMSD | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| ACOT1/2 | RNA | - | - | - |
| ACOT12 | RNA | Lipid Metabolism Nutrient Capture and Catabolic Pathways |
- | Metabolic Diseases |
| ACOT2 | RNA | - | - | - |
| ACOX1 | RNA | Nutrient Capture and Catabolic Pathways | - | Metabolic Diseases |
| ACOX2 | RNA | - | - | - |
| ACP5 | RNA | - | - | - |
| ACSF2 | RNA | - | - | - |
| ACSF3 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| ACSL1 | RNA | - | - | - |
| ACSL3 | RNA | Androgen Signaling mTOR Signaling |
- | Oncology |
| ACSL4 | RNA | - | - | - |
| ACSL5 | RNA | - | - | - |
| ACSL6 | RNA | - | - | - |
| ACSM3 | RNA | - | - | - |
| ACTA2 | RNA | - | - | - |
| ACTB | RNA | - | - | - |
| ACTG2 | RNA | - | - | - |
| ACTN1 | RNA | - | Neuronal Cytoskeleton | CNS |
| ACTR1A | RNA | - | - | - |
| ACTR1B | RNA | - | - | - |
| ACTR3B | RNA | - | - | - |
| ACVR1 | RNA | Cellular Differentiation | Cellular Growth Factor | Oncology |
| ACVR1B | RNA | TGF Beta Signaling | - | Oncology |
| ACVR1C | RNA | Proliferation TGF Beta Signaling |
Cellular Growth Factor | Oncology |
| ACVR2A | RNA | - | - | - |
| ACVRL1 | RNA | Angiogenesis Cell Proliferation Proliferation TGF Beta Signaling |
Axon and Dendrite Structure Cellular Growth Factor |
Cardiovascular CNS Oncology |
| ACY1 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| Acylcarnitine C18:0 | Lipid | - | - | - |
| ADA | RNA | Biosynthesis and Anabolic Pathways Nutrient Capture and Catabolic Pathways |
B Cell Function | CNS Metabolic Diseases Immuno-Oncology |
| ADA2 | RNA | - | - | - |
| ADAL | RNA | Nutrient Capture and Catabolic Pathways | - | Metabolic Diseases |
| ADAM10 | Protein | Amyloid Processing | AD Pathology Neural Connectivity |
CNS |
| ADAM10 | RNA | Amyloid Processing | AD Pathology Neural Connectivity |
CNS |
| ADAM12 | RNA | - | - | - |
| ADAM15 | RNA | Angiogenesis Cellular Differentiation Matrix Remodeling and Metastases |
- | Cardiovascular Oncology CNS |
| ADAM17 | RNA | Cell Proliferation Matrix Remodeling and Metastases |
Cellular Growth Factor | CNS Oncology |
| ADAM28 | RNA | Matrix Remodeling and Metastases | - | CNS Oncology |
| ADAM8 | RNA | Angiogenesis Cellular Differentiation Matrix Remodeling and Metastases |
- | Cardiovascular Oncology CNS |
| ADAM9 | RNA | Matrix Remodeling and Metastases | Cellular Growth Factor | CNS Oncology |
| ADAMTS1 | RNA | Cell Proliferation Cellular Differentiation Matrix Remodeling and Metastases |
- | CNS Oncology |
| ADAMTS12 | RNA | Matrix Remodeling and Metastases | - | CNS Oncology |
| ADAMTS16 | RNA | - | Immunity and Inflammation | Inflammation |
| ADAMTS8 | RNA | Cell Proliferation Matrix Remodeling and Metastases |
- | CNS Oncology |
| ADAP1 | RNA | - | - | - |
| ADAR | RNA | - | - | - |
| ADCY5 | RNA | - | Transmitter Release Transmitter Response and Reuptake |
CNS |
| ADCY7 | RNA | Adenosine Pathway | - | Immuno-Oncology |
| ADCY8 | RNA | - | Activated Microglia Transmitter Release Transmitter Response and Reuptake |
CNS |
| ADCY9 | RNA | ER Signaling | Axon and Dendrite Structure Transmitter Release Transmitter Response and Reuptake |
Oncology CNS |
| ADCYAP1 | RNA | Transmitter Synthesis | Axon and Dendrite Structure Neural Connectivity Vesicle Trafficking |
CNS |
| ADD1 | RNA | Cellular Differentiation ER Signaling |
- | Oncology |
| Adenosine | Amino-acid & Metabolites | - | - | - |
| ADGRE1 | RNA | - | - | - |
| ADGRE5 | RNA | - | - | - |
| ADGRG3 | RNA | - | - | - |
| ADH1A | RNA | Biosynthesis and Anabolic Pathways Lipid Metabolism Nutrient Capture and Catabolic Pathways |
- | CNS Metabolic Diseases |
| ADH1A/B/C | RNA | - | - | - |
| ADH1B | RNA | Biosynthesis and Anabolic Pathways Nutrient Capture and Catabolic Pathways |
- | CNS Metabolic Diseases |
| ADH1C | RNA | Biosynthesis and Anabolic Pathways Nutrient Capture and Catabolic Pathways |
- | CNS Metabolic Diseases |
| ADH4 | RNA | Biosynthesis and Anabolic Pathways Nutrient Capture and Catabolic Pathways |
- | CNS Metabolic Diseases |
| ADH6 | RNA | Biosynthesis and Anabolic Pathways Nutrient Capture and Catabolic Pathways |
- | CNS Metabolic Diseases |
| ADH7 | RNA | Biosynthesis and Anabolic Pathways Nutrient Capture and Catabolic Pathways |
- | CNS Metabolic Diseases |
| ADIPOQ | RNA | - | - | - |
| ADIPOR1 | RNA | - | - | - |
| ADK | RNA | Biosynthesis and Anabolic Pathways Nutrient Capture and Catabolic Pathways |
- | CNS Metabolic Diseases |
| ADM | RNA | DNA Damage Repair HIF1 Signaling |
- | Epigenic and Nuclear Signaling Inflammation Oncology |
| ADM2 | RNA | Angiogenesis | - | Cardiovascular Oncology |
| ADORA1 | RNA | - | Axon and Dendrite Structure Neural Connectivity Transmitter Response and Reuptake Vesicle Trafficking |
CNS |
| ADORA2A | RNA | Costimulatory Signaling Signaling Affecting Cellular Metabolism |
Immune Checkpoint Immune Suppression T Cell Costimulation Transmitter Release Transmitter Response and Reuptake |
Immuno-Oncology Metabolic Diseases CNS |
| ADORA2B | RNA | - | Immune Suppression | Immuno-Oncology |
| ADP | Amino-acid & Metabolites | - | - | - |
| ADPGK | RNA | - | - | - |
| ADRA2A | RNA | - | Activated Microglia Immunity and Inflammation Neural Connectivity Transmitter Response and Reuptake |
CNS Inflammation |
| ADRA2B | RNA | Angiogenesis Vasculogenesis |
Cellular Growth Factor | Cardiovascular Oncology |
| ADRB2 | RNA | - | Axon and Dendrite Structure Neural Connectivity Transmitter Release Transmitter Response and Reuptake Vesicle Trafficking |
CNS |
| Adrenic acid | Lipid | - | - | - |
| AEBP1 | RNA | Cellular Differentiation | - | Oncology |
| AFDN | RNA | - | - | - |
| AFMID | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| Agavegenin A | Lipid | - | - | - |
| AGER | RNA | Oxydative Stress | Axon and Dendrite Structure | Inflammation CNS |
| AGGF1 | RNA | Angiogenesis Cell Proliferation Cellular Differentiation Vasculogenesis |
- | Cardiovascular CNS Oncology |
| AGK | RNA | - | - | - |
| AGO2 | RNA | Epigenic and Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| AGO4 | RNA | Epigenic and Transcriptional Regulation | Immunity and Inflammation | Epigenic and Nuclear Signaling Inflammation |
| AGR2 | RNA | EMT | - | Oncology |
| AGRN | RNA | - | - | - |
| AGT | RNA | Proliferation Vasculogenesis |
Cellular Growth Factor | Oncology Cardiovascular |
| AGTR1 | RNA | - | - | - |
| AGXT | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| AGXT2 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| AHNAK | RNA | - | - | - |
| AHR | RNA | - | Immune Suppression | Immuno-Oncology |
| AICDA | RNA | - | - | - |
| AIF1 | RNA | Oxydative Stress | - | Inflammation |
| AIFM1 | RNA | - | Immune Activation Status | Immuno-Oncology |
| AIM2 | RNA | - | - | - |
| AIMP2 | RNA | Myc | - | Oncology |
| AIRE | RNA | - | - | - |
| AK1 | RNA | - | Immunity and Inflammation | Inflammation |
| AK3 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| AK4 | RNA | - | - | - |
| AKAP1 | RNA | - | - | - |
| AKAP12 | RNA | - | - | - |
| AKAP2 | RNA | - | - | - |
| AKR1B10 | RNA | Adenosine Pathway | - | Immuno-Oncology |
| AKR1C4 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| AKT1 | RNA | Apoptosis Autophagy Biosynthesis and Anabolic Pathways Carbohydrate Metabolism Cell Proliferation Cell Stress Cellular Differentiation Costimulatory Signaling Cytokine and Chemokine Signaling ERBB2 Signaling Hypoxia JAK-STAT MAPK Metabolism Stress Myelination Nutrient Capture and Catabolic Pathways Oxydative Stress PI3K-AKT RAS Signaling Affecting Cellular Metabolism |
Immune Activation Status Immunity and Inflammation Neural Connectivity Transmitter Release Transmitter Response and Reuptake Vesicle Trafficking |
Oncology Cardiovascular CNS Immuno-Oncology Metabolic Diseases Inflammation Oncology |
| AKT1S1 | RNA | Carbohydrate Metabolism mTOR Signaling Nutrient Capture and Catabolic Pathways Signaling Affecting Cellular Metabolism |
- | CNS Oncology Metabolic Diseases |
| AKT2 | RNA | Biosynthesis and Anabolic Pathways Carbohydrate Metabolism ERBB2 Signaling Myelination Nutrient Capture and Catabolic Pathways RAS Signaling Affecting Cellular Metabolism |
Immune Activation Status Immunity and Inflammation Transmitter Release Transmitter Response and Reuptake |
CNS Oncology Metabolic Diseases Immuno-Oncology Inflammation |
| AKT3 | RNA | Biosynthesis and Anabolic Pathways Carbohydrate Metabolism EMT ERBB2 Signaling JAK-STAT MAPK Nutrient Capture and Catabolic Pathways PI3K-AKT RAS Signaling Affecting Cellular Metabolism |
Immune Activation Status Transmitter Release Transmitter Response and Reuptake |
CNS Oncology Cardiovascular Metabolic Diseases Immuno-Oncology Inflammation Oncology |
| ALAD | RNA | - | - | - |
| Alanine | Amino-acid & Metabolites | - | - | - |
| ALAS1 | RNA | - | - | - |
| ALAS2 | RNA | - | - | - |
| ALB | RNA | - | - | - |
| ALCAM | RNA | - | - | - |
| ALDH1A1 | RNA | - | Immune Suppression | Immuno-Oncology |
| ALDH1A3 | RNA | Androgen Signaling | Immune Suppression | Oncology Immuno-Oncology |
| ALDH1B1 | RNA | - | - | - |
| ALDH1L1 | RNA | - | - | - |
| ALDH1L2 | RNA | - | - | - |
| ALDH2 | RNA | Biosynthesis and Anabolic Pathways Nutrient Capture and Catabolic Pathways |
- | CNS Metabolic Diseases |
| ALDH3A1 | RNA | - | - | - |
| ALDH3A2 | RNA | - | - | - |
| ALDH3B2 | RNA | - | - | - |
| ALDH7A1 | RNA | - | - | - |
| ALDH8A1 | RNA | - | - | - |
| ALDH9A1 | RNA | - | - | - |
| ALDOA | RNA | Biosynthesis and Anabolic Pathways Cellular Differentiation HIF1 Signaling Hypoxia mTOR Signaling Tumor Metabolism |
- | CNS Oncology Inflammation Cardiovascular Metabolic Diseases |
| ALDOB | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| ALDOC | RNA | - | - | - |
| algestone | Lipid | - | - | - |
| alhpa-tocopheronolactone | Lipid | - | - | - |
| ALK | RNA | - | - | - |
| ALKBH2 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| ALKBH3 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| ALOX12 | RNA | Biosynthesis and Anabolic Pathways Signaling Affecting Cellular Metabolism |
- | CNS Metabolic Diseases |
| ALOX15 | RNA | Biosynthesis and Anabolic Pathways Signaling Affecting Cellular Metabolism |
- | CNS Metabolic Diseases |
| ALOX5 | RNA | Biosynthesis and Anabolic Pathways Signaling Affecting Cellular Metabolism |
Immune Activation Status | CNS Metabolic Diseases Immuno-Oncology |
| ALOX5AP | RNA | - | - | - |
| Alpha-synuclein | Protein | - | PD Pathology | CNS |
| ALPK1 | RNA | - | - | - |
| ALPL | RNA | - | - | - |
| Amaronol B | Lipid | - | - | - |
| AMBP | RNA | - | - | - |
| AMBRA1 | RNA | - | - | - |
| AMDHD1 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| AMER1 | RNA | - | - | - |
| AMH | RNA | - | Cellular Growth Factor | Oncology |
| AMICA1 | RNA | - | - | - |
| AMIGO1 | RNA | Myelination | Activated Microglia Axon and Dendrite Structure |
CNS |
| AMIGO2 | RNA | - | - | - |
| AMMECR1L | RNA | - | - | - |
| AMOTL1 | RNA | - | - | - |
| AMOTL2 | RNA | Hippo Signaling | - | CNS Oncology |
| AMP | Amino-acid & Metabolites | - | - | - |
| AMPc | Amino-acid & Metabolites | - | - | - |
| AMPD1 | RNA | Biosynthesis and Anabolic Pathways Nutrient Capture and Catabolic Pathways |
- | CNS Metabolic Diseases |
| AMPD2 | RNA | Biosynthesis and Anabolic Pathways Nutrient Capture and Catabolic Pathways |
- | CNS Metabolic Diseases |
| AMPD3 | RNA | Biosynthesis and Anabolic Pathways Nutrient Capture and Catabolic Pathways |
- | CNS Metabolic Diseases |
| AMPH | RNA | - | Neural Connectivity Vesicle Trafficking |
CNS |
| Amyloid Precursor Protein | Protein | - | AD Pathology | CNS |
| Amyloid-Beta 1-40 | Protein | - | AD Pathology | CNS |
| Amyloid-Beta 1-42 | Protein | - | AD Pathology | CNS |
| Anandamide (20:l. n-9) | Lipid | - | - | - |
| ANAPC1 | RNA | - | - | - |
| ANAPC10 | RNA | - | - | - |
| ANAPC15 | RNA | - | - | - |
| ANAPC4 | RNA | - | Immune Activation Status | Immuno-Oncology |
| ANAPC7 | RNA | - | - | - |
| Anastatin A | Lipid | - | - | - |
| ANG | RNA | Angiogenesis Cell Proliferation |
- | Cardiovascular CNS Oncology |
| ANGPT1 | RNA | Angiogenesis Hypoxia MAPK PI3K-AKT RAS Vasculogenesis |
Adhesion and Migration Immune Activation Status Myeloid Compartment |
Cardiovascular Oncology CNS Immuno-Oncology |
| ANGPT2 | RNA | Angiogenesis HIF1 Signaling Hypoxia MAPK PI3K-AKT |
- | Cardiovascular Inflammation Oncology CNS |
| ANGPTL2 | RNA | - | - | - |
| ANGPTL4 | RNA | Angiogenesis | - | Cardiovascular Oncology |
| Anguvetin | Lipid | - | - | - |
| ANKRD28 | RNA | - | - | - |
| ANLN | RNA | Apoptosis DNA Damage Repair Proliferation |
Adhesion and Migration | Oncology Epigenic and Nuclear Signaling CNS |
| ANP32B | RNA | - | - | - |
| ANPEP | RNA | Angiogenesis | - | Cardiovascular Oncology |
| ANXA1 | RNA | - | - | - |
| ANXA2P2 | RNA | Angiogenesis Cellular Differentiation |
- | Cardiovascular Oncology |
| ANXA9 | RNA | ER Signaling | - | Oncology |
| AOC1 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| AOC3 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| AOX1 | RNA | Biosynthesis and Anabolic Pathways Signaling Affecting Cellular Metabolism |
- | CNS Metabolic Diseases |
| AP1B1 | RNA | - | - | - |
| AP1G1 | RNA | - | - | - |
| AP1M1 | RNA | - | - | - |
| AP1M2 | RNA | - | - | - |
| AP1S1 | RNA | - | Axon and Dendrite Structure Neural Connectivity |
CNS |
| AP1S2 | RNA | - | - | - |
| AP2A1 | RNA | - | - | - |
| AP2A2 | RNA | Transmitter Synthesis | - | CNS |
| AP2B1 | RNA | Transmitter Synthesis | - | CNS |
| AP2M1 | RNA | - | - | - |
| AP2S1 | RNA | Nutrient Capture and Catabolic Pathways Signaling Affecting Cellular Metabolism |
- | Metabolic Diseases |
| AP3M2 | RNA | - | Activated Microglia Axon and Dendrite Structure |
CNS |
| AP3S1 | RNA | - | Axon and Dendrite Structure | CNS |
| AP4S1 | RNA | - | - | - |
| APAF1 | RNA | - | - | - |
| APBB1IP | RNA | - | - | - |
| APC | RNA | Apoptosis Cell Proliferation Wnt Signaling |
Axon and Dendrite Structure Neural Connectivity |
Oncology CNS |
| APCS | RNA | - | - | - |
| APEX1 | RNA | - | - | - |
| APH1A | RNA | - | Immune Suppression | Immuno-Oncology |
| APH1B | RNA | DNA Damage Repair Notch |
- | Epigenic and Nuclear Signaling Immuno-Oncology |
| API5 | RNA | - | - | - |
| Apigenin 7-glucuronide-4-(6-malonylglucoside) | Lipid | - | - | - |
| APLNR | RNA | - | - | - |
| APLP2 | RNA | - | - | - |
| APOA1 | RNA | Adenosine Pathway Biosynthesis and Anabolic Pathways |
- | Immuno-Oncology CNS Metabolic Diseases |
| APOA2 | RNA | Adenosine Pathway Biosynthesis and Anabolic Pathways |
- | Immuno-Oncology CNS Metabolic Diseases |
| APOA4 | RNA | Adenosine Pathway Biosynthesis and Anabolic Pathways |
- | Immuno-Oncology CNS Metabolic Diseases |
| ApoA-I | Protein | - | PD Pathology | CNS |
| APOB | RNA | Adenosine Pathway Biosynthesis and Anabolic Pathways Nutrient Capture and Catabolic Pathways Signaling Affecting Cellular Metabolism |
Immune Activation Status | Immuno-Oncology CNS Metabolic Diseases |
| APOBEC3G | RNA | - | - | - |
| APOC2 | RNA | Adenosine Pathway Biosynthesis and Anabolic Pathways |
- | Immuno-Oncology CNS Metabolic Diseases |
| APOC3 | RNA | Adenosine Pathway Biosynthesis and Anabolic Pathways |
- | Immuno-Oncology CNS Metabolic Diseases |
| APOD | RNA | Angiogenesis Cell Proliferation Proliferation |
Adhesion and Migration Cellular Growth Factor |
Cardiovascular CNS Oncology |
| APOE | Protein | Biosynthesis and Anabolic Pathways Cell Proliferation Cell Stress Oxydative Stress Tumor Metabolism |
Activated Microglia AD Pathology Axon and Dendrite Structure Immunity and Inflammation Vesicle Trafficking |
CNS Inflammation Oncology Metabolic Diseases |
| APOE | RNA | Biosynthesis and Anabolic Pathways Cell Proliferation Cell Stress Oxydative Stress Tumor Metabolism |
Activated Microglia AD Pathology Axon and Dendrite Structure Immunity and Inflammation Vesicle Trafficking |
CNS Inflammation Oncology Metabolic Diseases |
| APOH | RNA | Cell Proliferation Cellular Differentiation |
- | CNS Oncology |
| APOL6 | RNA | - | - | - |
| APOM | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| APP | RNA | Adenosine Pathway Oxydative Stress |
Axon and Dendrite Structure Neural Connectivity Transmitter Release |
Immuno-Oncology Inflammation CNS |
| APRT | RNA | Biosynthesis and Anabolic Pathways Nutrient Capture and Catabolic Pathways |
- | CNS Metabolic Diseases |
| AQP1 | RNA | - | - | - |
| AQP4 | RNA | - | - | - |
| AQP7 | RNA | - | - | - |
| AQP8 | RNA | - | - | - |
| AQP9 | RNA | Metabolism Stress | - | Metabolic Diseases |
| AR | RNA | Androgen Signaling Transcriptional Regulation |
- | Oncology Epigenic and Nuclear Signaling |
| ARAF | RNA | - | - | - |
| ARAP2 | RNA | - | - | - |
| ARC | RNA | - | Axon and Dendrite Structure Neural Connectivity Vesicle Trafficking |
CNS |
| AREG | RNA | Cell Proliferation EMT Proliferation |
Cellular Growth Factor Myeloid Compartment |
CNS Oncology |
| ARF1 | RNA | - | - | - |
| ARF5 | RNA | Nutrient Capture and Catabolic Pathways | - | Metabolic Diseases |
| ARG1 | Protein | Biosynthesis and Anabolic Pathways | Immune Suppression Myeloid Compartment |
CNS Immuno-Oncology Metabolic Diseases |
| ARG1 | RNA | Biosynthesis and Anabolic Pathways | Immune Suppression Myeloid Compartment |
CNS Immuno-Oncology Metabolic Diseases |
| ARG2 | RNA | - | - | - |
| Arginine | Amino-acid & Metabolites | - | - | - |
| ARHGAP24 | RNA | - | Immunity and Inflammation | Inflammation |
| ARHGAP32 | RNA | - | - | - |
| ARHGAP35 | RNA | - | - | - |
| ARHGAP44 | RNA | - | Axon and Dendrite Structure Neural Connectivity |
CNS |
| ARHGDIB | RNA | - | - | - |
| ARHGEF1 | RNA | - | - | - |
| ARHGEF10 | RNA | Myelination | - | CNS |
| ARHGEF2 | RNA | Adenosine Pathway | - | Immuno-Oncology |
| ARHGEF6 | RNA | Adenosine Pathway | - | Immuno-Oncology |
| ARID1A | RNA | Androgen Signaling Chromatin Modification Epigenic and Transcriptional Regulation Transcriptional Regulation |
- | Oncology Epigenic and Nuclear Signaling |
| ARID1B | RNA | Epigenic and Transcriptional Regulation Transcriptional Regulation |
- | Epigenic and Nuclear Signaling |
| ARID2 | RNA | Epigenic and Transcriptional Regulation Transcriptional Regulation |
- | Epigenic and Nuclear Signaling |
| ARID4A | RNA | Epigenic and Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| ARID4B | RNA | Epigenic and Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| ARNT | RNA | - | - | - |
| ARNT2 | RNA | Transcriptional Misregulation | - | Epigenic and Nuclear Signaling |
| ARPC4 | RNA | Nutrient Capture and Catabolic Pathways | - | Metabolic Diseases |
| ARRB1 | RNA | Adenosine Pathway | - | Immuno-Oncology |
| ARRB2 | RNA | - | Activated Microglia Axon and Dendrite Structure Neural Connectivity Transmitter Release Vesicle Trafficking |
CNS |
| ARSA | RNA | Lipid Metabolism | - | Metabolic Diseases |
| ASB2 | RNA | - | Immunity and Inflammation | Inflammation |
| ASB4 | RNA | - | Antigen Presentation Immune Activation Status |
Immuno-Oncology |
| ASCL1 | RNA | Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| ASH1L | RNA | Biosynthesis and Anabolic Pathways Epigenic and Transcriptional Regulation Transcriptional Regulation |
- | CNS Epigenic and Nuclear Signaling Metabolic Diseases |
| ASH2L | RNA | - | - | - |
| ASL | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| ASMT | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| ASNS | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| ASPA | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| Asparagine | Amino-acid & Metabolites | - | - | - |
| Aspartate | Amino-acid & Metabolites | - | - | - |
| Aspartate | Neuropeptide & Neurotransmitter | - | - | - |
| ASPG | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| ASPH | RNA | - | Immunity and Inflammation | Inflammation |
| ASPM | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| ASPN | RNA | EMT Proliferation |
Cellular Growth Factor | Oncology |
| ASS1 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| ASXL1 | RNA | - | - | - |
| ASXL2 | RNA | Epigenic and Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| ATAD2 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| ATCAY | RNA | - | Axon and Dendrite Structure Neural Connectivity |
CNS |
| ATF1 | RNA | - | - | - |
| ATF2 | RNA | Epigenic and Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| ATF3 | RNA | - | Antigen Presentation Immunity and Inflammation |
Immuno-Oncology Inflammation |
| ATF4 | RNA | AP1 Signaling Epigenic and Transcriptional Regulation Oxydative Stress Signaling Affecting Cellular Metabolism Transcriptional Regulation |
Immune Activation Status Transmitter Release Transmitter Response and Reuptake |
Cardiovascular Epigenic and Nuclear Signaling Inflammation Metabolic Diseases Immuno-Oncology CNS Oncology |
| ATF6 | RNA | - | - | - |
| ATF7 | RNA | Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| ATF7IP | RNA | Epigenic and Transcriptional Regulation Transcriptional Regulation |
- | Epigenic and Nuclear Signaling |
| ATG10 | RNA | - | - | - |
| ATG101 | RNA | Nutrient Capture and Catabolic Pathways | - | Metabolic Diseases |
| ATG12 | Protein | Autophagy | - | Cardiovascular CNS Inflammation Metabolic Diseases Oncology |
| ATG12 | RNA | Autophagy | - | Cardiovascular CNS Inflammation Metabolic Diseases Oncology |
| ATG13 | RNA | - | - | - |
| ATG14 | RNA | - | - | - |
| ATG16L1 | RNA | - | - | - |
| ATG2B | RNA | Nutrient Capture and Catabolic Pathways | - | Metabolic Diseases |
| ATG3 | RNA | - | - | - |
| ATG4A | RNA | - | - | - |
| ATG4B | RNA | - | - | - |
| ATG5 | RNA | - | Immunity and Inflammation | Inflammation |
| ATG5 | Protein | Autophagy | - | Cardiovascular CNS Inflammation Metabolic Diseases Oncology |
| ATG7 | RNA | - | Immunity and Inflammation | Inflammation |
| ATG9A | RNA | - | - | - |
| ATK1 | - | Cytokine and Chemokine Signaling | - | Immuno-Oncology |
| ATM | RNA | DNA Damage Repair Epigenic and Transcriptional Regulation Metabolism Stress Proliferation p53 Signaling Transcriptional Misregulation |
Immune Activation Status Immunity and Inflammation |
Epigenic and Nuclear Signaling Metabolic Diseases Oncology Immuno-Oncology Inflammation |
| ATOX1 | RNA | Cell Stress | - | CNS Oncology |
| ATP | Amino-acid & Metabolites | - | - | - |
| ATP10B | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| ATP11C | RNA | - | - | - |
| ATP13A2 | RNA | Oxydative Stress | - | Inflammation |
| ATP2A2 | RNA | - | - | - |
| ATP2B3 | RNA | - | Transmitter Release Transmitter Response and Reuptake |
CNS |
| ATP5F1D | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| ATP5ME | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| ATP5MF | RNA | - | - | - |
| ATP5MG | RNA | - | - | - |
| ATP5PD | RNA | - | - | - |
| ATP6AP2 | RNA | - | - | - |
| ATP6V0A1 | RNA | - | - | - |
| ATP6V0C | RNA | Transmitter Synthesis | - | CNS |
| ATP6V0D1 | RNA | Transmitter Synthesis | Neural Connectivity | CNS |
| ATP6V0E1 | RNA | Transmitter Synthesis | Activated Microglia Immunity and Inflammation |
CNS Inflammation |
| ATP6V0E2 | RNA | Transmitter Synthesis | - | CNS |
| ATP6V1A | RNA | Transmitter Synthesis | Activated Microglia Immunity and Inflammation |
CNS Inflammation |
| ATP6V1B2 | RNA | - | - | - |
| ATP6V1C2 | RNA | - | - | - |
| ATP6V1D | RNA | Transmitter Synthesis | - | CNS |
| ATP6V1E1 | RNA | Transmitter Synthesis | - | CNS |
| ATP6V1F | RNA | Biosynthesis and Anabolic Pathways Signaling Affecting Cellular Metabolism |
- | CNS Metabolic Diseases |
| ATP6V1G2 | RNA | Transmitter Synthesis | - | CNS |
| ATP6V1G3 | RNA | - | Immune Activation Status | Immuno-Oncology |
| ATP6V1H | RNA | Transmitter Synthesis | - | CNS |
| ATP7A | RNA | Oxydative Stress Transmitter Synthesis |
- | Inflammation CNS |
| ATP8A2 | RNA | - | Activated Microglia | CNS |
| ATPIF1 | RNA | Angiogenesis Cell Proliferation |
- | Cardiovascular CNS Oncology |
| ATR | RNA | p53 Signaling | Immune Activation Status | Oncology Immuno-Oncology |
| ATRN | RNA | Myelination Oxydative Stress |
- | CNS Inflammation |
| ATRX | RNA | - | - | - |
| ATXN2 | RNA | - | - | - |
| ATXN3 | RNA | - | Vesicle Trafficking | CNS |
| ATXN7 | RNA | Epigenic and Transcriptional Regulation Transcriptional Regulation |
- | Epigenic and Nuclear Signaling |
| AURKA | RNA | Cell Cycle DNA Damage Repair mTOR Signaling Proliferation |
- | Oncology Epigenic and Nuclear Signaling |
| AURKB | RNA | Cell Cycle DNA Damage Repair Proliferation |
- | Oncology Epigenic and Nuclear Signaling |
| AVP | RNA | - | Axon and Dendrite Structure | CNS |
| AXIN1 | RNA | Wnt Signaling | - | CNS Oncology |
| AXIN2 | RNA | Wnt Signaling | - | CNS Oncology |
| AXL | RNA | Hippo Signaling | Immunity and Inflammation | CNS Inflammation Oncology |
| B2M | RNA | Interferon Signaling | Antigen Presentation | Immuno-Oncology |
| B3GAT1 | RNA | - | - | - |
| B3GNT3 | RNA | EMT | - | Oncology |
| B3GNT5 | RNA | - | - | - |
| B4GALNT1 | RNA | - | - | - |
| B4GALT1 | RNA | Androgen Signaling | Immune Suppression | Oncology Immuno-Oncology |
| B4GALT6 | RNA | Lipid Metabolism | - | Metabolic Diseases |
| B7-H3 | Protein | - | Immune Checkpoint | Immuno-Oncology |
| BABAM1 | RNA | - | - | - |
| BACE1 | Protein | Amyloid Processing | AD Pathology Axon and Dendrite Structure |
CNS |
| BACE1 | RNA | Amyloid Processing | AD Pathology Axon and Dendrite Structure |
CNS |
| BAD | Protein | Apoptosis Autophagy MAPK Nutrient Capture and Catabolic Pathways Oxydative Stress PI3K-AKT Proliferation RAS Signaling Affecting Cellular Metabolism |
Cellular Growth Factor Immunity and Inflammation Transmitter Response and Reuptake |
Oncology Cardiovascular Metabolic Diseases Inflammation CNS Oncology |
| BAD | RNA | Apoptosis Autophagy MAPK Nutrient Capture and Catabolic Pathways Oxydative Stress PI3K-AKT Proliferation RAS Signaling Affecting Cellular Metabolism |
Cellular Growth Factor Immunity and Inflammation Transmitter Response and Reuptake |
Oncology Cardiovascular Metabolic Diseases Inflammation CNS Oncology |
| BAG1 | RNA | - | - | - |
| BAG2 | RNA | - | - | - |
| BAG3 | Protein | Autophagy | - | Cardiovascular CNS Inflammation Metabolic Diseases Oncology |
| BAG3 | RNA | Autophagy | - | Cardiovascular CNS Inflammation Metabolic Diseases Oncology |
| BAG4 | RNA | - | Immunity and Inflammation | Inflammation |
| BAGE | RNA | - | - | - |
| BAI1 | RNA | Cell Proliferation | - | CNS Oncology |
| BAI3 | RNA | - | - | - |
| BAIAP2L1 | RNA | - | Adhesion and Migration | CNS |
| BAIAP3 | RNA | Transcriptional Misregulation | - | Epigenic and Nuclear Signaling |
| BAK1 | RNA | - | Immune Activation Status | Immuno-Oncology |
| BAMBI | RNA | TGF Beta Signaling Wnt Signaling |
- | Oncology CNS |
| BANF1 | RNA | - | - | - |
| BAP1 | RNA | - | - | - |
| BARD1 | RNA | - | - | - |
| BATF | RNA | AP1 Signaling | Immune Activation Status | Cardiovascular Immuno-Oncology CNS Inflammation Metabolic Diseases Oncology |
| BATF3 | RNA | - | Antigen Presentation | Immuno-Oncology |
| BAX | RNA | Apoptosis Epigenic and Transcriptional Regulation |
Immune Activation Status | Oncology Epigenic and Nuclear Signaling Immuno-Oncology |
| BBC3 | RNA | Apoptosis Cytotoxicity |
- | Oncology |
| BBOX1 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| BBS1 | RNA | - | - | - |
| BCAP31 | RNA | - | - | - |
| BCAS1 | RNA | EMT | Neural Connectivity | Oncology CNS |
| BCAS2 | RNA | - | - | - |
| BCAT1 | RNA | - | - | - |
| BCHE | RNA | Carbohydrate Metabolism | Vesicle Trafficking | CNS Metabolic Diseases |
| BCL10 | RNA | TCR Signaling | Immunity and Inflammation | Immuno-Oncology Inflammation |
| BCL11A | RNA | - | - | - |
| BCL2 | RNA | Apoptosis Autophagy Cell Stress Hypoxia JAK-STAT Nutrient Capture and Catabolic Pathways Oxydative Stress PI3K-AKT Signaling Affecting Cellular Metabolism |
Activated Microglia Immune Activation Status Immunity and Inflammation Transmitter Release |
Oncology Cardiovascular CNS Metabolic Diseases Inflammation Immuno-Oncology Oncology |
| Bcl-2 | Protein | Apoptosis | Pan-Tumor | Oncology |
| BCL2A1 | RNA | Epigenic and Transcriptional Regulation Signaling Affecting Cellular Metabolism Transcriptional Misregulation |
Immunity and Inflammation | Epigenic and Nuclear Signaling Metabolic Diseases Inflammation |
| BCL2L1 | RNA | Apoptosis Autophagy Epigenic and Transcriptional Regulation JAK-STAT MAPK Nutrient Capture and Catabolic Pathways PI3K-AKT RAS Signaling Affecting Cellular Metabolism Transcriptional Misregulation |
Immune Activation Status Immunity and Inflammation Neural Connectivity |
Oncology Cardiovascular Epigenic and Nuclear Signaling CNS Metabolic Diseases Immuno-Oncology Inflammation Oncology |
| BCL2L11 | RNA | - | - | - |
| BCL2L2 | RNA | - | - | - |
| BCL3 | RNA | - | - | - |
| BCL6 | Protein | Apoptosis Epigenic and Transcriptional Regulation |
- | Oncology Epigenic and Nuclear Signaling |
| BCL6 | RNA | Apoptosis Epigenic and Transcriptional Regulation |
- | Oncology Epigenic and Nuclear Signaling |
| BCL6B | RNA | Angiogenesis Apoptosis |
- | Cardiovascular Oncology |
| BCLAF1 | RNA | - | - | - |
| BCLXL | Protein | Apoptosis | - | Oncology |
| BCOR | RNA | - | - | - |
| BCR | RNA | - | - | - |
| BDKRB1 | RNA | - | - | - |
| BDKRB2 | RNA | - | - | - |
| BDNF | RNA | MAPK | Transmitter Response and Reuptake | Cardiovascular CNS Oncology |
| BECN1 | RNA | - | Axon and Dendrite Structure | CNS |
| Beta-2-microglobulin | Protein | - | Antigen Presentation Immune Cell Typing |
Immuno-Oncology |
| BGN | RNA | - | - | - |
| BHLHE40 | RNA | mTOR Signaling | - | Oncology |
| BHMT | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| BHMT2 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| BICC1 | RNA | - | - | - |
| BID | RNA | Apoptosis | Immune Activation Status Immunity and Inflammation |
Oncology Immuno-Oncology Inflammation |
| BIK | RNA | - | - | - |
| BIM | Protein | Apoptosis | - | Oncology |
| BIN1 | RNA | - | Immunity and Inflammation | Inflammation |
| BIRC2 | RNA | - | Immunity and Inflammation | Inflammation |
| BIRC3 | RNA | Apoptosis Epigenic and Transcriptional Regulation NF-kappaB Signaling Signaling Affecting Cellular Metabolism |
Immunity and Inflammation | Oncology Epigenic and Nuclear Signaling CNS Metabolic Diseases Inflammation |
| BIRC5 | RNA | Apoptosis Hippo Signaling Proliferation |
- | Oncology CNS |
| BIRC7 | RNA | - | - | - |
| BLK | RNA | - | B Cell Function Immune Activation Status Immune Cell Typing Immunity and Inflammation Lymphoid Compartment |
Immuno-Oncology Inflammation |
| BLM | RNA | Apoptosis DNA Damage Repair Proliferation |
- | Oncology Epigenic and Nuclear Signaling |
| BLNK | RNA | - | Immunity and Inflammation | Inflammation |
| BLVRA | RNA | - | - | - |
| BMI1 | RNA | - | - | - |
| BMP10 | RNA | - | - | - |
| BMP2 | RNA | Hedgehog Matrix Remodeling and Metastases TGF Beta Signaling |
Immune Suppression | CNS Oncology Immuno-Oncology Inflammation |
| BMP4 | RNA | Cell Proliferation Hedgehog Proliferation TGF Beta Signaling |
Cellular Growth Factor | CNS Oncology Inflammation |
| BMP5 | RNA | Proliferation TGF Beta Signaling |
Cellular Growth Factor | Oncology |
| BMP6 | RNA | TGF Beta Signaling | - | Oncology |
| BMP7 | RNA | Cell Proliferation Cellular Differentiation EMT Proliferation TGF Beta Signaling |
Adhesion and Migration Cellular Growth Factor |
CNS Oncology |
| BMP8A | RNA | TGF Beta Signaling | - | Oncology |
| BMP8A/B | RNA | - | Immune Suppression | Immuno-Oncology |
| BMPER | RNA | Cell Proliferation | - | CNS Oncology |
| BMPR1A | RNA | Cell Proliferation Proliferation TGF Beta Signaling |
Cellular Growth Factor | CNS Oncology |
| BMPR1B | RNA | Proliferation TGF Beta Signaling |
Cellular Growth Factor | Oncology |
| BMPR2 | RNA | Cell Proliferation Proliferation TGF Beta Signaling |
Cellular Growth Factor | CNS Oncology |
| BNC2 | RNA | EMT | - | Oncology |
| BNIP3 | RNA | Autophagy Chromatin Modification Epigenic and Transcriptional Regulation Oxydative Stress |
Axon and Dendrite Structure Immunity and Inflammation |
Cardiovascular Epigenic and Nuclear Signaling Inflammation CNS Metabolic Diseases Oncology |
| BNIP3L | RNA | - | - | - |
| BOK | RNA | - | - | - |
| BOLA2 | RNA | - | Immunity and Inflammation | Inflammation |
| BORCS7 | RNA | ER Signaling | - | Oncology |
| BPI | RNA | - | Immune Activation Status | Immuno-Oncology |
| BRAF | Protein | FGFR Signaling MAPK Signaling Affecting Cellular Metabolism |
Immunity and Inflammation | Cardiovascular Metabolic Diseases Inflammation CNS Oncology |
| BRAF | RNA | FGFR Signaling MAPK Signaling Affecting Cellular Metabolism |
Immunity and Inflammation | Cardiovascular Metabolic Diseases Inflammation CNS Oncology |
| BRCA1 | RNA | Androgen Signaling Biosynthesis and Anabolic Pathways Cell Stress DNA Damage Repair PI3K-AKT Proliferation Signaling Affecting Cellular Metabolism |
- | Oncology CNS Epigenic and Nuclear Signaling Metabolic Diseases |
| BRCA2 | RNA | Biosynthesis and Anabolic Pathways Cell Stress DNA Damage Repair Proliferation |
- | CNS Epigenic and Nuclear Signaling Oncology Metabolic Diseases |
| BRCC3 | RNA | Biosynthesis and Anabolic Pathways Cell Stress |
- | CNS Oncology Metabolic Diseases |
| BRD2 | RNA | - | - | - |
| BRD3 | RNA | Epigenic and Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| BRD4 | RNA | Epigenic and Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| BRD7 | RNA | - | - | - |
| BRIP1 | RNA | Biosynthesis and Anabolic Pathways Cell Cycle Cell Stress DNA Damage Repair |
- | CNS Oncology Epigenic and Nuclear Signaling Metabolic Diseases |
| BRMS1 | RNA | Cell Proliferation Epigenic and Transcriptional Regulation |
- | CNS Epigenic and Nuclear Signaling Oncology |
| BRMS1L | RNA | - | - | - |
| BRPF3 | RNA | - | - | - |
| BRWD1 | RNA | - | Immune Activation Status | Immuno-Oncology |
| BST1 | RNA | - | - | - |
| BST2 | RNA | - | Immune Activation Status | Immuno-Oncology |
| BTBD6 | RNA | - | - | - |
| BTG1 | RNA | Cell Proliferation | Cellular Growth Factor | CNS Oncology |
| BTG2 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| BTK | RNA | Signaling Affecting Cellular Metabolism | Immune Activation Status Immunity and Inflammation |
Metabolic Diseases Immuno-Oncology Inflammation |
| BTLA | RNA | Costimulatory Signaling | Immune Checkpoint | Immuno-Oncology |
| BTRC | RNA | - | Antigen Presentation Immune Activation Status |
Immuno-Oncology |
| BUB1 | RNA | Biosynthesis and Anabolic Pathways Cell Cycle mTOR Signaling |
- | CNS Oncology Metabolic Diseases |
| BUB1B | RNA | Biosynthesis and Anabolic Pathways Cell Cycle |
- | CNS Oncology Metabolic Diseases |
| Butyl 4-O-butanoyl-6-O-hexadecanoyl-neohesperidoside | Lipid | - | - | - |
| BYSL | RNA | Myc | - | Oncology |
| C10orf76 | RNA | - | - | - |
| C14orf166 | RNA | - | - | - |
| C17 Sphinganine | Lipid | - | - | - |
| C19orf40 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| C1QA | RNA | - | Immunity and Inflammation | Inflammation |
| C1QB | RNA | - | Immunity and Inflammation | Inflammation |
| C1QBP | RNA | - | Chemokines | Immuno-Oncology |
| C1QC | RNA | - | Immunity and Inflammation | Inflammation |
| C1R | RNA | - | - | - |
| C1S | RNA | - | - | - |
| C2 | RNA | - | - | - |
| C3 | RNA | Adenosine Pathway Vasculogenesis |
Activated Microglia Cellular Growth Factor Immunity and Inflammation |
Immuno-Oncology Cardiovascular CNS Oncology Inflammation |
| C3AR1 | RNA | Adenosine Pathway Cellular Differentiation Vasculogenesis |
Cellular Growth Factor Immunity and Inflammation Inflammation |
Immuno-Oncology Oncology Cardiovascular Inflammation |
| C4A | RNA | - | - | - |
| C4A/B | RNA | - | - | - |
| C4B | Protein | - | Astrocyte Glial Cell Subtyping |
CNS |
| C4B | RNA | - | Astrocyte Glial Cell Subtyping |
CNS |
| C4BPA | RNA | - | - | - |
| C5 | RNA | Adenosine Pathway | - | Immuno-Oncology |
| C5AR1 | RNA | - | Immunity and Inflammation Myeloid Compartment |
Inflammation CNS |
| C5orf38 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| C6 | RNA | - | Immunity and Inflammation | Inflammation |
| C7 | RNA | - | - | - |
| C8A | RNA | - | - | - |
| C8B | RNA | - | - | - |
| C8G | RNA | - | - | - |
| C9 | RNA | - | - | - |
| C9orf72 | RNA | - | - | - |
| CA12 | RNA | Cell Stress | - | CNS Oncology |
| CA2 | RNA | - | Axon and Dendrite Structure Vesicle Trafficking |
CNS |
| CA9 | RNA | Cell Stress HIF1 Signaling |
- | CNS Inflammation Oncology |
| CAB39 | RNA | Carbohydrate Metabolism Signaling Affecting Cellular Metabolism |
- | CNS Metabolic Diseases |
| CABLES1 | RNA | - | - | - |
| CACNA1A | RNA | Signaling Affecting Cellular Metabolism Transmitter Synthesis |
Axon and Dendrite Structure Neural Connectivity Transmitter Release Transmitter Response and Reuptake Vesicle Trafficking |
Metabolic Diseases CNS |
| CACNA1B | RNA | Transmitter Synthesis | Axon and Dendrite Structure Neural Connectivity Transmitter Release Transmitter Response and Reuptake Vesicle Trafficking |
CNS |
| CACNA1C | RNA | - | Neural Connectivity Transmitter Release Transmitter Response and Reuptake |
CNS |
| CACNA1D | RNA | MAPK | Transmitter Release Transmitter Response and Reuptake |
Cardiovascular CNS Oncology |
| CACNA1E | RNA | Signaling Affecting Cellular Metabolism | - | Metabolic Diseases |
| CACNA1F | RNA | - | Transmitter Release Transmitter Response and Reuptake |
CNS |
| CACNA1G | RNA | - | - | - |
| CACNA1H | RNA | MAPK | - | Cardiovascular CNS Oncology |
| CACNA1S | RNA | - | Transmitter Release Transmitter Response and Reuptake |
CNS |
| CACNA2D1 | RNA | MAPK | - | Cardiovascular CNS Oncology |
| CACNA2D2 | RNA | - | - | - |
| CACNA2D3 | RNA | MAPK | - | Cardiovascular CNS Oncology |
| CACNA2D4 | RNA | - | - | - |
| CACNB2 | RNA | - | Immune Activation Status Transmitter Release Vesicle Trafficking |
Immuno-Oncology CNS |
| CACNB3 | RNA | - | - | - |
| CACNB4 | RNA | Signaling Affecting Cellular Metabolism | Immune Activation Status Neural Connectivity Transmitter Release Vesicle Trafficking |
Metabolic Diseases Immuno-Oncology CNS |
| CACNG1 | RNA | MAPK | - | Cardiovascular CNS Oncology |
| CACNG2 | RNA | Signaling Affecting Cellular Metabolism | - | Metabolic Diseases |
| CACNG3 | RNA | Signaling Affecting Cellular Metabolism | - | Metabolic Diseases |
| CACNG4 | RNA | MAPK | - | Cardiovascular CNS Oncology |
| CACNG6 | RNA | MAPK | - | Cardiovascular CNS Oncology |
| CACNG7 | RNA | Signaling Affecting Cellular Metabolism | - | Metabolic Diseases |
| CACYBP | RNA | mTOR Signaling | - | Oncology |
| CAD | RNA | Biosynthesis and Anabolic Pathways Signaling Affecting Cellular Metabolism |
- | CNS Metabolic Diseases |
| CADM1 | RNA | - | Cellular Growth Factor | Oncology |
| CADM3 | RNA | - | - | - |
| CADPS | RNA | - | Neural Connectivity Vesicle Trafficking |
CNS |
| CALB1 | RNA | - | Axon and Dendrite Structure Neural Connectivity Vesicle Trafficking |
CNS |
| CALB2 | RNA | - | Axon and Dendrite Structure Neural Connectivity |
CNS |
| Calbindin | Protein | - | PD Pathology | CNS |
| CALCOCO2 | RNA | - | - | - |
| CALCRL | RNA | Angiogenesis Cell Proliferation |
- | Cardiovascular CNS Oncology |
| CALD1 | RNA | - | - | - |
| CALM1 | RNA | Adenosine Pathway | Immune Activation Status Transmitter Release Transmitter Response and Reuptake Vesicle Trafficking |
Immuno-Oncology CNS |
| CALML3 | RNA | RAS | - | Oncology |
| CALML5 | RNA | MAPK RAS |
Transmitter Release Transmitter Response and Reuptake |
Cardiovascular Oncology CNS |
| CALML6 | RNA | RAS | - | Oncology |
| CALR | RNA | - | Immunity and Inflammation | Inflammation |
| CAMK2A | RNA | - | - | - |
| CAMK2B | RNA | Wnt Signaling | Axon and Dendrite Structure Neural Connectivity Transmitter Release Transmitter Response and Reuptake Vesicle Trafficking |
CNS Oncology |
| CAMK2D | RNA | Cellular Differentiation Epigenic and Transcriptional Regulation |
Axon and Dendrite Structure Cellular Growth Factor Immune Activation Status Neural Connectivity Transmitter Release Transmitter Response and Reuptake |
Oncology Epigenic and Nuclear Signaling CNS Immuno-Oncology |
| CAMK2G | RNA | - | Transmitter Release Transmitter Response and Reuptake |
CNS |
| CAMK4 | RNA | - | Transmitter Release Transmitter Response and Reuptake |
CNS |
| CAMP | RNA | - | - | - |
| CAP1 | RNA | - | - | - |
| CAPN1 | RNA | - | - | - |
| CAPN2 | RNA | - | - | - |
| CAPN5 | RNA | - | - | - |
| CARD10 | RNA | - | - | - |
| CARD11 | RNA | Signaling Affecting Cellular Metabolism TCR Signaling |
Immune Activation Status | Metabolic Diseases Immuno-Oncology |
| CARD16 | RNA | - | - | - |
| CARD17 | RNA | - | - | - |
| CARD8 | RNA | - | - | - |
| CARD9 | RNA | - | - | - |
| CASP1 | RNA | Apoptosis | Immunity and Inflammation | Oncology Inflammation |
| CASP10 | RNA | - | - | - |
| CASP12 | RNA | - | - | - |
| CASP2 | RNA | - | Immunity and Inflammation | Inflammation |
| CASP3 | RNA | Apoptosis ECM Remodeling Hippo Signaling MAPK Matrix Remodeling and Metastases Oxydative Stress |
Immune Activation Status Immunity and Inflammation Transmitter Release |
Oncology Metabolic Diseases CNS Cardiovascular Inflammation Immuno-Oncology |
| CASP4 | RNA | - | Immunity and Inflammation | Inflammation |
| CASP5 | RNA | - | - | - |
| CASP6 | RNA | - | - | - |
| CASP7 | RNA | - | Immunity and Inflammation | Inflammation |
| CASP8 | RNA | Angiogenesis Apoptosis Matrix Remodeling and Metastases |
Activated Microglia Immune Activation Status Immunity and Inflammation |
Cardiovascular Oncology CNS Immuno-Oncology Inflammation |
| CASP9 | RNA | Apoptosis PI3K-AKT |
Immune Activation Status Immunity and Inflammation |
Oncology Immuno-Oncology Inflammation |
| Caspase-3 cleaved | Protein | - | - | - |
| CASS4 | RNA | - | Immunity and Inflammation | Inflammation |
| CAST | RNA | - | - | - |
| CAT | RNA | Biosynthesis and Anabolic Pathways Cell Stress |
- | CNS Oncology Metabolic Diseases |
| Cauliflorin A | Lipid | - | - | - |
| CAV1 | RNA | Angiogenesis Cell Proliferation EMT |
Adhesion and Migration | Cardiovascular CNS Oncology |
| CBFB | RNA | - | - | - |
| CBL | RNA | Nutrient Capture and Catabolic Pathways Signaling Affecting Cellular Metabolism |
Immune Activation Status Immune Suppression |
Metabolic Diseases Immuno-Oncology |
| CBLB | RNA | - | Antigen Presentation Immune Activation Status |
Immuno-Oncology |
| CBLC | RNA | Cytotoxicity EMT JAK-STAT Proliferation |
Cellular Growth Factor | Oncology CNS Inflammation Metabolic Diseases Oncology |
| CBR4 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| CBX2 | RNA | Epigenic and Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| CC2D1B | RNA | - | - | - |
| CCBE1 | RNA | - | - | - |
| CCBP2 | RNA | - | - | - |
| CCDC80 | RNA | - | - | - |
| CCK | RNA | - | Axon and Dendrite Structure Neural Connectivity |
CNS |
| CCL1 | RNA | - | Chemokines | Immuno-Oncology |
| CCL11 | RNA | Cell Proliferation | Chemokines | CNS Immuno-Oncology Oncology |
| CCL13 | RNA | Cytokine and Chemokine Signaling Signaling Affecting Cellular Metabolism |
Chemokines Immune Activation Status Immune Cell Typing |
Immuno-Oncology Metabolic Diseases |
| CCL14 | RNA | Cytokine and Chemokine Signaling | Chemokines | Immuno-Oncology |
| CCL15 | RNA | - | Chemokines | Immuno-Oncology |
| CCL16 | RNA | - | Chemokines | Immuno-Oncology |
| CCL17 | RNA | - | Chemokines | Immuno-Oncology |
| CCL18 | RNA | Cytokine and Chemokine Signaling | Chemokines | Immuno-Oncology |
| CCL19 | RNA | Cytokine and Chemokine Signaling Signaling Affecting Cellular Metabolism |
Chemokines | Immuno-Oncology Metabolic Diseases |
| CCL2 | RNA | Cytokine and Chemokine Signaling | Axon and Dendrite Structure Chemokines Immune Activation Status Immune Suppression Immunity and Inflammation Myeloid Compartment Neural Connectivity Vesicle Trafficking |
Immuno-Oncology CNS Inflammation |
| CCL20 | RNA | Cytokine and Chemokine Signaling | Chemokines Immune Activation Status Immune Suppression Myeloid Compartment |
Immuno-Oncology CNS |
| CCL21 | RNA | Cellular Differentiation Cytokine and Chemokine Signaling |
Adhesion and Migration Chemokines Immune Activation Status |
Oncology Immuno-Oncology CNS |
| CCL22 | RNA | Cytokine and Chemokine Signaling | Chemokines Immune Activation Status Immune Suppression |
Immuno-Oncology |
| CCL23 | RNA | - | Chemokines | Immuno-Oncology |
| CCL24 | RNA | - | Chemokines | Immuno-Oncology |
| CCL25 | RNA | - | Chemokines | Immuno-Oncology |
| CCL26 | RNA | - | Chemokines | Immuno-Oncology |
| CCL27 | RNA | - | Chemokines | Immuno-Oncology |
| CCL28 | RNA | - | Chemokines | Immuno-Oncology |
| CCL3 | RNA | - | Chemokines Immunity and Inflammation |
Immuno-Oncology Inflammation |
| CCL3/L1 | RNA | Cytokine and Chemokine Signaling | Immune Activation Status Immune Suppression |
Immuno-Oncology |
| CCL3/L1/L3 | RNA | - | - | - |
| CCL3L1 | RNA | - | Cytokines | Immuno-Oncology |
| CCL4 | RNA | Cytokine and Chemokine Signaling Signaling Affecting Cellular Metabolism |
Antigen Presentation Chemokines Immunity and Inflammation Myeloid Compartment |
Immuno-Oncology Metabolic Diseases Inflammation CNS |
| CCL4/L1 | RNA | - | Immune Activation Status Immune Suppression |
Immuno-Oncology |
| CCL4/L1/L2 | RNA | - | - | - |
| CCL5 | RNA | Cytokine and Chemokine Signaling Oxydative Stress Signaling Affecting Cellular Metabolism |
Activated Microglia Adhesion and Migration Chemokines Cytokines Immune Activation Status Immune Suppression Immunity and Inflammation Myeloid Compartment |
Immuno-Oncology Inflammation Metabolic Diseases CNS |
| CCL7 | RNA | Cell Proliferation Cellular Differentiation Cytokine and Chemokine Signaling Matrix Remodeling and Metastases |
Chemokines Immunity and Inflammation |
CNS Oncology Immuno-Oncology Inflammation |
| CCL8 | RNA | Cytokine and Chemokine Signaling EMT |
Chemokines Myeloid Compartment |
Immuno-Oncology Oncology CNS |
| CCN2 | RNA | - | - | - |
| CCNA1 | RNA | Biosynthesis and Anabolic Pathways Cell Stress DNA Damage Repair Metabolism Stress Proliferation Signaling Affecting Cellular Metabolism Transcriptional Misregulation |
Immune Activation Status | CNS Epigenic and Nuclear Signaling Metabolic Diseases Oncology Immuno-Oncology |
| CCNA2 | RNA | Biosynthesis and Anabolic Pathways Cell Cycle Cell Stress DNA Damage Repair Myc Proliferation Signaling Affecting Cellular Metabolism |
- | CNS Oncology Epigenic and Nuclear Signaling Metabolic Diseases |
| CCNB1 | RNA | Cell Cycle DNA Damage Repair Epigenic and Transcriptional Regulation Proliferation |
Immune Activation Status | Oncology Epigenic and Nuclear Signaling Immuno-Oncology |
| CCNB2 | RNA | Biosynthesis and Anabolic Pathways Cell Cycle |
- | CNS Oncology Metabolic Diseases |
| CCNB3 | RNA | - | Immune Activation Status | Immuno-Oncology |
| CCNC | RNA | - | Immune Suppression | Immuno-Oncology |
| CCND1 | RNA | Biosynthesis and Anabolic Pathways Carbohydrate Metabolism Cell Cycle DNA Damage Repair Epigenic and Transcriptional Regulation JAK-STAT Notch PI3K-AKT Proliferation Signaling Affecting Cellular Metabolism Transcriptional Regulation Wnt Signaling |
- | CNS Oncology Epigenic and Nuclear Signaling Immuno-Oncology Metabolic Diseases Inflammation Oncology |
| CCND2 | RNA | Angiogenesis Cell Cycle JAK-STAT PI3K-AKT Proliferation Transcriptional Misregulation Wnt Signaling |
- | Cardiovascular Oncology CNS Epigenic and Nuclear Signaling Inflammation Metabolic Diseases Oncology |
| CCND3 | RNA | JAK-STAT PI3K-AKT Proliferation Wnt Signaling |
- | CNS Oncology Inflammation Metabolic Diseases Oncology |
| CCNE1 | RNA | Androgen Signaling Angiogenesis Cell Cycle DNA Damage Repair Metabolism Stress Myc PI3K-AKT Proliferation |
- | Oncology Cardiovascular Epigenic and Nuclear Signaling Metabolic Diseases |
| CCNE2 | RNA | Cell Cycle PI3K-AKT Proliferation |
- | Oncology |
| CCNF | RNA | Cell Cycle mTOR Signaling |
- | Oncology |
| CCNG2 | RNA | - | - | - |
| CCNH | RNA | - | - | - |
| CCNI | RNA | - | - | - |
| CCNK | RNA | Cell Cycle p53 Signaling |
- | Oncology |
| CCNO | RNA | DNA Damage Repair Proliferation |
- | Epigenic and Nuclear Signaling Oncology |
| CCNT1 | RNA | Cell Cycle Epigenic and Transcriptional Regulation |
Immune Suppression | Oncology Epigenic and Nuclear Signaling Immuno-Oncology |
| CCNT2 | RNA | - | Immune Suppression | Immuno-Oncology |
| CCR1 | RNA | - | Chemokines Cytokines Immune Activation Status Immune Suppression M1 Activation NK Cell Function |
Immuno-Oncology CNS |
| CCR10 | RNA | - | - | - |
| CCR2 | RNA | Cytokine and Chemokine Signaling Proliferation Vasculogenesis |
Activated Microglia Axon and Dendrite Structure Cellular Growth Factor Cytokines Immune Activation Status Immune Suppression Immunity and Inflammation |
Immuno-Oncology Oncology Cardiovascular CNS Inflammation |
| CCR3 | RNA | Cell Proliferation | Chemokines | CNS Immuno-Oncology Oncology |
| CCR4 | RNA | Cytokine and Chemokine Signaling | Chemokines Cytokines Lymphoid Compartment M2 Activation |
Immuno-Oncology CNS |
| CCR5 | RNA | Cytokine and Chemokine Signaling | Activated Microglia Antigen Presentation Cytokines Immune Activation Status Immune Suppression Immunity and Inflammation |
Immuno-Oncology CNS Inflammation |
| CCR6 | Protein | Cytokine and Chemokine Signaling | - | Immuno-Oncology |
| CCR6 | RNA | Cytokine and Chemokine Signaling | - | Immuno-Oncology |
| CCR7 | RNA | - | Chemokines Immune Activation Status M2 Activation |
Immuno-Oncology CNS |
| CCR8 | RNA | - | - | - |
| CCR9 | RNA | - | - | - |
| CCRL1 | RNA | - | - | - |
| CCRL2 | RNA | - | Chemokines | Immuno-Oncology |
| CCS | RNA | Oxydative Stress | - | Inflammation |
| CD10 | Protein | - | - | - |
| CD101 | RNA | - | Immune Activation Status | Immuno-Oncology |
| CD106 | Protein | - | - | - |
| CD109 | RNA | - | - | - |
| CD11b | Protein | - | Microglia Myeloid Compartment Neural Cell Typing |
CNS |
| CD11c | Protein | - | Glial Cell Subtyping Immune Cell Typing Myeloid Compartment |
CNS Immuno-Oncology |
| CD127 | Protein | - | Immune Activation Status | Immuno-Oncology |
| CD138 | Protein | - | - | - |
| CD14 | Protein | Apoptosis Epigenic and Transcriptional Regulation MAPK Signaling Affecting Cellular Metabolism |
Antigen Presentation Immune Activation Status Immune Cell Typing Immune Suppression Immunity and Inflammation Inflammation Myeloid Compartment |
Oncology Epigenic and Nuclear Signaling Cardiovascular Metabolic Diseases Immuno-Oncology Inflammation CNS |
| CD14 | RNA | Apoptosis Epigenic and Transcriptional Regulation MAPK Signaling Affecting Cellular Metabolism |
Antigen Presentation Immune Activation Status Immune Cell Typing Immune Suppression Immunity and Inflammation Inflammation Myeloid Compartment |
Oncology Epigenic and Nuclear Signaling Cardiovascular Metabolic Diseases Immuno-Oncology Inflammation CNS |
| CD16 | Protein | - | - | - |
| CD160 | RNA | - | Immune Activation Status | Immuno-Oncology |
| CD163 | Protein | EMT | Immune Cell Typing Immune Suppression Microglia Myeloid Compartment Neural Cell Typing |
Oncology Immuno-Oncology CNS |
| CD163 | RNA | EMT | Immune Cell Typing Immune Suppression Microglia Myeloid Compartment Neural Cell Typing |
Oncology Immuno-Oncology CNS |
| CD164 | RNA | - | - | - |
| CD177 | RNA | - | - | - |
| CD180 | RNA | Signaling Affecting Cellular Metabolism | Immune Activation Status | Metabolic Diseases Immuno-Oncology |
| CD19 | RNA | PI3K-AKT Signaling Affecting Cellular Metabolism |
B Cell Function Immune Activation Status Immune Cell Typing Immunity and Inflammation Lymphoid Compartment |
Oncology Metabolic Diseases Immuno-Oncology Inflammation |
| CD1A | RNA | - | - | - |
| CD1B | RNA | - | - | - |
| CD1C | RNA | - | Antigen Presentation Lymphoid Compartment |
Immuno-Oncology |
| CD1D | RNA | - | B Cell Function | Immuno-Oncology |
| CD1E | RNA | Antigen Processing | Antigen Presentation | Immuno-Oncology |
| CD2 | RNA | Costimulatory Signaling | Immune Cell Adhesion and Migration Lymphoid Compartment NK Cell Function |
Immuno-Oncology |
| CD20 | Protein | - | B Cell Function Immune Cell Typing |
Immuno-Oncology |
| CD200 | RNA | - | - | - |
| CD200R1 | RNA | - | Immune Checkpoint | Immuno-Oncology |
| CD204 | Protein | - | - | - |
| CD207 | RNA | - | - | - |
| CD209 | RNA | - | Immune Cell Typing Immune Suppression |
Immuno-Oncology |
| CD21 | Protein | - | - | - |
| CD22 | RNA | - | B Cell Exhaustion B Cell Function Immune Activation Status |
Immuno-Oncology |
| CD226 | RNA | - | Immune Activation Status | Immuno-Oncology |
| CD24 | Protein | Cell Proliferation EMT Proliferation |
Adhesion and Migration Cellular Growth Factor Immunity and Inflammation |
CNS Oncology Inflammation |
| CD24 | RNA | Cell Proliferation EMT Proliferation |
Adhesion and Migration Cellular Growth Factor Immunity and Inflammation |
CNS Oncology Inflammation |
| CD244 | RNA | - | Immune Activation Status Immune Cell Typing Immunity and Inflammation T Cell Exhaustion |
Immuno-Oncology Inflammation |
| CD247 | RNA | Costimulatory Signaling Signaling Affecting Cellular Metabolism TCR Signaling |
- | Immuno-Oncology Metabolic Diseases |
| CD25 | Protein | - | Immune Activation Status T Cell Activation |
Immuno-Oncology |
| CD27 | Protein | Costimulatory Signaling NF-kappaB Signaling Signaling Affecting Cellular Metabolism TNF Superfamily |
B Cell Exhaustion B Cell Function Immune Activation Status Immune Checkpoint Lymphoid Compartment T Cell Activation T Cell Costimulation |
Immuno-Oncology CNS Metabolic Diseases Oncology Inflammation |
| CD27 | RNA | Costimulatory Signaling NF-kappaB Signaling Signaling Affecting Cellular Metabolism TNF Superfamily |
B Cell Exhaustion B Cell Function Immune Activation Status Immune Checkpoint Lymphoid Compartment T Cell Activation T Cell Costimulation |
Immuno-Oncology CNS Metabolic Diseases Oncology Inflammation |
| CD274 | RNA | Costimulatory Signaling Signaling Affecting Cellular Metabolism |
B Cell Function Immune Cell Adhesion and Migration Immune Checkpoint Lymphoid Compartment T Cell Costimulation |
Immuno-Oncology Metabolic Diseases |
| CD276 | RNA | Signaling Affecting Cellular Metabolism | Immune Cell Adhesion and Migration Immune Checkpoint T Cell Costimulation |
Metabolic Diseases Immuno-Oncology |
| CD28 | RNA | Costimulatory Signaling Signaling Affecting Cellular Metabolism TCR Signaling |
Immune Activation Status Immune Cell Adhesion and Migration Immune Checkpoint Lymphoid Compartment T Cell Costimulation |
Immuno-Oncology Metabolic Diseases |
| CD2AP | RNA | - | - | - |
| CD3 | Protein | - | Immune Cell Typing | Immuno-Oncology |
| CD300A | RNA | Metabolism Stress | Inflammation | Metabolic Diseases Inflammation |
| CD300C | RNA | - | - | - |
| CD300E | RNA | - | - | - |
| CD300LF | RNA | - | Immunity and Inflammation | Inflammation |
| CD31 | Protein | - | Neural Cell Typing | CNS |
| CD33 | RNA | - | Activated Microglia Immune Activation Status Immune Suppression Immunity and Inflammation Inflammation |
CNS Immuno-Oncology Inflammation |
| CD34 | Protein | Cell Proliferation Vasculogenesis |
Adhesion and Migration Immune Cell Typing |
CNS Cardiovascular Immuno-Oncology Oncology |
| CD34 | RNA | Cell Proliferation Vasculogenesis |
Adhesion and Migration Immune Cell Typing |
CNS Cardiovascular Immuno-Oncology Oncology |
| CD36 | RNA | Matrix Remodeling and Metastases Signaling Affecting Cellular Metabolism |
Adhesion and Migration Antigen Presentation Immunity and Inflammation |
CNS Metabolic Diseases Immuno-Oncology Inflammation Oncology |
| CD37 | RNA | - | - | - |
| CD38 | Protein | - | B Cell Function Immune Suppression Lymphoid Compartment |
Immuno-Oncology |
| CD38 | RNA | - | B Cell Function Immune Suppression Lymphoid Compartment |
Immuno-Oncology |
| CD39 | Protein | - | Inflammation Microglia Myeloid Compartment Neural Cell Typing |
Inflammation CNS |
| CD3D | RNA | Costimulatory Signaling Nutrient Capture and Catabolic Pathways Signaling Affecting Cellular Metabolism TCR Signaling |
Immune Activation Status Immune Cell Typing Immune Checkpoint Immunity and Inflammation Lymphoid Compartment |
Immuno-Oncology Metabolic Diseases Inflammation |
| CD3E | RNA | Costimulatory Signaling Signaling Affecting Cellular Metabolism TCR Signaling |
B Cell Function Immune Activation Status Immune Cell Typing Immune Checkpoint Immunity and Inflammation Lymphoid Compartment |
Immuno-Oncology Metabolic Diseases Inflammation |
| CD3EAP | RNA | - | - | - |
| CD3G | RNA | Costimulatory Signaling Nutrient Capture and Catabolic Pathways Signaling Affecting Cellular Metabolism TCR Signaling |
Immune Activation Status Immune Cell Typing Immune Checkpoint Immunity and Inflammation Lymphoid Compartment |
Immuno-Oncology Metabolic Diseases Inflammation |
| CD4 | Protein | Costimulatory Signaling Nutrient Capture and Catabolic Pathways Signaling Affecting Cellular Metabolism TCR Signaling |
Antigen Presentation Immune Activation Status Immune Cell Adhesion and Migration Immune Cell Typing Immune Checkpoint Myeloid Compartment |
Immuno-Oncology Metabolic Diseases CNS |
| CD4 | RNA | Costimulatory Signaling Nutrient Capture and Catabolic Pathways Signaling Affecting Cellular Metabolism TCR Signaling |
Antigen Presentation Immune Activation Status Immune Cell Adhesion and Migration Immune Cell Typing Immune Checkpoint Myeloid Compartment |
Immuno-Oncology Metabolic Diseases CNS |
| CD40 | Protein | Costimulatory Signaling Epigenic and Transcriptional Regulation NF-kappaB Signaling |
Immune Activation Status Immune Cell Adhesion and Migration Immune Checkpoint Immunity and Inflammation Inflammation Lymphoid Compartment Microglia Myeloid Compartment Neural Cell Typing T Cell Costimulation |
Immuno-Oncology Epigenic and Nuclear Signaling CNS Inflammation Oncology |
| CD40 | RNA | Costimulatory Signaling Epigenic and Transcriptional Regulation NF-kappaB Signaling |
Immune Activation Status Immune Cell Adhesion and Migration Immune Checkpoint Immunity and Inflammation Inflammation Lymphoid Compartment Microglia Myeloid Compartment Neural Cell Typing T Cell Costimulation |
Immuno-Oncology Epigenic and Nuclear Signaling CNS Inflammation Oncology |
| CD40LG | RNA | Costimulatory Signaling NF-kappaB Signaling Signaling Affecting Cellular Metabolism TCR Signaling |
Immune Activation Status Immune Cell Adhesion and Migration Immune Checkpoint Lymphoid Compartment T Cell Costimulation |
Immuno-Oncology CNS Metabolic Diseases Inflammation Oncology |
| CD44 | Protein | Angiogenesis Cellular Differentiation Costimulatory Signaling ECM Remodeling Interferon Signaling Matrix Remodeling and Metastases |
Activated Microglia Adhesion and Migration Immune Activation Status Immunity and Inflammation T Cell Activation T Cell Exhaustion |
Cardiovascular Oncology Immuno-Oncology Metabolic Diseases CNS Inflammation |
| CD44 | RNA | Angiogenesis Cellular Differentiation Costimulatory Signaling ECM Remodeling Interferon Signaling Matrix Remodeling and Metastases |
Activated Microglia Adhesion and Migration Immune Activation Status Immunity and Inflammation T Cell Activation T Cell Exhaustion |
Cardiovascular Oncology Immuno-Oncology Metabolic Diseases CNS Inflammation |
| CD45 | Protein | - | Immune Cell Typing Inflammation Microglia Neural Cell Typing |
Immuno-Oncology Inflammation CNS |
| CD45R0 | RNA | TCR Signaling | Immune Activation Status | Immuno-Oncology |
| CD45RA | RNA | TCR Signaling | Immune Activation Status | Immuno-Oncology |
| CD45RB | Protein | TCR Signaling | - | Immuno-Oncology |
| CD45RB | RNA | TCR Signaling | - | Immuno-Oncology |
| CD45RO | Protein | - | Immune Activation Status Immune Cell Typing |
Immuno-Oncology |
| CD45RO | RNA | - | Immune Activation Status Immune Cell Typing |
Immuno-Oncology |
| CD46 | RNA | - | - | - |
| CD47 | RNA | Cytotoxicity ECM Remodeling Matrix Remodeling and Metastases |
Inflammation Macrophage Function Myeloid Compartment |
Oncology Metabolic Diseases CNS Inflammation Immuno-Oncology |
| CD48 | RNA | Costimulatory Signaling | Immune Activation Status Lymphoid Compartment |
Immuno-Oncology |
| CD5 | RNA | - | B Cell Function Immune Activation Status Lymphoid Compartment |
Immuno-Oncology |
| CD52 | RNA | - | - | - |
| CD53 | RNA | - | Inflammation | Inflammation |
| CD55 | RNA | - | - | - |
| CD56 | Protein | - | Immune Cell Typing | Immuno-Oncology |
| CD58 | RNA | - | Immune Cell Adhesion and Migration | Immuno-Oncology |
| CD59 | RNA | - | - | - |
| CD6 | RNA | TCR Signaling | Immune Activation Status Immune Cell Adhesion and Migration Immune Cell Typing Lymphoid Compartment |
Immuno-Oncology |
| CD63 | RNA | Nutrient Capture and Catabolic Pathways | - | Metabolic Diseases |
| CD66b | Protein | - | Immune Cell Typing Myeloid Compartment |
Immuno-Oncology CNS |
| CD68 | Protein | DNA Damage Repair Nutrient Capture and Catabolic Pathways |
Activated Microglia Immune Cell Typing Immune Suppression Immunity and Inflammation Inflammation Microglia Myeloid Compartment Neural Cell Typing |
Epigenic and Nuclear Signaling Metabolic Diseases CNS Immuno-Oncology Inflammation |
| CD68 | RNA | DNA Damage Repair Nutrient Capture and Catabolic Pathways |
Activated Microglia Immune Cell Typing Immune Suppression Immunity and Inflammation Inflammation Microglia Myeloid Compartment Neural Cell Typing |
Epigenic and Nuclear Signaling Metabolic Diseases CNS Immuno-Oncology Inflammation |
| CD69 | RNA | Costimulatory Signaling | Immune Activation Status Immunity and Inflammation |
Immuno-Oncology Inflammation |
| CD7 | RNA | - | Lymphoid Compartment NK Cell Function |
Immuno-Oncology |
| CD70 | RNA | Costimulatory Signaling NF-kappaB Signaling |
B Cell Function Cytokines Immune Checkpoint Immunity and Inflammation Lymphoid Compartment |
Immuno-Oncology CNS Inflammation Oncology |
| CD72 | RNA | - | B Cell Exhaustion Immune Activation Status Immunity and Inflammation |
Immuno-Oncology Inflammation |
| CD74 | RNA | - | Antigen Presentation Immunity and Inflammation |
Immuno-Oncology Inflammation |
| CD79A | RNA | - | Lymphoid Compartment | Immuno-Oncology |
| CD79B | RNA | - | B Cell Function Immune Activation Status Lymphoid Compartment |
Immuno-Oncology |
| CD8 | Protein | - | Immune Cell Typing | Immuno-Oncology |
| CD80 | Protein | Costimulatory Signaling | B Cell Function Immune Activation Status Immune Cell Adhesion and Migration Immune Checkpoint Immune Suppression Lymphoid Compartment Macrophage Function Myeloid Compartment T Cell Costimulation |
Immuno-Oncology CNS |
| CD80 | RNA | Costimulatory Signaling | B Cell Function Immune Activation Status Immune Cell Adhesion and Migration Immune Checkpoint Immune Suppression Lymphoid Compartment Macrophage Function Myeloid Compartment T Cell Costimulation |
Immuno-Oncology CNS |
| CD81 | RNA | - | - | - |
| CD82 | RNA | - | - | - |
| CD83 | RNA | - | Immunity and Inflammation | Inflammation |
| CD84 | RNA | - | Immune Cell Typing Immune Suppression |
Immuno-Oncology |
| CD86 | RNA | Costimulatory Signaling Epigenic and Transcriptional Regulation |
B Cell Function Immune Activation Status Immune Cell Adhesion and Migration Immune Checkpoint Immune Suppression Immunity and Inflammation Lymphoid Compartment Macrophage Function T Cell Costimulation T Cell Exhaustion |
Immuno-Oncology Epigenic and Nuclear Signaling Inflammation |
| CD8A | RNA | Antigen Processing Cytokine and Chemokine Signaling Signaling Affecting Cellular Metabolism TCR Signaling |
Antigen Presentation Immune Activation Status Immune Cell Adhesion and Migration Immune Cell Typing Immunity and Inflammation Lymphoid Compartment |
Immuno-Oncology Metabolic Diseases Inflammation |
| CD8B | RNA | Signaling Affecting Cellular Metabolism TCR Signaling |
Antigen Presentation Immune Activation Status Immune Cell Adhesion and Migration Immune Cell Typing Immunity and Inflammation Lymphoid Compartment |
Metabolic Diseases Immuno-Oncology Inflammation |
| CD9 | Protein | Myelination | Activated Microglia Glial Cell Subtyping |
CNS |
| CD9 | RNA | Myelination | Activated Microglia Glial Cell Subtyping |
CNS |
| CD95/Fas | Protein | Apoptosis | - | Oncology |
| CD96 | RNA | - | Immune Activation Status Lymphoid Compartment |
Immuno-Oncology |
| CD97 | RNA | - | - | - |
| CD99 | RNA | - | - | - |
| CDA | RNA | Biosynthesis and Anabolic Pathways Nutrient Capture and Catabolic Pathways |
- | CNS Metabolic Diseases |
| CDC14A | RNA | Proliferation | - | Oncology |
| CDC14B | RNA | Proliferation | Immune Activation Status | Oncology Immuno-Oncology |
| CDC16 | RNA | - | Antigen Presentation Immune Activation Status |
Immuno-Oncology |
| CDC20 | RNA | Biosynthesis and Anabolic Pathways Cell Cycle Hippo Signaling Proliferation Signaling Affecting Cellular Metabolism |
Antigen Presentation Immune Activation Status |
CNS Oncology Metabolic Diseases Immuno-Oncology |
| CDC25A | RNA | Cell Cycle mTOR Signaling Proliferation |
Immune Activation Status | Oncology Immuno-Oncology |
| CDC25B | RNA | DNA Damage Repair MAPK Proliferation |
- | Epigenic and Nuclear Signaling Cardiovascular Oncology CNS |
| CDC25C | RNA | Cell Cycle DNA Damage Repair Proliferation |
- | Oncology Epigenic and Nuclear Signaling |
| CDC26 | RNA | - | - | - |
| CDC27 | RNA | - | - | - |
| CDC40 | RNA | - | - | - |
| CDC42 | RNA | - | Immune Activation Status | Immuno-Oncology |
| CDC6 | RNA | Proliferation | - | Oncology |
| CDC7 | RNA | DNA Damage Repair Proliferation |
- | Epigenic and Nuclear Signaling Oncology |
| CDCA5 | RNA | Biosynthesis and Anabolic Pathways Cell Cycle DNA Damage Repair |
- | CNS Oncology Epigenic and Nuclear Signaling Metabolic Diseases |
| CDCA7L | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| CDCA8 | RNA | Biosynthesis and Anabolic Pathways Cell Cycle DNA Damage Repair ER Signaling |
- | CNS Oncology Epigenic and Nuclear Signaling Metabolic Diseases |
| CDCP1 | RNA | - | - | - |
| CDH1 | RNA | Apoptosis ECM Remodeling EMT Hippo Signaling Matrix Remodeling and Metastases |
Adhesion and Migration Immune Cell Adhesion and Migration Immune Checkpoint |
Oncology Metabolic Diseases CNS Immuno-Oncology |
| CDH11 | RNA | - | Adhesion and Migration | CNS |
| CDH13 | RNA | Cell Proliferation | Cellular Growth Factor | CNS Oncology |
| CDH2 | RNA | EMT | Adhesion and Migration Immune Cell Adhesion and Migration |
Oncology CNS Immuno-Oncology |
| CDH3 | RNA | - | Adhesion and Migration | CNS |
| CDH5 | RNA | Angiogenesis | Adhesion and Migration Immune Cell Adhesion and Migration |
Cardiovascular CNS Immuno-Oncology Oncology |
| CDK1 | RNA | Cell Cycle DNA Damage Repair |
- | Oncology Epigenic and Nuclear Signaling |
| CDK12 | RNA | p53 Signaling | - | Oncology |
| CDK14 | RNA | - | - | - |
| CDK2 | RNA | Cell Cycle DNA Damage Repair Metabolism Stress Oxydative Stress PI3K-AKT Proliferation |
- | Oncology Epigenic and Nuclear Signaling Metabolic Diseases Inflammation |
| CDK20 | RNA | - | - | - |
| CDK4 | RNA | Cell Cycle Myc Proliferation TCR Signaling |
- | Oncology Immuno-Oncology |
| CDK5 | RNA | - | Axon and Dendrite Structure Neural Connectivity Transmitter Release Vesicle Trafficking |
CNS |
| CDK5R1 | RNA | - | Axon and Dendrite Structure Neural Connectivity |
CNS |
| CDK5RAP3 | RNA | - | - | - |
| CDK6 | RNA | Cell Cycle Metabolism Stress PI3K-AKT Proliferation |
- | Oncology Metabolic Diseases |
| CDK7 | RNA | - | - | - |
| CDK8 | RNA | - | - | - |
| CDK9 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| CDKN1A | RNA | Cell Cycle Cell Proliferation DNA Damage Repair Hypoxia JAK-STAT Metabolism Stress PI3K-AKT Proliferation Transcriptional Misregulation |
Immunity and Inflammation Myeloid Compartment |
Oncology CNS Epigenic and Nuclear Signaling Cardiovascular Metabolic Diseases Inflammation Oncology |
| CDKN1B | RNA | PI3K-AKT Proliferation Transcriptional Misregulation |
- | Oncology Epigenic and Nuclear Signaling |
| CDKN1C | RNA | DNA Damage Repair Proliferation |
Immune Activation Status | Epigenic and Nuclear Signaling Oncology Immuno-Oncology |
| CDKN2A | RNA | Cell Cycle Cell Proliferation Cellular Differentiation Metabolism Stress Proliferation |
Adhesion and Migration Cellular Growth Factor |
Oncology CNS Metabolic Diseases |
| CDKN2B | RNA | Metabolism Stress Proliferation TGF Beta Signaling |
- | Metabolic Diseases Oncology |
| CDKN2C | RNA | Proliferation Transcriptional Misregulation |
Immune Activation Status | Oncology Epigenic and Nuclear Signaling Immuno-Oncology |
| CDKN2D | RNA | Proliferation | - | Oncology |
| CDKN3 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| CDON | RNA | - | - | - |
| CDS1 | RNA | Lipid Metabolism | Activated Microglia | Metabolic Diseases CNS |
| CDY2A | RNA | Epigenic and Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| CEACAM1 | RNA | Angiogenesis ECM Remodeling |
Immune Activation Status Inflammation |
Cardiovascular Metabolic Diseases Immuno-Oncology Inflammation Oncology |
| CEACAM3 | RNA | - | Immune Cell Typing Inflammation |
Immuno-Oncology Inflammation |
| CEACAM5 | RNA | EMT | - | Oncology |
| CEACAM6 | RNA | EMT | - | Oncology |
| CEACAM8 | RNA | - | Chemokines | Immuno-Oncology |
| CEBPA | RNA | - | - | - |
| CEBPB | RNA | AP1 Signaling Metabolism Stress |
Immune Activation Status Myeloid Compartment |
Cardiovascular Metabolic Diseases Immuno-Oncology CNS Inflammation Oncology |
| CEBPD | RNA | - | Immune Activation Status | Immuno-Oncology |
| CEBPE | RNA | - | - | - |
| CENPA | RNA | Biosynthesis and Anabolic Pathways Cell Cycle |
- | CNS Oncology Metabolic Diseases |
| CENPF | RNA | DNA Damage Repair Proliferation |
- | Epigenic and Nuclear Signaling Oncology |
| CEP170 | RNA | - | - | - |
| CEP295 | RNA | - | - | - |
| CEP55 | RNA | DNA Damage Repair Proliferation |
- | Epigenic and Nuclear Signaling Oncology |
| Cer(d14:1(4E)/26:0(2OH)) | Lipid | - | - | - |
| Cer(d14:2(4E.6E)/22:0) | Lipid | - | - | - |
| Cer(d16:1(4E)/22:0(2OH)) | Lipid | - | - | - |
| Cer(d18:0/18:1(9Z)) | Lipid | - | - | - |
| Cer(d18:1/20:0) | Lipid | - | - | - |
| Cer(d18:1/24:1(15Z)) | Lipid | - | - | - |
| Cer(d18:2/22:0) | Lipid | - | - | - |
| Cer(m18:0/22:0) | Lipid | - | - | - |
| CER1 | RNA | - | Immune Suppression | Immuno-Oncology |
| CerP(d18:1/16:0) | Lipid | - | - | - |
| CerP(d18:1/18:0) | Lipid | - | - | - |
| CerP(d18:1/22:0) | Lipid | - | - | - |
| CerP(d18:1/24:1(15Z)) | Lipid | - | - | - |
| CerP(d18:1/8:0) | Lipid | - | - | - |
| CERS1 | RNA | Lipid Metabolism | - | Metabolic Diseases |
| CERS2 | RNA | Lipid Metabolism | - | Metabolic Diseases |
| CERS4 | RNA | Lipid Metabolism | - | Metabolic Diseases |
| CERS6 | RNA | Lipid Metabolism | - | Metabolic Diseases |
| CES3 | RNA | Angiogenesis | - | Cardiovascular Oncology |
| CETN2 | RNA | Proliferation | - | Oncology |
| CETP | RNA | - | - | - |
| CFB | RNA | - | - | - |
| CFD | RNA | - | - | - |
| CFH | RNA | - | - | - |
| CFHR1 | RNA | - | - | - |
| CFHR4 | RNA | - | - | - |
| CFHR5 | RNA | - | - | - |
| CFI | RNA | - | - | - |
| CFL1 | RNA | - | - | - |
| CFLAR | RNA | - | Immune Activation Status Immunity and Inflammation |
Immuno-Oncology Inflammation |
| CFP | RNA | - | - | - |
| CFTR | RNA | - | - | - |
| CGAS | RNA | - | - | - |
| CGN | RNA | - | - | - |
| CH25H | RNA | - | Immunity and Inflammation | Inflammation |
| CHAD | RNA | PI3K-AKT Proliferation |
Cellular Growth Factor | Oncology |
| CHAT | RNA | Lipid Metabolism Transmitter Synthesis |
Neural Connectivity Transmitter Release Vesicle Trafficking |
Metabolic Diseases CNS |
| CHD4 | RNA | - | - | - |
| CHD8 | RNA | - | - | - |
| CHEK1 | RNA | Epigenic and Transcriptional Regulation p53 Signaling |
Immune Activation Status | Epigenic and Nuclear Signaling Oncology Immuno-Oncology |
| CHEK2 | RNA | DNA Damage Repair Proliferation |
- | Epigenic and Nuclear Signaling Oncology |
| CHI3L1 | RNA | - | - | - |
| CHIT1 | RNA | - | - | - |
| CHL1 | RNA | - | Axon and Dendrite Structure | CNS |
| CHMP2A | RNA | Nutrient Capture and Catabolic Pathways | - | Metabolic Diseases |
| CHMP2B | RNA | - | - | - |
| CHMP3 | RNA | - | - | - |
| CHMP4A | RNA | - | - | - |
| CHMP4B | RNA | - | - | - |
| CHMP6 | RNA | Nutrient Capture and Catabolic Pathways | - | Metabolic Diseases |
| CHN2 | RNA | - | Immunity and Inflammation | Inflammation |
| Cholestanyl glucoside | Lipid | - | - | - |
| cholesterol sulfate | Lipid | - | - | - |
| CHP1 | RNA | - | - | - |
| CHP2 | RNA | - | - | - |
| CHRD | RNA | - | Immune Suppression | Immuno-Oncology |
| CHRDL1 | RNA | - | Immune Suppression | Immuno-Oncology |
| CHRM5 | RNA | - | Neural Connectivity Transmitter Release Transmitter Response and Reuptake Vesicle Trafficking |
CNS |
| CHRNA5 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| CHRNA7 | RNA | Cell Proliferation | Neural Connectivity Transmitter Release Transmitter Response and Reuptake Vesicle Trafficking |
CNS Oncology |
| CHRNB2 | RNA | Transmitter Synthesis | Neural Connectivity Transmitter Release Transmitter Response and Reuptake Vesicle Trafficking |
CNS |
| CHST8 | RNA | - | Immunity and Inflammation | Inflammation |
| CHUK | RNA | Costimulatory Signaling Cytokine and Chemokine Signaling MAPK NF-kappaB Signaling PI3K-AKT RAS TCR Signaling |
Immune Activation Status Immunity and Inflammation |
Immuno-Oncology Cardiovascular CNS Oncology Inflammation |
| CIB1 | RNA | Angiogenesis Cell Proliferation Cellular Differentiation |
- | Cardiovascular CNS Oncology |
| CIC | RNA | - | - | - |
| CIDEA | RNA | - | - | - |
| CIDEB | RNA | - | - | - |
| CIITA | RNA | - | Immune Activation Status | Immuno-Oncology |
| CISH | RNA | - | Immune Activation Status | Immuno-Oncology |
| Citrate | Amino-acid & Metabolites | - | - | - |
| CKAP4 | RNA | - | - | - |
| CKAP5 | RNA | - | - | - |
| CKB | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| CKLF | RNA | - | Chemokines | Immuno-Oncology |
| CKMT1A | RNA | EMT | - | Oncology |
| CKS1B | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| CL(1-18:1(9Z)/18:2(9Z.12Z).3-20:4(5Z.8Z.11Z.14Z)/20:4(5Z.8Z.11Z.14Z)) | Lipid | - | - | - |
| CL(1-18:2(9Z.12Z)/0:0.3-18:2(9Z.12Z)/0:0) | Lipid | - | - | - |
| CL(1-20:0/18:0.3-20:0/18:0) | Lipid | - | - | - |
| CL(1-20:0/18:1(9Z).3-18:2(9Z.12Z)/20:0) | Lipid | - | - | - |
| CL(1-20:0/18:1(9Z).3-20:0/20:0) | Lipid | - | - | - |
| CL(1-20:0/18:1(9Z).3-20:4(5Z.8Z.11Z.14Z)/20:0) | Lipid | - | - | - |
| CL(1-20:0/20:0.3-18:2(9Z.12Z)/20:0) | Lipid | - | - | - |
| CL(1-20:4(5Z.8Z.11Z.14Z)/20:0.3-20:0/18:2(9Z.12Z)) | Lipid | - | - | - |
| CL(1-20:4(5Z.8Z.11Z.14Z)/20:4(5Z.8Z.11Z.14Z).3-20:4(5Z.8Z.11Z.14Z)/18:1(9Z)) | Lipid | - | - | - |
| CL(1-22:1(13Z)/22:1(13Z).3-22:1(13Z)/14:1(9Z))rac | Lipid | - | - | - |
| CLCA1 | RNA | - | - | - |
| CLCF1 | RNA | - | Immune Activation Status Immunity and Inflammation |
Immuno-Oncology Inflammation |
| CLDN1 | RNA | - | Adhesion and Migration | CNS |
| CLDN15 | RNA | - | - | - |
| CLDN23 | RNA | - | - | - |
| CLDN3 | RNA | EMT | Adhesion and Migration | Oncology CNS |
| CLDN4 | RNA | EMT | Adhesion and Migration | Oncology CNS |
| CLDN5 | RNA | Myelination | Axon and Dendrite Structure | CNS |
| CLDN7 | RNA | EMT | Adhesion and Migration | Oncology CNS |
| Cleaved Caspase 9 | - | Apoptosis | - | Oncology |
| cleaved-caspase 9 | - | Apoptosis | - | Oncology |
| CLEC14A | RNA | Angiogenesis | Immune Cell Adhesion and Migration | Cardiovascular Immuno-Oncology Oncology |
| CLEC2B | RNA | - | - | - |
| CLEC3B | RNA | - | Cellular Growth Factor | Oncology |
| CLEC4A | RNA | - | - | - |
| CLEC4C | RNA | - | - | - |
| CLEC4E | RNA | - | Immune Cell Adhesion and Migration Myeloid Compartment |
Immuno-Oncology CNS |
| CLEC5A | RNA | - | Immune Cell Adhesion and Migration Myeloid Compartment |
Immuno-Oncology CNS |
| CLEC6A | RNA | - | - | - |
| CLEC7A | Protein | - | Glial Cell Subtyping Immune Cell Adhesion and Migration Myeloid Compartment |
CNS Immuno-Oncology |
| CLEC7A | RNA | - | Glial Cell Subtyping Immune Cell Adhesion and Migration Myeloid Compartment |
CNS Immuno-Oncology |
| CLECL1 | RNA | - | Immune Cell Adhesion and Migration | Immuno-Oncology |
| CLIC4 | RNA | Angiogenesis | Immunity and Inflammation | Cardiovascular Inflammation Oncology |
| CLN3 | RNA | - | Neural Connectivity | CNS |
| CLN8 | RNA | Oxydative Stress | Neural Connectivity | Inflammation CNS |
| CLOCK | RNA | Epigenic and Transcriptional Regulation Transcriptional Regulation |
- | Epigenic and Nuclear Signaling |
| CLSPN | RNA | Biosynthesis and Anabolic Pathways Cell Cycle Cell Stress |
- | CNS Oncology Metabolic Diseases |
| CLSTN1 | RNA | - | Immunity and Inflammation | Inflammation |
| CLU | RNA | Cell Proliferation Myelination |
Activated Microglia Axon and Dendrite Structure |
CNS Oncology |
| CMA1 | RNA | Cellular Differentiation Matrix Remodeling and Metastases |
- | Oncology CNS |
| CMIP | RNA | - | - | - |
| CMKLR1 | RNA | Cytokine and Chemokine Signaling Signaling Affecting Cellular Metabolism |
Chemokines Immune Activation Status |
Immuno-Oncology Metabolic Diseases |
| CMTM4 | RNA | - | - | - |
| CMTM6 | RNA | - | - | - |
| CMV UL83 | RNA | - | - | - |
| CNKSR2 | RNA | - | Neural Connectivity | CNS |
| CNN1 | RNA | - | - | - |
| CNN2 | RNA | - | - | - |
| CNOT10 | RNA | - | - | - |
| CNOT2 | RNA | - | - | - |
| CNOT4 | RNA | - | - | - |
| CNP | RNA | - | - | - |
| CNR1 | RNA | - | Axon and Dendrite Structure Transmitter Response and Reuptake Vesicle Trafficking |
CNS |
| CNTF | RNA | - | Axon and Dendrite Structure Immune Activation Status |
CNS Immuno-Oncology |
| CNTFR | RNA | Cytotoxicity JAK-STAT |
- | Oncology CNS Inflammation Metabolic Diseases Oncology |
| CNTN1 | RNA | - | Axon and Dendrite Structure | CNS |
| CNTN4 | RNA | - | Axon and Dendrite Structure Vesicle Trafficking |
CNS |
| CNTNAP1 | RNA | Myelination | Axon and Dendrite Structure | CNS |
| CNTNAP2 | RNA | - | Axon and Dendrite Structure | CNS |
| CoA(24:6(6Z.9Z.12Z.15Z.18Z.21Z)(3OH)) | Lipid | - | - | - |
| COA5 | RNA | - | Immunity and Inflammation | Inflammation |
| COG7 | RNA | - | - | - |
| COL10A1 | RNA | Collagen Biosynthesis & Modification | - | CNS |
| COL11A1 | RNA | Matrix Remodeling and Metastases PI3K-AKT |
Adhesion and Migration Myeloid Compartment |
CNS Oncology |
| COL11A2 | RNA | Matrix Remodeling and Metastases | - | CNS Oncology |
| COL14A1 | RNA | Collagen Biosynthesis & Modification | - | CNS |
| COL16A1 | RNA | Collagen Biosynthesis & Modification | - | CNS |
| COL17A1 | RNA | Matrix Remodeling and Metastases | Myeloid Compartment | CNS Oncology |
| COL18A1 | RNA | Angiogenesis Cell Proliferation |
- | Cardiovascular CNS Oncology |
| COL1A1 | RNA | Collagen Biosynthesis & Modification Vasculogenesis |
- | CNS Cardiovascular |
| COL1A2 | RNA | Collagen Biosynthesis & Modification Vasculogenesis |
Cellular Growth Factor | CNS Cardiovascular Oncology |
| COL24A1 | RNA | - | - | - |
| COL27A1 | RNA | PI3K-AKT | Adhesion and Migration | Oncology CNS |
| COL2A1 | RNA | PI3K-AKT | Adhesion and Migration | Oncology CNS |
| COL3A1 | RNA | Cellular Differentiation Collagen Biosynthesis & Modification Vasculogenesis |
Cellular Growth Factor | Oncology CNS Cardiovascular |
| COL4A1 | RNA | Collagen Biosynthesis & Modification ECM Remodeling PDGF Signaling Signaling Affecting Cellular Metabolism |
Adhesion and Migration Cellular Growth Factor |
CNS Metabolic Diseases Oncology |
| COL4A2 | RNA | Angiogenesis Collagen Biosynthesis & Modification ECM Remodeling PDGF Signaling |
Adhesion and Migration Cellular Growth Factor |
Cardiovascular CNS Metabolic Diseases Oncology |
| COL4A3 | RNA | - | - | - |
| COL4A4 | RNA | - | - | - |
| COL4A5 | RNA | Matrix Remodeling and Metastases PI3K-AKT |
- | CNS Oncology |
| COL4A6 | RNA | PI3K-AKT | Adhesion and Migration | Oncology CNS |
| COL5A1 | RNA | Collagen Biosynthesis & Modification Matrix Remodeling and Metastases Vasculogenesis |
Cellular Growth Factor | CNS Cardiovascular Oncology |
| COL5A2 | RNA | Cellular Differentiation | - | Oncology |
| COL5A3 | RNA | Collagen Biosynthesis & Modification | - | CNS |
| COL6A1 | RNA | ECM Remodeling PDGF Signaling Signaling Affecting Cellular Metabolism |
Adhesion and Migration Cellular Growth Factor |
Metabolic Diseases Oncology CNS |
| COL6A2 | RNA | ECM Remodeling PDGF Signaling |
Adhesion and Migration | Metabolic Diseases Oncology CNS |
| COL6A3 | RNA | Collagen Biosynthesis & Modification ECM Remodeling Matrix Remodeling and Metastases PI3K-AKT PDGF Signaling Signaling Affecting Cellular Metabolism |
Adhesion and Migration Immunity and Inflammation |
CNS Metabolic Diseases Oncology Inflammation |
| COL6A5 | RNA | Collagen Biosynthesis & Modification | - | CNS |
| COL6A6 | RNA | - | - | - |
| COL7A1 | RNA | Collagen Biosynthesis & Modification | Adhesion and Migration | CNS |
| COL9A3 | RNA | - | Adhesion and Migration | CNS |
| COLEC12 | RNA | - | - | - |
| Collagen Type I | Protein | - | - | - |
| COMP | RNA | Matrix Remodeling and Metastases PI3K-AKT TGF Beta Signaling |
Adhesion and Migration | CNS Oncology |
| COMT | RNA | Transmitter Synthesis | Axon and Dendrite Structure Neural Connectivity Transmitter Release |
CNS |
| COP1 | RNA | Cell Cycle p53 Signaling |
- | Oncology |
| COPS6 | RNA | Cell Stress Nutrient Capture and Catabolic Pathways |
- | CNS Metabolic Diseases Oncology |
| COTL1 | RNA | - | Immunity and Inflammation | Inflammation |
| COX14 | RNA | Biosynthesis and Anabolic Pathways Signaling Affecting Cellular Metabolism |
- | CNS Metabolic Diseases |
| COX16 | RNA | - | - | - |
| COX19 | RNA | - | - | - |
| COX4I1 | RNA | Biosynthesis and Anabolic Pathways Signaling Affecting Cellular Metabolism |
- | CNS Metabolic Diseases |
| COX4I2 | RNA | - | - | - |
| COX5A | RNA | Biosynthesis and Anabolic Pathways Signaling Affecting Cellular Metabolism |
- | CNS Metabolic Diseases |
| COX5B | RNA | Biosynthesis and Anabolic Pathways Signaling Affecting Cellular Metabolism |
Immunity and Inflammation | CNS Metabolic Diseases Inflammation |
| COX6A1 | RNA | Biosynthesis and Anabolic Pathways Signaling Affecting Cellular Metabolism |
- | CNS Metabolic Diseases |
| COX6B1 | RNA | Biosynthesis and Anabolic Pathways Signaling Affecting Cellular Metabolism |
- | CNS Metabolic Diseases |
| COX6C | RNA | - | - | - |
| COX7A2 | RNA | - | - | - |
| COX7B | RNA | Biosynthesis and Anabolic Pathways Signaling Affecting Cellular Metabolism |
- | CNS Metabolic Diseases |
| COX7C | RNA | Biosynthesis and Anabolic Pathways Signaling Affecting Cellular Metabolism |
- | CNS Metabolic Diseases |
| COX8A | RNA | Biosynthesis and Anabolic Pathways Signaling Affecting Cellular Metabolism |
- | CNS Metabolic Diseases |
| CP | RNA | - | - | - |
| CPA(16:0) | Lipid | - | - | - |
| CPA(18:0) | Lipid | - | - | - |
| CPA(18:1(9Z)) | Lipid | - | - | - |
| CPA3 | RNA | - | Immune Cell Typing Immune Suppression |
Immuno-Oncology |
| CPA4 | RNA | Epigenic and Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| CPB2 | RNA | - | - | - |
| CPLX1 | RNA | Transmitter Synthesis | Axon and Dendrite Structure Neural Connectivity Vesicle Trafficking |
CNS |
| CPN1 | RNA | - | - | - |
| CPS1 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| CPSF7 | RNA | - | - | - |
| CPT1A | RNA | Nutrient Capture and Catabolic Pathways Signaling Affecting Cellular Metabolism |
- | Metabolic Diseases |
| CPT1B | RNA | Carbohydrate Metabolism | - | CNS Metabolic Diseases |
| CPT1C | RNA | - | - | - |
| CPT2 | RNA | Lipid Metabolism | - | Metabolic Diseases |
| CR1 | RNA | - | Activated Microglia | CNS |
| CR2 | RNA | - | B Cell Exhaustion B Cell Function Immune Activation Status |
Immuno-Oncology |
| CRABP2 | RNA | - | Myeloid Compartment | CNS |
| CRADD | RNA | - | - | - |
| CRCP | RNA | - | - | - |
| CREB1 | RNA | Adenosine Pathway Carbohydrate Metabolism |
Axon and Dendrite Structure Immunity and Inflammation Transmitter Release Transmitter Response and Reuptake Vesicle Trafficking |
Immuno-Oncology CNS Inflammation Metabolic Diseases |
| CREB3 | RNA | - | - | - |
| CREB3L1 | RNA | - | - | - |
| CREB3L2 | RNA | - | Immune Activation Status | Immuno-Oncology |
| CREB3L3 | RNA | Signaling Affecting Cellular Metabolism Transcriptional Regulation |
- | Metabolic Diseases Epigenic and Nuclear Signaling |
| CREB3L4 | RNA | - | - | - |
| CREB5 | RNA | - | Immune Activation Status | Immuno-Oncology |
| CREBBP | RNA | Chromatin Modification Epigenic and Transcriptional Regulation JAK-STAT Notch Proliferation TGF Beta Signaling Wnt Signaling |
Immune Activation Status Immune Suppression Immunity and Inflammation Transmitter Response and Reuptake |
Epigenic and Nuclear Signaling CNS Immuno-Oncology Oncology Inflammation Metabolic Diseases Oncology |
| CREM | RNA | - | - | - |
| CRH | RNA | - | Axon and Dendrite Structure Transmitter Release Transmitter Response and Reuptake Vesicle Trafficking |
CNS |
| CRIP1 | RNA | - | Immunity and Inflammation | Inflammation |
| CRIP2 | RNA | Cell Proliferation | - | CNS Oncology |
| CRISPLD2 | RNA | - | - | - |
| CRK | RNA | Interleukin Signaling Met Signaling PDGF Signaling |
- | Immuno-Oncology Oncology |
| CRKL | RNA | - | - | - |
| CRLF1 | RNA | - | Immune Activation Status | Immuno-Oncology |
| CRLF2 | RNA | - | Immune Activation Status | Immuno-Oncology |
| CRP | RNA | - | - | - |
| CRTAM | RNA | - | Immune Activation Status | Immuno-Oncology |
| CRTC2 | RNA | Carbohydrate Metabolism | - | CNS Metabolic Diseases |
| CRYAB | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| CRYBA4 | RNA | - | Immunity and Inflammation | Inflammation |
| CS | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| CSF1 | RNA | Cytokine and Chemokine Signaling MAPK PI3K-AKT |
Activated Microglia Immune Activation Status Immune Suppression Immunity and Inflammation Myeloid Compartment |
Immuno-Oncology Cardiovascular Oncology CNS Inflammation |
| CSF1R | Protein | Cytokine and Chemokine Signaling Epigenic and Transcriptional Regulation Interleukin Signaling MAPK PI3K-AKT RAS |
Activated Microglia Glial Cell Subtyping Immune Activation Status Immunity and Inflammation Microglia Myeloid Compartment |
Immuno-Oncology Epigenic and Nuclear Signaling Cardiovascular Oncology CNS Inflammation |
| CSF1R | RNA | Cytokine and Chemokine Signaling Epigenic and Transcriptional Regulation Interleukin Signaling MAPK PI3K-AKT RAS |
Activated Microglia Glial Cell Subtyping Immune Activation Status Immunity and Inflammation Microglia Myeloid Compartment |
Immuno-Oncology Epigenic and Nuclear Signaling Cardiovascular Oncology CNS Inflammation |
| CSF2 | RNA | Cytokine and Chemokine Signaling JAK-STAT TCR Signaling |
Cytokines Immune Activation Status Immune Suppression Macrophage Function |
Immuno-Oncology CNS Inflammation Metabolic Diseases Oncology |
| CSF2RA | RNA | Interleukin Signaling | - | Immuno-Oncology |
| CSF2RB | RNA | Cytokine and Chemokine Signaling Interleukin Signaling JAK-STAT |
Chemokines Immunity and Inflammation |
Immuno-Oncology CNS Inflammation Metabolic Diseases Oncology |
| CSF3 | RNA | Cytokine and Chemokine Signaling JAK-STAT PI3K-AKT |
Immune Activation Status Immune Suppression |
Immuno-Oncology CNS Oncology Inflammation Metabolic Diseases Oncology |
| CSF3R | RNA | Cytokine and Chemokine Signaling Interleukin Signaling JAK-STAT PI3K-AKT Signaling Affecting Cellular Metabolism |
Cytokines Immune Activation Status Immune Cell Typing Immunity and Inflammation Myeloid Compartment |
Immuno-Oncology CNS Oncology Metabolic Diseases Inflammation Oncology |
| CSH2/GH2 | RNA | - | Immune Activation Status | Immuno-Oncology |
| CSK | RNA | - | Immunity and Inflammation | Inflammation |
| CSNK1A1 | RNA | - | - | - |
| CSNK1D | RNA | - | - | - |
| CSNK1E | RNA | - | - | - |
| CSNK1G3 | RNA | - | - | - |
| CSNK2A1 | RNA | - | - | - |
| CSNK2B | RNA | - | - | - |
| CSPG4 | RNA | Angiogenesis | Activated Microglia | Cardiovascular CNS Oncology |
| CST2 | RNA | - | - | - |
| CST7 | RNA | - | Immunity and Inflammation | Inflammation |
| CT45A1 | RNA | - | - | - |
| CTAG1A/B | RNA | - | - | - |
| CTAG1B | RNA | - | - | - |
| CTAGE1 | RNA | - | - | - |
| CTBP2 | RNA | - | Immune Suppression | Immuno-Oncology |
| CTCF | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| CTCFL | RNA | - | - | - |
| CTF1 | RNA | - | Immune Activation Status | Immuno-Oncology |
| CTLA4 | Protein | Costimulatory Signaling Signaling Affecting Cellular Metabolism TCR Signaling |
B Cell Function Immune Activation Status Immune Cell Adhesion and Migration Immune Cell Typing Immune Checkpoint Lymphoid Compartment T Cell Activation T Cell Costimulation T Cell Exhaustion |
Immuno-Oncology Metabolic Diseases |
| CTLA4 | RNA | Costimulatory Signaling Signaling Affecting Cellular Metabolism TCR Signaling |
B Cell Function Immune Activation Status Immune Cell Adhesion and Migration Immune Cell Typing Immune Checkpoint Lymphoid Compartment T Cell Activation T Cell Costimulation T Cell Exhaustion |
Immuno-Oncology Metabolic Diseases |
| CTLA4_all (common probe) | RNA | TCR Signaling | - | Immuno-Oncology |
| CTLA4-TM (membrane-bound form) | RNA | TCR Signaling | - | Immuno-Oncology |
| CTNNA1 | RNA | Hippo Signaling | Adhesion and Migration | CNS Oncology |
| CTNNB1 | RNA | Androgen Signaling Apoptosis Cell Proliferation Cellular Differentiation Myelination Wnt Signaling |
Adhesion and Migration Axon and Dendrite Structure Immune Cell Adhesion and Migration Neural Connectivity Vesicle Trafficking |
Oncology CNS Immuno-Oncology |
| CTNND1 | RNA | - | Adhesion and Migration | CNS |
| CTNS | RNA | - | - | - |
| CTPS1 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| CTSA | RNA | Nutrient Capture and Catabolic Pathways Signaling Affecting Cellular Metabolism |
- | Metabolic Diseases |
| CTSB | RNA | Collagen Biosynthesis & Modification | - | CNS |
| CTSC | RNA | - | - | - |
| CTSD | Protein | Nutrient Capture and Catabolic Pathways Signaling Affecting Cellular Metabolism |
Glial Cell Subtyping Microglia |
Metabolic Diseases CNS |
| CTSD | RNA | Nutrient Capture and Catabolic Pathways Signaling Affecting Cellular Metabolism |
Glial Cell Subtyping Microglia |
Metabolic Diseases CNS |
| CTSE | RNA | - | Activated Microglia Immunity and Inflammation |
CNS Inflammation |
| CTSF | RNA | - | Immunity and Inflammation | Inflammation |
| CTSG | RNA | Cellular Differentiation | - | Oncology |
| CTSH | RNA | Cell Proliferation | - | CNS Oncology |
| CTSK | RNA | - | - | - |
| CTSL | RNA | Collagen Biosynthesis & Modification Nutrient Capture and Catabolic Pathways Signaling Affecting Cellular Metabolism |
- | CNS Metabolic Diseases |
| CTSO | RNA | - | - | - |
| CTSS | RNA | Matrix Remodeling and Metastases Nutrient Capture and Catabolic Pathways Signaling Affecting Cellular Metabolism |
Antigen Presentation Immunity and Inflammation |
CNS Metabolic Diseases Immuno-Oncology Inflammation Oncology |
| CTSW | RNA | Nutrient Capture and Catabolic Pathways | Antigen Presentation Immune Activation Status Immune Cell Typing |
Metabolic Diseases Immuno-Oncology |
| CTSZ | RNA | Nutrient Capture and Catabolic Pathways | - | Metabolic Diseases |
| Cucurbitacin I | Lipid | - | - | - |
| CUL1 | RNA | Cell Proliferation Cellular Differentiation |
Activated Microglia Antigen Presentation Immune Activation Status Immune Suppression |
CNS Oncology Immuno-Oncology |
| CUL2 | RNA | - | Antigen Presentation Immune Activation Status |
Immuno-Oncology |
| CUL3 | RNA | - | - | - |
| CUL9 | RNA | - | - | - |
| CX3CL1 | RNA | Angiogenesis Cell Proliferation Cytokine and Chemokine Signaling Vasculogenesis |
Cellular Growth Factor Chemokines Immunity and Inflammation Leucocyte Function Lymphoid Compartment Neural Connectivity Vesicle Trafficking |
Cardiovascular CNS Immuno-Oncology Oncology Inflammation |
| CX3CR1 | RNA | Cytokine and Chemokine Signaling | Activated Microglia Chemokines Immunity and Inflammation Vesicle Trafficking |
Immuno-Oncology CNS Inflammation |
| CXADR | RNA | EMT | Adhesion and Migration | Oncology CNS |
| CXCL1 | RNA | Cytokine and Chemokine Signaling | Antigen Presentation Chemokines Myeloid Compartment |
Immuno-Oncology CNS |
| CXCL1/2/3 | RNA | - | Immune Activation Status | Immuno-Oncology |
| CXCL10 | RNA | Cell Proliferation Cytokine and Chemokine Signaling |
Activated Microglia Chemokines Cytokines Immunity and Inflammation Lymphoid Compartment |
CNS Immuno-Oncology Inflammation Oncology |
| CXCL11 | RNA | Cytokine and Chemokine Signaling Matrix Remodeling and Metastases |
Chemokines Immune Activation Status Lymphoid Compartment NK Cell Function |
Immuno-Oncology CNS Oncology |
| CXCL12 | RNA | Cell Proliferation Cytokine and Chemokine Signaling EMT Proliferation |
Adhesion and Migration Cellular Growth Factor Chemokines Immune Cell Adhesion and Migration Myeloid Compartment |
CNS Immuno-Oncology Oncology |
| CXCL13 | RNA | Cytokine and Chemokine Signaling EMT Proliferation |
Adhesion and Migration Cellular Growth Factor Chemokines Lymphoid Compartment |
Immuno-Oncology Oncology CNS |
| CXCL14 | RNA | Cytokine and Chemokine Signaling | Chemokines | Immuno-Oncology |
| CXCL16 | RNA | Cytokine and Chemokine Signaling | Activated Microglia Chemokines Lymphoid Compartment |
Immuno-Oncology CNS |
| CXCL17 | RNA | Angiogenesis | - | Cardiovascular Oncology |
| CXCL2 | RNA | Cytokine and Chemokine Signaling | Chemokines Myeloid Compartment |
Immuno-Oncology CNS |
| CXCL3 | RNA | Cytokine and Chemokine Signaling | Chemokines Myeloid Compartment |
Immuno-Oncology CNS |
| CXCL5 | RNA | Cytokine and Chemokine Signaling | Chemokines Myeloid Compartment |
Immuno-Oncology CNS |
| CXCL6 | RNA | Cytokine and Chemokine Signaling | Chemokines Myeloid Compartment |
Immuno-Oncology CNS |
| CXCL8 | RNA | Angiogenesis Cytokine and Chemokine Signaling Metabolism Stress Transcriptional Misregulation |
Immune Activation Status Immune Suppression |
Cardiovascular Immuno-Oncology Metabolic Diseases Epigenic and Nuclear Signaling Oncology |
| CXCL9 | RNA | Cytokine and Chemokine Signaling Signaling Affecting Cellular Metabolism |
Chemokines Immune Activation Status Immunity and Inflammation Lymphoid Compartment |
Immuno-Oncology Metabolic Diseases Inflammation |
| CXCR1 | RNA | - | Chemokines | Immuno-Oncology |
| CXCR2 | RNA | Cell Proliferation Cellular Differentiation Cytokine and Chemokine Signaling |
Chemokines | CNS Oncology Immuno-Oncology |
| CXCR3 | Protein | Angiogenesis Cellular Differentiation Cytokine and Chemokine Signaling |
B Cell Exhaustion Chemokines Immune Activation Status Lymphoid Compartment M1 Activation NK Cell Function |
Cardiovascular Oncology Immuno-Oncology CNS |
| CXCR3 | RNA | Angiogenesis Cellular Differentiation Cytokine and Chemokine Signaling |
B Cell Exhaustion Chemokines Immune Activation Status Lymphoid Compartment M1 Activation NK Cell Function |
Cardiovascular Oncology Immuno-Oncology CNS |
| CXCR4 | RNA | Cytokine and Chemokine Signaling mTOR Signaling Myelination |
Activated Microglia Chemokines Immune Cell Adhesion and Migration M2 Activation |
Immuno-Oncology Oncology CNS |
| CXCR5 | RNA | - | B Cell Function Chemokines |
Immuno-Oncology |
| CXCR6 | RNA | Cytokine and Chemokine Signaling Signaling Affecting Cellular Metabolism |
Chemokines Immune Activation Status M1 Activation |
Immuno-Oncology Metabolic Diseases CNS |
| CXorf36 | RNA | Angiogenesis | - | Cardiovascular Oncology |
| CXXC1 | RNA | - | - | - |
| CXXC4 | RNA | - | - | - |
| CXXC5 | RNA | - | - | - |
| CYB561 | RNA | - | - | - |
| CYBA | RNA | - | - | - |
| CYBB | RNA | Cell Stress Hypoxia Oxydative Stress Signaling Affecting Cellular Metabolism |
Activated Microglia Antigen Presentation Immune Cell Adhesion and Migration Inflammation Myeloid Compartment |
CNS Cardiovascular Inflammation Metabolic Diseases Immuno-Oncology Oncology |
| CYC1 | RNA | - | - | - |
| CYCS | RNA | Oxydative Stress | - | Inflammation |
| CYFIP1 | RNA | - | Inflammation | Inflammation |
| CYFIP2 | RNA | - | - | - |
| CYLD | RNA | - | Immune Activation Status | Immuno-Oncology |
| CYP19A1 | RNA | - | - | - |
| CYP1A1 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| CYP1A2 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| CYP1B1 | RNA | Angiogenesis Biosynthesis and Anabolic Pathways Vasculogenesis |
- | Cardiovascular CNS Metabolic Diseases Oncology |
| CYP26A1 | RNA | - | Immune Suppression | Immuno-Oncology |
| CYP26C1 | RNA | - | Immune Suppression | Immuno-Oncology |
| CYP27A1 | RNA | - | Immunity and Inflammation | Inflammation |
| CYP2C19 | RNA | - | - | - |
| CYP2C8 | RNA | - | - | - |
| CYP2C9 | RNA | - | - | - |
| CYP2E1 | RNA | - | - | - |
| CYP2J2 | RNA | - | - | - |
| CYP4A11 | RNA | Nutrient Capture and Catabolic Pathways | - | Metabolic Diseases |
| CYP4A11/22 | RNA | Lipid Metabolism | - | Metabolic Diseases |
| CYP4A22 | RNA | Nutrient Capture and Catabolic Pathways | - | Metabolic Diseases |
| CYP4F3 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| CYP4X1 | RNA | - | Transmitter Release | CNS |
| CYP7A1 | RNA | - | - | - |
| CYP7B1 | RNA | - | Immunity and Inflammation | Inflammation |
| CYP8B1 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| CYSLTR1 | RNA | - | - | - |
| CYSLTR2 | RNA | - | - | - |
| CYSTM1 | RNA | - | - | - |
| CYTIP | RNA | - | Immunity and Inflammation | Inflammation |
| D2HGDH | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| DAB2 | RNA | - | Immunity and Inflammation Myeloid Compartment |
Inflammation CNS |
| DAB2IP | RNA | - | - | - |
| DACH2 | RNA | - | - | - |
| DAG1 | RNA | - | - | - |
| DAGLA | RNA | Transmitter Synthesis | Axon and Dendrite Structure Transmitter Response and Reuptake |
CNS |
| DAO | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| DAP3 | RNA | - | - | - |
| DAPK1 | RNA | - | - | - |
| DAPP1 | RNA | - | Immune Activation Status | Immuno-Oncology |
| DAXX | RNA | - | - | - |
| DBH | RNA | Transmitter Synthesis | Vesicle Trafficking | CNS |
| DCC | RNA | - | - | - |
| DCK | RNA | Biosynthesis and Anabolic Pathways Nutrient Capture and Catabolic Pathways |
- | CNS Metabolic Diseases |
| DCN | RNA | DNA Damage Repair ECM Remodeling EMT TGF Beta Signaling |
Immune Suppression | Epigenic and Nuclear Signaling Metabolic Diseases Oncology Immuno-Oncology |
| DCTN6 | RNA | - | Antigen Presentation Immune Activation Status |
Immuno-Oncology |
| DCX | RNA | - | Axon and Dendrite Structure | CNS |
| DDAH2 | RNA | - | - | - |
| DDB2 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| DDC | RNA | Biosynthesis and Anabolic Pathways Transmitter Synthesis |
Axon and Dendrite Structure Neural Connectivity Transmitter Release |
CNS Metabolic Diseases |
| DDIT3 | RNA | Oxydative Stress | - | Inflammation |
| DDIT4 | RNA | - | - | - |
| DDOST | RNA | - | - | - |
| DDR2 | RNA | EMT | Adhesion and Migration | Oncology CNS |
| DDX23 | RNA | - | - | - |
| DDX24 | RNA | - | - | - |
| DDX39A | RNA | DNA Damage Repair ER Signaling |
- | Epigenic and Nuclear Signaling Oncology |
| DDX43 | RNA | - | - | - |
| DDX5 | RNA | - | - | - |
| DDX50 | RNA | - | - | - |
| DDX58 | RNA | - | Immunity and Inflammation | Inflammation |
| DECR1 | RNA | - | - | - |
| DEFA1 | RNA | - | - | - |
| DEFA4 | RNA | - | - | - |
| DEFB1 | RNA | - | - | - |
| DEFB103A | RNA | - | - | - |
| DEFB103A/B | RNA | - | - | - |
| DEFB103B | RNA | - | - | - |
| DEFB134 | RNA | - | - | - |
| DEFB4A | RNA | - | - | - |
| Delphinidin 3-(2-galloylgalactoside) | Lipid | - | - | - |
| DENND5A | RNA | - | - | - |
| DENR | RNA | Cell Proliferation Cellular Differentiation |
- | CNS Oncology |
| DEPDC1 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| DEPDC5 | RNA | - | - | - |
| DEPTOR | RNA | Autophagy Metabolism Stress Nutrient Capture and Catabolic Pathways Signaling Affecting Cellular Metabolism |
- | Cardiovascular Metabolic Diseases CNS Inflammation Oncology |
| DERA | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| DERL1 | RNA | - | - | - |
| DERL2 | RNA | - | - | - |
| DES | RNA | - | Neural Connectivity Neuronal Cytoskeleton |
CNS |
| DESI1 | RNA | - | - | - |
| DG(14:0/18:0/0:0)iso2 | Lipid | - | - | - |
| DG(14:0/20:1(11Z)/0:0)iso2 | Lipid | - | - | - |
| DG(16:0/18:2(9Z.12Z)/0:0)iso2 | Lipid | - | - | - |
| DG(17:1(9Z)/19:0/0:0)iso2 | Lipid | - | - | - |
| DG(18:0/20:4(5Z.8Z.11Z.14Z)/0:0)iso2 | Lipid | - | - | - |
| DG(18:1(9Z)/22:5(7Z.10Z.13Z.16Z.19Z)/0:0)iso2 | Lipid | - | - | - |
| DG(19:0/22:0/0:0)iso2 | Lipid | - | - | - |
| DG(19:1(9Z)/20:5(5Z.8Z.11Z.14Z.17Z)/0:0)iso2 | Lipid | - | - | - |
| DG(P-14:0/18:1(9Z)) | Lipid | - | - | - |
| DGKA | RNA | - | - | - |
| DGKB | RNA | Lipid Metabolism | - | Metabolic Diseases |
| DGKE | RNA | Lipid Metabolism | - | Metabolic Diseases |
| DGKZ | RNA | - | - | - |
| DGLUCY | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| DGTS(16:0/16:0) | Lipid | - | - | - |
| DGUOK | RNA | Biosynthesis and Anabolic Pathways Nutrient Capture and Catabolic Pathways |
- | CNS Metabolic Diseases |
| DHFR2 | RNA | - | - | - |
| DHRS2 | RNA | - | - | - |
| DHRS3 | RNA | - | Immune Suppression | Immuno-Oncology |
| DHRS4 | RNA | - | - | - |
| DHX16 | RNA | - | - | - |
| DHX58 | RNA | - | - | - |
| DIABLO | RNA | - | Immune Activation Status | Immuno-Oncology |
| DIAPH1 | RNA | - | - | - |
| DICER1 | RNA | Angiogenesis Cell Proliferation Epigenic and Transcriptional Regulation |
- | Cardiovascular CNS Epigenic and Nuclear Signaling Oncology |
| Dinorlithocholic acid | Lipid | - | - | - |
| Dioctyl hexanedioate | Lipid | - | - | - |
| Diospolysaponin A | Lipid | - | - | - |
| DIPK2B | RNA | - | - | - |
| DKC1 | RNA | Cell Cycle | - | Oncology |
| DKK1 | RNA | Wnt Signaling | - | CNS Oncology |
| DKK2 | RNA | Wnt Signaling | - | CNS Oncology |
| DKK4 | RNA | - | - | - |
| DL-Acetylcarnitine | Lipid | - | - | - |
| DLAT | RNA | Carbohydrate Metabolism | - | CNS Metabolic Diseases |
| DLC1 | RNA | Cellular Differentiation | - | Oncology |
| DLD | RNA | Carbohydrate Metabolism | Immune Suppression | CNS Immuno-Oncology Metabolic Diseases |
| DLG1 | RNA | Cell Proliferation Cellular Differentiation |
- | CNS Oncology |
| DLG3 | RNA | - | Axon and Dendrite Structure Neural Connectivity Vesicle Trafficking |
CNS |
| DLG4 | RNA | - | Axon and Dendrite Structure Immunity and Inflammation Neural Connectivity Transmitter Release Transmitter Response and Reuptake Vesicle Trafficking |
CNS Inflammation |
| DLGAP1 | RNA | - | Neural Connectivity Transmitter Release Vesicle Trafficking |
CNS |
| DLGAP5 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| DLL1 | RNA | Notch | - | Immuno-Oncology |
| DLL3 | RNA | Notch | Immune Suppression | Immuno-Oncology |
| DLL4 | RNA | Angiogenesis Notch |
Immune Suppression Myeloid Compartment |
Cardiovascular Immuno-Oncology CNS Oncology |
| DLX1 | RNA | - | - | - |
| DLX2 | RNA | - | - | - |
| DMBT1 | RNA | - | - | - |
| DMGDH | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| DNA2 | RNA | Cell Cycle | - | Oncology |
| DNAH1 | RNA | - | Neuronal Cytoskeleton | CNS |
| DNAJA2 | RNA | - | - | - |
| DNAJC10 | RNA | - | - | - |
| DNAJC12 | RNA | ER Signaling | - | Oncology |
| DNAJC14 | RNA | - | - | - |
| DNM1L | RNA | - | Activated Microglia Immune Activation Status Neural Connectivity |
CNS Immuno-Oncology |
| DNM2 | RNA | Oxydative Stress Transmitter Synthesis |
Neural Connectivity | Inflammation CNS |
| DNMT1 | RNA | Epigenic and Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| DNMT3A | RNA | Epigenic and Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| DNMT3B | RNA | - | - | - |
| DNMT3L | RNA | Epigenic and Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| DOCK1 | RNA | - | Adhesion and Migration | CNS |
| DOCK2 | RNA | - | Inflammation | Inflammation |
| DOCK9 | RNA | - | - | - |
| Docosanamide | Lipid | - | - | - |
| Dopamine | Amino-acid & Metabolites | - | - | - |
| Dopamine | Neuropeptide & Neurotransmitter | - | - | - |
| DOT1L | RNA | - | - | - |
| DPP4 | RNA | Costimulatory Signaling | Lymphoid Compartment Macrophage Function |
Immuno-Oncology |
| DPT | RNA | Cell Proliferation EMT |
Adhesion and Migration | CNS Oncology |
| DPYSL3 | RNA | - | - | - |
| DRAP1 | RNA | - | Immune Suppression | Immuno-Oncology |
| DRD1 | RNA | Transmitter Synthesis | Axon and Dendrite Structure Neural Connectivity Transmitter Release Transmitter Response and Reuptake Vesicle Trafficking |
CNS |
| DRD2 | RNA | Transmitter Synthesis | Axon and Dendrite Structure Neural Connectivity Transmitter Release Transmitter Response and Reuptake Vesicle Trafficking |
CNS |
| DRD4 | RNA | Transmitter Synthesis | Axon and Dendrite Structure Neural Connectivity Transmitter Release Transmitter Response and Reuptake Vesicle Trafficking |
CNS |
| DSC2 | RNA | EMT | Adhesion and Migration | Oncology CNS |
| DSC3 | RNA | - | - | - |
| DSP | RNA | - | - | - |
| DST | RNA | - | Immunity and Inflammation | Inflammation |
| DTL | RNA | Cell Stress | - | CNS Oncology |
| DTX1 | RNA | Notch | - | Immuno-Oncology |
| DTX3 | RNA | Notch | - | Immuno-Oncology |
| DTX3L | RNA | Notch | Antigen Presentation | Immuno-Oncology |
| DTX4 | RNA | Notch | Immune Suppression | Immuno-Oncology |
| DUOX1 | RNA | Cell Stress | - | CNS Oncology |
| DUOX2 | RNA | Cell Stress | - | CNS Oncology |
| DUOXA1 | RNA | - | Immunity and Inflammation | Inflammation |
| DUSP1 | RNA | MAPK | Immune Activation Status | Cardiovascular Immuno-Oncology CNS Oncology |
| DUSP10 | RNA | - | - | - |
| DUSP2 | RNA | MAPK | - | Cardiovascular CNS Oncology |
| DUSP4 | RNA | MAPK | - | Cardiovascular CNS Oncology |
| DUSP5 | RNA | MAPK | - | Cardiovascular CNS Oncology |
| DUSP6 | RNA | MAPK Transcriptional Misregulation |
- | Cardiovascular Epigenic and Nuclear Signaling CNS Oncology |
| DUSP7 | RNA | - | Immunity and Inflammation | Inflammation |
| DUSP8 | RNA | - | - | - |
| DUSP9 | RNA | - | Immune Activation Status | Immuno-Oncology |
| DVL1 | RNA | - | Immune Activation Status Immune Suppression |
Immuno-Oncology |
| DVL2 | RNA | - | - | - |
| DYDC1 | RNA | Epigenic and Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| DYNLL1 | RNA | - | - | - |
| DYNLL2 | RNA | - | - | - |
| Dynorphin B | Neuropeptide & Neurotransmitter | - | - | - |
| DYSF | RNA | - | - | - |
| E2F1 | RNA | Cell Cycle Proliferation |
Immune Activation Status Immune Suppression |
Oncology Immuno-Oncology |
| E2F2 | RNA | Cell Cycle | Immune Activation Status | Oncology Immuno-Oncology |
| E2F3 | RNA | Angiogenesis Metabolism Stress Notch Proliferation |
- | Cardiovascular Metabolic Diseases Immuno-Oncology Oncology |
| E2F4 | RNA | - | - | - |
| E2F5 | RNA | Proliferation TGF Beta Signaling |
Immune Activation Status Immune Suppression |
Oncology Immuno-Oncology |
| EBI3 | RNA | - | Cytokines | Immuno-Oncology |
| EBV LMP2 | RNA | - | - | - |
| Ecalcidene | Lipid | - | - | - |
| ECHS1 | RNA | Biosynthesis and Anabolic Pathways Nutrient Capture and Catabolic Pathways |
- | CNS Metabolic Diseases |
| ECM1 | RNA | Angiogenesis Cell Proliferation |
- | Cardiovascular CNS Oncology |
| ECM2 | RNA | EMT | - | Oncology |
| ECSCR | RNA | Angiogenesis | - | Cardiovascular Oncology |
| ECSIT | RNA | - | - | - |
| EDC3 | RNA | - | - | - |
| EDN1 | RNA | Angiogenesis Cell Proliferation HIF1 Signaling Hypoxia Proliferation |
Cellular Growth Factor | Cardiovascular CNS Inflammation Oncology |
| EDNRB | RNA | - | - | - |
| EEA1 | RNA | Nutrient Capture and Catabolic Pathways Signaling Affecting Cellular Metabolism |
- | Metabolic Diseases |
| EED | RNA | - | - | - |
| EEF2K | RNA | - | Immunity and Inflammation | Inflammation |
| EFNA1 | RNA | RAS | Immune Activation Status | Oncology Immuno-Oncology |
| EFNA2 | RNA | RAS | - | Oncology |
| EFNA3 | RNA | MAPK PI3K-AKT RAS |
- | Cardiovascular Oncology CNS |
| EFNA4 | RNA | Signaling Affecting Cellular Metabolism | - | Metabolic Diseases |
| EFNA5 | RNA | MAPK PI3K-AKT RAS |
- | Cardiovascular Oncology CNS |
| EFNB3 | RNA | - | - | - |
| EFR3A | RNA | - | - | - |
| EGF | RNA | Angiogenesis Cell Proliferation EGFR Signaling ERBB2 Signaling Hypoxia MAPK PI3K-AKT Proliferation RAS |
Cellular Growth Factor Immune Activation Status |
Cardiovascular CNS Oncology Immuno-Oncology |
| EGFL7 | RNA | Angiogenesis Vasculogenesis |
- | Cardiovascular Oncology |
| EGFR | RNA | Adenosine Pathway Cell Proliferation Cell Stress Cellular Differentiation EGFR Signaling ERBB2 Signaling Hypoxia MAPK Metabolism Stress Nutrient Capture and Catabolic Pathways PI3K-AKT Proliferation RAS Signaling Affecting Cellular Metabolism |
Cellular Growth Factor Immune Activation Status Immunity and Inflammation Transmitter Release |
Immuno-Oncology CNS Oncology Cardiovascular Metabolic Diseases Inflammation |
| EGLN1 | RNA | - | - | - |
| EGLN2 | RNA | Proliferation Tumor Metabolism |
Cellular Growth Factor | Oncology |
| EGLN3 | RNA | Cell Proliferation HIF1 Signaling mTOR Signaling Tumor Metabolism |
- | CNS Inflammation Oncology |
| EGR1 | RNA | Costimulatory Signaling Interferon Signaling |
Immunity and Inflammation Lymphoid Compartment |
Immuno-Oncology Inflammation |
| EGR2 | RNA | Myelination | Activated Microglia Vesicle Trafficking |
CNS |
| EHHADH | RNA | Biosynthesis and Anabolic Pathways Lipid Metabolism Nutrient Capture and Catabolic Pathways |
- | CNS Metabolic Diseases |
| EHMT1 | RNA | - | - | - |
| EHMT2 | RNA | - | - | - |
| EIF1 | RNA | - | - | - |
| EIF2AK2 | RNA | Interferon Signaling | - | Immuno-Oncology |
| EIF2AK3 | RNA | Angiogenesis Tumor Metabolism |
- | Cardiovascular Oncology |
| EIF2B4 | RNA | - | - | - |
| EIF2S1 | RNA | - | - | - |
| EIF3B | RNA | ER Signaling | - | Oncology |
| EIF3F | RNA | - | - | - |
| EIF4A2 | RNA | - | - | - |
| EIF4B | RNA | - | Immune Activation Status | Immuno-Oncology |
| EIF4E2 | RNA | Cellular Differentiation Tumor Metabolism |
- | Oncology |
| EIF4EBP1 | RNA | Hypoxia Metabolism Stress mTOR Signaling PI3K-AKT Tumor Metabolism |
- | Cardiovascular Metabolic Diseases Oncology |
| EIF4G1 | RNA | mTOR Signaling | - | Oncology |
| EIF5AL1 | RNA | - | - | - |
| Elaidic carnitine | Lipid | - | - | - |
| ELANE | RNA | - | - | - |
| ELAVL1 | RNA | - | - | - |
| ELF3 | RNA | EMT | - | Oncology |
| ELK1 | RNA | - | - | - |
| ELK3 | RNA | Angiogenesis Transcriptional Misregulation |
- | Cardiovascular Epigenic and Nuclear Signaling Oncology |
| ELMO1 | RNA | - | - | - |
| ELN | RNA | - | - | - |
| ELOB | RNA | - | - | - |
| ELOVL2 | RNA | ER Signaling | - | Oncology |
| ELOVL3 | RNA | - | - | - |
| ELOVL4 | RNA | - | - | - |
| ELOVL5 | RNA | Androgen Signaling mTOR Signaling |
- | Oncology |
| ELOVL6 | RNA | - | - | - |
| ELOVL7 | RNA | - | - | - |
| EMCN | RNA | Angiogenesis Cellular Differentiation |
- | Cardiovascular Oncology |
| EME1 | RNA | Cell Stress | - | CNS Oncology |
| EMILIN1 | RNA | Cellular Differentiation | - | Oncology |
| EMILIN3 | RNA | - | - | - |
| EMP1 | Protein | - | Astrocyte Glial Cell Subtyping |
CNS |
| EMP1 | RNA | - | Astrocyte Glial Cell Subtyping |
CNS |
| EMP2 | RNA | - | - | - |
| EMP3 | RNA | Cell Proliferation | Cellular Growth Factor | CNS Oncology |
| ENDOG | RNA | - | - | - |
| ENG | RNA | - | - | - |
| ENO1 | RNA | Biosynthesis and Anabolic Pathways Hypoxia Metabolism Stress Proliferation Signaling Affecting Cellular Metabolism Tumor Metabolism |
Cellular Growth Factor | CNS Cardiovascular Metabolic Diseases Oncology |
| ENO2 | RNA | - | - | - |
| ENO3 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| ENPEP | RNA | Angiogenesis Cell Proliferation |
- | Cardiovascular CNS Oncology |
| ENPP2 | RNA | EMT | - | Oncology |
| ENPP6 | RNA | - | - | - |
| ENTPD1 | RNA | - | Immune Suppression | Immuno-Oncology |
| ENTPD2 | RNA | - | Immune Suppression T Cell Exhaustion Transmitter Response and Reuptake |
Immuno-Oncology CNS |
| ENTPD4 | RNA | - | Activated Microglia | CNS |
| EOMES | RNA | Transcriptional Regulation | Immune Cell Typing Lymphoid Compartment T Cell Exhaustion |
Epigenic and Nuclear Signaling Immuno-Oncology |
| EP300 | RNA | DNA Damage Repair Epigenic and Transcriptional Regulation HIF1 Signaling JAK-STAT Notch Oxydative Stress Proliferation TGF Beta Signaling Wnt Signaling |
Immunity and Inflammation Transmitter Response and Reuptake |
Epigenic and Nuclear Signaling Inflammation CNS Immuno-Oncology Oncology Metabolic Diseases Oncology |
| EP400 | RNA | - | - | - |
| EPAS1 | RNA | Angiogenesis | - | Cardiovascular Oncology |
| EPC1 | RNA | Epigenic and Transcriptional Regulation Transcriptional Regulation |
- | Epigenic and Nuclear Signaling |
| EpCAM | Protein | - | - | - |
| EPCAM | RNA | Cell Proliferation | - | CNS |
| EpCAM | - | EMT | Pan-Tumor | Oncology |
| EPCAM | - | Cell Proliferation | - | Oncology |
| EPG5 | RNA | - | - | - |
| EPHA1 | RNA | Angiogenesis Cell Proliferation |
- | Cardiovascular CNS Oncology |
| EPHA2 | RNA | Angiogenesis Cell Proliferation RAS Vasculogenesis |
- | Cardiovascular CNS Oncology |
| EPHA3 | RNA | - | - | - |
| EPHA4 | RNA | - | Axon and Dendrite Structure Neural Connectivity |
CNS |
| EPHA5 | RNA | - | Axon and Dendrite Structure | CNS |
| EPHA6 | RNA | - | - | - |
| EPHA7 | RNA | - | Axon and Dendrite Structure Neural Connectivity |
CNS |
| EPHB1 | RNA | Angiogenesis Cell Proliferation |
- | Cardiovascular CNS Oncology |
| EPHB3 | RNA | Angiogenesis Cellular Differentiation |
- | Cardiovascular Oncology |
| EPHB4 | RNA | Angiogenesis | - | Cardiovascular Oncology |
| EPHX2 | RNA | - | - | - |
| EPM2AIP1 | RNA | - | - | - |
| EPN3 | RNA | - | - | - |
| EPO | RNA | - | - | - |
| EPOR | RNA | - | - | - |
| EPS8L1 | RNA | - | - | - |
| EPSTI1 | RNA | - | Immunity and Inflammation | Inflammation |
| ER-alpha | Protein | ER Signaling | Pan-Tumor | Oncology |
| ERAP2 | RNA | - | - | - |
| ERBB2 | RNA | EMT ERBB2 Signaling Hypoxia Metabolism Stress Proliferation |
Cellular Growth Factor | Oncology Cardiovascular Metabolic Diseases |
| ERBB2IP | RNA | - | Cellular Growth Factor | Oncology |
| ERBB3 | RNA | Cell Proliferation Cellular Differentiation |
Cellular Growth Factor Immunity and Inflammation Transmitter Release |
CNS Oncology Inflammation |
| ERBB4 | RNA | - | - | - |
| ERC1 | RNA | - | - | - |
| ERCC1 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| ERCC2 | RNA | DNA Damage Repair | Immunity and Inflammation | Epigenic and Nuclear Signaling Inflammation |
| ERCC3 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| ERCC6 | RNA | Cell Stress DNA Damage Repair |
- | CNS Epigenic and Nuclear Signaling Oncology |
| EREG | RNA | Angiogenesis Cell Proliferation Proliferation |
Cellular Growth Factor | Cardiovascular CNS Oncology |
| ERG | RNA | - | - | - |
| Eriotriochin | Lipid | - | - | - |
| ERLEC1 | RNA | - | - | - |
| ERMP1 | RNA | - | - | - |
| ERN1 | RNA | Nutrient Capture and Catabolic Pathways | - | Metabolic Diseases |
| ERO1A | RNA | Metabolism Stress mTOR Signaling |
- | Metabolic Diseases Oncology |
| ERP29 | RNA | - | - | - |
| Erybraedin E | Lipid | - | - | - |
| ESAM | RNA | - | - | - |
| ESPL1 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| ESR1 | RNA | ER Signaling | - | Oncology |
| ESR2 | RNA | - | - | - |
| ESRP1 | RNA | FGFR Signaling | - | Cardiovascular CNS Inflammation Oncology |
| ESRP2 | RNA | FGFR Signaling | - | Cardiovascular CNS Inflammation Oncology |
| Estradiol dipropionate | Lipid | - | - | - |
| Etioline | Lipid | - | - | - |
| ETS1 | RNA | - | - | - |
| ETS2 | RNA | RAS | Immunity and Inflammation | Oncology Inflammation |
| ETV1 | RNA | - | - | - |
| ETV4 | RNA | Cell Proliferation Transcriptional Misregulation |
- | CNS Epigenic and Nuclear Signaling Oncology |
| ETV7 | RNA | Transcriptional Misregulation | - | Epigenic and Nuclear Signaling |
| EVI2A | RNA | - | - | - |
| EVL | RNA | - | - | - |
| EVPL | RNA | - | - | - |
| EWSR1 | RNA | - | - | - |
| Exiguaflavanone J | Lipid | - | - | - |
| EXO1 | RNA | Biosynthesis and Anabolic Pathways Cell Cycle Cell Stress DNA Damage Repair Proliferation |
- | CNS Oncology Epigenic and Nuclear Signaling Metabolic Diseases |
| EYA1 | RNA | DNA Damage Repair Epigenic and Transcriptional Regulation |
- | Epigenic and Nuclear Signaling |
| EYA2 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| EYA4 | RNA | DNA Damage Repair Epigenic and Transcriptional Regulation |
- | Epigenic and Nuclear Signaling |
| EZH1 | RNA | - | - | - |
| EZH2 | RNA | Angiogenesis Biosynthesis and Anabolic Pathways Epigenic and Transcriptional Regulation Metabolism Stress Transcriptional Regulation |
- | Cardiovascular CNS Epigenic and Nuclear Signaling Metabolic Diseases Oncology |
| F11R | RNA | Cellular Differentiation | - | Oncology |
| F12 | RNA | - | - | - |
| F13A1 | RNA | - | - | - |
| F2 | RNA | - | Transmitter Response and Reuptake | CNS |
| F2RL1 | RNA | - | Lymphoid Compartment Macrophage Function |
Immuno-Oncology |
| F3 | RNA | Cell Proliferation Proliferation |
Cellular Growth Factor Immunity and Inflammation |
CNS Oncology Inflammation |
| F5 | RNA | - | - | - |
| F8 | RNA | - | - | - |
| FA2H | RNA | Myelination | - | CNS |
| FAAP24 | RNA | - | - | - |
| FABP1 | RNA | - | - | - |
| FABP4 | RNA | - | - | - |
| FABP5 | RNA | Biosynthesis and Anabolic Pathways | Immunity and Inflammation | CNS Inflammation Metabolic Diseases |
| FADD | RNA | Apoptosis | Immune Activation Status Immunity and Inflammation |
Oncology Immuno-Oncology Inflammation |
| FAH | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| FAHD1 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| Falcarindiol | Lipid | - | - | - |
| FAM124B | RNA | Angiogenesis | - | Cardiovascular Oncology |
| FAM126A | RNA | Myelination | - | CNS |
| FAM129C | RNA | - | - | - |
| FAM174B | RNA | - | - | - |
| FAM198B | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| FAM214A | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| FAM30A | RNA | - | Immune Cell Typing | Immuno-Oncology |
| FAM83A | RNA | EGFR Signaling | - | Oncology |
| FAM83D | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| FANCA | RNA | Cell Stress DNA Damage Repair |
- | CNS Epigenic and Nuclear Signaling Oncology |
| FANCB | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| FANCC | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| FANCD2 | RNA | Cell Stress p53 Signaling |
- | CNS Oncology |
| FANCE | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| FANCF | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| FANCG | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| FANCI | RNA | Cell Stress p53 Signaling |
- | CNS Oncology |
| FANCL | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| FAP | RNA | Angiogenesis EMT |
- | Cardiovascular Oncology |
| FAP-alpha | - | - | Immune Cell Typing | Immuno-Oncology |
| FAS | RNA | Apoptosis Cytokine and Chemokine Signaling MAPK Oxydative Stress TNF Superfamily |
Axon and Dendrite Structure B Cell Function Immune Activation Status Immunity and Inflammation |
Oncology Immuno-Oncology Cardiovascular Inflammation CNS |
| FASLG | RNA | Cell Proliferation Cytotoxicity MAPK Myc NF-kappaB Signaling PI3K-AKT RAS Signaling Affecting Cellular Metabolism TNF Superfamily |
Immune Activation Status Immunity and Inflammation |
CNS Oncology Cardiovascular Metabolic Diseases Immuno-Oncology Inflammation |
| FASN | RNA | Biosynthesis and Anabolic Pathways Signaling Affecting Cellular Metabolism |
- | CNS Metabolic Diseases |
| FBLIM1 | RNA | - | Adhesion and Migration | CNS |
| FBLL1 | RNA | Epigenic and Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| FBLN1 | RNA | - | - | - |
| FBLN2 | RNA | ECM Remodeling | - | Metabolic Diseases Oncology |
| FBLN5 | RNA | Cellular Differentiation | - | Oncology |
| FBN1 | RNA | ECM Remodeling EMT |
- | Metabolic Diseases Oncology |
| FBN2 | RNA | - | - | - |
| FBP1 | RNA | Biosynthesis and Anabolic Pathways Cytotoxicity Metabolism Stress Signaling Affecting Cellular Metabolism |
Cellular Growth Factor | CNS Oncology Metabolic Diseases |
| FBP2 | RNA | - | - | - |
| FBXO6 | RNA | - | - | - |
| FBXO7 | RNA | - | - | - |
| FBXW11 | RNA | - | - | - |
| FBXW4 | RNA | - | Antigen Presentation Immune Activation Status |
Immuno-Oncology |
| FBXW7 | RNA | - | - | - |
| FCAR | RNA | - | Immune Cell Typing Inflammation Myeloid Compartment |
Immuno-Oncology Inflammation CNS |
| FCER1A | RNA | - | - | - |
| FCER1G | RNA | - | Immune Activation Status Immunity and Inflammation |
Immuno-Oncology Inflammation |
| FCER2 | RNA | - | Immune Activation Status Immune Suppression |
Immuno-Oncology |
| FCF1 | RNA | - | - | - |
| FCGR1A | RNA | Interferon Signaling | Antigen Presentation Immunity and Inflammation Myeloid Compartment |
Immuno-Oncology Inflammation CNS |
| FCGR1A/B | RNA | - | Antigen Presentation Immune Activation Status |
Immuno-Oncology |
| FCGR2A | RNA | - | - | - |
| FCGR2A/C | RNA | - | - | - |
| FCGR2B | RNA | - | B Cell Exhaustion Immune Activation Status Immunity and Inflammation |
Immuno-Oncology Inflammation |
| FCGR3A | RNA | - | Immunity and Inflammation | Inflammation |
| FCGR3A/B | RNA | - | Immune Activation Status Immune Cell Typing Inflammation |
Immuno-Oncology Inflammation |
| FCGRT | RNA | - | - | - |
| FCN1 | RNA | - | Myeloid Compartment | CNS |
| FCRL1 | RNA | - | - | - |
| FCRL2 | RNA | - | B Cell Function Immune Cell Typing |
Immuno-Oncology |
| FCRL3 | RNA | - | - | - |
| FCRL4 | RNA | - | B Cell Exhaustion | Immuno-Oncology |
| FCRL5 | RNA | - | - | - |
| FCRLA | RNA | - | Immunity and Inflammation | Inflammation |
| FCRLB | RNA | - | Immunity and Inflammation | Inflammation |
| FDX1 | RNA | Cell Stress | - | CNS Oncology |
| FDXR | RNA | Cell Stress | - | CNS Oncology |
| FEN1 | RNA | Cell Cycle DNA Damage Repair |
- | Oncology Epigenic and Nuclear Signaling |
| FERMT2 | RNA | - | - | - |
| FES | RNA | - | - | - |
| FEZ1 | RNA | - | - | - |
| FGA | RNA | - | Immune Activation Status | Immuno-Oncology |
| FGB | RNA | - | - | - |
| FGCR2A/B | RNA | - | - | - |
| FGD2 | RNA | Adenosine Pathway | Immunity and Inflammation | Immuno-Oncology Inflammation |
| FGF1 | RNA | MAPK PI3K-AKT RAS Signaling Affecting Cellular Metabolism |
- | Cardiovascular Oncology Metabolic Diseases CNS |
| FGF10 | RNA | MAPK PI3K-AKT RAS |
Immune Activation Status | Cardiovascular Oncology Immuno-Oncology CNS |
| FGF11 | RNA | RAS | - | Oncology |
| FGF12 | RNA | MAPK PI3K-AKT RAS |
Vesicle Trafficking | Cardiovascular Oncology CNS |
| FGF13 | RNA | MAPK PI3K-AKT RAS |
Immunity and Inflammation | Cardiovascular Oncology Inflammation CNS |
| FGF14 | RNA | RAS | Vesicle Trafficking | Oncology CNS |
| FGF16 | RNA | RAS | - | Oncology |
| FGF17 | RNA | RAS | - | Oncology |
| FGF18 | RNA | Angiogenesis Cell Proliferation MAPK PI3K-AKT RAS Vasculogenesis |
Cellular Growth Factor Immune Activation Status |
Cardiovascular CNS Oncology Immuno-Oncology |
| FGF19 | RNA | RAS | Immune Activation Status | Oncology Immuno-Oncology |
| FGF2 | RNA | Cell Proliferation MAPK PI3K-AKT Proliferation RAS |
Cellular Growth Factor Immune Activation Status |
CNS Cardiovascular Oncology Immuno-Oncology |
| FGF20 | RNA | RAS | - | Oncology |
| FGF21 | RNA | RAS | - | Oncology |
| FGF22 | RNA | RAS | Immune Activation Status | Oncology Immuno-Oncology |
| FGF23 | RNA | RAS | - | Oncology |
| FGF3 | RNA | RAS | - | Oncology |
| FGF4 | RNA | RAS | - | Oncology |
| FGF5 | RNA | RAS | - | Oncology |
| FGF6 | RNA | RAS | - | Oncology |
| FGF7 | RNA | FGFR Signaling MAPK PI3K-AKT RAS |
- | Cardiovascular Oncology CNS Inflammation |
| FGF8 | RNA | RAS | - | Oncology |
| FGF9 | RNA | Angiogenesis Cell Proliferation MAPK PI3K-AKT Proliferation RAS Vasculogenesis |
Cellular Growth Factor | Cardiovascular CNS Oncology |
| FGFBP1 | RNA | FGFR Signaling | - | Cardiovascular CNS Inflammation Oncology |
| FGFR1 | RNA | Angiogenesis Cell Proliferation FGFR Signaling MAPK Metabolism Stress PI3K-AKT RAS |
Cellular Growth Factor | Cardiovascular CNS Metabolic Diseases Oncology Inflammation |
| FGFR2 | RNA | Angiogenesis Cell Proliferation FGFR Signaling MAPK PI3K-AKT Proliferation RAS |
Cellular Growth Factor | Cardiovascular CNS Oncology Inflammation |
| FGFR3 | RNA | Cell Proliferation EMT FGFR Signaling MAPK PI3K-AKT Proliferation RAS |
Adhesion and Migration Cellular Growth Factor |
CNS Oncology Cardiovascular Inflammation |
| FGFR4 | RNA | Cell Proliferation MAPK PI3K-AKT Proliferation RAS |
Cellular Growth Factor | CNS Cardiovascular Oncology |
| FGG | RNA | - | - | - |
| FGL2 | RNA | EMT | Immunity and Inflammation | Oncology Inflammation |
| FGR | RNA | - | - | - |
| FH | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| FHL1 | RNA | EMT Proliferation |
Cellular Growth Factor | Oncology |
| Fibronectin | Protein | - | Immune Cell Typing | Immuno-Oncology |
| FIGF | RNA | Angiogenesis Cell Proliferation RAS Vasculogenesis |
Cellular Growth Factor | Cardiovascular CNS Oncology |
| FKBP1A | RNA | - | - | - |
| FKBP5 | RNA | - | - | - |
| FLCN | RNA | - | - | - |
| FLG | RNA | - | - | - |
| FLI1 | RNA | EMT | - | Oncology |
| FLNA | RNA | - | - | - |
| FLNB | RNA | Interferon Signaling MAPK |
- | Immuno-Oncology Cardiovascular CNS Oncology |
| FLNC | RNA | MAPK | - | Cardiovascular CNS Oncology |
| FLRT3 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| FLT1 | RNA | Angiogenesis Cell Proliferation HIF1 Signaling Hypoxia MAPK PI3K-AKT RAS Signaling Affecting Cellular Metabolism Vasculogenesis VEGFR Signaling |
Activated Microglia Cellular Growth Factor Immunity and Inflammation |
Cardiovascular CNS Inflammation Oncology Metabolic Diseases |
| FLT3 | RNA | Signaling Affecting Cellular Metabolism Transcriptional Misregulation |
- | Metabolic Diseases Epigenic and Nuclear Signaling |
| Flt3 ligand | Protein | - | - | - |
| Flt3/Flk-2/CD135 | Protein | - | - | - |
| FLT3LG | RNA | - | Cytokines | Immuno-Oncology |
| FLT4 | RNA | Cell Proliferation Vasculogenesis VEGFR Signaling |
Adhesion and Migration Cellular Growth Factor |
CNS Cardiovascular Oncology |
| Fluoxymesterone | Lipid | - | - | - |
| FMOD | RNA | Cellular Differentiation ECM Remodeling |
Cellular Growth Factor | Oncology Metabolic Diseases |
| FMR1 | RNA | - | Axon and Dendrite Structure Neural Connectivity Vesicle Trafficking |
CNS |
| FN1 | RNA | Angiogenesis Oxydative Stress |
Activated Microglia | Cardiovascular Inflammation CNS Oncology |
| FNBP1 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| FNIP1 | RNA | Signaling Affecting Cellular Metabolism | - | Metabolic Diseases |
| FNIP2 | RNA | Signaling Affecting Cellular Metabolism | - | Metabolic Diseases |
| FOLH1 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| FOLH1B | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| FOLR1 | RNA | Nutrient Capture and Catabolic Pathways | - | Metabolic Diseases |
| FOLR3 | RNA | Nutrient Capture and Catabolic Pathways | - | Metabolic Diseases |
| FOS | RNA | AP1 Signaling MAPK Oxydative Stress TCR Signaling |
Immune Activation Status Immunity and Inflammation Transmitter Release Transmitter Response and Reuptake |
Cardiovascular Inflammation Immuno-Oncology CNS Oncology Metabolic Diseases Oncology |
| FOSB | RNA | - | - | - |
| FOSL1 | RNA | Wnt Signaling | Myeloid Compartment | CNS Oncology |
| FOXA1 | RNA | - | - | - |
| FOXA2 | RNA | - | - | - |
| FOXC1 | RNA | - | - | - |
| FOXC2 | RNA | Cell Proliferation Cellular Differentiation EMT Vasculogenesis |
- | CNS Oncology Cardiovascular |
| FOXJ1 | RNA | - | - | - |
| FOXL2 | RNA | - | - | - |
| FOXM1 | RNA | Biosynthesis and Anabolic Pathways Cell Cycle DNA Damage Repair Transcriptional Regulation |
- | CNS Oncology Epigenic and Nuclear Signaling Metabolic Diseases |
| FOXO1 | RNA | - | Immune Activation Status | Immuno-Oncology |
| FOXO3 | RNA | - | Immune Activation Status | Immuno-Oncology |
| FOXO4 | RNA | Cell Proliferation RAS |
Cellular Growth Factor | CNS Oncology |
| FOXP1 | RNA | Androgen Signaling | - | Oncology |
| FOXP3 | Protein | Epigenic and Transcriptional Regulation Transcriptional Regulation |
Cytokines Immune Cell Typing |
Epigenic and Nuclear Signaling Immuno-Oncology |
| FOXP3 | RNA | Epigenic and Transcriptional Regulation Transcriptional Regulation |
Cytokines Immune Cell Typing |
Epigenic and Nuclear Signaling Immuno-Oncology |
| FPR1 | RNA | Adenosine Pathway Signaling Affecting Cellular Metabolism |
Immune Cell Typing Immune Suppression Inflammation Myeloid Compartment |
Immuno-Oncology Metabolic Diseases Inflammation CNS |
| FPR2 | RNA | - | - | - |
| FPR3 | RNA | - | Myeloid Compartment | CNS |
| FRAS1 | RNA | Cellular Differentiation | - | Oncology |
| FREM1 | RNA | - | - | - |
| FREM2 | RNA | - | Adhesion and Migration | CNS |
| FRMD6 | RNA | Hippo Signaling | - | CNS Oncology |
| FRMPD4 | RNA | - | Axon and Dendrite Structure Neural Connectivity |
CNS |
| FRS2 | RNA | - | - | - |
| Fructose 1 P | Amino-acid & Metabolites | - | - | - |
| FSCN1 | RNA | - | Immunity and Inflammation | Inflammation |
| FST | RNA | TGF Beta Signaling | - | Oncology |
| FSTL1 | RNA | EMT Hippo Signaling |
- | Oncology CNS |
| FSTL3 | RNA | Angiogenesis | - | Cardiovascular Oncology |
| FTCD | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| FTSJ2 | RNA | - | - | - |
| FUBP1 | RNA | - | - | - |
| Fucalpha1-2Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0) | Lipid | - | - | - |
| fumagillin | Lipid | - | - | - |
| Fumarate | Amino-acid & Metabolites | - | - | - |
| FURIN | RNA | - | - | - |
| FUS | Protein | - | Axon and Dendrite Structure Neural Connectivity PD Pathology |
CNS |
| FUS | RNA | - | Axon and Dendrite Structure Neural Connectivity PD Pathology |
CNS |
| FUT3 | RNA | EMT | - | Oncology |
| FUT4 | RNA | - | Immune Suppression | Immuno-Oncology |
| FUT5 | RNA | - | - | - |
| FUT7 | RNA | - | Leucocyte Function | Immuno-Oncology |
| FUT8 | RNA | - | - | - |
| FXN | RNA | Oxydative Stress | - | Inflammation |
| FXYD2 | RNA | - | - | - |
| FXYD3 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| FXYD6 | RNA | - | - | - |
| FYN | RNA | Costimulatory Signaling TCR Signaling |
Immune Activation Status Immune Checkpoint Immunity and Inflammation Neural Connectivity Transmitter Release |
Immuno-Oncology Inflammation CNS |
| FZD1 | RNA | - | - | - |
| FZD10 | RNA | Wnt Signaling | - | CNS Oncology |
| FZD2 | RNA | - | Immune Activation Status | Immuno-Oncology |
| FZD3 | RNA | - | - | - |
| FZD4 | RNA | - | - | - |
| FZD5 | RNA | - | - | - |
| FZD6 | RNA | - | - | - |
| FZD7 | RNA | Wnt Signaling | Immune Activation Status | CNS Immuno-Oncology Oncology |
| FZD8 | RNA | Wnt Signaling | - | CNS Oncology |
| FZD9 | RNA | Wnt Signaling | - | CNS Oncology |
| G6PC | RNA | Biosynthesis and Anabolic Pathways Signaling Affecting Cellular Metabolism |
- | CNS Metabolic Diseases |
| G6PD | RNA | Biosynthesis and Anabolic Pathways Metabolism Stress Signaling Affecting Cellular Metabolism |
- | CNS Metabolic Diseases |
| GAA | RNA | - | Activated Microglia | CNS |
| GAB1 | RNA | - | - | - |
| GAB2 | RNA | - | - | - |
| GABA gamma-Aminobutyric acid | Neuropeptide & Neurotransmitter | - | - | - |
| GABARAP | RNA | Nutrient Capture and Catabolic Pathways | - | Metabolic Diseases |
| GABPA | RNA | - | - | - |
| GABRA1 | RNA | - | Neural Connectivity Transmitter Release Transmitter Response and Reuptake Vesicle Trafficking |
CNS |
| GABRA4 | RNA | - | Neural Connectivity Transmitter Release Transmitter Response and Reuptake Vesicle Trafficking |
CNS |
| GABRB2 | RNA | - | Neural Connectivity Transmitter Release Transmitter Response and Reuptake Vesicle Trafficking |
CNS |
| GABRB3 | RNA | - | Neural Connectivity Transmitter Release Transmitter Response and Reuptake Vesicle Trafficking |
CNS |
| GABRG2 | RNA | - | Axon and Dendrite Structure Neural Connectivity Transmitter Release Transmitter Response and Reuptake Vesicle Trafficking |
CNS |
| GABRP | RNA | - | Neural Connectivity Transmitter Release Transmitter Response and Reuptake |
CNS |
| GABRR1 | RNA | - | Neural Connectivity Transmitter Release Transmitter Response and Reuptake Vesicle Trafficking |
CNS |
| GABRR3 | RNA | - | Neural Connectivity Transmitter Release Transmitter Response and Reuptake Vesicle Trafficking |
CNS |
| GAD1 | RNA | Biosynthesis and Anabolic Pathways Transmitter Synthesis |
Neural Connectivity Transmitter Release Vesicle Trafficking |
CNS Metabolic Diseases |
| GAD2 | RNA | Transmitter Synthesis | Axon and Dendrite Structure Neural Connectivity Transmitter Release Vesicle Trafficking |
CNS |
| GADD45A | RNA | MAPK Proliferation |
Immune Activation Status | Cardiovascular Oncology Immuno-Oncology CNS |
| GADD45B | RNA | MAPK Proliferation |
- | Cardiovascular Oncology CNS |
| GADD45G | RNA | MAPK Proliferation |
- | Cardiovascular Oncology CNS |
| GADL1 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| GAGE1 | RNA | - | - | - |
| GAL3ST1 | RNA | Lipid Metabolism Myelination |
- | Metabolic Diseases CNS |
| Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0) | Lipid | - | - | - |
| Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/18:0) | Lipid | - | - | - |
| Galalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0) | Lipid | - | - | - |
| Galbeta1-3(NeuAcalpha2-6)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0) | Lipid | - | - | - |
| GALC | RNA | Lipid Metabolism | Activated Microglia | Metabolic Diseases CNS |
| GalCer(d18:1/18:0) | Lipid | - | - | - |
| GalCer(d18:1/24:0) | Lipid | - | - | - |
| GalCer(d18:1/24:1(15Z)) | Lipid | - | - | - |
| GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0) | Lipid | - | - | - |
| GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0) | Lipid | - | - | - |
| GALNT3 | RNA | FGFR Signaling | - | Cardiovascular CNS Inflammation Oncology |
| GALNT7 | RNA | - | - | - |
| Gangetin | Lipid | - | - | - |
| GAPDH | Protein | Biosynthesis and Anabolic Pathways | Immune Cell Typing Neural Cell Typing |
CNS Immuno-Oncology Metabolic Diseases |
| GAPDH | RNA | Biosynthesis and Anabolic Pathways | Immune Cell Typing Neural Cell Typing |
CNS Immuno-Oncology Metabolic Diseases |
| GAPDHS | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| GAPVD1 | RNA | Nutrient Capture and Catabolic Pathways | - | Metabolic Diseases |
| GARS | RNA | - | - | - |
| GART | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| GAS1 | RNA | Hedgehog | - | CNS Inflammation Oncology |
| GATA1 | RNA | - | - | - |
| GATA2 | RNA | - | - | - |
| GATA3 | Protein | DNA Damage Repair Epigenic and Transcriptional Regulation |
Immune Activation Status M2 Activation |
Epigenic and Nuclear Signaling Immuno-Oncology CNS |
| GATA3 | RNA | DNA Damage Repair Epigenic and Transcriptional Regulation |
Immune Activation Status M2 Activation |
Epigenic and Nuclear Signaling Immuno-Oncology CNS |
| GATA4 | RNA | Proliferation Vasculogenesis |
Cellular Growth Factor | Oncology Cardiovascular |
| GATA6 | RNA | - | - | - |
| GATM | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| GBA | Protein | Autophagy Lipid Metabolism Nutrient Capture and Catabolic Pathways |
Activated Microglia Immunity and Inflammation |
Cardiovascular Metabolic Diseases CNS Inflammation Oncology |
| GBA | RNA | Autophagy Lipid Metabolism Nutrient Capture and Catabolic Pathways |
Activated Microglia Immunity and Inflammation |
Cardiovascular Metabolic Diseases CNS Inflammation Oncology |
| GBP1 | RNA | Interferon Signaling | - | Immuno-Oncology |
| GBP2 | RNA | Interferon Signaling | Immune Activation Status Immunity and Inflammation |
Immuno-Oncology Inflammation |
| GBP3 | RNA | - | Immune Activation Status | Immuno-Oncology |
| GBP4 | RNA | Interferon Signaling | - | Immuno-Oncology |
| GBP5 | RNA | - | - | - |
| GCA | RNA | - | - | - |
| GCDH | RNA | Biosynthesis and Anabolic Pathways Nutrient Capture and Catabolic Pathways |
- | CNS Metabolic Diseases |
| GCK | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| GCKR | RNA | - | - | - |
| GCLC | RNA | Biosynthesis and Anabolic Pathways Cell Stress |
Immunity and Inflammation | CNS Inflammation Oncology Metabolic Diseases |
| GCNT1 | RNA | - | - | - |
| GDA | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| GDF15 | RNA | EMT Proliferation |
Cellular Growth Factor | Oncology |
| GDF5 | RNA | Proliferation TGF Beta Signaling |
Cellular Growth Factor | Oncology |
| GDF6 | RNA | - | Cellular Growth Factor Immune Suppression |
Oncology Immuno-Oncology |
| GDNF | RNA | - | Transmitter Release Vesicle Trafficking |
CNS |
| GDP | Amino-acid & Metabolites | - | - | - |
| GDPD2 | RNA | Lipid Metabolism | - | Metabolic Diseases |
| GFAP | Protein | - | Astrocyte Inflammation Neural Cell Typing Neuronal Cytoskeleton Vesicle Trafficking |
CNS Inflammation |
| GFAP | RNA | - | Astrocyte Inflammation Neural Cell Typing Neuronal Cytoskeleton Vesicle Trafficking |
CNS Inflammation |
| GFER | RNA | - | - | - |
| GFI1 | RNA | - | - | - |
| GFM1 | RNA | - | - | - |
| GFPT1 | RNA | - | - | - |
| GGA1 | RNA | - | - | - |
| GGH | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| GGT1 | RNA | Carbohydrate Metabolism Lipid Metabolism |
- | CNS Metabolic Diseases |
| GHDC | RNA | - | - | - |
| GHR | RNA | Cytotoxicity Interferon Signaling JAK-STAT PI3K-AKT |
Immune Activation Status | Oncology Immuno-Oncology CNS Inflammation Metabolic Diseases Oncology |
| Gibberellin A51 | Lipid | - | - | - |
| GIMAP4 | RNA | - | - | - |
| GIMAP6 | RNA | - | - | - |
| Ginkgolide A | Lipid | - | - | - |
| GITR | Protein | - | T Cell Activation | Immuno-Oncology |
| GJA1 | RNA | - | - | - |
| GJA5 | RNA | Angiogenesis Cellular Differentiation Vasculogenesis |
- | Cardiovascular Oncology |
| GJB1 | RNA | Myelination | - | CNS |
| GJB2 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| GK | RNA | - | - | - |
| GLA | RNA | - | - | - |
| GLB1 | RNA | - | - | - |
| GlcCer(d14:1(4E)/24:1(15Z)(2OH)) | Lipid | - | - | - |
| GlcCer(d14:1/24:0) | Lipid | - | - | - |
| GlcCer(d15:1/20:0) | Lipid | - | - | - |
| GlcCer(d16:1(4E)/22:0(2OH)) | Lipid | - | - | - |
| GlcCer(d16:1/24:0) | Lipid | - | - | - |
| GlcCer(d16:2(4E.6E)/24:0(2OH)) | Lipid | - | - | - |
| GlcCer(d16:2(4E.6E)/24:0) | Lipid | - | - | - |
| GlcCer(d18:1/23:0) | Lipid | - | - | - |
| GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0) | Lipid | - | - | - |
| GLI1 | RNA | Hedgehog | - | CNS Inflammation Oncology |
| GLI2 | RNA | - | - | - |
| GLI3 | RNA | Hedgehog | - | CNS Inflammation Oncology |
| GLP1R | RNA | Adenosine Pathway | - | Immuno-Oncology |
| GLRB | RNA | - | Axon and Dendrite Structure Neural Connectivity Transmitter Release Transmitter Response and Reuptake Vesicle Trafficking |
CNS |
| GLRX | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| GLS | RNA | Biosynthesis and Anabolic Pathways Carbohydrate Metabolism Metabolism Stress Signaling Affecting Cellular Metabolism |
Transmitter Release Vesicle Trafficking |
CNS Metabolic Diseases |
| GLS2 | RNA | Biosynthesis and Anabolic Pathways Signaling Affecting Cellular Metabolism |
- | CNS Metabolic Diseases |
| Glucose | Amino-acid & Metabolites | - | - | - |
| Glucose 6P | Amino-acid & Metabolites | - | - | - |
| GLUD1 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| GLUD1/2 | RNA | - | - | - |
| GLUD2 | RNA | - | - | - |
| GLUL | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| glutamate | Amino-acid & Metabolites | - | - | - |
| Glutamate | Neuropeptide & Neurotransmitter | - | - | - |
| Glutamine | Amino-acid & Metabolites | - | - | - |
| GLYAT | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| Glycine | Amino-acid & Metabolites | - | - | - |
| GLYCTK | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| GLYR1 | RNA | - | - | - |
| GMIP | RNA | - | - | - |
| GMP | Amino-acid & Metabolites | - | - | - |
| GMPR | RNA | Biosynthesis and Anabolic Pathways Nutrient Capture and Catabolic Pathways |
- | CNS Metabolic Diseases |
| GMPR2 | RNA | Biosynthesis and Anabolic Pathways Nutrient Capture and Catabolic Pathways |
- | CNS Metabolic Diseases |
| GMPS | RNA | Biosynthesis and Anabolic Pathways mTOR Signaling |
- | CNS Oncology Metabolic Diseases |
| GNA11 | RNA | - | - | - |
| GNA15 | RNA | - | Immunity and Inflammation | Inflammation |
| GNAI1 | RNA | - | Transmitter Release Transmitter Response and Reuptake Vesicle Trafficking |
CNS |
| GNAI2 | RNA | - | Axon and Dendrite Structure Transmitter Release Transmitter Response and Reuptake Vesicle Trafficking |
CNS |
| GNAI3 | RNA | - | Inflammation Transmitter Release Transmitter Response and Reuptake |
Inflammation CNS |
| GNAO1 | RNA | Oxydative Stress | Axon and Dendrite Structure Transmitter Release Transmitter Response and Reuptake |
Inflammation CNS |
| GNAQ | RNA | - | Axon and Dendrite Structure Transmitter Release Transmitter Response and Reuptake |
CNS |
| GNAS | RNA | - | - | - |
| GNB1 | RNA | - | - | - |
| GNB4 | RNA | Adenosine Pathway | - | Immuno-Oncology |
| GNB5 | RNA | - | Transmitter Release Transmitter Response and Reuptake |
CNS |
| GNG10 | RNA | - | - | - |
| GNG12 | RNA | RAS Signaling Affecting Cellular Metabolism |
Immune Activation Status | Oncology Metabolic Diseases Immuno-Oncology |
| GNG2 | RNA | Adenosine Pathway | Activated Microglia Transmitter Release Transmitter Response and Reuptake |
Immuno-Oncology CNS |
| GNG4 | RNA | Cytokine and Chemokine Signaling MAPK PI3K-AKT RAS |
- | Immuno-Oncology Cardiovascular Oncology CNS |
| GNG7 | RNA | RAS | - | Oncology |
| GNGT1 | RNA | RAS | Transmitter Release Transmitter Response and Reuptake |
Oncology CNS |
| GNLY | RNA | Cytotoxicity | Immune Activation Status Immune Cell Typing Lymphoid Compartment |
Oncology Immuno-Oncology |
| GNPTAB | RNA | - | Activated Microglia | CNS |
| GNPTG | RNA | - | Activated Microglia | CNS |
| GNS | RNA | Nutrient Capture and Catabolic Pathways | - | Metabolic Diseases |
| GOT1 | RNA | Biosynthesis and Anabolic Pathways Metabolism Stress |
- | CNS Metabolic Diseases |
| GOT2 | RNA | Biosynthesis and Anabolic Pathways Metabolism Stress |
- | CNS Metabolic Diseases |
| GP1BB | RNA | - | - | - |
| GPATCH3 | RNA | - | - | - |
| GPC4 | RNA | Adenosine Pathway Wnt Signaling |
- | Immuno-Oncology CNS Oncology |
| GPD1L | RNA | Lipid Metabolism | - | Metabolic Diseases |
| GPI | RNA | Angiogenesis Biosynthesis and Anabolic Pathways Signaling Affecting Cellular Metabolism |
Cellular Growth Factor | Cardiovascular CNS Metabolic Diseases Oncology |
| GPNMB | Protein | - | Glial Cell Subtyping | CNS |
| GPNMB | RNA | - | Glial Cell Subtyping | CNS |
| GPR124 | RNA | - | - | - |
| GPR160 | RNA | - | - | - |
| GPR183 | RNA | - | Immunity and Inflammation | Inflammation |
| GPR34 | RNA | - | Immunity and Inflammation | Inflammation |
| GPR37 | RNA | Oxydative Stress Transmitter Synthesis |
- | Inflammation CNS |
| GPR4 | RNA | - | - | - |
| GPR56 | RNA | Angiogenesis | - | Cardiovascular Oncology |
| GPR62 | RNA | - | - | - |
| GPR65 | RNA | Adenosine Pathway | - | Immuno-Oncology |
| GPR84 | RNA | - | Activated Microglia Immunity and Inflammation |
CNS Inflammation |
| GPRASP1 | RNA | - | Activated Microglia | CNS |
| GPS1 | RNA | Cell Stress Nutrient Capture and Catabolic Pathways |
- | CNS Metabolic Diseases Oncology |
| GPSM3 | RNA | - | - | - |
| GPT | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| GPX1 | RNA | Angiogenesis Cell Proliferation Cell Stress Vasculogenesis |
- | Cardiovascular CNS Oncology |
| GPX2 | RNA | - | - | - |
| GPX3 | RNA | - | - | - |
| GPX4 | RNA | Cell Stress | - | CNS Oncology |
| GPX7 | RNA | - | - | - |
| Grandiflorone | Lipid | - | - | - |
| GRAP | RNA | - | Immunity and Inflammation | Inflammation |
| GRAP2 | RNA | Signaling Affecting Cellular Metabolism TCR Signaling |
Immune Activation Status | Metabolic Diseases Immuno-Oncology |
| GRB10 | RNA | - | Immune Activation Status | Immuno-Oncology |
| GRB2 | RNA | JAK-STAT MAPK PI3K-AKT RAS |
Immune Activation Status | CNS Cardiovascular Oncology Immuno-Oncology Inflammation Metabolic Diseases Oncology |
| GRB7 | RNA | ERBB2 Signaling PDGF Signaling |
- | Oncology |
| GREM1 | RNA | EMT Proliferation |
Cellular Growth Factor | Oncology |
| GREM2 | RNA | - | Immune Suppression | Immuno-Oncology |
| GRHL2 | RNA | - | - | - |
| GRIA1 | RNA | - | Axon and Dendrite Structure Neural Connectivity Transmitter Release Transmitter Response and Reuptake Vesicle Trafficking |
CNS |
| GRIA2 | RNA | - | Neural Connectivity Transmitter Release Transmitter Response and Reuptake Vesicle Trafficking |
CNS |
| GRIA3 | RNA | Transcriptional Misregulation | Axon and Dendrite Structure Neural Connectivity Transmitter Release Transmitter Response and Reuptake Vesicle Trafficking |
Epigenic and Nuclear Signaling CNS |
| GRIA4 | RNA | - | Axon and Dendrite Structure Neural Connectivity Transmitter Release Transmitter Response and Reuptake Vesicle Trafficking |
CNS |
| GRIK2 | RNA | - | Axon and Dendrite Structure Neural Connectivity Transmitter Release Transmitter Response and Reuptake Vesicle Trafficking |
CNS |
| GRIN1 | RNA | Biosynthesis and Anabolic Pathways MAPK RAS |
Axon and Dendrite Structure Neural Connectivity Transmitter Release Transmitter Response and Reuptake Vesicle Trafficking |
CNS Cardiovascular Oncology Metabolic Diseases |
| GRIN2A | RNA | MAPK RAS Transmitter Synthesis |
Immunity and Inflammation Neural Connectivity Transmitter Release Transmitter Response and Reuptake Vesicle Trafficking |
Cardiovascular Oncology CNS Inflammation |
| GRIN2B | RNA | RAS | Immunity and Inflammation Neural Connectivity Transmitter Release Transmitter Response and Reuptake Vesicle Trafficking |
Oncology Inflammation CNS |
| GRIN2C | RNA | - | Neural Connectivity Transmitter Release Transmitter Response and Reuptake Vesicle Trafficking |
CNS |
| GRIN2D | RNA | - | Neural Connectivity Transmitter Release Transmitter Response and Reuptake Vesicle Trafficking |
CNS |
| GRIN3B | RNA | - | Neural Connectivity Transmitter Release Transmitter Response and Reuptake Vesicle Trafficking |
CNS |
| GRK2 | RNA | - | - | - |
| GRK4 | RNA | - | - | - |
| GRK6 | RNA | - | - | - |
| GRM1 | RNA | - | Axon and Dendrite Structure Neural Connectivity Transmitter Release Transmitter Response and Reuptake Vesicle Trafficking |
CNS |
| GRM2 | RNA | - | Axon and Dendrite Structure Neural Connectivity Transmitter Release Transmitter Response and Reuptake Vesicle Trafficking |
CNS |
| GRM3 | RNA | - | - | - |
| GRM5 | RNA | - | Neural Connectivity Transmitter Release Transmitter Response and Reuptake Vesicle Trafficking |
CNS |
| GRM8 | RNA | - | Neural Connectivity Transmitter Release Transmitter Response and Reuptake Vesicle Trafficking |
CNS |
| GRN | RNA | - | Activated Microglia Immunity and Inflammation |
CNS Inflammation |
| GRPEL1 | RNA | - | - | - |
| GSDMD | RNA | - | - | - |
| GSK3B | RNA | Biosynthesis and Anabolic Pathways Carbohydrate Metabolism Epigenic and Transcriptional Regulation Hedgehog Oxydative Stress PI3K-AKT Proliferation Signaling Affecting Cellular Metabolism Wnt Signaling |
Axon and Dendrite Structure Immune Activation Status Neural Connectivity Transmitter Release Vesicle Trafficking |
CNS Epigenic and Nuclear Signaling Inflammation Oncology Metabolic Diseases Immuno-Oncology |
| GSN | RNA | - | Immunity and Inflammation Neuronal Cytoskeleton |
Inflammation CNS |
| GSR | RNA | Androgen Signaling mTOR Signaling Oxydative Stress |
- | Oncology Inflammation |
| GSS | RNA | Carbohydrate Metabolism Oxydative Stress |
- | CNS Inflammation Metabolic Diseases |
| GSTM1 | RNA | - | Immunity and Inflammation | Inflammation |
| GSTM4 | RNA | - | Inflammation | Inflammation |
| GSTP1 | RNA | Oxydative Stress | - | Inflammation |
| GTF2A1 | RNA | - | - | - |
| GTF2B | RNA | - | - | - |
| GTF2H1 | RNA | - | - | - |
| GTF2H2 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| GTF2H3 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| GTF2I | RNA | - | - | - |
| GTF2IRD1 | RNA | - | Transmitter Response and Reuptake | CNS |
| GTF3C1 | RNA | - | - | - |
| GTP | Amino-acid & Metabolites | - | - | - |
| GTSE1 | RNA | Biosynthesis and Anabolic Pathways Cell Cycle p53 Signaling |
- | CNS Oncology Metabolic Diseases |
| Guanine | Amino-acid & Metabolites | - | - | - |
| guanosine | Amino-acid & Metabolites | - | - | - |
| GUCY1A1 | RNA | - | - | - |
| GUCY1B1 | RNA | - | - | - |
| GUCY1B3 | RNA | Oxydative Stress | Transmitter Response and Reuptake | Inflammation CNS |
| GUSB | RNA | Nutrient Capture and Catabolic Pathways | Activated Microglia | Metabolic Diseases CNS |
| GYS2 | RNA | Signaling Affecting Cellular Metabolism | Immune Activation Status | Metabolic Diseases Immuno-Oncology |
| GzB | Protein | - | - | - |
| GZMA | Protein | Apoptosis Cytotoxicity |
Immune Activation Status Immune Cell Typing Lymphoid Compartment |
Oncology Immuno-Oncology |
| GZMA | RNA | Apoptosis Cytotoxicity |
Immune Activation Status Immune Cell Typing Lymphoid Compartment |
Oncology Immuno-Oncology |
| GZMB | Protein | Apoptosis Cytotoxicity Notch |
Immune Activation Status Immune Cell Typing Immune Suppression Immunity and Inflammation Lymphoid Compartment T Cell Activation |
Oncology Immuno-Oncology Inflammation |
| GZMB | RNA | Apoptosis Cytotoxicity Notch |
Immune Activation Status Immune Cell Typing Immune Suppression Immunity and Inflammation Lymphoid Compartment T Cell Activation |
Oncology Immuno-Oncology Inflammation |
| GZMH | RNA | Cytotoxicity | Immune Activation Status Immune Cell Typing Lymphoid Compartment |
Oncology Immuno-Oncology |
| GZMK | RNA | Cytotoxicity | Immune Activation Status Lymphoid Compartment |
Oncology Immuno-Oncology |
| GZMM | RNA | Cytotoxicity | Immune Activation Status Lymphoid Compartment |
Oncology Immuno-Oncology |
| H2AFX | RNA | DNA Damage Repair Epigenic and Transcriptional Regulation Metabolism Stress Proliferation |
- | Epigenic and Nuclear Signaling Metabolic Diseases Oncology |
| H2AFY2 | RNA | - | - | - |
| H2AX | RNA | - | - | - |
| H3-3A | RNA | - | - | - |
| H3-5 | RNA | - | - | - |
| H3C10 | RNA | - | - | - |
| H3C2 | RNA | - | - | - |
| H3C8 | RNA | - | - | - |
| H3F3A | RNA | - | - | - |
| H3F3C | RNA | - | - | - |
| H6PD | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| HAAO | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| HACD2 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| HACD4 | RNA | - | - | - |
| HADH | RNA | Biosynthesis and Anabolic Pathways Nutrient Capture and Catabolic Pathways |
- | CNS Metabolic Diseases |
| HADHA | RNA | - | - | - |
| HADHB | RNA | - | - | - |
| HAMP | RNA | - | - | - |
| HAP1 | RNA | - | Axon and Dendrite Structure Neural Connectivity Transmitter Release Vesicle Trafficking |
CNS |
| HAPLN1 | RNA | - | Adhesion and Migration | CNS |
| HAS1 | RNA | - | Adhesion and Migration | CNS |
| HAT1 | RNA | - | - | - |
| HAVCR1 | RNA | - | - | - |
| HAVCR2 | RNA | Costimulatory Signaling | Immune Activation Status Immune Checkpoint Inflammation T Cell Costimulation T Cell Exhaustion |
Immuno-Oncology Inflammation |
| HBB | RNA | - | - | - |
| HCAR2 | RNA | Adenosine Pathway | Immunity and Inflammation | Immuno-Oncology Inflammation |
| HCFC1 | RNA | - | - | - |
| HCK | RNA | Cytokine and Chemokine Signaling | Inflammation Leucocyte Function Myeloid Compartment |
Immuno-Oncology Inflammation CNS |
| HCN1 | RNA | - | Axon and Dendrite Structure Transmitter Release |
CNS |
| HCST | RNA | - | Immune Activation Status | Immuno-Oncology |
| HDAC1 | RNA | Androgen Signaling Chromatin Modification Epigenic and Transcriptional Regulation Notch Proliferation Transcriptional Misregulation |
- | Oncology Epigenic and Nuclear Signaling Immuno-Oncology |
| HDAC10 | RNA | Chromatin Modification Epigenic and Transcriptional Regulation |
- | Epigenic and Nuclear Signaling |
| HDAC11 | RNA | Chromatin Modification Epigenic and Transcriptional Regulation Notch |
- | Epigenic and Nuclear Signaling Immuno-Oncology |
| HDAC2 | RNA | Chromatin Modification Epigenic and Transcriptional Regulation Notch Oxydative Stress Proliferation Transcriptional Misregulation |
- | Epigenic and Nuclear Signaling Immuno-Oncology Inflammation Oncology |
| HDAC3 | RNA | Epigenic and Transcriptional Regulation Notch |
- | Epigenic and Nuclear Signaling Immuno-Oncology |
| HDAC4 | RNA | Chromatin Modification Epigenic and Transcriptional Regulation Notch |
- | Epigenic and Nuclear Signaling Immuno-Oncology |
| HDAC5 | RNA | Chromatin Modification Epigenic and Transcriptional Regulation Notch |
- | Epigenic and Nuclear Signaling Immuno-Oncology |
| HDAC6 | RNA | Chromatin Modification Epigenic and Transcriptional Regulation Oxydative Stress |
Axon and Dendrite Structure | Epigenic and Nuclear Signaling Inflammation CNS |
| HDAC7 | RNA | Epigenic and Transcriptional Regulation | Immune Suppression | Epigenic and Nuclear Signaling Immuno-Oncology |
| HDAC8 | RNA | - | - | - |
| HDAC9 | RNA | Epigenic and Transcriptional Regulation | Immune Suppression | Epigenic and Nuclear Signaling Immuno-Oncology |
| HDC | RNA | Biosynthesis and Anabolic Pathways | Immune Cell Typing | CNS Immuno-Oncology Metabolic Diseases |
| HDHD3 | RNA | - | - | - |
| HEG1 | RNA | Cellular Differentiation EMT Vasculogenesis |
- | Oncology Cardiovascular |
| HELLS | RNA | Chromatin Modification DNA Damage Repair Epigenic and Transcriptional Regulation |
- | Epigenic and Nuclear Signaling |
| HEMK1 | RNA | ER Signaling | - | Oncology |
| HER2 | Protein | - | - | - |
| Her2 | - | - | Pan-Tumor | Oncology |
| HERC1 | RNA | Signaling Affecting Cellular Metabolism | - | Metabolic Diseases |
| HERC5 | RNA | - | - | - |
| HERC6 | RNA | - | - | - |
| HES1 | RNA | Notch | - | Immuno-Oncology |
| HES5 | RNA | - | - | - |
| HEXA | RNA | Nutrient Capture and Catabolic Pathways | - | Metabolic Diseases |
| Hexacosanedioic acid | Lipid | - | - | - |
| HEXB | RNA | Myelination Nutrient Capture and Catabolic Pathways |
- | CNS Metabolic Diseases |
| HEY1 | RNA | Angiogenesis Notch |
Immune Suppression | Cardiovascular Immuno-Oncology Oncology |
| HEY2 | RNA | - | Immune Suppression | Immuno-Oncology |
| HFE | RNA | - | - | - |
| HGF | RNA | Cell Proliferation Cellular Differentiation EMT MAPK Met Signaling Myelination Oxydative Stress PI3K-AKT Proliferation RAS |
Cellular Growth Factor Immune Activation Status |
CNS Oncology Cardiovascular Inflammation Immuno-Oncology |
| HHEX | RNA | - | - | - |
| HHIP | RNA | - | - | - |
| HIAA (5-hydroxy-Indole-3-acetic acid) | Amino-acid & Metabolites | - | - | - |
| HIF | - | HIF1 Signaling | - | Inflammation Oncology |
| HIF1A | RNA | Angiogenesis Autophagy Cell Stress Cytokine and Chemokine Signaling EMT HIF1 Signaling Hypoxia Metabolism Stress Notch Nutrient Capture and Catabolic Pathways Oxydative Stress Proliferation Signaling Affecting Cellular Metabolism Transcriptional Regulation Vasculogenesis |
Activated Microglia Axon and Dendrite Structure Cellular Growth Factor Immunity and Inflammation T Cell Exhaustion |
Cardiovascular CNS Immuno-Oncology Oncology Inflammation Metabolic Diseases Epigenic and Nuclear Signaling Oncology |
| HIF3A | RNA | Cell Stress Transcriptional Regulation |
- | CNS Epigenic and Nuclear Signaling Oncology |
| HIKESHI | RNA | - | - | - |
| HILPDA | RNA | - | Immunity and Inflammation | Inflammation |
| HIPK1 | RNA | Cell Proliferation | - | CNS Oncology |
| HIPK2 | RNA | Cell Proliferation | Cellular Growth Factor | CNS Oncology |
| HIRA | RNA | - | - | - |
| HIST1H1C | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| HIST1H1D | RNA | - | Immunity and Inflammation | Inflammation |
| HIST1H2AC | RNA | - | - | - |
| HIST1H2AE | RNA | - | - | - |
| HIST1H2BD | RNA | - | - | - |
| HIST1H2BF | RNA | - | - | - |
| HIST1H2BH | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| HIST1H2BK | RNA | - | - | - |
| HIST1H3B | RNA | - | - | - |
| HIST1H3G | RNA | - | - | - |
| HIST1H3H | RNA | Transcriptional Misregulation | - | Epigenic and Nuclear Signaling |
| HIST1H4E | RNA | - | - | - |
| HIST1H4H | RNA | - | - | - |
| HIST3H2BB | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| Histone H3 | Protein | - | Immune Cell Typing Neural Cell Typing |
Immuno-Oncology CNS |
| HJURP | RNA | Biosynthesis and Anabolic Pathways Cell Cycle |
- | CNS Oncology Metabolic Diseases |
| HK1 | RNA | Biosynthesis and Anabolic Pathways Hypoxia Metabolism Stress |
- | CNS Cardiovascular Metabolic Diseases Oncology |
| HK2 | RNA | Biosynthesis and Anabolic Pathways HIF1 Signaling Hypoxia Metabolism Stress mTOR Signaling Myc Tumor Metabolism |
- | CNS Inflammation Cardiovascular Metabolic Diseases Oncology |
| HK3 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| HKDC1 | RNA | - | - | - |
| HLA-A | RNA | Antigen Processing Interferon Signaling Nutrient Capture and Catabolic Pathways Signaling Affecting Cellular Metabolism |
Antigen Presentation Immune Cell Adhesion and Migration |
Immuno-Oncology Metabolic Diseases |
| HLA-B | RNA | Antigen Processing Interferon Signaling |
Antigen Presentation Immune Cell Adhesion and Migration |
Immuno-Oncology |
| HLA-C | RNA | Antigen Processing Interferon Signaling Nutrient Capture and Catabolic Pathways Signaling Affecting Cellular Metabolism |
Antigen Presentation Immune Cell Adhesion and Migration |
Immuno-Oncology Metabolic Diseases |
| HLA-DMA | RNA | Antigen Processing | Antigen Presentation Immune Cell Adhesion and Migration |
Immuno-Oncology |
| HLA-DMB | RNA | Antigen Processing | Antigen Presentation Immune Cell Adhesion and Migration |
Immuno-Oncology |
| HLA-DOA | RNA | - | Antigen Presentation Immune Cell Adhesion and Migration |
Immuno-Oncology |
| HLA-DOB | RNA | Antigen Processing | Antigen Presentation Cytokines Immune Cell Adhesion and Migration Lymphoid Compartment |
Immuno-Oncology |
| HLA-DPA1 | RNA | Antigen Processing Costimulatory Signaling Interferon Signaling TCR Signaling |
Antigen Presentation Immune Activation Status Immune Cell Adhesion and Migration Immune Checkpoint |
Immuno-Oncology |
| HLA-DPB1 | RNA | Antigen Processing Costimulatory Signaling Interferon Signaling TCR Signaling |
Antigen Presentation Immune Activation Status Immune Cell Adhesion and Migration Immune Checkpoint |
Immuno-Oncology |
| HLA-DQ | - | - | Antigen Presentation | Immuno-Oncology |
| HLA-DQA | RNA | - | - | - |
| HLA-DQA1 | RNA | Antigen Processing Costimulatory Signaling Interferon Signaling Signaling Affecting Cellular Metabolism TCR Signaling |
Antigen Presentation Immune Activation Status Immune Cell Adhesion and Migration Immune Checkpoint |
Immuno-Oncology Metabolic Diseases |
| HLA-DQA2 | RNA | Costimulatory Signaling Interferon Signaling |
Antigen Presentation Immune Activation Status Immune Cell Adhesion and Migration Immune Checkpoint |
Immuno-Oncology |
| HLA-DQB1 | RNA | Antigen Processing Costimulatory Signaling Interferon Signaling TCR Signaling |
Antigen Presentation Immune Activation Status Immune Cell Adhesion and Migration Immune Checkpoint |
Immuno-Oncology |
| HLA-DQB2 | RNA | - | Antigen Presentation Immune Activation Status Immune Checkpoint |
Immuno-Oncology |
| HLA-DR | Protein | - | Antigen Presentation Immune Cell Typing Microglia Myeloid Compartment Neural Cell Typing |
Immuno-Oncology CNS |
| HLA-DRA | RNA | Antigen Processing Costimulatory Signaling Interferon Signaling TCR Signaling |
Antigen Presentation Immune Activation Status Immune Cell Adhesion and Migration Immune Checkpoint |
Immuno-Oncology |
| HLA-DRB | RNA | - | Antigen Presentation | Immuno-Oncology |
| HLA-DRB1 | RNA | Costimulatory Signaling Interferon Signaling Signaling Affecting Cellular Metabolism TCR Signaling |
Antigen Presentation Immune Cell Adhesion and Migration |
Immuno-Oncology Metabolic Diseases |
| HLA-DRB1/3 | RNA | - | Antigen Presentation Immune Activation Status Immune Checkpoint |
Immuno-Oncology |
| HLA-DRB3 | RNA | Antigen Processing TCR Signaling |
- | Immuno-Oncology |
| HLA-DRB3/4 | RNA | - | - | - |
| HLA-DRB4 | RNA | Antigen Processing | - | Immuno-Oncology |
| HLA-DRB5 | RNA | Costimulatory Signaling Interferon Signaling |
Antigen Presentation Immune Cell Adhesion and Migration |
Immuno-Oncology |
| HLA-E | RNA | DNA Damage Repair Interferon Signaling Nutrient Capture and Catabolic Pathways Signaling Affecting Cellular Metabolism |
Antigen Presentation Immune Activation Status Immune Cell Adhesion and Migration Immunity and Inflammation |
Epigenic and Nuclear Signaling Immuno-Oncology Metabolic Diseases Inflammation |
| HLA-F | RNA | Interferon Signaling | Antigen Presentation Immune Cell Adhesion and Migration |
Immuno-Oncology |
| HLA-G | RNA | - | - | - |
| HLX | RNA | - | - | - |
| HMGA1 | RNA | Chromatin Modification Epigenic and Transcriptional Regulation Metabolism Stress |
- | Epigenic and Nuclear Signaling Metabolic Diseases |
| HMGA2 | RNA | - | - | - |
| HMGB1 | RNA | Apoptosis Autophagy |
Immune Activation Status Immunity and Inflammation |
Oncology Cardiovascular Immuno-Oncology Inflammation CNS Metabolic Diseases Oncology |
| HMGB2 | RNA | - | - | - |
| HMGCR | RNA | - | - | - |
| HMGCS2 | RNA | - | - | - |
| HMGN1 | RNA | - | - | - |
| HMGN5 | RNA | - | - | - |
| HMOX1 | RNA | Angiogenesis Cell Proliferation Cell Stress Cellular Differentiation HIF1 Signaling Oxydative Stress Signaling Affecting Cellular Metabolism |
- | Cardiovascular CNS Oncology Inflammation Metabolic Diseases |
| HNF1A | RNA | Epigenic and Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| HNF4A | RNA | Signaling Affecting Cellular Metabolism Transcriptional Regulation |
- | Metabolic Diseases Epigenic and Nuclear Signaling |
| HNRNPM | RNA | - | - | - |
| HOMER1 | RNA | - | Axon and Dendrite Structure Neural Connectivity Transmitter Release Vesicle Trafficking |
CNS |
| Homomurideoxycholic acid | Lipid | - | - | - |
| Homo-omega-muricholic acid | Lipid | - | - | - |
| HOXA10 | RNA | - | - | - |
| HOXA11 | RNA | - | - | - |
| HOXA5 | RNA | Cell Proliferation Transcriptional Misregulation |
- | CNS Epigenic and Nuclear Signaling Oncology |
| HOXA7 | RNA | Angiogenesis Transcriptional Misregulation |
- | Cardiovascular Epigenic and Nuclear Signaling Oncology |
| HOXA9 | RNA | Transcriptional Misregulation | - | Epigenic and Nuclear Signaling |
| HOXB13 | RNA | Angiogenesis Transcriptional Misregulation |
- | Cardiovascular Epigenic and Nuclear Signaling Oncology |
| HOXB3 | RNA | Angiogenesis Transcriptional Misregulation |
- | Cardiovascular Epigenic and Nuclear Signaling Oncology |
| HPD | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| HPGD | RNA | - | - | - |
| HPGDS | RNA | Lipid Metabolism | - | Metabolic Diseases |
| HPRT1 | RNA | Biosynthesis and Anabolic Pathways Nutrient Capture and Catabolic Pathways |
- | CNS Metabolic Diseases |
| HPS4 | RNA | - | Immunity and Inflammation | Inflammation |
| HPSE | RNA | Cellular Differentiation Vasculogenesis |
Cellular Growth Factor | Oncology Cardiovascular |
| HRAS | RNA | Autophagy Cell Proliferation Cytokine and Chemokine Signaling EGFR Signaling ERBB2 Signaling FGFR Signaling JAK-STAT MAPK Met Signaling Metabolism Stress Nutrient Capture and Catabolic Pathways PI3K-AKT PDGF Signaling RAS Signaling Affecting Cellular Metabolism TCR Signaling |
Cellular Growth Factor Immune Activation Status Transmitter Release Transmitter Response and Reuptake Vesicle Trafficking |
Cardiovascular CNS Immuno-Oncology Oncology Metabolic Diseases Inflammation Oncology |
| HRK | RNA | - | - | - |
| HSBP1 | RNA | - | - | - |
| HSC70 | Protein | Autophagy | - | Cardiovascular CNS Inflammation Metabolic Diseases Oncology |
| HSD11B1 | RNA | - | Immune Cell Typing | Immuno-Oncology |
| HSD17B12 | RNA | - | - | - |
| HSD17B4 | RNA | - | - | - |
| HSD17B8 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| HSF1 | RNA | Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| HSF2 | RNA | Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| HSH2D | RNA | - | - | - |
| HSP90AA1 | RNA | - | - | - |
| HSP90AB1 | RNA | - | - | - |
| HSP90B1 | RNA | Cellular Differentiation | - | Oncology |
| HSPA1A | RNA | - | - | - |
| HSPA2 | RNA | Biosynthesis and Anabolic Pathways MAPK Nutrient Capture and Catabolic Pathways Signaling Affecting Cellular Metabolism |
- | CNS Cardiovascular Metabolic Diseases Oncology |
| HSPA4 | RNA | Signaling Affecting Cellular Metabolism | - | Metabolic Diseases |
| HSPA6 | RNA | - | - | - |
| HSPA9 | RNA | - | - | - |
| HSPB1 | RNA | Cellular Differentiation Oxydative Stress VEGFR Signaling |
- | Oncology Inflammation Cardiovascular |
| HSPB2 | RNA | - | - | - |
| HSPE1 | RNA | Signaling Affecting Cellular Metabolism | - | Metabolic Diseases |
| HSPG2 | RNA | Adenosine Pathway Angiogenesis |
- | Immuno-Oncology Cardiovascular Oncology |
| HTR1A | RNA | Transmitter Synthesis | Transmitter Release Transmitter Response and Reuptake |
CNS |
| HTR5A | RNA | - | Axon and Dendrite Structure Transmitter Release Transmitter Response and Reuptake |
CNS |
| HTRA2 | RNA | Oxydative Stress | - | Inflammation |
| HTT | RNA | - | Axon and Dendrite Structure Neural Connectivity |
CNS |
| HUNK | RNA | Cellular Differentiation | - | Oncology |
| HUS1 | RNA | - | - | - |
| HUWE1 | RNA | - | Inflammation | Inflammation |
| HVCN1 | RNA | - | - | - |
| Hydrocortisone caproate | Lipid | - | - | - |
| Hypoxanthine | Amino-acid & Metabolites | - | - | - |
| IBA1 | Protein | - | Microglia Neural Cell Typing |
CNS |
| IBSP | RNA | PI3K-AKT Proliferation |
Adhesion and Migration Cellular Growth Factor |
Oncology CNS |
| ICAM1 | RNA | Interferon Signaling Matrix Remodeling and Metastases |
Adhesion and Migration Immune Activation Status Immune Suppression |
Immuno-Oncology CNS Oncology |
| ICAM2 | RNA | Matrix Remodeling and Metastases | Immunity and Inflammation | CNS Inflammation Oncology |
| ICAM3 | RNA | Matrix Remodeling and Metastases | - | CNS Oncology |
| ICAM4 | RNA | - | - | - |
| ICAM5 | RNA | - | - | - |
| ICOS | Protein | Costimulatory Signaling Signaling Affecting Cellular Metabolism TCR Signaling |
Immune Activation Status Immune Checkpoint Lymphoid Compartment M1 Activation M2 Activation T Cell Activation T Cell Costimulation |
Immuno-Oncology Metabolic Diseases CNS |
| ICOS | RNA | Costimulatory Signaling Signaling Affecting Cellular Metabolism TCR Signaling |
Immune Activation Status Immune Checkpoint Lymphoid Compartment M1 Activation M2 Activation T Cell Activation T Cell Costimulation |
Immuno-Oncology Metabolic Diseases CNS |
| ICOSLG | RNA | Costimulatory Signaling | Immune Checkpoint Lymphoid Compartment |
Immuno-Oncology |
| ID1 | RNA | Angiogenesis Cellular Differentiation Proliferation TGF Beta Signaling Vasculogenesis |
Cellular Growth Factor | Cardiovascular Oncology |
| ID2 | RNA | Cell Proliferation TGF Beta Signaling Transcriptional Misregulation |
Immune Activation Status Immune Suppression |
CNS Oncology Epigenic and Nuclear Signaling Immuno-Oncology |
| ID4 | RNA | Cell Proliferation TGF Beta Signaling |
- | CNS Oncology |
| IDE | Protein | Amyloid Processing Carbohydrate Metabolism |
AD Pathology | CNS Metabolic Diseases |
| IDE | RNA | Amyloid Processing Carbohydrate Metabolism |
AD Pathology | CNS Metabolic Diseases |
| IDH1 | RNA | Biosynthesis and Anabolic Pathways Carbohydrate Metabolism Cell Stress mTOR Signaling Oxydative Stress |
- | CNS Oncology Inflammation Metabolic Diseases |
| IDH2 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| IDH3A | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| IDH3B | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| IDH3G | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| IDNK | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| IDO1 | Protein | Biosynthesis and Anabolic Pathways | Cytokines Immune Suppression Lymphoid Compartment Myeloid Compartment |
CNS Immuno-Oncology Metabolic Diseases |
| IDO1 | RNA | Biosynthesis and Anabolic Pathways | Cytokines Immune Suppression Lymphoid Compartment Myeloid Compartment |
CNS Immuno-Oncology Metabolic Diseases |
| IDO2 | RNA | Biosynthesis and Anabolic Pathways | Immune Suppression | CNS Immuno-Oncology Metabolic Diseases |
| IER3 | RNA | - | Myeloid Compartment | CNS |
| IFI16 | RNA | Cytotoxicity Interferon Signaling |
Chemokines | Oncology Immuno-Oncology |
| IFI27 | RNA | Cytotoxicity Interferon Signaling |
Chemokines Lymphoid Compartment |
Oncology Immuno-Oncology |
| IFI30 | RNA | - | Immunity and Inflammation | Inflammation |
| IFI35 | RNA | Cytotoxicity Interferon Signaling |
Chemokines | Oncology Immuno-Oncology |
| IFI44 | RNA | - | - | - |
| IFI44L | RNA | - | - | - |
| IFI6 | RNA | Cytotoxicity Interferon Signaling |
- | Oncology Immuno-Oncology |
| IFIH1 | RNA | Cytotoxicity Interferon Signaling |
Immunity and Inflammation | Oncology Immuno-Oncology Inflammation |
| IFIT1 | RNA | Cytotoxicity Interferon Signaling |
Chemokines Immune Activation Status Lymphoid Compartment |
Oncology Immuno-Oncology |
| IFIT2 | RNA | Cytotoxicity Interferon Signaling |
Chemokines | Oncology Immuno-Oncology |
| IFIT3 | RNA | Cytotoxicity Interferon Signaling |
Immune Activation Status | Oncology Immuno-Oncology |
| IFITM1 | RNA | Cytotoxicity Interferon Signaling |
Lymphoid Compartment | Oncology Immuno-Oncology |
| IFITM2 | RNA | Cytotoxicity Interferon Signaling |
Immunity and Inflammation | Oncology Immuno-Oncology Inflammation |
| IFITM3 | RNA | - | Immunity and Inflammation | Inflammation |
| IFNA1 | RNA | Interferon Signaling JAK-STAT PI3K-AKT |
Interleukins | Immuno-Oncology CNS Oncology Inflammation Metabolic Diseases Oncology |
| IFNA1/13 | RNA | - | Immune Activation Status | Immuno-Oncology |
| IFNA14/16 | RNA | - | - | - |
| IFNA17 | RNA | - | Interleukins | Inflammation |
| IFNA2 | RNA | - | Interleukins | Inflammation |
| IFNA4/7/10/17/21 | RNA | - | Immune Activation Status | Immuno-Oncology |
| IFNA5 | RNA | - | Immune Activation Status | Immuno-Oncology |
| IFNA6 | RNA | - | Immune Activation Status | Immuno-Oncology |
| IFNA7 | RNA | - | Interleukins | Inflammation |
| IFNA7/17 | RNA | - | - | - |
| IFNA8 | RNA | - | Interleukins | Inflammation |
| IFNAR1 | RNA | Interferon Signaling JAK-STAT PI3K-AKT |
Immunity and Inflammation | Immuno-Oncology CNS Oncology Inflammation Metabolic Diseases Oncology |
| IFNAR2 | RNA | - | Chemokines Immunity and Inflammation |
Immuno-Oncology Inflammation |
| IFNB1 | RNA | - | - | - |
| IFNG | RNA | Cell Proliferation Cytotoxicity Hypoxia Interferon Signaling JAK-STAT Signaling Affecting Cellular Metabolism TCR Signaling TGF Beta Signaling |
Antigen Presentation Cytokines Immune Activation Status Immune Suppression Interleukins Leucocyte Function Lymphoid Compartment Macrophage Function M1 Activation NK Cell Function |
CNS Oncology Cardiovascular Immuno-Oncology Metabolic Diseases Inflammation Oncology |
| IFNGR1 | RNA | Hypoxia Interferon Signaling JAK-STAT |
M1 Activation M2 Activation |
Cardiovascular Immuno-Oncology CNS Oncology Inflammation Metabolic Diseases Oncology |
| IFNGR2 | RNA | Hypoxia Interferon Signaling JAK-STAT |
- | Cardiovascular Immuno-Oncology CNS Oncology Inflammation Metabolic Diseases Oncology |
| IFNK | RNA | - | Immune Activation Status | Immuno-Oncology |
| IFNL1 | RNA | - | Cytokines Interleukins |
Immuno-Oncology Inflammation |
| IFNL2 | RNA | - | Chemokines | Immuno-Oncology |
| IFNL2/3 | RNA | - | - | - |
| IFNL4 | RNA | - | - | - |
| IFNLR1 | RNA | - | - | - |
| IFNW1 | RNA | - | - | - |
| IFT140 | RNA | ER Signaling | - | Oncology |
| IgD | Protein | - | - | - |
| IGF1 | RNA | Carbohydrate Metabolism Cell Proliferation EMT MAPK PI3K-AKT Proliferation RAS Transcriptional Misregulation |
Activated Microglia Cellular Growth Factor Immunity and Inflammation Transmitter Response and Reuptake |
CNS Oncology Cardiovascular Epigenic and Nuclear Signaling Inflammation Metabolic Diseases |
| IGF1R | RNA | Carbohydrate Metabolism MAPK PI3K-AKT RAS Transcriptional Misregulation |
Transmitter Response and Reuptake | CNS Cardiovascular Oncology Epigenic and Nuclear Signaling Metabolic Diseases |
| IGF2R | RNA | Cytotoxicity Interferon Signaling |
Immunity and Inflammation Lymphoid Compartment |
Oncology Immuno-Oncology Inflammation |
| IGFBP3 | RNA | HIF1 Signaling | - | Inflammation Oncology |
| IGFBP4 | RNA | Cell Proliferation | Cellular Growth Factor | CNS Oncology |
| IGFBP7 | RNA | Cell Proliferation | Cellular Growth Factor | CNS Oncology |
| IGHA1 | RNA | - | Immune Activation Status | Immuno-Oncology |
| IGHD | RNA | - | Immune Activation Status | Immuno-Oncology |
| IGHG1 | RNA | - | Immune Activation Status | Immuno-Oncology |
| IGHG2 | RNA | - | Immune Activation Status | Immuno-Oncology |
| IGHG3 | RNA | - | Immune Activation Status | Immuno-Oncology |
| IGHG4 | RNA | - | Immune Activation Status | Immuno-Oncology |
| IGHM | RNA | - | Immune Activation Status | Immuno-Oncology |
| IGHV4-59 | RNA | - | Immune Activation Status | Immuno-Oncology |
| IGKC | RNA | - | Immune Activation Status | Immuno-Oncology |
| IGLC1 | RNA | - | Immune Activation Status | Immuno-Oncology |
| IGLL1 | RNA | - | - | - |
| IGSF10 | RNA | - | Immunity and Inflammation | Inflammation |
| IGSF6 | RNA | - | Immunity and Inflammation | Inflammation |
| IHH | RNA | Hedgehog | - | CNS Inflammation Oncology |
| IKBKAP | RNA | - | - | - |
| IKBKB | RNA | Costimulatory Signaling Cytokine and Chemokine Signaling MAPK Metabolism Stress NF-kappaB Signaling PI3K-AKT RAS TCR Signaling |
Immunity and Inflammation | Immuno-Oncology Cardiovascular Metabolic Diseases CNS Oncology Inflammation |
| IKBKE | RNA | - | Immunity and Inflammation | Inflammation |
| IKBKG | RNA | Costimulatory Signaling Cytokine and Chemokine Signaling MAPK NF-kappaB Signaling PI3K-AKT RAS TCR Signaling |
Immunity and Inflammation | Immuno-Oncology Cardiovascular CNS Oncology Inflammation |
| IKZF1 | RNA | - | - | - |
| IKZF2 | RNA | - | - | - |
| IKZF3 | RNA | Angiogenesis | - | Cardiovascular Oncology |
| IKZF4 | RNA | - | - | - |
| IL10 | RNA | Cytokine and Chemokine Signaling Interleukin Signaling JAK-STAT Signaling Affecting Cellular Metabolism TCR Signaling |
Immune Suppression Interleukins M1 Activation M2 Activation |
Immuno-Oncology CNS Metabolic Diseases Inflammation Oncology |
| IL10RA | RNA | Cytokine and Chemokine Signaling EMT Interleukin Signaling JAK-STAT |
Cytokines Immune Suppression |
Immuno-Oncology Oncology CNS Inflammation Metabolic Diseases Oncology |
| IL10RB | RNA | - | Immune Suppression Immunity and Inflammation |
Immuno-Oncology Inflammation |
| IL11 | RNA | Cell Proliferation Cytokine and Chemokine Signaling Interleukin Signaling JAK-STAT |
B Cell Function Cellular Growth Factor Cytokines Immune Activation Status Interleukins Lymphoid Compartment |
CNS Immuno-Oncology Oncology Inflammation Metabolic Diseases Oncology |
| IL11RA | RNA | Cytokine and Chemokine Signaling Cytotoxicity JAK-STAT |
Chemokines Immune Activation Status |
Immuno-Oncology Oncology CNS Inflammation Metabolic Diseases Oncology |
| IL12A | RNA | - | Cytokines Immune Activation Status Immune Suppression Interleukins NK Cell Function |
Immuno-Oncology Inflammation |
| IL12B | RNA | Cytokine and Chemokine Signaling Interleukin Signaling |
Cytokines Immune Activation Status Immune Suppression Interleukins NK Cell Function |
Immuno-Oncology Inflammation |
| IL12RB1 | RNA | Interleukin Signaling | Immune Activation Status NK Cell Function |
Immuno-Oncology |
| IL12RB2 | RNA | Cytokine and Chemokine Signaling Cytotoxicity JAK-STAT |
Cytokines Lymphoid Compartment NK Cell Function |
Immuno-Oncology Oncology CNS Inflammation Metabolic Diseases Oncology |
| IL13 | RNA | - | Cytokines Immune Activation Status Interleukins M2 Activation |
Immuno-Oncology Inflammation CNS |
| IL13RA1 | RNA | - | Cytokines Immune Activation Status |
Immuno-Oncology |
| IL13RA2 | RNA | - | Chemokines | Immuno-Oncology |
| IL15 | RNA | Cell Proliferation Costimulatory Signaling Cytokine and Chemokine Signaling Interleukin Signaling JAK-STAT |
Immune Activation Status Interleukins |
CNS Immuno-Oncology Inflammation Oncology Metabolic Diseases Oncology |
| IL15RA | RNA | Interleukin Signaling | Chemokines Immunity and Inflammation |
Immuno-Oncology Inflammation |
| IL16 | RNA | Cytokine and Chemokine Signaling | Immune Activation Status Interleukins |
Immuno-Oncology Inflammation |
| IL17A | RNA | Costimulatory Signaling Cytokine and Chemokine Signaling |
Cytokines Immune Activation Status Interleukins |
Immuno-Oncology Inflammation |
| IL17B | RNA | - | Chemokines Interleukins |
Immuno-Oncology Inflammation |
| IL17C | RNA | - | - | - |
| IL17D | RNA | - | - | - |
| IL17F | RNA | - | Interleukins | Inflammation |
| IL17RA | RNA | - | - | - |
| IL17RB | RNA | - | Chemokines | Immuno-Oncology |
| IL17RC | RNA | - | - | - |
| IL17RD | RNA | - | - | - |
| IL17RE | RNA | - | - | - |
| IL18 | RNA | Angiogenesis Cell Proliferation Costimulatory Signaling Cytokine and Chemokine Signaling |
Immune Activation Status Immune Suppression Interleukins NK Cell Function |
Cardiovascular CNS Immuno-Oncology Inflammation Oncology |
| IL18BP | RNA | - | - | - |
| IL18R1 | RNA | Costimulatory Signaling Cytokine and Chemokine Signaling |
Lymphoid Compartment M1 Activation NK Cell Function |
Immuno-Oncology CNS |
| IL18RAP | RNA | - | NK Cell Function | Immuno-Oncology |
| IL19 | RNA | - | Chemokines Interleukins |
Immuno-Oncology Inflammation |
| IL1A | RNA | Cell Proliferation Cytokine and Chemokine Signaling MAPK Metabolism Stress Vasculogenesis |
Cellular Growth Factor Cytokines Immune Activation Status Immune Suppression Immunity and Inflammation Interleukins Myeloid Compartment |
CNS Immuno-Oncology Cardiovascular Metabolic Diseases Oncology Inflammation |
| IL1B | RNA | Cell Proliferation Cellular Differentiation Cytokine and Chemokine Signaling MAPK Oxydative Stress Proliferation Vasculogenesis |
Activated Microglia Cellular Growth Factor Chemokines Cytokines Immune Activation Status Immunity and Inflammation Interleukins Myeloid Compartment |
CNS Oncology Immuno-Oncology Cardiovascular Inflammation |
| IL1F10 | RNA | - | - | - |
| IL1R1 | RNA | Oxydative Stress | Activated Microglia Axon and Dendrite Structure Immune Activation Status Immune Suppression Immunity and Inflammation Neural Connectivity |
Inflammation CNS Immuno-Oncology |
| IL1R2 | RNA | Cytokine and Chemokine Signaling DNA Damage Repair MAPK Transcriptional Misregulation |
Cytokines Immune Activation Status Immune Suppression Immunity and Inflammation |
Immuno-Oncology Epigenic and Nuclear Signaling Cardiovascular Inflammation CNS Oncology |
| IL1RAP | RNA | - | Immunity and Inflammation | Inflammation |
| IL1RAPL1 | RNA | - | Immune Activation Status | Immuno-Oncology |
| IL1RAPL2 | RNA | - | - | - |
| IL1RL1 | RNA | - | Immune Activation Status | Immuno-Oncology |
| IL1RL2 | RNA | - | Immune Activation Status Immunity and Inflammation |
Immuno-Oncology Inflammation |
| IL1RN | RNA | Cytokine and Chemokine Signaling EMT |
Adhesion and Migration Cytokines Immune Activation Status Immune Suppression Immunity and Inflammation Interleukins Myeloid Compartment |
Immuno-Oncology Oncology CNS Inflammation |
| IL2 | RNA | Costimulatory Signaling Cytokine and Chemokine Signaling JAK-STAT PI3K-AKT Signaling Affecting Cellular Metabolism TCR Signaling |
Cytokines Immune Activation Status |
Immuno-Oncology CNS Oncology Metabolic Diseases Inflammation Oncology |
| IL20 | RNA | - | - | - |
| IL20RA | RNA | JAK-STAT | - | CNS Inflammation Metabolic Diseases Oncology |
| IL20RB | RNA | JAK-STAT | - | CNS Inflammation Metabolic Diseases Oncology |
| IL21 | RNA | - | Cytokines Immune Activation Status Interleukins |
Immuno-Oncology Inflammation |
| IL21R | RNA | Cytokine and Chemokine Signaling Interleukin Signaling JAK-STAT Signaling Affecting Cellular Metabolism |
Immune Activation Status Immune Cell Typing Immunity and Inflammation |
Immuno-Oncology CNS Metabolic Diseases Inflammation Oncology |
| IL22 | RNA | - | Cytokines | Immuno-Oncology |
| IL22RA1 | RNA | Cytokine and Chemokine Signaling Cytotoxicity JAK-STAT |
Chemokines | Immuno-Oncology Oncology CNS Inflammation Metabolic Diseases Oncology |
| IL22RA2 | RNA | Interleukin Signaling JAK-STAT |
Chemokines | Immuno-Oncology CNS Inflammation Metabolic Diseases Oncology |
| IL23A | RNA | - | Interleukins | Inflammation |
| IL23R | RNA | - | Cytokines | Immuno-Oncology |
| IL24 | RNA | Cytokine and Chemokine Signaling JAK-STAT |
Cytokines Immune Activation Status Interleukins |
Immuno-Oncology CNS Inflammation Metabolic Diseases Oncology |
| IL25 | RNA | - | Interleukins | Inflammation |
| IL26 | RNA | - | Cytokines Interleukins |
Immuno-Oncology Inflammation |
| IL27 | RNA | - | Interleukins M1 Activation |
Inflammation CNS |
| IL27RA | RNA | Interleukin Signaling | Immune Activation Status | Immuno-Oncology |
| IL28A | RNA | - | - | - |
| IL28A/B | RNA | - | - | - |
| IL29 | RNA | - | - | - |
| IL2RA | RNA | Costimulatory Signaling Cytokine and Chemokine Signaling Interleukin Signaling JAK-STAT Nutrient Capture and Catabolic Pathways PI3K-AKT Signaling Affecting Cellular Metabolism |
Immune Activation Status | Immuno-Oncology CNS Metabolic Diseases Oncology Inflammation Oncology |
| IL2RB | RNA | Costimulatory Signaling Cytokine and Chemokine Signaling Interleukin Signaling JAK-STAT PI3K-AKT Transcriptional Misregulation |
Cytokines | Immuno-Oncology CNS Oncology Epigenic and Nuclear Signaling Inflammation Metabolic Diseases Oncology |
| IL2RG | RNA | Costimulatory Signaling Cytokine and Chemokine Signaling Interleukin Signaling JAK-STAT PI3K-AKT |
Chemokines Immunity and Inflammation Lymphoid Compartment |
Immuno-Oncology CNS Oncology Inflammation Metabolic Diseases Oncology |
| IL3 | RNA | - | Immune Activation Status Immunity and Inflammation |
Immuno-Oncology Inflammation |
| IL31 | RNA | - | Immune Activation Status | Immuno-Oncology |
| IL31RA | RNA | - | Immune Activation Status | Immuno-Oncology |
| IL32 | RNA | Cytokine and Chemokine Signaling | Chemokines Interleukins |
Immuno-Oncology Inflammation |
| IL33 | RNA | Cytokine and Chemokine Signaling | M2 Activation | Immuno-Oncology CNS |
| IL34 | RNA | Cytokine and Chemokine Signaling | Interleukins | Immuno-Oncology Inflammation |
| IL36A | RNA | - | - | - |
| IL36B | RNA | - | - | - |
| IL36G | RNA | - | Immune Activation Status | Immuno-Oncology |
| IL36RN | RNA | - | - | - |
| IL37 | RNA | - | - | - |
| IL3RA | RNA | Interleukin Signaling JAK-STAT PI3K-AKT |
Immunity and Inflammation | Immuno-Oncology CNS Oncology Inflammation Metabolic Diseases Oncology |
| IL4 | RNA | Costimulatory Signaling Cytokine and Chemokine Signaling JAK-STAT PI3K-AKT Signaling Affecting Cellular Metabolism TCR Signaling |
Immune Activation Status Interleukins M2 Activation |
Immuno-Oncology CNS Oncology Metabolic Diseases Inflammation Oncology |
| IL4I1 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| IL4R | RNA | Interleukin Signaling | Cytokines | Immuno-Oncology |
| IL5 | RNA | TCR Signaling | Cytokines Immune Activation Status Interleukins |
Immuno-Oncology Inflammation |
| IL5RA | RNA | - | Cytokines | Immuno-Oncology |
| IL6 | RNA | Cell Proliferation Cytokine and Chemokine Signaling Hypoxia Interleukin Signaling JAK-STAT Metabolism Stress Oxydative Stress PI3K-AKT Proliferation Signaling Affecting Cellular Metabolism Transcriptional Misregulation |
Cellular Growth Factor Immune Activation Status Interleukins M2 Activation |
CNS Immuno-Oncology Cardiovascular Metabolic Diseases Inflammation Oncology Epigenic and Nuclear Signaling Oncology |
| IL6R | RNA | Cytokine and Chemokine Signaling Hypoxia JAK-STAT PI3K-AKT |
Activated Microglia Cytokines Immune Activation Status Immunity and Inflammation |
Immuno-Oncology Cardiovascular CNS Oncology Inflammation Metabolic Diseases Oncology |
| IL6ST | RNA | Interleukin Signaling | Chemokines Immune Activation Status |
Immuno-Oncology |
| IL7 | RNA | Interleukin Signaling Signaling Affecting Cellular Metabolism |
Immune Activation Status Interleukins |
Immuno-Oncology Metabolic Diseases Inflammation |
| IL7R | RNA | Cytokine and Chemokine Signaling Interleukin Signaling JAK-STAT PI3K-AKT |
Cytokines Immune Activation Status |
Immuno-Oncology CNS Oncology Inflammation Metabolic Diseases Oncology |
| IL8 | RNA | - | Chemokines Cytokines Interleukins |
Immuno-Oncology Inflammation |
| IL9 | RNA | - | Cytokines Immune Activation Status |
Immuno-Oncology |
| IL9R | RNA | Interleukin Signaling | Immune Activation Status | Immuno-Oncology |
| ILF3 | RNA | - | Chemokines | Immuno-Oncology |
| ILK | RNA | Cell Proliferation | Cellular Growth Factor | CNS Oncology |
| IMP | Amino-acid & Metabolites | - | - | - |
| IMPDH1 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| IMPDH2 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| INA | RNA | - | Neuronal Cytoskeleton | CNS |
| INHBA | RNA | Cell Proliferation Proliferation TGF Beta Signaling |
Cellular Growth Factor | CNS Oncology |
| INHBB | RNA | TGF Beta Signaling | - | Oncology |
| INHBE | RNA | - | Cellular Growth Factor | Oncology |
| INMT | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| Inosine | Amino-acid & Metabolites | - | - | - |
| INPP4A | RNA | - | - | - |
| INPP4B | Protein | PI3K-AKT | - | Oncology |
| INPP5D | RNA | - | Immune Activation Status Immunity and Inflammation |
Immuno-Oncology Inflammation |
| INPP5F | RNA | - | - | - |
| INPPL1 | RNA | - | Immune Activation Status | Immuno-Oncology |
| INS | RNA | Carbohydrate Metabolism Oxydative Stress |
Immune Activation Status Transmitter Response and Reuptake |
CNS Inflammation Immuno-Oncology Metabolic Diseases |
| INSR | RNA | Carbohydrate Metabolism Signaling Affecting Cellular Metabolism |
Neural Connectivity Transmitter Response and Reuptake |
CNS Metabolic Diseases |
| IPCEF1 | RNA | Oxydative Stress | - | Inflammation |
| IQGAP1 | RNA | - | - | - |
| IQSEC1 | RNA | - | - | - |
| IRAK1 | RNA | - | Immunity and Inflammation | Inflammation |
| IRAK2 | RNA | - | Immunity and Inflammation | Inflammation |
| IRAK3 | RNA | - | Immune Activation Status Immunity and Inflammation |
Immuno-Oncology Inflammation |
| IRAK4 | RNA | - | Immune Activation Status Immunity and Inflammation |
Immuno-Oncology Inflammation |
| IRF1 | RNA | Cytotoxicity Interferon Signaling Signaling Affecting Cellular Metabolism Transcriptional Regulation |
Chemokines Immunity and Inflammation NK Cell Function |
Oncology Immuno-Oncology Metabolic Diseases Epigenic and Nuclear Signaling Inflammation |
| IRF2 | RNA | Interferon Signaling | Chemokines Immune Activation Status Immunity and Inflammation |
Immuno-Oncology Inflammation |
| IRF3 | RNA | Interferon Signaling | Immunity and Inflammation | Immuno-Oncology Inflammation |
| IRF4 | RNA | Cytotoxicity Epigenic and Transcriptional Regulation Signaling Affecting Cellular Metabolism Transcriptional Regulation |
B Cell Function Immune Activation Status Immunity and Inflammation Lymphoid Compartment |
Oncology Epigenic and Nuclear Signaling Metabolic Diseases Immuno-Oncology Inflammation |
| IRF5 | RNA | - | - | - |
| IRF6 | RNA | Cell Proliferation EMT |
Immunity and Inflammation | CNS Oncology Inflammation |
| IRF7 | RNA | - | Immunity and Inflammation | Inflammation |
| IRF8 | RNA | - | Activated Microglia Antigen Presentation Chemokines Immune Activation Status Immunity and Inflammation |
CNS Immuno-Oncology Inflammation |
| IRF9 | RNA | Cytotoxicity JAK-STAT |
Lymphoid Compartment | Oncology CNS Immuno-Oncology Inflammation Metabolic Diseases Oncology |
| IRGM | RNA | - | - | - |
| IRS1 | RNA | - | Immune Activation Status | Immuno-Oncology |
| IRX1 | RNA | - | - | - |
| ISG15 | RNA | Cytotoxicity DNA Damage Repair |
Lymphoid Compartment | Oncology Epigenic and Nuclear Signaling Immuno-Oncology |
| ISG20 | RNA | - | - | - |
| ISL1 | RNA | Cell Proliferation | - | CNS Oncology |
| ISLR | RNA | - | - | - |
| ISLR2 | RNA | - | - | - |
| ISM1 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| Isorhamnetin 3-(6-malonylglucoside) | Lipid | - | - | - |
| ITCH | RNA | Nutrient Capture and Catabolic Pathways Signaling Affecting Cellular Metabolism |
Immune Activation Status Immune Suppression |
Metabolic Diseases Immuno-Oncology |
| ITGA1 | RNA | ECM Remodeling Matrix Remodeling and Metastases PI3K-AKT Signaling Affecting Cellular Metabolism |
Adhesion and Migration Lymphoid Compartment NK Cell Function |
Metabolic Diseases CNS Oncology Immuno-Oncology |
| ITGA10 | RNA | - | Immune Activation Status | Immuno-Oncology |
| ITGA11 | RNA | ECM Remodeling Signaling Affecting Cellular Metabolism |
Adhesion and Migration | Metabolic Diseases CNS Oncology |
| ITGA2 | RNA | Cellular Differentiation Matrix Remodeling and Metastases PI3K-AKT |
- | Oncology CNS |
| ITGA2B | RNA | - | - | - |
| ITGA3 | RNA | - | - | - |
| ITGA4 | RNA | Matrix Remodeling and Metastases PI3K-AKT |
- | CNS Oncology |
| ITGA5 | RNA | Angiogenesis Cellular Differentiation ECM Remodeling Vasculogenesis |
Activated Microglia Adhesion and Migration Cellular Growth Factor Neural Connectivity |
Cardiovascular Oncology Metabolic Diseases CNS |
| ITGA6 | RNA | Matrix Remodeling and Metastases PI3K-AKT |
Adhesion and Migration Immune Activation Status Immunity and Inflammation |
CNS Oncology Immuno-Oncology Inflammation |
| ITGA7 | RNA | - | - | - |
| ITGA8 | RNA | ECM Remodeling | Adhesion and Migration Cellular Growth Factor |
Metabolic Diseases CNS Oncology |
| ITGA9 | RNA | - | - | - |
| ITGAE | RNA | Matrix Remodeling and Metastases | Immune Activation Status | CNS Immuno-Oncology Oncology |
| ITGAL | RNA | Matrix Remodeling and Metastases | Activated Microglia Adhesion and Migration Immune Activation Status Inflammation |
CNS Immuno-Oncology Inflammation Oncology |
| ITGAM | RNA | Matrix Remodeling and Metastases Signaling Affecting Cellular Metabolism |
Adhesion and Migration Immunity and Inflammation Inflammation Myeloid Compartment |
CNS Metabolic Diseases Inflammation Oncology |
| ITGAV | RNA | Androgen Signaling Angiogenesis ECM Remodeling Matrix Remodeling and Metastases PI3K-AKT |
Adhesion and Migration Antigen Presentation Immune Activation Status Immunity and Inflammation Inflammation |
Oncology Cardiovascular Metabolic Diseases CNS Immuno-Oncology Inflammation |
| ITGAX | RNA | ECM Remodeling Matrix Remodeling and Metastases |
Activated Microglia Adhesion and Migration B Cell Exhaustion Immune Activation Status Immunity and Inflammation Inflammation Myeloid Compartment |
Metabolic Diseases CNS Immuno-Oncology Inflammation Oncology |
| ITGB1 | RNA | Cell Proliferation Cellular Differentiation ECM Remodeling Met Signaling Signaling Affecting Cellular Metabolism |
Adhesion and Migration Inflammation |
CNS Oncology Metabolic Diseases Inflammation |
| ITGB1BP1 | RNA | - | - | - |
| ITGB2 | RNA | Cellular Differentiation Hippo Signaling Matrix Remodeling and Metastases mTOR Signaling Signaling Affecting Cellular Metabolism |
Adhesion and Migration Inflammation |
Oncology CNS Metabolic Diseases Inflammation |
| ITGB3 | RNA | Angiogenesis Cell Proliferation ECM Remodeling Matrix Remodeling and Metastases PI3K-AKT Proliferation Vasculogenesis |
Adhesion and Migration Cellular Growth Factor Immune Activation Status Inflammation |
Cardiovascular CNS Metabolic Diseases Oncology Immuno-Oncology Inflammation |
| ITGB4 | RNA | - | - | - |
| ITGB5 | RNA | ECM Remodeling Hippo Signaling Signaling Affecting Cellular Metabolism |
Adhesion and Migration Immunity and Inflammation |
Metabolic Diseases CNS Inflammation Oncology |
| ITGB6 | RNA | ECM Remodeling EMT PI3K-AKT |
Adhesion and Migration | Metabolic Diseases Oncology CNS |
| ITGB7 | RNA | - | - | - |
| ITGB8 | RNA | ECM Remodeling Matrix Remodeling and Metastases PI3K-AKT Vasculogenesis |
Adhesion and Migration Immune Activation Status |
Metabolic Diseases CNS Oncology Cardiovascular Immuno-Oncology |
| ITK | RNA | Signaling Affecting Cellular Metabolism TCR Signaling |
Inflammation | Metabolic Diseases Immuno-Oncology Inflammation |
| ITLN1 | RNA | - | - | - |
| ITLN2 | RNA | - | - | - |
| ITM2A | RNA | - | - | - |
| ITPK1 | RNA | Angiogenesis | - | Cardiovascular Oncology |
| ITPR1 | RNA | ER Signaling | Immune Activation Status Neural Connectivity Transmitter Release Transmitter Response and Reuptake |
Oncology Immuno-Oncology CNS |
| ITPR2 | RNA | Adenosine Pathway | Immune Activation Status Transmitter Release Transmitter Response and Reuptake |
Immuno-Oncology CNS |
| ITPR3 | RNA | - | Axon and Dendrite Structure Transmitter Release Transmitter Response and Reuptake Vesicle Trafficking |
CNS |
| JADE1 | RNA | - | - | - |
| JAG1 | RNA | Angiogenesis Cell Proliferation Cellular Differentiation Notch Proliferation |
Cellular Growth Factor Immune Activation Status Immune Suppression Immunity and Inflammation |
Cardiovascular CNS Oncology Immuno-Oncology Inflammation |
| JAG2 | RNA | Notch | - | Immuno-Oncology |
| JAK1 | RNA | Cytotoxicity JAK-STAT PI3K-AKT |
Cytokines Immune Activation Status Lymphoid Compartment |
Oncology CNS Immuno-Oncology Inflammation Metabolic Diseases Oncology |
| JAK2 | RNA | Biosynthesis and Anabolic Pathways Cell Stress Cytokine and Chemokine Signaling Cytotoxicity Epigenic and Transcriptional Regulation JAK-STAT PI3K-AKT Signaling Affecting Cellular Metabolism Transcriptional Regulation |
Cytokines Immune Activation Status Lymphoid Compartment |
CNS Immuno-Oncology Oncology Epigenic and Nuclear Signaling Metabolic Diseases Inflammation Oncology |
| JAK3 | RNA | Cytokine and Chemokine Signaling Cytotoxicity JAK-STAT PI3K-AKT |
Cytokines Immune Activation Status |
Immuno-Oncology Oncology CNS Inflammation Metabolic Diseases Oncology |
| JAM2 | RNA | EMT | Adhesion and Migration Immunity and Inflammation |
Oncology CNS Inflammation |
| JAM3 | RNA | Angiogenesis Myelination |
Activated Microglia | Cardiovascular CNS Oncology |
| JAML | RNA | - | - | - |
| JARID2 | RNA | Epigenic and Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| JCAD | RNA | EMT | - | Oncology |
| JMJD1C | RNA | Epigenic and Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| JMJD4 | RNA | - | - | - |
| JUN | RNA | Angiogenesis AP1 Signaling Cell Proliferation Cellular Differentiation MAPK Oxydative Stress TCR Signaling Wnt Signaling |
Immune Activation Status Immune Suppression Immunity and Inflammation Transmitter Response and Reuptake |
Cardiovascular CNS Oncology Inflammation Immuno-Oncology Metabolic Diseases Oncology |
| JUNB | RNA | AP1 Signaling | Immune Activation Status Immune Suppression |
Cardiovascular Immuno-Oncology CNS Inflammation Metabolic Diseases Oncology |
| JUND | RNA | AP1 Signaling | Immune Activation Status | Cardiovascular Immuno-Oncology CNS Inflammation Metabolic Diseases Oncology |
| JUP | RNA | - | Adhesion and Migration | CNS |
| Kaempferol 3-rhamnosyl-(1->2)-glucosyl-(1->3)-(4-p-coumaroylrhamnosyl)-(1->6)-galactoside | Lipid | - | - | - |
| KANSL1 | RNA | Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| KAT2A | RNA | - | - | - |
| KAT2B | RNA | Epigenic and Transcriptional Regulation Notch |
- | Epigenic and Nuclear Signaling Immuno-Oncology |
| KAT6A | RNA | Epigenic and Transcriptional Regulation Transcriptional Regulation |
- | Epigenic and Nuclear Signaling |
| KAT6B | RNA | Epigenic and Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| KATNA1 | RNA | - | Axon and Dendrite Structure Neuronal Cytoskeleton |
CNS |
| KBTBD8 | RNA | - | - | - |
| KCNA1 | RNA | - | Axon and Dendrite Structure Neural Connectivity Transmitter Release Vesicle Trafficking |
CNS |
| KCNB1 | RNA | DNA Damage Repair | Axon and Dendrite Structure Neural Connectivity Transmitter Release Vesicle Trafficking |
Epigenic and Nuclear Signaling CNS |
| KCND1 | RNA | - | Immunity and Inflammation | Inflammation |
| KCNJ10 | RNA | Myelination | Neural Connectivity Transmitter Release Transmitter Response and Reuptake Vesicle Trafficking |
CNS |
| KCNJ2 | RNA | - | - | - |
| KCNJ8 | RNA | - | - | - |
| KCNK13 | RNA | - | Immunity and Inflammation | Inflammation |
| KCNK2 | RNA | - | - | - |
| KDM1A | RNA | Epigenic and Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| KDM1B | RNA | - | - | - |
| KDM2A | RNA | - | - | - |
| KDM2B | RNA | - | - | - |
| KDM3A | RNA | Epigenic and Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| KDM3B | RNA | Epigenic and Transcriptional Regulation Transcriptional Regulation |
- | Epigenic and Nuclear Signaling |
| KDM4A | RNA | - | - | - |
| KDM4B | RNA | - | - | - |
| KDM4C | RNA | - | - | - |
| KDM4D | RNA | - | - | - |
| KDM5A | RNA | Epigenic and Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| KDM5B | RNA | - | - | - |
| KDM5C | RNA | - | - | - |
| KDM5D | RNA | - | - | - |
| KDM6A | RNA | Epigenic and Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| KDM6B | RNA | - | - | - |
| KDR | RNA | Angiogenesis Cell Proliferation MAPK Matrix Remodeling and Metastases PI3K-AKT Proliferation Vasculogenesis VEGFR Signaling |
Cellular Growth Factor | Cardiovascular CNS Oncology |
| KEAP1 | RNA | Biosynthesis and Anabolic Pathways Cell Stress Signaling Affecting Cellular Metabolism |
- | CNS Metabolic Diseases Oncology |
| KEL | RNA | Myelination | - | CNS |
| Ki-67 | Protein | Proliferation | Immune Cell Typing Neural Cell Typing |
Oncology Immuno-Oncology CNS |
| KIAA0040 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| KIAA1161 | RNA | - | - | - |
| KIAA1462 | RNA | - | - | - |
| KIF11 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| KIF14 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| KIF20A | RNA | Cell Cycle | - | Oncology |
| KIF22 | RNA | - | - | - |
| KIF23 | RNA | Cell Cycle DNA Damage Repair |
- | Oncology Epigenic and Nuclear Signaling |
| KIF2C | RNA | Biosynthesis and Anabolic Pathways Cell Cycle DNA Damage Repair Proliferation Signaling Affecting Cellular Metabolism |
Antigen Presentation Immunity and Inflammation |
CNS Oncology Epigenic and Nuclear Signaling Metabolic Diseases Immuno-Oncology Inflammation |
| KIF3A | RNA | - | Neural Connectivity | CNS |
| KIFC1 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| KIR Family | RNA | - | - | - |
| KIR_Activating_Subgroup_1 | RNA | - | NK Cell Function | Immuno-Oncology |
| KIR_Activating_Subgroup_2 | RNA | - | NK Cell Function | Immuno-Oncology |
| KIR_Inhibiting_Subgroup_1 | RNA | - | NK Cell Function | Immuno-Oncology |
| KIR_Inhibiting_Subgroup_2 | RNA | - | NK Cell Function | Immuno-Oncology |
| KIR2DL1 | RNA | - | - | - |
| KIR2DL1/2 | RNA | - | Immune Activation Status | Immuno-Oncology |
| KIR2DL3 | RNA | Cytotoxicity | Antigen Presentation Immune Cell Typing Lymphoid Compartment |
Oncology Immuno-Oncology |
| KIR2DL3/4 | RNA | - | Immune Activation Status | Immuno-Oncology |
| KIR2DL4 | RNA | - | - | - |
| KIR2DL5A/B | RNA | - | Immune Activation Status | Immuno-Oncology |
| KIR2DS1/4 | RNA | - | Immune Activation Status | Immuno-Oncology |
| KIR2DS4 | RNA | - | - | - |
| KIR3DL1 | RNA | Cytotoxicity | Antigen Presentation Immune Cell Typing Immunity and Inflammation Lymphoid Compartment NK Cell Function |
Oncology Immuno-Oncology Inflammation |
| KIR3DL1/2 | RNA | - | Immune Activation Status | Immuno-Oncology |
| KIR3DL1/3 | RNA | - | - | - |
| KIR3DL2 | RNA | Cytotoxicity | Antigen Presentation Immune Cell Typing Lymphoid Compartment NK Cell Function |
Oncology Immuno-Oncology |
| KIR3DL3 | RNA | - | Immune Activation Status NK Cell Function |
Immuno-Oncology |
| KISS1 | RNA | Cell Proliferation | - | CNS Oncology |
| KIT | RNA | MAPK Metabolism Stress PI3K-AKT RAS |
Immunity and Inflammation | Cardiovascular Metabolic Diseases Oncology Inflammation CNS |
| KITLG | RNA | RAS | - | Oncology |
| KLC1 | RNA | - | - | - |
| KLF2 | RNA | - | - | - |
| KLF4 | RNA | - | - | - |
| KLF5 | RNA | Epigenic and Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| KLK2 | RNA | Androgen Signaling ECM Remodeling |
- | Oncology Metabolic Diseases |
| KLK3 | RNA | Androgen Signaling Cellular Differentiation |
- | Oncology |
| KLK4 | RNA | Androgen Signaling | - | Oncology |
| KLK6 | RNA | Myelination | - | CNS |
| KLKB1 | RNA | - | - | - |
| KLRAP1 | RNA | - | - | - |
| KLRB1 | RNA | Cytotoxicity | Chemokines Immune Activation Status Immune Cell Typing Immunity and Inflammation Lymphoid Compartment NK Cell Function |
Oncology Immuno-Oncology Inflammation |
| KLRC1 | RNA | - | Immune Activation Status NK Cell Function |
Immuno-Oncology |
| KLRC1/2 | RNA | - | - | - |
| KLRC2 | RNA | - | NK Cell Function | Immuno-Oncology |
| KLRC2/3 | RNA | - | Immune Activation Status | Immuno-Oncology |
| KLRC3 | RNA | - | - | - |
| KLRC4 | RNA | - | - | - |
| KLRD1 | RNA | Cytotoxicity | Antigen Presentation Immune Activation Status Immune Cell Typing Immunity and Inflammation Lymphoid Compartment NK Cell Function |
Oncology Immuno-Oncology Inflammation |
| KLRF1 | RNA | - | NK Cell Function | Immuno-Oncology |
| KLRF2 | RNA | - | - | - |
| KLRG1 | RNA | - | Immune Activation Status NK Cell Function T Cell Exhaustion |
Immuno-Oncology |
| KLRG2 | RNA | - | - | - |
| KLRK1 | RNA | Cytotoxicity | Immune Activation Status Immune Cell Typing Immunity and Inflammation Lymphoid Compartment NK Cell Function |
Oncology Immuno-Oncology Inflammation |
| KMO | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| KMT2A | RNA | Biosynthesis and Anabolic Pathways Epigenic and Transcriptional Regulation Transcriptional Regulation |
- | CNS Epigenic and Nuclear Signaling Metabolic Diseases |
| KMT2C | RNA | - | - | - |
| KMT2D | RNA | Biosynthesis and Anabolic Pathways Epigenic and Transcriptional Regulation Transcriptional Regulation |
- | CNS Epigenic and Nuclear Signaling Metabolic Diseases |
| KMT2E | RNA | Biosynthesis and Anabolic Pathways Transcriptional Regulation |
- | CNS Epigenic and Nuclear Signaling Metabolic Diseases |
| KNG1 | RNA | Adenosine Pathway | - | Immuno-Oncology |
| KPNA2 | RNA | Cell Stress Signaling Affecting Cellular Metabolism |
- | CNS Metabolic Diseases Oncology |
| KPNB1 | RNA | - | - | - |
| KRAS | RNA | Autophagy Cell Proliferation Cytokine and Chemokine Signaling MAPK Metabolism Stress Nutrient Capture and Catabolic Pathways PI3K-AKT RAS Signaling Affecting Cellular Metabolism |
Cellular Growth Factor Immune Activation Status Transmitter Release Transmitter Response and Reuptake Vesicle Trafficking |
Cardiovascular CNS Immuno-Oncology Metabolic Diseases Oncology Inflammation Oncology |
| KRIT1 | RNA | Angiogenesis Cell Proliferation |
- | Cardiovascular CNS Oncology |
| KRT1 | RNA | Cell Stress | - | CNS Oncology |
| KRT10 | RNA | - | - | - |
| KRT14 | RNA | Cellular Differentiation | Adhesion and Migration | Oncology CNS |
| KRT16 | RNA | - | - | - |
| KRT17 | RNA | - | Adhesion and Migration | CNS |
| KRT18 | RNA | - | - | - |
| KRT19 | RNA | - | - | - |
| KRT5 | RNA | - | Adhesion and Migration | CNS |
| KRT6A/B/C | RNA | - | - | - |
| KRT6B | RNA | DNA Damage Repair | Adhesion and Migration | Epigenic and Nuclear Signaling CNS |
| KRT7 | RNA | EMT | Adhesion and Migration | Oncology CNS |
| Kushenol D | Lipid | - | - | - |
| KYAT1 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| KYAT3 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| KYNU | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| kynurenic acid | Amino-acid & Metabolites | - | - | - |
| L1CAM | RNA | - | Axon and Dendrite Structure | CNS |
| L2HGDH | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| LACC1 | RNA | - | Immunity and Inflammation | Inflammation |
| LacCer(d18:0/18:0) | Lipid | - | - | - |
| LacCer(d18:0/20:0) | Lipid | - | - | - |
| LacCer(d18:0/22:0) | Lipid | - | - | - |
| LacCer(d18:1/12:0) | Lipid | - | - | - |
| LacCer(d18:1/14:0) | Lipid | - | - | - |
| Lactate | Amino-acid & Metabolites | - | - | - |
| LAD1 | RNA | EMT | - | Oncology |
| LAG3 | Protein | Costimulatory Signaling Signaling Affecting Cellular Metabolism |
Immune Cell Typing Immune Checkpoint Lymphoid Compartment T Cell Activation T Cell Costimulation T Cell Exhaustion |
Immuno-Oncology Metabolic Diseases |
| LAG3 | RNA | Costimulatory Signaling Signaling Affecting Cellular Metabolism |
Immune Cell Typing Immune Checkpoint Lymphoid Compartment T Cell Activation T Cell Costimulation T Cell Exhaustion |
Immuno-Oncology Metabolic Diseases |
| LAIR1 | RNA | - | B Cell Exhaustion Immune Activation Status Immunity and Inflammation Inflammation |
Immuno-Oncology Inflammation |
| LAIR2 | RNA | - | - | - |
| LAMA1 | RNA | Matrix Remodeling and Metastases PI3K-AKT |
- | CNS Oncology |
| LAMA2 | RNA | ECM Remodeling Met Signaling Myelination |
Adhesion and Migration Axon and Dendrite Structure Neural Connectivity Vesicle Trafficking |
Metabolic Diseases Oncology CNS |
| LAMA3 | RNA | Collagen Biosynthesis & Modification PI3K-AKT |
Adhesion and Migration | CNS Oncology |
| LAMA4 | RNA | Cellular Differentiation ECM Remodeling Met Signaling Signaling Affecting Cellular Metabolism Vasculogenesis |
Adhesion and Migration | Oncology Metabolic Diseases Cardiovascular CNS |
| LAMA5 | RNA | Angiogenesis Cell Proliferation |
- | Cardiovascular CNS Oncology |
| LAMB1 | RNA | ECM Remodeling Met Signaling Signaling Affecting Cellular Metabolism |
Adhesion and Migration | Metabolic Diseases Oncology CNS |
| LAMB2 | RNA | - | Neural Connectivity | CNS |
| LAMB3 | RNA | ECM Remodeling Matrix Remodeling and Metastases Met Signaling PI3K-AKT |
Adhesion and Migration Myeloid Compartment |
Metabolic Diseases CNS Oncology |
| LAMB4 | RNA | - | Immune Activation Status | Immuno-Oncology |
| LAMC1 | RNA | Cell Proliferation ECM Remodeling Met Signaling Signaling Affecting Cellular Metabolism |
Adhesion and Migration | CNS Metabolic Diseases Oncology |
| LAMC2 | RNA | ECM Remodeling Matrix Remodeling and Metastases Met Signaling PI3K-AKT |
Adhesion and Migration | Metabolic Diseases CNS Oncology |
| LAMC3 | RNA | - | - | - |
| LAMP1 | RNA | - | Axon and Dendrite Structure Immune Activation Status Immunity and Inflammation Neural Connectivity |
CNS Immuno-Oncology Inflammation |
| LAMP2 | RNA | - | - | - |
| LAMP2A | Protein | Autophagy | - | Cardiovascular CNS Inflammation Metabolic Diseases Oncology |
| LAMP3 | RNA | - | - | - |
| LAMTOR1 | RNA | mTOR Signaling | - | Oncology |
| LAMTOR2 | RNA | mTOR Signaling Nutrient Capture and Catabolic Pathways Signaling Affecting Cellular Metabolism |
- | Oncology Metabolic Diseases |
| LAMTOR3 | RNA | - | Immune Activation Status | Immuno-Oncology |
| LAMTOR4 | RNA | mTOR Signaling Nutrient Capture and Catabolic Pathways Signaling Affecting Cellular Metabolism |
- | Oncology Metabolic Diseases |
| LAMTOR5 | RNA | mTOR Signaling Nutrient Capture and Catabolic Pathways Signaling Affecting Cellular Metabolism |
- | Oncology Metabolic Diseases |
| LANCL1 | RNA | - | - | - |
| LAT | RNA | RAS Signaling Affecting Cellular Metabolism TCR Signaling |
- | Oncology Metabolic Diseases Immuno-Oncology |
| LAT2 | RNA | - | - | - |
| LATS1 | RNA | Hippo Signaling | - | CNS Oncology |
| LATS2 | RNA | - | - | - |
| LBP | RNA | - | Macrophage Function | Immuno-Oncology |
| LC3B | Protein | Autophagy | - | Cardiovascular CNS Inflammation Metabolic Diseases Oncology |
| LCK | RNA | Costimulatory Signaling Signaling Affecting Cellular Metabolism TCR Signaling |
Immune Activation Status Immune Checkpoint Inflammation Lymphoid Compartment |
Immuno-Oncology Metabolic Diseases Inflammation |
| LCLAT1 | RNA | Lipid Metabolism | - | Metabolic Diseases |
| LCN2 | RNA | - | Immunity and Inflammation Inflammation |
Inflammation |
| LCOR | RNA | - | - | - |
| LCP1 | RNA | - | Leucocyte Function Macrophage Function |
Immuno-Oncology |
| LCP2 | RNA | TCR Signaling | Immune Activation Status | Immuno-Oncology |
| LDHA | RNA | Biosynthesis and Anabolic Pathways HIF1 Signaling Hypoxia Metabolism Stress mTOR Signaling Myc Signaling Affecting Cellular Metabolism |
Immunity and Inflammation | CNS Inflammation Cardiovascular Metabolic Diseases Oncology |
| LDHAL6A | RNA | - | - | - |
| LDHB | RNA | Biosynthesis and Anabolic Pathways Metabolism Stress |
- | CNS Metabolic Diseases |
| LDHC | RNA | Biosynthesis and Anabolic Pathways Carbohydrate Metabolism |
- | CNS Metabolic Diseases |
| LDLRAD3 | RNA | - | Immunity and Inflammation | Inflammation |
| LDLRAP1 | RNA | - | - | - |
| L-DOPA | Amino-acid & Metabolites | - | - | - |
| LEF1 | RNA | Epigenic and Transcriptional Regulation Wnt Signaling |
- | Epigenic and Nuclear Signaling CNS Oncology |
| LEFTY1 | RNA | - | Cellular Growth Factor | Oncology |
| LEFTY1/2 | RNA | - | Immune Suppression | Immuno-Oncology |
| LEFTY2 | RNA | TGF Beta Signaling | - | Oncology |
| LEMD1 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| LEP | RNA | JAK-STAT | - | CNS Inflammation Metabolic Diseases Oncology |
| LEPR | RNA | JAK-STAT Signaling Affecting Cellular Metabolism |
Immune Activation Status | CNS Metabolic Diseases Immuno-Oncology Inflammation Oncology |
| Lespedezaflavanone F | Lipid | - | - | - |
| Leucadenone B | Lipid | - | - | - |
| Leucine (Isoleucine) | Amino-acid & Metabolites | - | - | - |
| Leu-Enk-Arg | Neuropeptide & Neurotransmitter | - | - | - |
| Leu-Enk-Arg-Arg | Neuropeptide & Neurotransmitter | - | - | - |
| LFNG | RNA | Notch | Immunity and Inflammation | Immuno-Oncology Inflammation |
| LGALS1 | RNA | - | - | - |
| LGALS3 | RNA | - | - | - |
| LGALS9 | RNA | - | Immune Activation Status | Immuno-Oncology |
| LGMN | RNA | - | Immunity and Inflammation | Inflammation |
| LGR5 | RNA | - | - | - |
| LHFP | RNA | - | - | - |
| LIF | RNA | Cytotoxicity Epigenic and Transcriptional Regulation JAK-STAT |
Immune Activation Status Immune Suppression Myeloid Compartment |
Oncology Epigenic and Nuclear Signaling CNS Immuno-Oncology Inflammation Metabolic Diseases Oncology |
| LIFR | RNA | Cell Proliferation JAK-STAT Proliferation |
Cellular Growth Factor Immune Activation Status |
CNS Oncology Immuno-Oncology Inflammation Metabolic Diseases Oncology |
| LIG1 | RNA | Cell Cycle | - | Oncology |
| LIG4 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| LILRA1 | RNA | - | Immune Activation Status | Immuno-Oncology |
| LILRA2 | RNA | - | - | - |
| LILRA3 | RNA | - | Immune Activation Status | Immuno-Oncology |
| LILRA4 | RNA | - | Immune Activation Status | Immuno-Oncology |
| LILRA5 | RNA | - | Myeloid Compartment | CNS |
| LILRA6 | RNA | - | - | - |
| LILRB1 | RNA | - | B Cell Exhaustion Immune Activation Status NK Cell Function |
Immuno-Oncology |
| LILRB2 | RNA | Costimulatory Signaling | B Cell Exhaustion Immune Activation Status Inflammation Myeloid Compartment |
Immuno-Oncology Inflammation CNS |
| LILRB3 | RNA | - | Immune Activation Status | Immuno-Oncology |
| LILRB4 | RNA | - | Immune Activation Status Immunity and Inflammation |
Immuno-Oncology Inflammation |
| LILRB5 | RNA | - | - | - |
| LIMK1 | RNA | - | - | - |
| LIMK2 | RNA | - | - | - |
| LIN9 | RNA | Cell Cycle | - | Oncology |
| LINC02381 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| LINGO1 | RNA | - | - | - |
| LIPA | RNA | - | - | - |
| LIPC | RNA | - | - | - |
| LIPG | RNA | - | - | - |
| LITAF | RNA | - | - | - |
| LLGL2 | RNA | - | - | - |
| LMNA | RNA | - | Activated Microglia Immunity and Inflammation |
CNS Inflammation |
| LMNB1 | RNA | - | Immunity and Inflammation | Inflammation |
| LNX1 | RNA | - | - | - |
| LOX | RNA | Collagen Biosynthesis & Modification Vasculogenesis |
Activated Microglia Immunity and Inflammation |
CNS Cardiovascular Inflammation |
| LOXL1 | RNA | Collagen Biosynthesis & Modification | - | CNS |
| LOXL2 | RNA | Collagen Biosynthesis & Modification Matrix Remodeling and Metastases |
- | CNS Oncology |
| LOXL4 | RNA | Collagen Biosynthesis & Modification | - | CNS |
| LPA | RNA | - | - | - |
| LPAR1 | RNA | Myelination | Axon and Dendrite Structure Immune Activation Status Neural Connectivity Transmitter Response and Reuptake |
CNS Immuno-Oncology |
| LPAR5 | RNA | Adenosine Pathway | - | Immuno-Oncology |
| LPAR6 | RNA | - | - | - |
| LPCAT1 | RNA | - | - | - |
| LPIN1 | RNA | - | - | - |
| LPL | RNA | Adenosine Pathway | - | Immuno-Oncology |
| LPO | RNA | Oxydative Stress | - | Inflammation |
| LRG1 | RNA | - | Immunity and Inflammation | Inflammation |
| LRP1 | RNA | Adenosine Pathway | Axon and Dendrite Structure | Immuno-Oncology CNS |
| LRP2 | RNA | Adenosine Pathway Hedgehog |
- | Immuno-Oncology CNS Inflammation Oncology |
| LRP5 | RNA | - | - | - |
| LRP6 | RNA | - | Immune Activation Status | Immuno-Oncology |
| LRR1 | RNA | - | - | - |
| LRRC25 | RNA | - | - | - |
| LRRC3 | RNA | - | Immunity and Inflammation | Inflammation |
| LRRC32 | RNA | - | - | - |
| LRRC4 | RNA | - | Axon and Dendrite Structure Neural Connectivity |
CNS |
| LRRC41 | RNA | - | - | - |
| LRRK2 | Protein | Epigenic and Transcriptional Regulation Oxydative Stress |
Axon and Dendrite Structure Neural Connectivity PD Pathology Vesicle Trafficking |
Epigenic and Nuclear Signaling Inflammation CNS |
| LRRK2 | RNA | Epigenic and Transcriptional Regulation Oxydative Stress |
Axon and Dendrite Structure Neural Connectivity PD Pathology Vesicle Trafficking |
Epigenic and Nuclear Signaling Inflammation CNS |
| LRRN3 | RNA | - | - | - |
| LSM2 | RNA | - | - | - |
| LSM7 | RNA | - | - | - |
| LSR | RNA | Lipid Metabolism | - | Metabolic Diseases |
| LST1 | RNA | - | Immunity and Inflammation | Inflammation |
| LTA | RNA | Signaling Affecting Cellular Metabolism | Chemokines Immunity and Inflammation Inflammation M1 Activation |
Metabolic Diseases Immuno-Oncology Inflammation CNS |
| LTA4H | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| LTB | RNA | NF-kappaB Signaling Signaling Affecting Cellular Metabolism |
Cytokines Immunity and Inflammation Inflammation |
CNS Metabolic Diseases Immuno-Oncology Inflammation Oncology |
| LTB4R | RNA | - | - | - |
| LTB4R2 | RNA | - | - | - |
| LTBP1 | RNA | ECM Remodeling Matrix Remodeling and Metastases TGF Beta Signaling |
Immune Suppression | Metabolic Diseases CNS Oncology Immuno-Oncology |
| LTBP4 | RNA | Cellular Differentiation | Cellular Growth Factor | Oncology |
| LTBR | RNA | HIF1 Signaling | Chemokines Immunity and Inflammation Inflammation |
Inflammation Immuno-Oncology Oncology |
| LTC4S | RNA | Biosynthesis and Anabolic Pathways | Immunity and Inflammation | CNS Inflammation Metabolic Diseases |
| LTF | RNA | - | - | - |
| LTK | RNA | - | - | - |
| LUM | RNA | - | Cellular Growth Factor | Oncology |
| LY6E | RNA | - | - | - |
| LY86 | RNA | Signaling Affecting Cellular Metabolism | - | Metabolic Diseases |
| LY9 | RNA | Costimulatory Signaling | Lymphoid Compartment | Immuno-Oncology |
| LY96 | RNA | Apoptosis Signaling Affecting Cellular Metabolism |
Myeloid Compartment | Oncology Metabolic Diseases CNS |
| LYN | RNA | - | Immune Activation Status Immune Checkpoint Immunity and Inflammation Inflammation |
Immuno-Oncology Inflammation |
| LYPLA1 | RNA | Lipid Metabolism | - | Metabolic Diseases |
| Lysine | Amino-acid & Metabolites | - | - | - |
| LysoPC(20:4(8Z.11Z.14Z.17Z)) | Lipid | - | - | - |
| LysoPE(0:0/16:0) | Lipid | - | - | - |
| LysoPE(0:0/18:0) | Lipid | - | - | - |
| LysoPE(0:0/22:6(4Z.7Z.10Z.13Z.16Z.19Z)) | Lipid | - | - | - |
| LYZ | RNA | - | Myeloid Compartment | CNS |
| MAD2L1 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| MAD2L2 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| MAF | RNA | EMT | - | Oncology |
| MAFB | RNA | - | - | - |
| MAFF | RNA | - | Immunity and Inflammation | Inflammation |
| MAFG | RNA | - | - | - |
| MAFK | RNA | - | - | - |
| MAG | RNA | Myelination | Axon and Dendrite Structure | CNS |
| MAGEA1 | RNA | - | - | - |
| MAGEA12 | RNA | - | - | - |
| MAGEA3 | RNA | - | - | - |
| MAGEA3/A6 | RNA | - | - | - |
| MAGEA4 | RNA | - | - | - |
| MAGEB2 | RNA | - | - | - |
| MAGEC1 | RNA | - | - | - |
| MAGEC2 | RNA | - | - | - |
| MAGED1 | RNA | - | - | - |
| MAGEE1 | RNA | - | Axon and Dendrite Structure Neural Connectivity |
CNS |
| MAGI2 | RNA | - | Immune Activation Status | Immuno-Oncology |
| MAL | RNA | Myelination | - | CNS |
| malate | Amino-acid & Metabolites | - | - | - |
| MALL | RNA | - | - | - |
| MALT1 | RNA | TCR Signaling | Immune Activation Status | Immuno-Oncology |
| MAML1 | RNA | - | - | - |
| MAML2 | RNA | Notch | - | Immuno-Oncology |
| MAML3 | RNA | - | Immune Suppression | Immuno-Oncology |
| MAN2B1 | RNA | - | Immunity and Inflammation | Inflammation |
| Manbeta1-4Glcbeta-Cer(d18:1/18:0) | Lipid | - | - | - |
| Manniflavanone | Lipid | - | - | - |
| MAP1LC3A | RNA | - | - | - |
| MAP1LC3B | RNA | Nutrient Capture and Catabolic Pathways | - | Metabolic Diseases |
| MAP2 | Protein | - | Axon and Dendrite Structure Cytoskeleton Neural Cell Typing |
CNS |
| MAP2 | RNA | - | Axon and Dendrite Structure Cytoskeleton Neural Cell Typing |
CNS |
| MAP2K1 | RNA | Nutrient Capture and Catabolic Pathways RAS Signaling Affecting Cellular Metabolism Vasculogenesis |
Cellular Growth Factor Immunity and Inflammation Transmitter Release Transmitter Response and Reuptake |
Metabolic Diseases Oncology Cardiovascular Inflammation CNS |
| MAP2K2 | RNA | Nutrient Capture and Catabolic Pathways RAS Signaling Affecting Cellular Metabolism |
Cellular Growth Factor Immune Activation Status Transmitter Response and Reuptake |
Metabolic Diseases Oncology Immuno-Oncology CNS |
| MAP2K3 | RNA | Signaling Affecting Cellular Metabolism | - | Metabolic Diseases |
| MAP2K4 | RNA | DNA Damage Repair MAPK |
Immunity and Inflammation | Epigenic and Nuclear Signaling Cardiovascular Inflammation CNS Oncology |
| MAP2K6 | RNA | - | - | - |
| MAP2K7 | RNA | - | - | - |
| MAP3K1 | RNA | - | Immunity and Inflammation | Inflammation |
| MAP3K12 | RNA | Chromatin Modification Epigenic and Transcriptional Regulation MAPK Signaling Affecting Cellular Metabolism |
- | Epigenic and Nuclear Signaling Cardiovascular Metabolic Diseases CNS Oncology |
| MAP3K13 | RNA | - | Immune Activation Status | Immuno-Oncology |
| MAP3K14 | RNA | - | Immunity and Inflammation | Inflammation |
| MAP3K20 | RNA | - | - | - |
| MAP3K3 | RNA | - | - | - |
| MAP3K5 | RNA | MAPK Metabolism Stress |
- | Cardiovascular Metabolic Diseases CNS Oncology |
| MAP3K7 | RNA | Angiogenesis Autophagy Costimulatory Signaling MAPK Wnt Signaling |
- | Cardiovascular Immuno-Oncology CNS Oncology Inflammation Metabolic Diseases Oncology |
| MAP3K8 | RNA | Costimulatory Signaling MAPK |
Immune Activation Status | Immuno-Oncology Cardiovascular CNS Oncology |
| MAP3K9 | RNA | - | - | - |
| MAP4K1 | RNA | - | - | - |
| MAP4K2 | RNA | - | - | - |
| MAP4K4 | RNA | - | - | - |
| MAPK1 | RNA | Biosynthesis and Anabolic Pathways FGFR Signaling MAPK Nutrient Capture and Catabolic Pathways PI3K-AKT Proliferation RAS Signaling Affecting Cellular Metabolism TCR Signaling TGF Beta Signaling |
Adhesion and Migration Axon and Dendrite Structure Cellular Growth Factor Immune Activation Status Transmitter Release Transmitter Response and Reuptake Vesicle Trafficking |
CNS Cardiovascular Metabolic Diseases Oncology Immuno-Oncology Inflammation |
| MAPK10 | RNA | AP1 Signaling Autophagy MAPK Metabolism Stress RAS Wnt Signaling |
Immune Activation Status Immunity and Inflammation Transmitter Release Transmitter Response and Reuptake |
Cardiovascular Metabolic Diseases Oncology CNS Immuno-Oncology Inflammation Oncology |
| MAPK11 | RNA | AP1 Signaling TCR Signaling |
Immune Activation Status | Cardiovascular Immuno-Oncology CNS Inflammation Metabolic Diseases Oncology |
| MAPK12 | RNA | - | Immunity and Inflammation | Inflammation |
| MAPK13 | RNA | VEGFR Signaling | Immune Activation Status | Cardiovascular Immuno-Oncology Oncology |
| MAPK14 | RNA | AP1 Signaling TCR Signaling VEGFR Signaling |
Immune Activation Status Immunity and Inflammation |
Cardiovascular Immuno-Oncology Inflammation Oncology CNS Metabolic Diseases Oncology |
| MAPK15 | RNA | - | - | - |
| MAPK3 | RNA | Cellular Differentiation FGFR Signaling MAPK PI3K-AKT Proliferation RAS TGF Beta Signaling |
Adhesion and Migration Cellular Growth Factor Immune Activation Status Transmitter Release Transmitter Response and Reuptake |
Oncology Cardiovascular CNS Immuno-Oncology Inflammation |
| MAPK7 | RNA | - | - | - |
| MAPK8 | RNA | AP1 Signaling Cell Stress Nutrient Capture and Catabolic Pathways RAS Signaling Affecting Cellular Metabolism |
Immune Activation Status Transmitter Release Transmitter Response and Reuptake |
Cardiovascular CNS Metabolic Diseases Oncology Immuno-Oncology Inflammation Oncology |
| MAPK8IP1 | RNA | Signaling Affecting Cellular Metabolism | - | Metabolic Diseases |
| MAPK8IP2 | RNA | MAPK | - | Cardiovascular CNS Oncology |
| MAPK9 | RNA | AP1 Signaling RAS |
Immune Activation Status Transmitter Release Transmitter Response and Reuptake |
Cardiovascular Oncology Immuno-Oncology CNS Inflammation Metabolic Diseases Oncology |
| MAPKAP1 | RNA | Signaling Affecting Cellular Metabolism | - | Metabolic Diseases |
| MAPKAPK2 | RNA | - | - | - |
| MAPKAPK3 | RNA | - | - | - |
| MAPKAPK5 | RNA | - | - | - |
| MAPT | RNA | ER Signaling MAPK Oxydative Stress Signaling Affecting Cellular Metabolism |
Axon and Dendrite Structure Neural Connectivity Neuronal Cytoskeleton |
Oncology Cardiovascular Inflammation Metabolic Diseases CNS |
| MARCKS | RNA | - | - | - |
| MARCO | RNA | - | Activated Microglia Immunity and Inflammation Myeloid Compartment |
CNS Inflammation |
| MART1 | Protein | - | Pan-Tumor | Oncology |
| MASP1 | RNA | - | - | - |
| MASP2 | RNA | - | - | - |
| MAT1A | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| MAT2A | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| MAVS | RNA | - | Immunity and Inflammation | Inflammation |
| MAX | RNA | - | - | - |
| MB21D1 | RNA | - | Immunity and Inflammation | Inflammation |
| MBD2 | RNA | - | - | - |
| MBD3 | RNA | Epigenic and Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| MBL2 | RNA | - | - | - |
| MBNL1 | RNA | - | - | - |
| MBNL3 | RNA | - | - | - |
| MBP | RNA | Myelination | Axon and Dendrite Structure Vesicle Trafficking |
CNS |
| MBTPS2 | RNA | - | - | - |
| MCAM | RNA | Angiogenesis Vasculogenesis |
- | Cardiovascular Oncology |
| MCAT | RNA | Biosynthesis and Anabolic Pathways Nutrient Capture and Catabolic Pathways |
- | CNS Metabolic Diseases |
| MCL1 | RNA | - | Immune Activation Status | Immuno-Oncology |
| MCM2 | RNA | Cell Cycle DNA Damage Repair mTOR Signaling Proliferation |
Immunity and Inflammation | Oncology Epigenic and Nuclear Signaling Inflammation |
| MCM3 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| MCM4 | RNA | Cell Cycle mTOR Signaling Myc |
- | Oncology |
| MCM5 | RNA | - | Immune Activation Status Immunity and Inflammation |
Immuno-Oncology Inflammation |
| MCM6 | RNA | - | - | - |
| MCM7 | RNA | - | Immune Activation Status | Immuno-Oncology |
| MDC1 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| MDFIC | RNA | - | - | - |
| MDH2 | RNA | - | - | - |
| MDM2 | RNA | Cell Cycle PI3K-AKT Proliferation p53 Signaling Transcriptional Misregulation |
Immunity and Inflammation | Oncology Epigenic and Nuclear Signaling Inflammation |
| MDM4 | RNA | - | - | - |
| ME2 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| MEAF6 | RNA | - | - | - |
| MECOM | RNA | - | - | - |
| MECP2 | RNA | - | Neural Connectivity Vesicle Trafficking |
CNS |
| MED1 | RNA | Angiogenesis Cellular Differentiation Transcriptional Misregulation |
- | Cardiovascular Oncology Epigenic and Nuclear Signaling |
| MED12 | RNA | - | - | - |
| MED23 | RNA | - | - | - |
| MEF2A | RNA | - | - | - |
| MEF2BNB-MEF2B | RNA | - | - | - |
| MEF2C | RNA | - | Immunity and Inflammation | Inflammation |
| MEF2D | RNA | - | - | - |
| MEFV | RNA | - | - | - |
| MEG3 | RNA | Cell Proliferation Cellular Differentiation Vasculogenesis |
Cellular Growth Factor | CNS Oncology Cardiovascular |
| Megalomicin B | Lipid | - | - | - |
| MELK | RNA | Proliferation | - | Oncology |
| MEN1 | RNA | - | - | - |
| MEOX2 | RNA | Angiogenesis EMT |
- | Cardiovascular Oncology |
| MERTK | Protein | - | Glial Cell Subtyping Immunity and Inflammation |
CNS Inflammation |
| MERTK | RNA | - | Glial Cell Subtyping Immunity and Inflammation |
CNS Inflammation |
| MET | Protein | Cell Proliferation MAPK Met Signaling Metabolism Stress PI3K-AKT Proliferation RAS Transcriptional Misregulation |
Cellular Growth Factor | CNS Cardiovascular Oncology Metabolic Diseases Epigenic and Nuclear Signaling |
| MET | RNA | Cell Proliferation MAPK Met Signaling Metabolism Stress PI3K-AKT Proliferation RAS Transcriptional Misregulation |
Cellular Growth Factor | CNS Cardiovascular Oncology Metabolic Diseases Epigenic and Nuclear Signaling |
| methyl 4-2-(2-formyl-vinyl)-3-hydroxy-5-oxo-cyclopentyl-butanoate | Lipid | - | - | - |
| methyl 5-hydroperoxy-6.8.9.11-bisepidioxy-12.14-eicosadienoate | Lipid | - | - | - |
| MFAP3 | RNA | - | - | - |
| MFAP4 | RNA | - | - | - |
| MFGE8 | RNA | - | - | - |
| MFN2 | RNA | - | - | - |
| MFNG | RNA | Notch | - | Immuno-Oncology |
| MG(16:0/0:0/0:0) | Lipid | - | - | - |
| MG(18:0/0:0/0:0)rac | Lipid | - | - | - |
| MGA | RNA | Myc | - | Oncology |
| MGAM | RNA | - | - | - |
| MGAT5 | RNA | - | - | - |
| MGDG(18:2(9Z.12Z)/18:2(9Z.12Z)) | Lipid | - | - | - |
| MGMT | RNA | DNA Damage Repair Oxydative Stress |
- | Epigenic and Nuclear Signaling Inflammation |
| MGP | RNA | - | - | - |
| MGST3 | RNA | Cell Stress | - | CNS Oncology |
| MIA | RNA | - | - | - |
| MIB1 | RNA | - | - | - |
| MICA | RNA | - | - | - |
| MICB | RNA | - | - | - |
| MID1IP1 | RNA | - | - | - |
| MIF | RNA | - | Immune Activation Status | Immuno-Oncology |
| MINOS1 | RNA | - | - | - |
| MIS18A | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| MISP | RNA | - | - | - |
| MKI67 | RNA | Biosynthesis and Anabolic Pathways Cell Cycle DNA Damage Repair Proliferation |
- | CNS Oncology Epigenic and Nuclear Signaling Metabolic Diseases |
| MKNK1 | RNA | - | - | - |
| MLANA | RNA | - | - | - |
| MLF1 | RNA | - | - | - |
| MLH1 | RNA | DNA Damage Repair Proliferation |
- | Epigenic and Nuclear Signaling Oncology |
| MLKL | RNA | - | - | - |
| MLLT3 | RNA | Transcriptional Misregulation | - | Epigenic and Nuclear Signaling |
| MLLT4 | RNA | RAS | - | Oncology |
| MLPH | RNA | - | - | - |
| MLST8 | RNA | Nutrient Capture and Catabolic Pathways Signaling Affecting Cellular Metabolism |
- | Metabolic Diseases |
| MLXIPL | RNA | - | - | - |
| MLYCD | RNA | Signaling Affecting Cellular Metabolism | - | Metabolic Diseases |
| MME | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| MMP1 | RNA | Cellular Differentiation Matrix Remodeling and Metastases |
Myeloid Compartment | Oncology CNS |
| MMP10 | RNA | Matrix Remodeling and Metastases | - | CNS Oncology |
| MMP11 | RNA | - | Adhesion and Migration | CNS |
| MMP12 | RNA | Cell Proliferation Matrix Remodeling and Metastases |
Activated Microglia Immunity and Inflammation |
CNS Inflammation Oncology |
| MMP13 | RNA | Collagen Biosynthesis & Modification Matrix Remodeling and Metastases |
- | CNS Oncology |
| MMP14 | RNA | Angiogenesis Cell Proliferation Matrix Remodeling and Metastases Oxydative Stress |
Activated Microglia Adhesion and Migration Immune Activation Status Immunity and Inflammation |
Cardiovascular CNS Inflammation Immuno-Oncology Oncology |
| MMP16 | RNA | - | - | - |
| MMP17 | RNA | Matrix Remodeling and Metastases | - | CNS Oncology |
| MMP19 | RNA | - | - | - |
| MMP2 | RNA | Angiogenesis Matrix Remodeling and Metastases |
- | Cardiovascular CNS Oncology |
| MMP24 | RNA | Cellular Differentiation Matrix Remodeling and Metastases |
- | Oncology CNS |
| MMP3 | RNA | Adenosine Pathway Cellular Differentiation Collagen Biosynthesis & Modification Matrix Remodeling and Metastases Transcriptional Misregulation |
Adhesion and Migration Immune Activation Status |
Immuno-Oncology Oncology CNS Epigenic and Nuclear Signaling |
| MMP7 | RNA | Collagen Biosynthesis & Modification Matrix Remodeling and Metastases Wnt Signaling |
Adhesion and Migration | CNS Oncology |
| MMP8 | RNA | - | - | - |
| MMP9 | RNA | Angiogenesis Collagen Biosynthesis & Modification ECM Remodeling Matrix Remodeling and Metastases Proliferation Transcriptional Misregulation |
Adhesion and Migration Cellular Growth Factor Immune Activation Status |
Cardiovascular CNS Metabolic Diseases Oncology Epigenic and Nuclear Signaling Immuno-Oncology |
| MMRN1 | RNA | - | - | - |
| MMRN2 | RNA | Angiogenesis | - | Cardiovascular Oncology |
| MMUT | RNA | - | - | - |
| MNAT1 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| MNDA | RNA | - | Inflammation | Inflammation |
| MNX1 | RNA | - | - | - |
| MOB1B | RNA | - | - | - |
| MOBP | RNA | - | - | - |
| MOG | RNA | Myelination | - | CNS |
| MPC1 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| MPC2 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| MPDZ | RNA | - | - | - |
| MPEG1 | RNA | - | Immunity and Inflammation | Inflammation |
| MPG | RNA | - | - | - |
| MPL | RNA | - | - | - |
| MPO | Protein | Cell Stress | - | CNS Oncology |
| MPO | RNA | Cell Stress | - | CNS Oncology |
| MPPED1 | RNA | - | - | - |
| MPV17 | RNA | - | - | - |
| MPZ | RNA | - | Vesicle Trafficking | CNS |
| MPZL1 | RNA | - | - | - |
| MR1 | RNA | Antigen Processing | Immunity and Inflammation | Immuno-Oncology Inflammation |
| MRAS | RNA | Nutrient Capture and Catabolic Pathways Signaling Affecting Cellular Metabolism |
Immune Activation Status | Metabolic Diseases Immuno-Oncology |
| MRC1 | RNA | - | Antigen Presentation Myeloid Compartment |
Immuno-Oncology CNS |
| MRE11 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| MRM2 | RNA | - | - | - |
| MRPL19 | RNA | - | - | - |
| MRPS5 | RNA | - | - | - |
| MRPS7 | RNA | - | - | - |
| Ms IgG1 | Protein | - | Immune Cell Typing Neural Cell Typing |
Immuno-Oncology CNS |
| Ms IgG2a | Protein | - | Immune Cell Typing Neural Cell Typing |
Immuno-Oncology CNS |
| MS4A1 | RNA | - | B Cell Exhaustion B Cell Function Immune Activation Status Immune Cell Typing Lymphoid Compartment |
Immuno-Oncology |
| MS4A2 | RNA | - | Chemokines Immune Cell Typing Immune Suppression Immunity and Inflammation |
Immuno-Oncology Inflammation |
| MS4A4A | RNA | - | Immune Cell Typing Immune Suppression |
Immuno-Oncology |
| MS4A6A | RNA | - | - | - |
| MS4A7 | RNA | - | - | - |
| MSH2 | RNA | Cell Stress DNA Damage Repair |
- | CNS Epigenic and Nuclear Signaling Oncology |
| MSH6 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| MSLN | RNA | - | - | - |
| MSN | RNA | - | Neuronal Cytoskeleton | CNS |
| MSR1 | RNA | - | Immunity and Inflammation | Inflammation |
| MSRA | RNA | - | - | - |
| MSRB2 | RNA | Cell Stress | - | CNS Oncology |
| MST1R | RNA | - | Immune Suppression | Immuno-Oncology |
| MT1G | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| MT2A | RNA | - | - | - |
| MT3 | RNA | Cell Proliferation Vasculogenesis |
Cellular Growth Factor | CNS Cardiovascular Oncology |
| MTA adenosine | Amino-acid & Metabolites | - | - | - |
| MTA1 | RNA | - | - | - |
| MTA2 | RNA | - | - | - |
| MTBP | RNA | Cell Proliferation | - | CNS Oncology |
| MTCP1 | RNA | - | - | - |
| MTDH | RNA | - | - | - |
| MTF1 | RNA | Cell Stress | - | CNS Oncology |
| MTF2 | RNA | - | - | - |
| MTHFD1 | RNA | - | - | - |
| MTHFD1L | RNA | - | - | - |
| MTHFD2 | RNA | mTOR Signaling | - | Oncology |
| MTHFR | RNA | - | - | - |
| MTHFS | RNA | - | - | - |
| MTMR14 | RNA | - | - | - |
| MTMR3 | RNA | - | - | - |
| MTMR4 | RNA | - | - | - |
| MTOR | RNA | Autophagy Carbohydrate Metabolism Cell Proliferation Costimulatory Signaling Hypoxia JAK-STAT Metabolism Stress mTOR Signaling Myelination Nutrient Capture and Catabolic Pathways PI3K-AKT Proliferation Signaling Affecting Cellular Metabolism Tumor Metabolism |
Axon and Dendrite Structure Cellular Growth Factor |
Cardiovascular CNS Immuno-Oncology Metabolic Diseases Oncology Inflammation Oncology |
| MTR | RNA | - | - | - |
| MUC1 | RNA | EMT | - | Oncology |
| MUC16 | RNA | - | - | - |
| MUC4 | RNA | - | - | - |
| MUC5B | RNA | - | - | - |
| MUS81 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| MUTYH | RNA | DNA Damage Repair Oxydative Stress |
- | Epigenic and Nuclear Signaling Inflammation |
| MVP | RNA | - | Immunity and Inflammation | Inflammation |
| MX1 | RNA | Cytotoxicity | Immune Activation Status Lymphoid Compartment |
Oncology Immuno-Oncology |
| MX2 | RNA | - | Immune Activation Status | Immuno-Oncology |
| MXI1 | RNA | - | - | - |
| MYB | RNA | Signaling Affecting Cellular Metabolism Transcriptional Regulation |
- | Metabolic Diseases Epigenic and Nuclear Signaling |
| MYBL1 | RNA | Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| MYBL2 | RNA | Biosynthesis and Anabolic Pathways Cell Cycle DNA Damage Repair Transcriptional Regulation |
- | CNS Oncology Epigenic and Nuclear Signaling Metabolic Diseases |
| MYC | RNA | Biosynthesis and Anabolic Pathways Cell Proliferation Epigenic and Transcriptional Regulation JAK-STAT MAPK Metabolism Stress Myc Notch PI3K-AKT Proliferation Signaling Affecting Cellular Metabolism TGF Beta Signaling Transcriptional Misregulation Transcriptional Regulation Tumor Metabolism Wnt Signaling |
Immunity and Inflammation | CNS Epigenic and Nuclear Signaling Cardiovascular Metabolic Diseases Oncology Immuno-Oncology Inflammation Oncology |
| MYCL | RNA | Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| MYCN | RNA | Transcriptional Misregulation Transcriptional Regulation |
- | Epigenic and Nuclear Signaling |
| MYCT1 | RNA | Angiogenesis | - | Cardiovascular Oncology |
| MYD88 | RNA | Signaling Affecting Cellular Metabolism | Immunity and Inflammation Inflammation Neural Connectivity |
Metabolic Diseases Inflammation CNS |
| Myelin basic protein | Protein | - | Neural Cell Typing | CNS |
| MYH10 | RNA | - | Axon and Dendrite Structure Neural Connectivity |
CNS |
| MYH11 | RNA | - | - | - |
| MYL2 | RNA | - | - | - |
| MYL9 | RNA | - | Adhesion and Migration | CNS |
| MYLK | RNA | - | - | - |
| MYO1D | RNA | - | - | - |
| MYO5C | RNA | - | - | - |
| MYORG | RNA | - | - | - |
| MYRF | RNA | Myelination | - | CNS |
| Myrigalon B | Lipid | - | - | - |
| MYSM1 | RNA | Epigenic and Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| MZB1 | RNA | - | - | - |
| N.N-dimethyl-Safingol | Lipid | - | - | - |
| NAA15 | RNA | Angiogenesis | - | Cardiovascular Oncology |
| NAA20 | RNA | - | - | - |
| NAA50 | RNA | Epigenic and Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| NAALAD2 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| NADK | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| NADK2 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| NAE1 | RNA | - | - | - |
| NAGLU | RNA | Nutrient Capture and Catabolic Pathways | Activated Microglia | Metabolic Diseases CNS |
| NAMPT | RNA | - | - | - |
| N-amyl arachidohoyl amine | Lipid | - | - | - |
| NANOG | RNA | - | - | - |
| NAP1L3 | RNA | - | - | - |
| NAPSA | RNA | - | - | - |
| NASP | RNA | Chromatin Modification Epigenic and Transcriptional Regulation |
- | Epigenic and Nuclear Signaling |
| NAT1 | RNA | ER Signaling | - | Oncology |
| NAT8L | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| NBL1 | RNA | - | - | - |
| NBN | RNA | DNA Damage Repair Metabolism Stress Proliferation |
- | Epigenic and Nuclear Signaling Metabolic Diseases Oncology |
| NCAM1 | RNA | Matrix Remodeling and Metastases | Adhesion and Migration Vesicle Trafficking |
CNS Oncology |
| NCAPD2 | RNA | - | - | - |
| NCAPG | RNA | Cell Cycle | - | Oncology |
| NCAPG2 | RNA | - | - | - |
| NCAPH | RNA | Biosynthesis and Anabolic Pathways | Immunity and Inflammation | CNS Inflammation Metabolic Diseases |
| NCAPH2 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| NCEH1 | RNA | - | - | - |
| NCF1 | RNA | Oxydative Stress | Immunity and Inflammation | Inflammation |
| NCF2 | RNA | - | - | - |
| NCF4 | RNA | - | Antigen Presentation Immune Activation Status |
Immuno-Oncology |
| NCK1 | RNA | PDGF Signaling TCR Signaling |
- | Oncology Immuno-Oncology |
| NCK2 | RNA | - | - | - |
| NCKAP1L | RNA | - | - | - |
| NCL | RNA | Angiogenesis | - | Cardiovascular Oncology |
| NCOA2 | RNA | Biosynthesis and Anabolic Pathways Transcriptional Regulation |
- | CNS Epigenic and Nuclear Signaling Metabolic Diseases |
| NCOR1 | RNA | Androgen Signaling Biosynthesis and Anabolic Pathways Epigenic and Transcriptional Regulation Transcriptional Regulation |
- | Oncology CNS Epigenic and Nuclear Signaling Metabolic Diseases |
| NCOR2 | RNA | - | - | - |
| NCR1 | RNA | - | Immune Activation Status Immune Cell Typing Immunity and Inflammation NK Cell Function |
Immuno-Oncology Inflammation |
| NCR2 | RNA | - | Immune Activation Status | Immuno-Oncology |
| NCR3 | RNA | - | Immune Activation Status | Immuno-Oncology |
| NCSTN | RNA | - | - | - |
| NDC1 | RNA | Biosynthesis and Anabolic Pathways Signaling Affecting Cellular Metabolism |
- | CNS Metabolic Diseases |
| NDC80 | RNA | - | - | - |
| NDNF | RNA | - | Cellular Growth Factor | Oncology |
| NDP | RNA | Cell Proliferation Proliferation Vasculogenesis |
Cellular Growth Factor | CNS Oncology Cardiovascular |
| NDRG1 | RNA | - | - | - |
| NDUFA1 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| NDUFA11 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| NDUFA12 | RNA | Biosynthesis and Anabolic Pathways Cell Stress |
- | CNS Oncology Metabolic Diseases |
| NDUFA13 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| NDUFA2 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| NDUFA3 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| NDUFA4 | RNA | Biosynthesis and Anabolic Pathways Signaling Affecting Cellular Metabolism |
- | CNS Metabolic Diseases |
| NDUFA4L2 | RNA | - | - | - |
| NDUFA6 | RNA | Biosynthesis and Anabolic Pathways Cell Stress |
- | CNS Oncology Metabolic Diseases |
| NDUFA7 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| NDUFAB1 | RNA | - | - | - |
| NDUFB1 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| NDUFB10 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| NDUFB11 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| NDUFB2 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| NDUFB4 | RNA | Biosynthesis and Anabolic Pathways Cell Stress |
- | CNS Oncology Metabolic Diseases |
| NDUFB5 | RNA | - | - | - |
| NDUFB6 | RNA | - | - | - |
| NDUFB7 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| NDUFB8 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| NDUFB9 | RNA | - | - | - |
| NDUFC1 | RNA | - | - | - |
| NDUFS3 | RNA | - | - | - |
| NDUFS5 | RNA | - | - | - |
| NDUFS7 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| NDUFS8 | RNA | Biosynthesis and Anabolic Pathways Cell Stress |
- | CNS Oncology Metabolic Diseases |
| NECTIN1 | RNA | - | - | - |
| NECTIN2 | RNA | Costimulatory Signaling | - | Immuno-Oncology |
| NEDD8 | RNA | Nutrient Capture and Catabolic Pathways | - | Metabolic Diseases |
| NEFH | RNA | Oxydative Stress | Axon and Dendrite Structure Neuronal Cytoskeleton |
Inflammation CNS |
| NEFL | RNA | - | Axon and Dendrite Structure Immunity and Inflammation Neuronal Cytoskeleton |
CNS Inflammation |
| NEGR1 | RNA | - | - | - |
| NEIL1 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| NEIL2 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| NEIL3 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| NEK2 | RNA | Cell Cycle | - | Oncology |
| NELFA | RNA | - | - | - |
| NELL2 | RNA | - | Axon and Dendrite Structure | CNS |
| NEO1 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| Neoendorphin | Neuropeptide & Neurotransmitter | - | - | - |
| Neprilysin | Protein | Amyloid Processing | AD Pathology | CNS |
| NES | RNA | - | Neuronal Cytoskeleton | CNS |
| NETO2 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| NEU1 | RNA | Nutrient Capture and Catabolic Pathways | - | Metabolic Diseases |
| NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/16:0) | Lipid | - | - | - |
| NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/18:0) | Lipid | - | - | - |
| NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/20:0) | Lipid | - | - | - |
| NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/22:0) | Lipid | - | - | - |
| NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/24:0) | Lipid | - | - | - |
| NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) | Lipid | - | - | - |
| NeuAcalpha2-6Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0) | Lipid | - | - | - |
| NeuN | Protein | - | Neural Cell Typing | CNS |
| Neurofilament light | Protein | - | Neural Cell Typing | CNS |
| NF1 | Protein | Apoptosis Cell Proliferation Cellular Differentiation MAPK Myelination RAS |
Axon and Dendrite Structure Neural Connectivity Transmitter Response and Reuptake Vesicle Trafficking |
Oncology CNS Cardiovascular |
| NF1 | RNA | Apoptosis Cell Proliferation Cellular Differentiation MAPK Myelination RAS |
Axon and Dendrite Structure Neural Connectivity Transmitter Response and Reuptake Vesicle Trafficking |
Oncology CNS Cardiovascular |
| NF2 | RNA | Cell Proliferation | - | CNS Oncology |
| NFAM1 | RNA | - | Inflammation Myeloid Compartment |
Inflammation CNS |
| NFAT5 | RNA | Transcriptional Regulation | Immune Activation Status | Epigenic and Nuclear Signaling Immuno-Oncology |
| NFATC1 | RNA | MAPK TCR Signaling Wnt Signaling |
Immune Activation Status | Cardiovascular Immuno-Oncology CNS Oncology |
| NFATC2 | RNA | Cell Proliferation Costimulatory Signaling TCR Signaling Wnt Signaling |
Immune Activation Status | CNS Immuno-Oncology Oncology |
| NFATC2IP | RNA | - | - | - |
| NFATC3 | RNA | TCR Signaling | Immune Activation Status | Immuno-Oncology |
| NFATC4 | RNA | - | - | - |
| NFE2L1 | RNA | - | - | - |
| NFE2L2 | RNA | Biosynthesis and Anabolic Pathways Cell Stress Oxydative Stress Transcriptional Regulation |
- | CNS Inflammation Epigenic and Nuclear Signaling Oncology Metabolic Diseases |
| NFIL3 | RNA | Angiogenesis | Immune Activation Status | Cardiovascular Immuno-Oncology Oncology |
| NFKB1 | RNA | Costimulatory Signaling Cytokine and Chemokine Signaling Hypoxia MAPK Metabolism Stress NF-kappaB Signaling PI3K-AKT RAS Signaling Affecting Cellular Metabolism TCR Signaling Transcriptional Regulation |
Immune Activation Status Immunity and Inflammation |
Immuno-Oncology Cardiovascular Metabolic Diseases CNS Oncology Epigenic and Nuclear Signaling Inflammation |
| NFKB2 | RNA | MAPK NF-kappaB Signaling Signaling Affecting Cellular Metabolism Transcriptional Regulation |
Immune Activation Status Immunity and Inflammation |
Cardiovascular CNS Metabolic Diseases Epigenic and Nuclear Signaling Immuno-Oncology Inflammation Oncology |
| NFKBIA | RNA | Costimulatory Signaling Cytokine and Chemokine Signaling NF-kappaB Signaling TCR Signaling |
Immune Activation Status Immunity and Inflammation Transmitter Response and Reuptake |
Immuno-Oncology CNS Inflammation Oncology |
| NFKBIB | RNA | - | Immune Activation Status | Immuno-Oncology |
| NFKBIE | RNA | NF-kappaB Signaling | Immune Activation Status Immunity and Inflammation |
CNS Immuno-Oncology Inflammation Oncology |
| NFKBIZ | RNA | Transcriptional Misregulation | - | Epigenic and Nuclear Signaling |
| NFS1 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| NGF | RNA | RAS | - | Oncology |
| NGFR | RNA | MAPK Myelination Oxydative Stress PI3K-AKT RAS Signaling Affecting Cellular Metabolism Transcriptional Misregulation |
Immunity and Inflammation Vesicle Trafficking |
Cardiovascular CNS Inflammation Oncology Metabolic Diseases Epigenic and Nuclear Signaling |
| NGLY1 | RNA | - | - | - |
| NID1 | RNA | - | - | - |
| NID2 | RNA | Cellular Differentiation Matrix Remodeling and Metastases |
- | Oncology CNS |
| NINJ2 | RNA | - | - | - |
| NKD1 | RNA | - | - | - |
| NKG7 | RNA | Cytotoxicity | Immune Activation Status Immune Cell Typing |
Oncology Immuno-Oncology |
| NKIRAS2 | RNA | - | - | - |
| NKX2-1 | RNA | - | - | - |
| NKX3-1 | RNA | Androgen Signaling | - | Oncology |
| NKX6-2 | RNA | Myelination | - | CNS |
| NLGN1 | RNA | - | - | - |
| NLGN2 | RNA | - | - | - |
| NLGN4X | RNA | - | Axon and Dendrite Structure Neural Connectivity Vesicle Trafficking |
CNS |
| NLRC4 | RNA | - | - | - |
| NLRC5 | RNA | - | - | - |
| NLRP1 | RNA | - | - | - |
| NLRP3 | RNA | - | Activated Microglia Immunity and Inflammation Myeloid Compartment |
CNS Inflammation |
| NMB | RNA | - | - | - |
| NME1 | RNA | Biosynthesis and Anabolic Pathways Cell Proliferation Myc Signaling Affecting Cellular Metabolism |
- | CNS Oncology Metabolic Diseases |
| NME2 | RNA | Biosynthesis and Anabolic Pathways Signaling Affecting Cellular Metabolism |
- | CNS Metabolic Diseases |
| NME4 | RNA | - | - | - |
| NME5 | RNA | Oxydative Stress | - | Inflammation |
| NMNAT2 | RNA | - | Neural Connectivity | CNS |
| NMT1 | RNA | - | - | - |
| NOD1 | RNA | - | Immunity and Inflammation | Inflammation |
| NOD2 | RNA | Signaling Affecting Cellular Metabolism | Cytokines | Metabolic Diseases Immuno-Oncology |
| NODAL | RNA | Cell Proliferation Cellular Differentiation Vasculogenesis |
Cellular Growth Factor | CNS Oncology Cardiovascular |
| NOG | RNA | - | - | - |
| NOL3 | RNA | Oxydative Stress | - | Inflammation |
| NOL7 | RNA | - | - | - |
| Nonadecyl palmitoleate | Lipid | - | - | - |
| Noradrenaline | Neuropeptide & Neurotransmitter | - | - | - |
| Norlithocholic acid | Lipid | - | - | - |
| NOS1 | RNA | Biosynthesis and Anabolic Pathways Oxydative Stress Transmitter Synthesis |
Axon and Dendrite Structure Neural Connectivity Transmitter Release Transmitter Response and Reuptake Vesicle Trafficking |
CNS Inflammation Metabolic Diseases |
| NOS2 | RNA | Biosynthesis and Anabolic Pathways Cell Proliferation HIF1 Signaling Hypoxia Signaling Affecting Cellular Metabolism |
Immune Activation Status Immune Suppression Inflammation Myeloid Compartment Transmitter Release |
CNS Inflammation Cardiovascular Metabolic Diseases Immuno-Oncology Oncology |
| NOS2A | RNA | - | - | - |
| NOS3 | RNA | Angiogenesis Biosynthesis and Anabolic Pathways Cell Proliferation HIF1 Signaling Oxydative Stress Signaling Affecting Cellular Metabolism VEGFR Signaling |
Transmitter Release Transmitter Response and Reuptake |
Cardiovascular CNS Inflammation Metabolic Diseases Oncology |
| NOSTRIN | RNA | - | - | - |
| NOTCH1 | RNA | Cellular Differentiation Notch |
- | Oncology Immuno-Oncology |
| NOTCH2 | RNA | Notch | Immune Suppression | Immuno-Oncology |
| NOTCH3 | RNA | Notch | - | Immuno-Oncology |
| NOTCH4 | RNA | - | - | - |
| NOVA1 | RNA | - | Vesicle Trafficking | CNS |
| NOX1 | RNA | Cell Stress | - | CNS Oncology |
| NOX3 | RNA | Cell Stress | - | CNS Oncology |
| NOX4 | RNA | Cell Stress | - | CNS Oncology |
| NOX5 | RNA | Angiogenesis Cell Proliferation |
- | Cardiovascular CNS Oncology |
| NPAS4 | RNA | - | Activated Microglia Neural Connectivity Vesicle Trafficking |
CNS |
| NPC1 | RNA | - | - | - |
| NPC2 | RNA | - | Activated Microglia | CNS |
| NPEPPS | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| NPHP4 | RNA | - | - | - |
| NPL | RNA | - | Immunity and Inflammation | Inflammation |
| NPM1 | RNA | Biosynthesis and Anabolic Pathways Signaling Affecting Cellular Metabolism |
- | CNS Metabolic Diseases |
| NPM2 | RNA | Chromatin Modification | - | Epigenic and Nuclear Signaling |
| NPNT | RNA | - | Immunity and Inflammation | Inflammation |
| NPR1 | RNA | Biosynthesis and Anabolic Pathways Proliferation |
Cellular Growth Factor | CNS Oncology Metabolic Diseases |
| NPR2 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| NPRL2 | RNA | - | - | - |
| NPRL3 | RNA | - | Immune Activation Status | Immuno-Oncology |
| NPTN | RNA | - | Axon and Dendrite Structure Neural Connectivity Transmitter Response and Reuptake Vesicle Trafficking |
CNS |
| NPTX1 | RNA | - | - | - |
| NPY | RNA | Carbohydrate Metabolism | Transmitter Response and Reuptake Vesicle Trafficking |
CNS Metabolic Diseases |
| NQO1 | RNA | Cell Stress Oxydative Stress |
Vesicle Trafficking | CNS Inflammation Oncology |
| NR1H2 | RNA | - | - | - |
| NR1H3 | RNA | - | - | - |
| NR1H4 | RNA | - | - | - |
| NR2F1 | RNA | Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| NR3C1 | RNA | Cell Proliferation Vasculogenesis |
Cellular Growth Factor | CNS Cardiovascular Oncology |
| NR4A1 | RNA | Cell Proliferation MAPK PI3K-AKT |
Immune Activation Status | CNS Cardiovascular Oncology Immuno-Oncology |
| NR4A2 | RNA | Oxydative Stress Transmitter Synthesis |
- | Inflammation CNS |
| NR4A3 | RNA | Cell Proliferation Transcriptional Misregulation |
- | CNS Epigenic and Nuclear Signaling Oncology |
| NRAS | RNA | Autophagy Cytokine and Chemokine Signaling EGFR Signaling ERBB2 Signaling FGFR Signaling MAPK Met Signaling Metabolism Stress Nutrient Capture and Catabolic Pathways PI3K-AKT PDGF Signaling RAS Signaling Affecting Cellular Metabolism |
Immune Activation Status | Cardiovascular Immuno-Oncology Oncology Metabolic Diseases CNS Inflammation Oncology |
| NRBF2 | RNA | - | - | - |
| NRCAM | RNA | Angiogenesis Cellular Differentiation |
Adhesion and Migration | Cardiovascular Oncology CNS |
| NRDE2 | RNA | - | - | - |
| NRF1 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| NRG1 | RNA | Myelination | Axon and Dendrite Structure Neural Connectivity |
CNS |
| NRGN | Protein | - | AD Pathology | CNS |
| NRGN | RNA | - | AD Pathology | CNS |
| NRIP3 | RNA | - | M2 Activation | CNS |
| NRL | RNA | AP1 Signaling | Immune Activation Status | Cardiovascular Immuno-Oncology CNS Inflammation Metabolic Diseases Oncology |
| NRM | RNA | - | Immunity and Inflammation | Inflammation |
| NRP1 | RNA | Angiogenesis Cell Proliferation Vasculogenesis |
Cellular Growth Factor | Cardiovascular CNS Oncology |
| NRP2 | RNA | Angiogenesis Cell Proliferation Vasculogenesis |
Cellular Growth Factor Immunity and Inflammation |
Cardiovascular CNS Oncology Inflammation |
| NRXN1 | RNA | Angiogenesis | Adhesion and Migration Axon and Dendrite Structure Neural Connectivity Vesicle Trafficking |
Cardiovascular CNS Oncology |
| NRXN3 | RNA | Angiogenesis Cellular Differentiation |
Adhesion and Migration | Cardiovascular Oncology CNS |
| NSD1 | RNA | Biosynthesis and Anabolic Pathways Chromatin Modification Epigenic and Transcriptional Regulation Transcriptional Regulation |
- | CNS Epigenic and Nuclear Signaling Metabolic Diseases |
| NSD2 | RNA | - | - | - |
| NSD3 | RNA | Epigenic and Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| NSF | RNA | Transmitter Synthesis | Axon and Dendrite Structure Neural Connectivity Transmitter Release Vesicle Trafficking |
CNS |
| NT5E | RNA | Biosynthesis and Anabolic Pathways | Immune Suppression | CNS Immuno-Oncology Metabolic Diseases |
| NTF3 | RNA | Myelination | Immune Activation Status Vesicle Trafficking |
CNS Immuno-Oncology |
| NTHL1 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| NTNG1 | RNA | - | - | - |
| NTNG2 | RNA | - | - | - |
| NTRK1 | RNA | Cell Proliferation Cellular Differentiation |
Axon and Dendrite Structure Cellular Growth Factor Vesicle Trafficking |
CNS Oncology |
| NTRK2 | RNA | MAPK | - | Cardiovascular CNS Oncology |
| NTS | RNA | - | Neural Connectivity | CNS |
| NUBP1 | RNA | - | - | - |
| NUDT1 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| NUDT2 | RNA | - | - | - |
| NUF2 | RNA | Cell Cycle | - | Oncology |
| NUMB | RNA | - | - | - |
| NUMBL | RNA | Notch | - | Immuno-Oncology |
| NUP107 | RNA | - | - | - |
| NUP205 | RNA | Biosynthesis and Anabolic Pathways Signaling Affecting Cellular Metabolism |
- | CNS Metabolic Diseases |
| NUP54 | RNA | - | - | - |
| NUP62 | RNA | Biosynthesis and Anabolic Pathways Signaling Affecting Cellular Metabolism |
- | CNS Metabolic Diseases |
| NUPR1 | RNA | Transcriptional Misregulation | - | Epigenic and Nuclear Signaling |
| NWD1 | RNA | - | - | - |
| NY-ESO-1 | Protein | - | Pan-Tumor | Oncology |
| OAS1 | RNA | Cytotoxicity | Immune Activation Status Immunity and Inflammation |
Oncology Immuno-Oncology Inflammation |
| OAS2 | RNA | Cytotoxicity | Immune Activation Status | Oncology Immuno-Oncology |
| OAS3 | RNA | Cytotoxicity | Cytokines Immune Activation Status |
Oncology Immuno-Oncology |
| OASL | RNA | - | - | - |
| OAT | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| OAZ1 | RNA | - | - | - |
| OCIAD2 | RNA | - | - | - |
| OCLN | RNA | EMT | - | Oncology |
| ODC1 | RNA | Biosynthesis and Anabolic Pathways Signaling Affecting Cellular Metabolism |
- | CNS Metabolic Diseases |
| OGDH | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| OGDHL | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| OGG1 | RNA | - | - | - |
| OGN | RNA | Cell Proliferation Proliferation |
Cellular Growth Factor | CNS Oncology |
| OGT | RNA | - | - | - |
| OH-Chlorobactene glucoside laurate | Lipid | - | - | - |
| Oleyl alcohol | Lipid | - | - | - |
| OLFM3 | RNA | - | Neural Connectivity | CNS |
| OLFML2B | RNA | EMT | - | Oncology |
| OLFML3 | RNA | - | - | - |
| Olig2 | Protein | - | - | - |
| OLIG2 | RNA | Myelination | - | CNS |
| Olig2 | - | - | Neural Cell Typing | CNS |
| OLR1 | RNA | - | Myeloid Compartment | CNS |
| OMA1 | RNA | - | - | - |
| OPA1 | RNA | - | Axon and Dendrite Structure | CNS |
| OPALIN | RNA | - | - | - |
| OPN3 | RNA | - | - | - |
| OPTN | RNA | - | Activated Microglia Immunity and Inflammation |
CNS Inflammation |
| ORAI1 | RNA | - | - | - |
| ORC2 | RNA | - | Immune Activation Status | Immuno-Oncology |
| ORC4 | RNA | - | Immune Activation Status | Immuno-Oncology |
| ORC6 | RNA | - | - | - |
| ornithine | Amino-acid & Metabolites | - | - | - |
| OS9 | RNA | - | - | - |
| OSBPL5 | RNA | - | - | - |
| OSGIN1 | RNA | - | - | - |
| OSM | RNA | - | Immune Activation Status Inflammation |
Immuno-Oncology Inflammation |
| OSMR | RNA | - | Immune Activation Status Immunity and Inflammation Inflammation |
Immuno-Oncology Inflammation |
| OTC | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| OTOA | RNA | - | - | - |
| OTUD7B | RNA | - | - | - |
| OTULIN | RNA | - | - | - |
| OVOL2 | RNA | Angiogenesis Cell Proliferation Vasculogenesis |
- | Cardiovascular CNS Oncology |
| OX40L | Protein | - | Myeloid Compartment T Cell Activation |
CNS Immuno-Oncology |
| OXER1 | RNA | - | - | - |
| OXR1 | RNA | Oxydative Stress | - | Inflammation |
| OXSM | RNA | - | - | - |
| P2RX4 | RNA | - | Activated Microglia Axon and Dendrite Structure Neural Connectivity Transmitter Release Transmitter Response and Reuptake |
CNS |
| P2RX7 | Protein | - | AD Pathology Immunity and Inflammation Inflammation Microglia Neural Connectivity Transmitter Release Transmitter Response and Reuptake Vesicle Trafficking |
CNS Inflammation |
| P2RX7 | RNA | - | AD Pathology Immunity and Inflammation Inflammation Microglia Neural Connectivity Transmitter Release Transmitter Response and Reuptake Vesicle Trafficking |
CNS Inflammation |
| P2ry12 | Protein | - | - | - |
| P2RY12 | RNA | - | Activated Microglia Immunity and Inflammation |
CNS Inflammation |
| P2ry12 | - | - | Microglia Neural Cell Typing |
CNS |
| P2RY13 | RNA | Adenosine Pathway | Myeloid Compartment | Immuno-Oncology CNS |
| P3H1 | RNA | - | - | - |
| P3H2 | RNA | Cellular Differentiation | - | Oncology |
| P3H3 | RNA | Collagen Biosynthesis & Modification | - | CNS |
| p44/42 MAPK ERK1/2 | - | MAPK | - | Cardiovascular CNS Oncology |
| P4HA1 | RNA | - | - | - |
| P4HA2 | RNA | HIF1 Signaling | - | Inflammation Oncology |
| P4HB | RNA | Collagen Biosynthesis & Modification | - | CNS |
| p53 | - | Apoptosis DNA Damage Repair |
- | Oncology Epigenic and Nuclear Signaling |
| P62 | Protein | Autophagy | - | Cardiovascular CNS Inflammation Metabolic Diseases Oncology |
| PA(12:0/21:0) | Lipid | - | - | - |
| PA(13:0/0:0) | Lipid | - | - | - |
| PA(13:0/16:1(9Z)) | Lipid | - | - | - |
| PA(14:0/18:0) | Lipid | - | - | - |
| PA(16:1(9Z)/22:1(11Z)) | Lipid | - | - | - |
| PA(17:1(9Z)/0:0) | Lipid | - | - | - |
| PA(17:1(9Z)/13:0) | Lipid | - | - | - |
| PA(18:0/0:0) | Lipid | - | - | - |
| PA(18:1(9Z)/0:0) | Lipid | - | - | - |
| PA(18:3(6Z.9Z.12Z)/14:1(9Z)) | Lipid | - | - | - |
| PA(18:3(9Z.12Z.15Z)/0:0) | Lipid | - | - | - |
| PA(18:4(6Z.9Z.12Z.15Z)/0:0) | Lipid | - | - | - |
| PA(20:1(11Z)/22:6(4Z.7Z.10Z.13Z.16Z.19Z)) | Lipid | - | - | - |
| PA(20:2(11Z.14Z)/20:0) | Lipid | - | - | - |
| PA(20:3(8Z.11Z.14Z)/16:1(9Z)) | Lipid | - | - | - |
| PA(20:3(8Z.11Z.14Z)/18:0) | Lipid | - | - | - |
| PA(20:4(5Z.8Z.11Z.14Z)/20:2(11Z.14Z)) | Lipid | - | - | - |
| PA(20:5(5Z.8Z.11Z.14Z.17Z)/20:2(11Z.14Z)) | Lipid | - | - | - |
| PA(21:0/13:0) | Lipid | - | - | - |
| PA(22:1(11Z)/16:0) | Lipid | - | - | - |
| PA(22:6(4Z.7Z.10Z.13Z.16Z.19Z)/16:0) | Lipid | - | - | - |
| PA(O-16:0/20:3(8Z.11Z.14Z)) | Lipid | - | - | - |
| PA(O-16:0/22:2(13Z.16Z)) | Lipid | - | - | - |
| PA(O-18:0/21:0) | Lipid | - | - | - |
| PA(O-20:0/21:0) | Lipid | - | - | - |
| PA(P-16:0/0:0) | Lipid | - | - | - |
| PA(P-16:0/20:1(11Z)) | Lipid | - | - | - |
| PA(P-18:0/16:0) | Lipid | - | - | - |
| PA(P-18:0/22:6(4Z.7Z.10Z.13Z.16Z.19Z)) | Lipid | - | - | - |
| PA(P-20:0/12:0) | Lipid | - | - | - |
| PA(P-20:0/18:2(9Z.12Z)) | Lipid | - | - | - |
| PA(P-20:0/18:4(6Z.9Z.12Z.15Z)) | Lipid | - | - | - |
| PA2G4 | RNA | Myc | Inflammation | Oncology Inflammation |
| PACSIN1 | RNA | - | Immunity and Inflammation | Inflammation |
| PADI2 | RNA | - | - | - |
| PADI4 | RNA | - | - | - |
| PAH | RNA | Biosynthesis and Anabolic Pathways Transmitter Synthesis |
- | CNS Metabolic Diseases |
| PAK1 | RNA | - | Axon and Dendrite Structure Immunity and Inflammation Transmitter Response and Reuptake |
CNS Inflammation |
| PAK2 | RNA | TCR Signaling | Adhesion and Migration | Immuno-Oncology CNS |
| PAK3 | RNA | RAS | - | Oncology |
| PAK5 | RNA | - | - | - |
| PAK7 | RNA | RAS | - | Oncology |
| PALB2 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| PALM | RNA | - | Axon and Dendrite Structure Neural Connectivity |
CNS |
| PALMD | RNA | Angiogenesis | - | Cardiovascular Oncology |
| Palmitoylcarnitine | Lipid | - | - | - |
| Pan-AKT | Protein | PI3K-AKT | - | Oncology |
| Panaxynol | Lipid | - | - | - |
| PanCk | Protein | EMT | Immune Cell Typing | Oncology Immuno-Oncology |
| Pan-Keratin | Protein | - | - | - |
| pan-RAS | Protein | MAPK | - | Cardiovascular CNS Oncology |
| Pantothenol | Lipid | - | - | - |
| PANX1 | RNA | - | - | - |
| PARD3 | RNA | Hippo Signaling | Adhesion and Migration | CNS Oncology |
| PARK2 | RNA | - | - | - |
| Park5 | Protein | - | PD Pathology | CNS |
| Park7 | Protein | - | - | - |
| PARK7 | RNA | Oxydative Stress Transmitter Synthesis |
Axon and Dendrite Structure Neural Connectivity |
Inflammation CNS |
| Park7 | - | - | PD Pathology | CNS |
| PARK7 | - | - | Transmitter Release Vesicle Trafficking |
CNS |
| PARP | Protein | Apoptosis DNA Damage Repair |
- | Oncology Epigenic and Nuclear Signaling |
| PARP1 | RNA | DNA Damage Repair Oxydative Stress |
Immunity and Inflammation | Epigenic and Nuclear Signaling Inflammation |
| PARP12 | RNA | - | - | - |
| PARP2 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| PARP3 | RNA | - | - | - |
| PARP4 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| PARP9 | RNA | - | - | - |
| PARVA | RNA | - | Adhesion and Migration | CNS |
| PASD1 | RNA | - | - | - |
| PAX3 | RNA | - | - | - |
| PAX5 | RNA | Transcriptional Misregulation | - | Epigenic and Nuclear Signaling |
| PAX8 | RNA | Transcriptional Misregulation | - | Epigenic and Nuclear Signaling |
| PBK | RNA | - | - | - |
| PBRM1 | RNA | Epigenic and Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| PBX1 | RNA | - | Immune Suppression | Immuno-Oncology |
| PBX3 | RNA | Transcriptional Misregulation | - | Epigenic and Nuclear Signaling |
| PC | RNA | Metabolism Stress | - | Metabolic Diseases |
| PC(0:0/18:0) | Lipid | - | - | - |
| PC(0:0/18:1(6Z)) | Lipid | - | - | - |
| PC(15:1(9Z)/0:0) | Lipid | - | - | - |
| PC(16:0/9:0(CHO)) | Lipid | - | - | - |
| PC(16:0/9:0(COOH)) | Lipid | - | - | - |
| PC(16:1(9Z)/2:0) | Lipid | - | - | - |
| PC(18:0/19:0) | Lipid | - | - | - |
| PC(20:1(11Z)/0:0) | Lipid | - | - | - |
| PC(20:3(8Z.11Z.14Z)/21:0) | Lipid | - | - | - |
| PC(20:5(5Z.8Z.11Z.14Z.17Z)/22:4(7Z.10Z.13Z.16Z)) | Lipid | - | - | - |
| PC(22:1(11Z)/22:4(7Z.10Z.13Z.16Z)) | Lipid | - | - | - |
| PC(22:4(7Z.10Z.13Z.16Z)/18:3(6Z.9Z.12Z)) | Lipid | - | - | - |
| PC(22:6(4Z.7Z.10Z.13Z.16Z.19Z)/0:0) | Lipid | - | - | - |
| PC(22:6(4Z.7Z.10Z.13Z.16Z.19Z)/22:6(4Z.7Z.10Z.13Z.16Z.19Z)) | Lipid | - | - | - |
| PC(6:2(3E.5E)/14:2(11E.13E)) | Lipid | - | - | - |
| PC(O-11:1(10E)/2:0) | Lipid | - | - | - |
| PC(O-15:0/20:4(5Z.8Z.11Z.14Z)) | Lipid | - | - | - |
| PC(O-16:0/18:1(9Z)) | Lipid | - | - | - |
| PC(O-16:0/O-1:0) | Lipid | - | - | - |
| PC(O-17:0/20:4(5Z.8Z.11Z.14Z)) | Lipid | - | - | - |
| PC(O-18:0/18:2(9Z.12Z)) | Lipid | - | - | - |
| PC(O-20:0/17:2(9Z.12Z)) | Lipid | - | - | - |
| PC(O-20:0/18:2(9Z.12Z)) | Lipid | - | - | - |
| PC(O-8:0/O-8:0) | Lipid | - | - | - |
| PC(P-18:0/17:2(9Z.12Z)) | Lipid | - | - | - |
| PC(P-18:0/19:0) | Lipid | - | - | - |
| PC(P-18:0/20:0) | Lipid | - | - | - |
| PC(P-20:0/19:1(9Z)) | Lipid | - | - | - |
| PC(P-20:0/20:1(11Z)) | Lipid | - | - | - |
| PCCA | RNA | - | - | - |
| PCCB | RNA | - | - | - |
| PCGF2 | RNA | - | - | - |
| PCK1 | RNA | Biosynthesis and Anabolic Pathways PI3K-AKT Signaling Affecting Cellular Metabolism |
Immune Activation Status | CNS Oncology Metabolic Diseases Immuno-Oncology |
| PCK2 | RNA | Biosynthesis and Anabolic Pathways Metabolism Stress PI3K-AKT Signaling Affecting Cellular Metabolism |
- | CNS Metabolic Diseases Oncology |
| PCLAF | RNA | Cell Stress | - | CNS Oncology |
| PCNA | RNA | Cell Cycle DNA Damage Repair Proliferation |
- | Oncology Epigenic and Nuclear Signaling |
| PCOLCE | RNA | - | - | - |
| PCSK2 | RNA | - | Axon and Dendrite Structure | CNS |
| PCTP | RNA | - | - | - |
| PD-1 | Protein | - | Immune Activation Status Immune Cell Typing Immune Checkpoint T Cell Activation |
Immuno-Oncology |
| PDCD1 | RNA | Costimulatory Signaling Signaling Affecting Cellular Metabolism TCR Signaling |
B Cell Exhaustion Immune Activation Status Immune Checkpoint Lymphoid Compartment T Cell Costimulation T Cell Exhaustion |
Immuno-Oncology Metabolic Diseases |
| PDCD10 | RNA | Angiogenesis Cell Proliferation Cellular Differentiation |
- | Cardiovascular CNS Oncology |
| PDCD1LG2 | RNA | Costimulatory Signaling Signaling Affecting Cellular Metabolism |
Immune Activation Status Immune Checkpoint T Cell Costimulation |
Immuno-Oncology Metabolic Diseases |
| PDCD2 | RNA | - | - | - |
| PDCL3 | RNA | Angiogenesis Cellular Differentiation |
- | Cardiovascular Oncology |
| PDE1B | RNA | Transmitter Synthesis | Transmitter Release | CNS |
| PDE2A | RNA | Adenosine Pathway | - | Immuno-Oncology |
| PDE3B | RNA | Adenosine Pathway | - | Immuno-Oncology |
| PDE4D | RNA | - | Transmitter Response and Reuptake | CNS |
| PDE9A | RNA | - | - | - |
| PDGFA | RNA | Angiogenesis Cell Proliferation Cellular Differentiation MAPK Matrix Remodeling and Metastases PI3K-AKT RAS |
Cellular Growth Factor | Cardiovascular CNS Oncology |
| PDGFB | RNA | Angiogenesis MAPK Matrix Remodeling and Metastases PI3K-AKT PDGF Signaling RAS Signaling Affecting Cellular Metabolism |
- | Cardiovascular CNS Oncology Metabolic Diseases |
| PDGFC | RNA | Cell Proliferation RAS Vasculogenesis |
Cellular Growth Factor | CNS Oncology Cardiovascular |
| PDGFD | RNA | RAS | Immune Activation Status | Oncology Immuno-Oncology |
| PDGFRA | RNA | MAPK PI3K-AKT PDGF Signaling RAS |
Immune Activation Status | Cardiovascular Oncology Immuno-Oncology CNS |
| PDGFRB | RNA | Cell Proliferation MAPK Metabolism Stress Oxydative Stress PI3K-AKT Proliferation PDGF Signaling RAS Signaling Affecting Cellular Metabolism |
Cellular Growth Factor Immune Activation Status Transmitter Release |
CNS Cardiovascular Metabolic Diseases Inflammation Oncology Immuno-Oncology |
| PDHA1 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| PDHB | RNA | - | Immune Suppression | Immuno-Oncology |
| PDK1 | RNA | Biosynthesis and Anabolic Pathways HIF1 Signaling Hypoxia Metabolism Stress mTOR Signaling |
- | CNS Inflammation Cardiovascular Metabolic Diseases Oncology |
| PDK2 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| PDK3 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| PDK4 | RNA | Biosynthesis and Anabolic Pathways | Immune Suppression | CNS Immuno-Oncology Metabolic Diseases |
| PD-L1 | Protein | - | Immune Activation Status Immune Cell Typing Immune Checkpoint Myeloid Compartment |
Immuno-Oncology CNS |
| PD-L2 | Protein | - | Immune Activation Status Immune Checkpoint |
Immuno-Oncology |
| PDLIM5 | RNA | Androgen Signaling | - | Oncology |
| PDP1 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| PDPK1 | RNA | Carbohydrate Metabolism Nutrient Capture and Catabolic Pathways Signaling Affecting Cellular Metabolism |
Adhesion and Migration | CNS Metabolic Diseases |
| PDPN | RNA | Cell Proliferation Cellular Differentiation |
- | CNS Oncology |
| PDZK1IP1 | RNA | - | Myeloid Compartment | CNS |
| PE(17:1(9Z)/0:0) | Lipid | - | - | - |
| PE(18:0/20:4(5Z.8Z.10E.14Z)(12OHS)) | Lipid | - | - | - |
| PE(18:0/22:6(4Z.7Z.10Z.12E.16Z.19Z)(14OH)) | Lipid | - | - | - |
| PE(19:0/0:0) | Lipid | - | - | - |
| PE(20:3(8Z.11Z.14Z)/22:6(4Z.7Z.10Z.13Z.16Z.19Z)) | Lipid | - | - | - |
| PE(20:4(5Z.8Z.11Z.14Z)/0:0) | Lipid | - | - | - |
| PE(22:2(13Z.16Z)/22:2(13Z.16Z)) | Lipid | - | - | - |
| PE(22:4(7Z.10Z.13Z.16Z)/20:3(8Z.11Z.14Z)) | Lipid | - | - | - |
| PE(22:6(4Z.7Z.10Z.13Z.16Z.19Z)/19:1(9Z)) | Lipid | - | - | - |
| PE(22:6(4Z.7Z.10Z.13Z.16Z.19Z)/22:1(11Z)) | Lipid | - | - | - |
| PE(22:6(4Z.7Z.10Z.13Z.16Z.19Z)/22:4(7Z.10Z.13Z.16Z)) | Lipid | - | - | - |
| PE(O-16:0/20:1(11Z)) | Lipid | - | - | - |
| PE(O-16:0/22:5(7Z.10Z.13Z.16Z.19Z)) | Lipid | - | - | - |
| PE(O-16:0/22:6(4Z.7Z.10Z.13Z.16Z.19Z)) | Lipid | - | - | - |
| PE(O-18:0/18:0) | Lipid | - | - | - |
| PE(O-18:0/18:2(9Z.12Z)) | Lipid | - | - | - |
| PE(O-18:0/18:3(6Z.9Z.12Z)) | Lipid | - | - | - |
| PE(O-18:0/22:6(4Z.7Z.10Z.13Z.16Z.19Z)) | Lipid | - | - | - |
| PE(O-20:0/19:1(9Z)) | Lipid | - | - | - |
| PE(O-20:0/20:3(8Z.11Z.14Z)) | Lipid | - | - | - |
| PE(O-20:0/22:6(4Z.7Z.10Z.13Z.16Z.19Z)) | Lipid | - | - | - |
| PE(P-16:0/0:0) | Lipid | - | - | - |
| PE(P-16:0/20:4(5Z.8Z.11Z.14Z)) | Lipid | - | - | - |
| PE(P-16:0/20:5(5Z.8Z.11Z.14Z.17Z)) | Lipid | - | - | - |
| PE(P-16:0/22:1(11Z)) | Lipid | - | - | - |
| PE(P-16:0/22:6(4Z.7Z.10Z.13Z.16Z.19Z)) | Lipid | - | - | - |
| PE(P-18:0/0:0) | Lipid | - | - | - |
| PE(P-18:0/19:0) | Lipid | - | - | - |
| PE(P-18:0/22:6(4Z.7Z.10Z.13Z.16Z.19Z)) | Lipid | - | - | - |
| PE(P-19:1(12Z)/0:0) | Lipid | - | - | - |
| PE(P-20:0/18:0) | Lipid | - | - | - |
| PE(P-20:0/20:4(5Z.8Z.11Z.14Z)) | Lipid | - | - | - |
| PE(P-20:0/22:6(4Z.7Z.10Z.13Z.16Z.19Z)) | Lipid | - | - | - |
| PEBP1 | RNA | Cell Stress | - | CNS Oncology |
| PEBP4 | RNA | - | - | - |
| PECAM1 | RNA | Matrix Remodeling and Metastases | Adhesion and Migration Immune Checkpoint |
CNS Immuno-Oncology Oncology |
| PE-Cer(d14:1(4E)/24:0) | Lipid | - | - | - |
| PE-Cer(d14:1(4E)/24:1(15Z)) | Lipid | - | - | - |
| PE-Cer(d14:2(4E.6E)/16:0) | Lipid | - | - | - |
| PE-Cer(d15:1(4E)/22:0(2OH)) | Lipid | - | - | - |
| PE-Cer(d15:1(4E)/24:0) | Lipid | - | - | - |
| PE-Cer(d16:1(4E)/20:0) | Lipid | - | - | - |
| PE-Cer(d16:1(4E)/24:0(2OH)) | Lipid | - | - | - |
| PE-Cer(d16:1(4E)/24:1(15Z)) | Lipid | - | - | - |
| PE-Cer(d16:2(4E.6E)/22:0(2OH)) | Lipid | - | - | - |
| PELI1 | RNA | - | - | - |
| PELI2 | RNA | - | - | - |
| PEMT | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| PEX14 | RNA | - | - | - |
| PF4 | RNA | Cytokine and Chemokine Signaling | - | Immuno-Oncology |
| PF4V1 | RNA | - | - | - |
| PFA | - | Cytokine and Chemokine Signaling | - | Immuno-Oncology |
| PFDN2 | RNA | ER Signaling | - | Oncology |
| PFKFB1 | RNA | Biosynthesis and Anabolic Pathways Signaling Affecting Cellular Metabolism |
- | CNS Metabolic Diseases |
| PFKFB3 | RNA | HIF1 Signaling Hypoxia Metabolism Stress |
- | Inflammation Cardiovascular Metabolic Diseases Oncology |
| PFKFB4 | RNA | - | - | - |
| PFKL | RNA | Biosynthesis and Anabolic Pathways Signaling Affecting Cellular Metabolism |
- | CNS Metabolic Diseases |
| PFKM | RNA | Biosynthesis and Anabolic Pathways Metabolism Stress Signaling Affecting Cellular Metabolism |
- | CNS Metabolic Diseases |
| PFKP | RNA | HIF1 Signaling | - | Inflammation Oncology |
| PFN1 | RNA | - | Neural Connectivity Neuronal Cytoskeleton |
CNS |
| PG(13:0/0:0) | Lipid | - | - | - |
| PG(13:0/21:0) | Lipid | - | - | - |
| PG(18:0/18:0) | Lipid | - | - | - |
| PG(18:2(9Z.12Z)/22:0) | Lipid | - | - | - |
| PG(19:0/21:0) | Lipid | - | - | - |
| PG(20:1(11Z)/18:0) | Lipid | - | - | - |
| PG(20:2(11Z.14Z)/22:0) | Lipid | - | - | - |
| PG(20:5(5Z.8Z.11Z.14Z.17Z)/0:0) | Lipid | - | - | - |
| PG(22:1(11Z)/20:4(5Z.8Z.11Z.14Z)) | Lipid | - | - | - |
| PG(22:1(11Z)/22:4(7Z.10Z.13Z.16Z)) | Lipid | - | - | - |
| PG(22:2(13Z.16Z)/20:4(5Z.8Z.11Z.14Z)) | Lipid | - | - | - |
| PG(22:2(13Z.16Z)/21:0) | Lipid | - | - | - |
| PG(22:2(13Z.16Z)/22:0) | Lipid | - | - | - |
| PG(22:4(7Z.10Z.13Z.16Z)/14:0) | Lipid | - | - | - |
| PG(22:6(4Z.7Z.10Z.13Z.16Z.19Z)/22:6(4Z.7Z.10Z.13Z.16Z.19Z)) | Lipid | - | - | - |
| PG(O-18:0/18:3(9Z.12Z.15Z)) | Lipid | - | - | - |
| PG(O-18:0/22:1(11Z)) | Lipid | - | - | - |
| PG(O-20:0/20:0) | Lipid | - | - | - |
| PG(P-16:0/18:2(9Z.12Z)) | Lipid | - | - | - |
| PG(P-18:0/14:0) | Lipid | - | - | - |
| PG(P-18:0/18:0) | Lipid | - | - | - |
| PG(P-18:0/18:1(9Z)) | Lipid | - | - | - |
| PGAM1 | RNA | Carbohydrate Metabolism | - | CNS Metabolic Diseases |
| PGAM2 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| PGB3 | Lipid | - | - | - |
| PGD | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| PGF | RNA | RAS | Adhesion and Migration | Oncology CNS |
| PGK1 | RNA | Biosynthesis and Anabolic Pathways Carbohydrate Metabolism HIF1 Signaling mTOR Signaling Tumor Metabolism |
Activated Microglia | CNS Inflammation Oncology Metabolic Diseases |
| PGLYRP2 | RNA | - | Immune Activation Status | Immuno-Oncology |
| PGLYRP3 | RNA | - | Immune Activation Status | Immuno-Oncology |
| PGM1 | RNA | - | - | - |
| PGM2 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| PGPEP1 | RNA | Angiogenesis | - | Cardiovascular Oncology |
| PGR | RNA | ER Signaling | - | Oncology |
| PHB | RNA | Androgen Signaling Myc |
- | Oncology |
| PHC3 | RNA | - | - | - |
| phenolic phthiocerol | Lipid | - | - | - |
| Phenylalanine | Amino-acid & Metabolites | - | - | - |
| PHF19 | RNA | - | - | - |
| PHF2 | RNA | - | - | - |
| PHF21A | RNA | - | - | - |
| PHF6 | RNA | - | - | - |
| PHGDH | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| PHLPP1 | RNA | - | - | - |
| Phospho-AKT1 (S473) | - | PI3K-AKT | - | Oncology |
| Phospho-Alpha-synuclein (S129) | Protein | - | PD Pathology | CNS |
| Phospho-c-RAF (S338) | - | MAPK | - | Cardiovascular CNS Oncology |
| Phospho-GSK3A (S21)/Phospho-GSK3B (S9) | - | PI3K-AKT | - | Oncology |
| Phospho-GSK3B (S9) | Protein | PI3K-AKT | - | Oncology |
| Phospho-JNK (T183/Y185) | Protein | MAPK | - | Cardiovascular CNS Oncology |
| Phospho-MEK1 (S217/S221) | Protein | MAPK | - | Cardiovascular CNS Oncology |
| Phospho-p38 MAPK (T180/Y182) | - | MAPK | - | Cardiovascular CNS Oncology |
| Phospho-p44/42 MAPK ERK1/2 (T202/Y204) | Protein | MAPK | - | Cardiovascular CNS Oncology |
| Phospho-p90 RSK (T359/S363) | Protein | MAPK | - | Cardiovascular CNS Oncology |
| Phospho-PRAS40 (T246) | - | PI3K-AKT | - | Oncology |
| Phospho-Tau (S199) | Protein | - | AD Pathology Cytoskeleton |
CNS |
| Phospho-Tau (S214) | Protein | - | AD Pathology Cytoskeleton |
CNS |
| Phospho-Tau (S396) | Protein | - | AD Pathology Cytoskeleton |
CNS |
| Phospho-Tau (S404) | Protein | - | AD Pathology Cytoskeleton |
CNS |
| Phospho-Tau (T231) | Protein | - | AD Pathology Cytoskeleton |
CNS |
| Phospho-Tdp-43 (S409/S410) | Protein | - | AD Pathology | CNS |
| Phospho-Tuberin (T1462) | Protein | PI3K-AKT | - | Oncology |
| PHYKPL | RNA | - | - | - |
| PI(12:0/12:0) | Lipid | - | - | - |
| PI(16:0/18:0) | Lipid | - | - | - |
| PI(16:0/22:0) | Lipid | - | - | - |
| PI(18:0/0:0) | Lipid | - | - | - |
| PI(18:0/18:4(6Z.9Z.12Z.15Z)) | Lipid | - | - | - |
| PI(18:3(6Z.9Z.12Z)/20:3(8Z.11Z.14Z)) | Lipid | - | - | - |
| PI(19:0/18:0) | Lipid | - | - | - |
| PI(20:3(8Z.11Z.14Z)/18:0) | Lipid | - | - | - |
| PI(20:4(5Z.8Z.11Z.14Z)/0:0) | Lipid | - | - | - |
| PI(20:5(5Z.8Z.11Z.14Z.17Z)/20:2(11Z.14Z)) | Lipid | - | - | - |
| PI(21:0/20:0) | Lipid | - | - | - |
| PI(22:0/17:0) | Lipid | - | - | - |
| PI(22:1(11Z)/17:0) | Lipid | - | - | - |
| PI(22:2(13Z.16Z)/18:4(6Z.9Z.12Z.15Z)) | Lipid | - | - | - |
| PI(O-20:0/19:1(9Z)) | Lipid | - | - | - |
| PI(P-16:0/0:0) | Lipid | - | - | - |
| PI(P-20:0/12:0) | Lipid | - | - | - |
| PI(P-20:0/19:1(9Z)) | Lipid | - | - | - |
| PIAS1 | RNA | - | Immune Activation Status | Immuno-Oncology |
| PIAS2 | RNA | - | Immune Activation Status | Immuno-Oncology |
| PIAS4 | RNA | DNA Damage Repair JAK-STAT Proliferation |
- | Epigenic and Nuclear Signaling CNS Oncology Inflammation Metabolic Diseases Oncology |
| PI-Cer(d18:0/16:0(2OH)) | Lipid | - | - | - |
| PI-Cer(d18:0/16:0) | Lipid | - | - | - |
| PI-Cer(d18:0/18:0(2OH)) | Lipid | - | - | - |
| PI-Cer(d18:0/22:0) | Lipid | - | - | - |
| PI-Cer(d18:1/22:0) | Lipid | - | - | - |
| PI-Cer(d20:0/16:0) | Lipid | - | - | - |
| PI-Cer(d20:0/18:0) | Lipid | - | - | - |
| PI-Cer(d20:0/26:0) | Lipid | - | - | - |
| PIDD1 | RNA | - | - | - |
| PIGR | RNA | - | - | - |
| PIK3AP1 | RNA | - | Immune Activation Status | Immuno-Oncology |
| PIK3C2A | RNA | Nutrient Capture and Catabolic Pathways | - | Metabolic Diseases |
| PIK3C2G | RNA | - | - | - |
| PIK3C3 | RNA | - | - | - |
| PIK3CA | RNA | Angiogenesis Autophagy Carbohydrate Metabolism Costimulatory Signaling Cytokine and Chemokine Signaling EGFR Signaling ERBB2 Signaling FGFR Signaling Hypoxia JAK-STAT MAPK Met Signaling Metabolism Stress Nutrient Capture and Catabolic Pathways PI3K-AKT Proliferation PDGF Signaling RAS Signaling Affecting Cellular Metabolism Tumor Metabolism Vasculogenesis |
Cellular Growth Factor Immune Activation Status Immunity and Inflammation Transmitter Release Transmitter Response and Reuptake |
Cardiovascular CNS Immuno-Oncology Oncology Metabolic Diseases Inflammation Oncology |
| PIK3CB | RNA | Carbohydrate Metabolism Nutrient Capture and Catabolic Pathways PDGF Signaling RAS Signaling Affecting Cellular Metabolism |
Immune Activation Status Immunity and Inflammation Transmitter Release Transmitter Response and Reuptake |
CNS Metabolic Diseases Oncology Immuno-Oncology Inflammation |
| PIK3CD | RNA | Autophagy Cytokine and Chemokine Signaling Hypoxia JAK-STAT MAPK Metabolism Stress Nutrient Capture and Catabolic Pathways PI3K-AKT RAS Signaling Affecting Cellular Metabolism |
Immune Activation Status Immunity and Inflammation |
Cardiovascular Immuno-Oncology CNS Metabolic Diseases Oncology Inflammation Oncology |
| PIK3CG | RNA | Angiogenesis Cell Proliferation Cytokine and Chemokine Signaling Hypoxia JAK-STAT MAPK Metabolism Stress PI3K-AKT RAS |
Adhesion and Migration Immunity and Inflammation |
Cardiovascular CNS Immuno-Oncology Metabolic Diseases Oncology Inflammation Oncology |
| PIK3R1 | RNA | Autophagy Carbohydrate Metabolism Costimulatory Signaling Cytokine and Chemokine Signaling EGFR Signaling ERBB2 Signaling FGFR Signaling Hypoxia JAK-STAT MAPK Met Signaling Metabolism Stress Nutrient Capture and Catabolic Pathways PI3K-AKT PDGF Signaling RAS Signaling Affecting Cellular Metabolism |
Adhesion and Migration Immune Activation Status Immunity and Inflammation Transmitter Release Transmitter Response and Reuptake |
Cardiovascular CNS Immuno-Oncology Oncology Metabolic Diseases Inflammation Oncology |
| PIK3R2 | RNA | Autophagy Costimulatory Signaling Cytokine and Chemokine Signaling Hypoxia JAK-STAT MAPK Metabolism Stress Nutrient Capture and Catabolic Pathways PI3K-AKT Proliferation PDGF Signaling RAS Signaling Affecting Cellular Metabolism |
Cellular Growth Factor Immune Activation Status Immunity and Inflammation |
Cardiovascular Immuno-Oncology CNS Metabolic Diseases Oncology Inflammation Oncology |
| PIK3R3 | RNA | JAK-STAT MAPK Nutrient Capture and Catabolic Pathways PI3K-AKT RAS Signaling Affecting Cellular Metabolism |
Immune Activation Status | CNS Cardiovascular Metabolic Diseases Oncology Immuno-Oncology Inflammation Oncology |
| PIK3R4 | RNA | Nutrient Capture and Catabolic Pathways Signaling Affecting Cellular Metabolism |
- | Metabolic Diseases |
| PIK3R5 | RNA | Cytokine and Chemokine Signaling Hypoxia JAK-STAT MAPK Metabolism Stress PI3K-AKT RAS |
Immunity and Inflammation | Immuno-Oncology Cardiovascular CNS Metabolic Diseases Oncology Inflammation Oncology |
| PIK3R6 | RNA | Angiogenesis | - | Cardiovascular Oncology |
| PILRA | RNA | - | Immunity and Inflammation | Inflammation |
| PILRB | RNA | - | Immunity and Inflammation | Inflammation |
| PIM1 | RNA | JAK-STAT | - | CNS Inflammation Metabolic Diseases Oncology |
| PIM1(16:0/16:1(9Z)) | Lipid | - | - | - |
| PIM1(19:0/18:1(9Z)) | Lipid | - | - | - |
| PIN1 | RNA | - | - | - |
| PINK1 | Protein | Oxydative Stress | Axon and Dendrite Structure PD Pathology Transmitter Release Vesicle Trafficking |
Inflammation CNS |
| PINK1 | RNA | Oxydative Stress | Axon and Dendrite Structure PD Pathology Transmitter Release Vesicle Trafficking |
Inflammation CNS |
| PIP | RNA | - | - | - |
| PITX2 | RNA | - | Immune Suppression | Immuno-Oncology |
| PKHD1 | RNA | - | - | - |
| PKLR | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| PKM | RNA | Biosynthesis and Anabolic Pathways HIF1 Signaling Metabolism Stress |
- | CNS Inflammation Metabolic Diseases Oncology |
| PKMYT1 | RNA | DNA Damage Repair Proliferation |
- | Epigenic and Nuclear Signaling Oncology |
| PKN1 | RNA | Cellular Differentiation | - | Oncology |
| PKN2 | RNA | - | Immune Activation Status | Immuno-Oncology |
| PKNOX1 | RNA | Angiogenesis | - | Cardiovascular Oncology |
| PKP3 | RNA | - | - | - |
| PLA1A | RNA | MAPK RAS |
- | Cardiovascular Oncology CNS |
| PLA2G10 | RNA | RAS | - | Oncology |
| PLA2G15 | RNA | Nutrient Capture and Catabolic Pathways | - | Metabolic Diseases |
| PLA2G16 | RNA | Lipid Metabolism | - | Metabolic Diseases |
| PLA2G1B | RNA | - | - | - |
| PLA2G2A | RNA | Lipid Metabolism MAPK RAS |
- | Metabolic Diseases Cardiovascular Oncology CNS |
| PLA2G2D | RNA | - | - | - |
| PLA2G2E | RNA | Lipid Metabolism | - | Metabolic Diseases |
| PLA2G2F | RNA | Lipid Metabolism | - | Metabolic Diseases |
| PLA2G3 | RNA | MAPK RAS |
- | Cardiovascular Oncology CNS |
| PLA2G4A | RNA | Lipid Metabolism MAPK Oxydative Stress RAS VEGFR Signaling |
Transmitter Release Transmitter Response and Reuptake |
Metabolic Diseases Cardiovascular Inflammation Oncology CNS |
| PLA2G4B | RNA | Lipid Metabolism | Transmitter Release Transmitter Response and Reuptake |
Metabolic Diseases CNS |
| PLA2G4C | RNA | Lipid Metabolism RAS |
Transmitter Release Transmitter Response and Reuptake |
Metabolic Diseases Oncology CNS |
| PLA2G4D | RNA | Lipid Metabolism | Transmitter Release Transmitter Response and Reuptake |
Metabolic Diseases CNS |
| PLA2G4E | RNA | Lipid Metabolism RAS |
Transmitter Release Transmitter Response and Reuptake |
Metabolic Diseases Oncology CNS |
| PLA2G4F | RNA | Lipid Metabolism MAPK RAS |
Transmitter Release Transmitter Response and Reuptake |
Metabolic Diseases Cardiovascular Oncology CNS |
| PLA2G5 | RNA | RAS | - | Oncology |
| PLA2G6 | RNA | Lipid Metabolism | Vesicle Trafficking | Metabolic Diseases CNS |
| PLAT | RNA | Transcriptional Misregulation | - | Epigenic and Nuclear Signaling |
| PLAU | RNA | Cell Proliferation Matrix Remodeling and Metastases |
- | CNS Oncology |
| PLAUR | RNA | Cell Proliferation | - | CNS Oncology |
| PLCB1 | RNA | Wnt Signaling | Transmitter Release Transmitter Response and Reuptake |
CNS Oncology |
| PLCB2 | RNA | Adenosine Pathway | Transmitter Release Transmitter Response and Reuptake |
Immuno-Oncology CNS |
| PLCB3 | RNA | Adenosine Pathway | Transmitter Release Transmitter Response and Reuptake Vesicle Trafficking |
Immuno-Oncology CNS |
| PLCB4 | RNA | Wnt Signaling | Axon and Dendrite Structure Neural Connectivity Transmitter Release Transmitter Response and Reuptake |
CNS Oncology |
| PLCE1 | RNA | MAPK RAS |
- | Cardiovascular Oncology CNS |
| PLCG1 | Protein | PI3K-AKT Signaling Affecting Cellular Metabolism |
Cellular Growth Factor Immune Activation Status |
Oncology Metabolic Diseases Immuno-Oncology |
| PLCG1 | RNA | PI3K-AKT Signaling Affecting Cellular Metabolism |
Cellular Growth Factor Immune Activation Status |
Oncology Metabolic Diseases Immuno-Oncology |
| PLCG2 | RNA | RAS VEGFR Signaling |
Immune Activation Status Immunity and Inflammation |
Oncology Cardiovascular Immuno-Oncology Inflammation |
| PLCL2 | RNA | - | Activated Microglia Vesicle Trafficking |
CNS |
| PLD1 | RNA | MAPK RAS |
- | Cardiovascular Oncology CNS |
| PLD2 | RNA | - | - | - |
| PLD3 | RNA | - | - | - |
| PLEK | RNA | - | - | - |
| PLEK2 | RNA | - | - | - |
| PLEKHA1 | RNA | - | - | - |
| PLEKHB1 | RNA | - | - | - |
| PLEKHB2 | RNA | - | - | - |
| PLEKHM1 | RNA | - | - | - |
| PLEKHO1 | RNA | - | - | - |
| PLEKHO2 | RNA | - | - | - |
| PLG | RNA | - | - | - |
| PLIN4 | RNA | - | - | - |
| PLK1 | RNA | Biosynthesis and Anabolic Pathways Cell Cycle mTOR Signaling Myc |
- | CNS Oncology Metabolic Diseases |
| PLLP | RNA | Myelination | - | CNS |
| PLOD2 | RNA | Matrix Remodeling and Metastases | - | CNS Oncology |
| PLP1 | RNA | - | - | - |
| PLPP4 | RNA | - | - | - |
| PLS1 | RNA | - | Neuronal Cytoskeleton | CNS |
| PLSCR1 | RNA | - | - | - |
| PLTP | RNA | - | - | - |
| PLXDC1 | RNA | Angiogenesis | - | Cardiovascular Oncology |
| PLXDC2 | RNA | - | - | - |
| PLXNB3 | RNA | - | - | - |
| PLXNC1 | RNA | - | Activated Microglia | CNS |
| PLXND1 | RNA | Angiogenesis | - | Cardiovascular Oncology |
| PMAIP1 | RNA | p53 Signaling | - | Oncology |
| PMCH | RNA | - | - | - |
| PMEL | RNA | - | - | - |
| PML | RNA | Epigenic and Transcriptional Regulation | Immune Activation Status | Epigenic and Nuclear Signaling Immuno-Oncology |
| PMP22 | RNA | Cell Proliferation Myelination |
Immunity and Inflammation Vesicle Trafficking |
CNS Inflammation Oncology |
| PMS2 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| PNAd | Protein | - | - | - |
| PnE(16:0/18:1(9Z)) | Lipid | - | - | - |
| PNKD | RNA | Transmitter Synthesis | Transmitter Release Vesicle Trafficking |
CNS |
| PNMA1 | RNA | - | - | - |
| PNOC | RNA | Adenosine Pathway | Immune Cell Typing | Immuno-Oncology |
| PNP | RNA | Biosynthesis and Anabolic Pathways Nutrient Capture and Catabolic Pathways |
- | CNS Metabolic Diseases |
| PNPLA3 | RNA | - | - | - |
| PNPLA6 | RNA | Angiogenesis | - | Cardiovascular Oncology |
| podoplanin | Protein | - | - | - |
| POLB | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| POLD1 | RNA | DNA Damage Repair Proliferation |
- | Epigenic and Nuclear Signaling Oncology |
| POLD4 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| POLE | RNA | Biosynthesis and Anabolic Pathways Cell Cycle Cell Stress |
- | CNS Oncology Metabolic Diseases |
| POLE2 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| POLQ | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| POLR1C | RNA | - | - | - |
| POLR1D | RNA | - | - | - |
| POLR2A | RNA | Biosynthesis and Anabolic Pathways Cell Stress DNA Damage Repair |
- | CNS Epigenic and Nuclear Signaling Oncology Metabolic Diseases |
| POLR2B | RNA | - | - | - |
| POLR2D | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| POLR2H | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| POLR2J | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| POLR2K | RNA | - | - | - |
| POLR2L | RNA | - | - | - |
| POLR3D | RNA | - | - | - |
| POLR3H | RNA | - | - | - |
| POMC | RNA | - | - | - |
| POPDC3 | RNA | EMT | - | Oncology |
| POSTN | RNA | - | - | - |
| POU2AF1 | RNA | - | - | - |
| POU2F2 | RNA | - | - | - |
| POU5F1 | RNA | - | - | - |
| PPA(18:1(9Z)/18:1(9Z)) | Lipid | - | - | - |
| PPAN | RNA | Myc | - | Oncology |
| PPARA | RNA | - | - | - |
| PPARD | RNA | - | - | - |
| PPARG | RNA | Signaling Affecting Cellular Metabolism Transcriptional Misregulation Transcriptional Regulation |
- | Metabolic Diseases Epigenic and Nuclear Signaling |
| PPARGC1A | RNA | Biosynthesis and Anabolic Pathways Carbohydrate Metabolism Chromatin Modification Epigenic and Transcriptional Regulation Oxydative Stress Signaling Affecting Cellular Metabolism |
Axon and Dendrite Structure | CNS Epigenic and Nuclear Signaling Inflammation Metabolic Diseases |
| PPARGC1B | RNA | - | - | - |
| PPAT | RNA | Biosynthesis and Anabolic Pathways Signaling Affecting Cellular Metabolism |
- | CNS Metabolic Diseases |
| PPBP | RNA | - | Chemokines | Immuno-Oncology |
| PPFIA4 | RNA | - | Immunity and Inflammation | Inflammation |
| PPFIBP2 | RNA | - | - | - |
| PPIA | RNA | - | - | - |
| PPL | RNA | - | - | - |
| PPM1A | RNA | Signaling Affecting Cellular Metabolism | Immune Activation Status Immune Suppression |
Metabolic Diseases Immuno-Oncology |
| PPM1F | RNA | Epigenic and Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| PPM1L | RNA | - | Activated Microglia | CNS |
| PPP1CB | RNA | - | Immune Suppression | Immuno-Oncology |
| PPP1R12B | RNA | - | - | - |
| PPP1R16B | RNA | - | - | - |
| PPP2CA | RNA | Adenosine Pathway Carbohydrate Metabolism |
Immune Activation Status Immune Checkpoint Transmitter Release Transmitter Response and Reuptake |
Immuno-Oncology CNS Metabolic Diseases |
| PPP2CB | RNA | PI3K-AKT TGF Beta Signaling |
Immune Activation Status Immune Checkpoint |
Oncology Immuno-Oncology |
| PPP2R1A | RNA | PI3K-AKT Proliferation TGF Beta Signaling |
Cellular Growth Factor Immune Activation Status Immune Checkpoint |
Oncology Immuno-Oncology |
| PPP2R1B | RNA | - | Immune Activation Status Immune Checkpoint |
Immuno-Oncology |
| PPP2R2B | RNA | - | - | - |
| PPP2R2C | RNA | PI3K-AKT | - | Oncology |
| PPP2R3A | RNA | - | - | - |
| PPP2R5A | RNA | - | Immune Activation Status Immune Checkpoint |
Immuno-Oncology |
| PPP2R5B | RNA | - | Immune Activation Status Immune Checkpoint |
Immuno-Oncology |
| PPP2R5C | RNA | Carbohydrate Metabolism | Immune Activation Status Immune Checkpoint Transmitter Release |
CNS Immuno-Oncology Metabolic Diseases |
| PPP2R5D | RNA | - | - | - |
| PPP2R5E | RNA | Carbohydrate Metabolism | Immune Activation Status Immune Checkpoint Transmitter Release |
CNS Immuno-Oncology Metabolic Diseases |
| PPP3CA | RNA | - | Immune Activation Status Immunity and Inflammation Neural Connectivity Transmitter Release Transmitter Response and Reuptake Vesicle Trafficking |
Immuno-Oncology Inflammation CNS |
| PPP3CB | RNA | - | Immunity and Inflammation Transmitter Release Transmitter Response and Reuptake Vesicle Trafficking |
Inflammation CNS |
| PPP3CC | RNA | - | Immune Activation Status Transmitter Release Transmitter Response and Reuptake |
Immuno-Oncology CNS |
| PPP3R1 | RNA | - | Immune Activation Status Immunity and Inflammation |
Immuno-Oncology Inflammation |
| PPP3R2 | RNA | - | Immunity and Inflammation | Inflammation |
| PPT1 | RNA | - | Axon and Dendrite Structure Neural Connectivity Vesicle Trafficking |
CNS |
| PPT2 | RNA | - | - | - |
| PQBP1 | RNA | - | - | - |
| PR | Protein | ER Signaling | Pan-Tumor | Oncology |
| PRAME | RNA | - | - | - |
| PRAP1 | RNA | - | - | - |
| PRC1 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| PRCP | RNA | - | - | - |
| PRDM1 | RNA | - | Immune Activation Status | Immuno-Oncology |
| PRDM16 | RNA | Epigenic and Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| PRDX1 | RNA | Cell Stress mTOR Signaling Signaling Affecting Cellular Metabolism |
- | CNS Oncology Metabolic Diseases |
| PRDX2 | RNA | - | - | - |
| PRDX5 | RNA | Cell Stress | - | CNS Oncology |
| PRDX6 | RNA | - | - | - |
| PRELP | RNA | Cellular Differentiation | - | Oncology |
| PREP | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| PREX1 | RNA | Adenosine Pathway | - | Immuno-Oncology |
| PRF1 | RNA | Cytotoxicity | Immune Activation Status Immune Cell Typing Immunity and Inflammation Lymphoid Compartment |
Oncology Immuno-Oncology Inflammation |
| PRG2 | RNA | - | - | - |
| PRICKLE3 | RNA | - | - | - |
| PRIM1 | RNA | Biosynthesis and Anabolic Pathways Cell Cycle |
- | CNS Oncology Metabolic Diseases |
| PRIM2 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| PRKAA1 | RNA | Nutrient Capture and Catabolic Pathways Signaling Affecting Cellular Metabolism |
Immune Activation Status | Metabolic Diseases Immuno-Oncology |
| PRKAA2 | RNA | Autophagy Biosynthesis and Anabolic Pathways Carbohydrate Metabolism Metabolism Stress Nutrient Capture and Catabolic Pathways PI3K-AKT Signaling Affecting Cellular Metabolism |
Immune Activation Status | Cardiovascular CNS Metabolic Diseases Oncology Immuno-Oncology Inflammation Oncology |
| PRKAB1 | RNA | Biosynthesis and Anabolic Pathways Nutrient Capture and Catabolic Pathways Signaling Affecting Cellular Metabolism |
- | CNS Metabolic Diseases |
| PRKAB2 | RNA | Biosynthesis and Anabolic Pathways Nutrient Capture and Catabolic Pathways Signaling Affecting Cellular Metabolism |
- | CNS Metabolic Diseases |
| PRKACA | RNA | Hedgehog MAPK RAS Wnt Signaling |
Immunity and Inflammation Neural Connectivity Transmitter Release Transmitter Response and Reuptake Vesicle Trafficking |
CNS Cardiovascular Oncology Inflammation |
| PRKACB | RNA | Autophagy Cytokine and Chemokine Signaling Hedgehog MAPK RAS Wnt Signaling |
Immunity and Inflammation Transmitter Release Transmitter Response and Reuptake |
Cardiovascular Immuno-Oncology CNS Oncology Inflammation Metabolic Diseases Oncology |
| PRKACG | RNA | RAS | Transmitter Release Transmitter Response and Reuptake |
Oncology CNS |
| PRKAG1 | RNA | Biosynthesis and Anabolic Pathways Nutrient Capture and Catabolic Pathways Signaling Affecting Cellular Metabolism |
- | CNS Metabolic Diseases |
| PRKAG2 | RNA | Biosynthesis and Anabolic Pathways Nutrient Capture and Catabolic Pathways Signaling Affecting Cellular Metabolism |
- | CNS Metabolic Diseases |
| PRKAG3 | RNA | - | Immune Activation Status | Immuno-Oncology |
| PRKAR1A | RNA | - | - | - |
| PRKAR1B | RNA | - | - | - |
| PRKAR2A | RNA | - | - | - |
| PRKAR2B | RNA | - | - | - |
| PRKCA | RNA | Adenosine Pathway ERBB2 Signaling Hypoxia MAPK Matrix Remodeling and Metastases Metabolism Stress PI3K-AKT Proliferation RAS Wnt Signaling |
Transmitter Release Transmitter Response and Reuptake |
Immuno-Oncology Oncology Cardiovascular CNS Metabolic Diseases |
| PRKCB | RNA | Cellular Differentiation Epigenic and Transcriptional Regulation HIF1 Signaling MAPK Proliferation RAS Vasculogenesis Wnt Signaling |
Cellular Growth Factor Immune Activation Status Transmitter Release Transmitter Response and Reuptake |
Oncology Epigenic and Nuclear Signaling Inflammation Cardiovascular CNS Immuno-Oncology |
| PRKCD | RNA | - | - | - |
| PRKCE | RNA | - | Macrophage Function Transmitter Response and Reuptake Vesicle Trafficking |
Immuno-Oncology CNS |
| PRKCG | RNA | Cellular Differentiation RAS Signaling Affecting Cellular Metabolism |
Axon and Dendrite Structure Cellular Growth Factor Neural Connectivity Transmitter Release Transmitter Response and Reuptake Vesicle Trafficking |
Oncology Metabolic Diseases CNS |
| PRKCQ | RNA | - | Immunity and Inflammation Neural Connectivity |
Inflammation CNS |
| PRKCSH | RNA | - | - | - |
| PRKCZ | RNA | - | Immune Suppression | Immuno-Oncology |
| PRKDC | RNA | DNA Damage Repair Proliferation |
Immune Activation Status Immunity and Inflammation |
Epigenic and Nuclear Signaling Oncology Immuno-Oncology Inflammation |
| PRKN | RNA | Cell Stress | - | CNS Oncology |
| PRKX | RNA | Hedgehog MAPK RAS Wnt Signaling |
- | CNS Cardiovascular Oncology Inflammation |
| PRL | RNA | - | Immune Activation Status Transmitter Response and Reuptake |
Immuno-Oncology CNS |
| PRLR | RNA | Cytotoxicity JAK-STAT PI3K-AKT |
- | Oncology CNS Inflammation Metabolic Diseases Oncology |
| PRM1 | RNA | - | - | - |
| PRMT5 | RNA | - | - | - |
| PRMT8 | RNA | Chromatin Modification | - | Epigenic and Nuclear Signaling |
| PRNP | RNA | Oxydative Stress | - | Inflammation |
| PROCR | RNA | - | - | - |
| PRODH2 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| PROK2 | RNA | Angiogenesis Cell Proliferation Cellular Differentiation |
- | Cardiovascular CNS Oncology |
| Proline | Amino-acid & Metabolites | - | - | - |
| PROM1 | RNA | Transcriptional Misregulation | - | Epigenic and Nuclear Signaling |
| PROS1 | RNA | - | - | - |
| PRPF3 | RNA | - | - | - |
| PRPF31 | RNA | - | - | - |
| PRPF38A | RNA | - | - | - |
| PRPS1 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| PRR15L | RNA | - | - | - |
| PRR5 | RNA | Costimulatory Signaling Metabolism Stress Signaling Affecting Cellular Metabolism |
- | Immuno-Oncology Metabolic Diseases |
| PRSS22 | RNA | Matrix Remodeling and Metastases | - | CNS Oncology |
| PRSS8 | RNA | Matrix Remodeling and Metastases | - | CNS Oncology |
| PRUNE1 | RNA | - | - | - |
| PS(15:0/20:0) | Lipid | - | - | - |
| PS(16:0/17:0) | Lipid | - | - | - |
| PS(18:0/18:0) | Lipid | - | - | - |
| PS(18:2(9Z.12Z)/22:4(7Z.10Z.13Z.16Z)) | Lipid | - | - | - |
| PS(20:0/18:1(9Z)) | Lipid | - | - | - |
| PS(20:2(11Z.14Z)/20:5(5Z.8Z.11Z.14Z.17Z)) | Lipid | - | - | - |
| PS(20:3(8Z.11Z.14Z)/0:0) | Lipid | - | - | - |
| PS(20:5(5Z.8Z.11Z.14Z.17Z)/17:0) | Lipid | - | - | - |
| PS(22:0/18:0) | Lipid | - | - | - |
| PS(22:2(13Z.16Z)/20:5(5Z.8Z.11Z.14Z.17Z)) | Lipid | - | - | - |
| PS(22:2(13Z.16Z)/22:6(4Z.7Z.10Z.13Z.16Z.19Z)) | Lipid | - | - | - |
| PS(22:4(7Z.10Z.13Z.16Z)/17:1(9Z)) | Lipid | - | - | - |
| PS(22:4(7Z.10Z.13Z.16Z)/20:4(5Z.8Z.11Z.14Z)) | Lipid | - | - | - |
| PS(22:4(7Z.10Z.13Z.16Z)/20:5(5Z.8Z.11Z.14Z.17Z)) | Lipid | - | - | - |
| PS(22:4(7Z.10Z.13Z.16Z)/21:0) | Lipid | - | - | - |
| PS(22:4(7Z.10Z.13Z.16Z)/22:0) | Lipid | - | - | - |
| PS(22:4(7Z.10Z.13Z.16Z)/22:1(11Z)) | Lipid | - | - | - |
| PS(O-16:0/18:2(9Z.12Z)) | Lipid | - | - | - |
| PS(O-16:0/20:1(11Z)) | Lipid | - | - | - |
| PS(O-16:0/21:0) | Lipid | - | - | - |
| PS(O-16:0/22:4(7Z.10Z.13Z.16Z)) | Lipid | - | - | - |
| PS(O-18:0/15:1(9Z)) | Lipid | - | - | - |
| PS(O-18:0/22:1(11Z)) | Lipid | - | - | - |
| PS(O-18:0/22:4(7Z.10Z.13Z.16Z)) | Lipid | - | - | - |
| PS(O-20:0/14:0) | Lipid | - | - | - |
| PS(O-20:0/17:1(9Z)) | Lipid | - | - | - |
| PS(P-16:0/13:0) | Lipid | - | - | - |
| PS(P-16:0/18:0) | Lipid | - | - | - |
| PS(P-16:0/19:1(9Z)) | Lipid | - | - | - |
| PS(P-16:0/20:2(11Z.14Z)) | Lipid | - | - | - |
| PS(P-16:0/22:0) | Lipid | - | - | - |
| PS(P-18:0/20:1(11Z)) | Lipid | - | - | - |
| PS(P-18:0/22:6(4Z.7Z.10Z.13Z.16Z.19Z)) | Lipid | - | - | - |
| PS(P-20:0/18:4(6Z.9Z.12Z.15Z)) | Lipid | - | - | - |
| PS(P-20:0/19:0) | Lipid | - | - | - |
| PS(P-20:0/19:1(9Z)) | Lipid | - | - | - |
| PS(P-20:0/20:5(5Z.8Z.11Z.14Z.17Z)) | Lipid | - | - | - |
| PS(P-20:0/22:1(11Z)) | Lipid | - | - | - |
| PS(P-20:0/22:6(4Z.7Z.10Z.13Z.16Z.19Z)) | Lipid | - | - | - |
| PSAP | RNA | - | - | - |
| PSAT1 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| PSEN1 | Protein | Amyloid Processing Oxydative Stress |
AD Pathology Axon and Dendrite Structure Neural Connectivity Vesicle Trafficking |
CNS Inflammation |
| PSEN1 | RNA | Amyloid Processing Oxydative Stress |
AD Pathology Axon and Dendrite Structure Neural Connectivity Vesicle Trafficking |
CNS Inflammation |
| PSEN2 | RNA | - | Activated Microglia Immunity and Inflammation Macrophage Function |
CNS Inflammation Immuno-Oncology |
| PSENEN | RNA | - | - | - |
| PSIP1 | RNA | - | - | - |
| PSMA1 | RNA | - | Antigen Presentation Immune Activation Status |
Immuno-Oncology |
| PSMA2 | RNA | - | - | - |
| PSMA3 | RNA | Biosynthesis and Anabolic Pathways Cell Stress Signaling Affecting Cellular Metabolism |
- | CNS Metabolic Diseases Oncology |
| PSMA6 | RNA | - | Antigen Presentation Immune Activation Status |
Immuno-Oncology |
| PSMA7 | RNA | Biosynthesis and Anabolic Pathways Cell Stress Signaling Affecting Cellular Metabolism |
- | CNS Metabolic Diseases Oncology |
| PSMB1 | RNA | Biosynthesis and Anabolic Pathways Cell Stress Signaling Affecting Cellular Metabolism |
- | CNS Metabolic Diseases Oncology |
| PSMB10 | RNA | Apoptosis Biosynthesis and Anabolic Pathways Cell Stress Costimulatory Signaling Hedgehog NF-kappaB Signaling Proliferation Signaling Affecting Cellular Metabolism TCR Signaling |
Antigen Presentation Immune Activation Status |
Oncology CNS Immuno-Oncology Metabolic Diseases Inflammation |
| PSMB3 | RNA | Biosynthesis and Anabolic Pathways Cell Stress Signaling Affecting Cellular Metabolism |
- | CNS Metabolic Diseases Oncology |
| PSMB5 | RNA | Apoptosis Costimulatory Signaling Hedgehog NF-kappaB Signaling Proliferation TCR Signaling |
Antigen Presentation | Oncology Immuno-Oncology CNS Inflammation |
| PSMB7 | RNA | Antigen Processing TCR Signaling |
Antigen Presentation | Immuno-Oncology |
| PSMB8 | RNA | Apoptosis Costimulatory Signaling Hedgehog NF-kappaB Signaling Proliferation TCR Signaling |
Activated Microglia Antigen Presentation Chemokines Immunity and Inflammation |
Oncology Immuno-Oncology CNS Inflammation |
| PSMB9 | RNA | Antigen Processing Apoptosis Costimulatory Signaling Hedgehog NF-kappaB Signaling Proliferation TCR Signaling |
Activated Microglia Antigen Presentation Immune Activation Status |
Immuno-Oncology Oncology CNS Inflammation |
| PSMC1 | RNA | Biosynthesis and Anabolic Pathways Cell Stress Signaling Affecting Cellular Metabolism |
- | CNS Metabolic Diseases Oncology |
| PSMC2 | RNA | TCR Signaling | - | Immuno-Oncology |
| PSMC3 | RNA | - | - | - |
| PSMC4 | RNA | Apoptosis Costimulatory Signaling Hedgehog NF-kappaB Signaling Proliferation |
Antigen Presentation | Oncology Immuno-Oncology CNS Inflammation |
| PSMC6 | RNA | - | Antigen Presentation Immune Activation Status |
Immuno-Oncology |
| PSMD13 | RNA | Biosynthesis and Anabolic Pathways Cell Stress Signaling Affecting Cellular Metabolism |
- | CNS Metabolic Diseases Oncology |
| PSMD6 | RNA | - | Antigen Presentation Immune Activation Status |
Immuno-Oncology |
| PSMD7 | RNA | TCR Signaling | - | Immuno-Oncology |
| PSME2 | RNA | Biosynthesis and Anabolic Pathways Cell Stress Signaling Affecting Cellular Metabolism |
Antigen Presentation Immune Activation Status |
CNS Metabolic Diseases Immuno-Oncology Oncology |
| PSPH | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| PSTPIP1 | RNA | - | - | - |
| psychosine sulfate | Lipid | - | - | - |
| PTAFR | RNA | Adenosine Pathway | Immune Activation Status Immune Suppression |
Immuno-Oncology |
| PTCD1 | RNA | - | - | - |
| PTCD2 | RNA | - | - | - |
| PTCH1 | RNA | Hedgehog | - | CNS Inflammation Oncology |
| PTCH2 | RNA | - | - | - |
| PTCRA | RNA | - | - | - |
| PTDSS1 | RNA | Lipid Metabolism | - | Metabolic Diseases |
| PTDSS2 | RNA | Lipid Metabolism | - | Metabolic Diseases |
| PTEN | RNA | Angiogenesis Autophagy Cell Proliferation Costimulatory Signaling Metabolism Stress Myelination Nutrient Capture and Catabolic Pathways PI3K-AKT Proliferation Signaling Affecting Cellular Metabolism Tumor Metabolism |
Axon and Dendrite Structure Cellular Growth Factor Immunity and Inflammation Neural Connectivity Pan-Tumor Vesicle Trafficking |
Cardiovascular CNS Immuno-Oncology Metabolic Diseases Oncology Inflammation Oncology |
| PTGDR2 | RNA | - | - | - |
| PTGDS | RNA | EMT | - | Oncology |
| PTGER1 | RNA | - | - | - |
| PTGER2 | RNA | - | - | - |
| PTGER3 | RNA | ER Signaling | Immunity and Inflammation | Oncology Inflammation |
| PTGER4 | RNA | Adenosine Pathway | Immune Cell Typing Immunity and Inflammation |
Immuno-Oncology Inflammation |
| PTGES | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| PTGFR | RNA | - | - | - |
| PTGIR | RNA | - | - | - |
| PTGIS | RNA | - | - | - |
| PTGR1 | RNA | - | - | - |
| PTGS1 | RNA | Cell Stress | - | CNS Oncology |
| PTGS2 | RNA | Angiogenesis Biosynthesis and Anabolic Pathways Cell Proliferation Cell Stress Cellular Differentiation Costimulatory Signaling Lipid Metabolism Oxydative Stress Proliferation Signaling Affecting Cellular Metabolism Vasculogenesis |
Activated Microglia Cellular Growth Factor Cytokines Immune Activation Status Immune Suppression Immunity and Inflammation Myeloid Compartment Transmitter Release Transmitter Response and Reuptake Vesicle Trafficking |
Cardiovascular CNS Oncology Immuno-Oncology Metabolic Diseases Inflammation |
| Ptilosteroid C | Lipid | - | - | - |
| PTK2 | RNA | Angiogenesis Cellular Differentiation Signaling Affecting Cellular Metabolism Vasculogenesis |
- | Cardiovascular Oncology Metabolic Diseases |
| PTK2B | RNA | Angiogenesis Cell Proliferation |
Cellular Growth Factor Immune Activation Status |
Cardiovascular CNS Oncology Immuno-Oncology |
| PTK6 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| PTMS | RNA | - | Immunity and Inflammation | Inflammation |
| PTPA | RNA | - | - | - |
| PTPN1 | RNA | - | - | - |
| PTPN11 | RNA | Costimulatory Signaling JAK-STAT MAPK RAS |
Immune Activation Status Immune Checkpoint |
Immuno-Oncology CNS Cardiovascular Oncology Inflammation Metabolic Diseases Oncology |
| PTPN12 | RNA | - | - | - |
| PTPN18 | RNA | - | Immune Activation Status | Immuno-Oncology |
| PTPN2 | RNA | - | Immune Activation Status | Immuno-Oncology |
| PTPN22 | RNA | TCR Signaling | Immune Activation Status | Immuno-Oncology |
| PTPN4 | RNA | - | - | - |
| PTPN5 | RNA | Signaling Affecting Cellular Metabolism | - | Metabolic Diseases |
| PTPN6 | RNA | TCR Signaling | Immune Activation Status Immune Checkpoint Immunity and Inflammation |
Immuno-Oncology Inflammation |
| PTPN7 | RNA | - | Immune Activation Status | Immuno-Oncology |
| PTPRB | RNA | Angiogenesis Cellular Differentiation |
- | Cardiovascular Oncology |
| PTPRC | RNA | Cell Proliferation Costimulatory Signaling Signaling Affecting Cellular Metabolism TCR Signaling |
B Cell Function Immune Activation Status Immune Cell Typing Immunity and Inflammation |
CNS Immuno-Oncology Metabolic Diseases Inflammation Oncology |
| PTPRC_all (common probe) | RNA | TCR Signaling | - | Immuno-Oncology |
| PTPRJ | RNA | - | Immune Activation Status | Immuno-Oncology |
| PTPRK | RNA | - | - | - |
| PTPRM | RNA | Cell Proliferation | - | CNS Oncology |
| PTPRN2 | RNA | - | Axon and Dendrite Structure Neural Connectivity Vesicle Trafficking |
CNS |
| PTPRR | RNA | - | - | - |
| PTPRS | RNA | - | - | - |
| PTRF | RNA | - | - | - |
| PTTG1 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| PTTG2 | RNA | - | - | - |
| PTX3 | RNA | - | - | - |
| PUDP | RNA | Nutrient Capture and Catabolic Pathways | - | Metabolic Diseases |
| PUM1 | RNA | - | - | - |
| PURA | RNA | - | - | - |
| PVALB | RNA | - | Axon and Dendrite Structure Neural Connectivity |
CNS |
| PVR | RNA | - | Lymphoid Compartment | Immuno-Oncology |
| PVRIG | RNA | Costimulatory Signaling | Immune Checkpoint | Immuno-Oncology |
| PXDN | RNA | - | - | - |
| PXN | RNA | - | - | - |
| PYCARD | RNA | EMT | Immunity and Inflammation | Oncology Inflammation |
| PYCR1 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| PYCR2 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| PYCR3 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| PYGM | RNA | - | - | - |
| Pyruvate | Amino-acid & Metabolites | - | - | - |
| QKI | RNA | Vasculogenesis | - | Cardiovascular |
| Quercetagetin 7-(6-acetylglucoside) | Lipid | - | - | - |
| Quercetin 5.7.3.4-tetramethyl ether 3-galactoside | Lipid | - | - | - |
| Quercetin 7-methyl ether 3.3.4-trisulfate | Lipid | - | - | - |
| Quinestrol | Lipid | - | - | - |
| RAB25 | RNA | Cell Proliferation | - | CNS Oncology |
| RAB2A | RNA | Carbohydrate Metabolism | - | CNS Metabolic Diseases |
| RAB31 | RNA | - | - | - |
| RAB3A | RNA | Transmitter Synthesis | Axon and Dendrite Structure Neural Connectivity Vesicle Trafficking |
CNS |
| RAB3C | RNA | - | Neural Connectivity | CNS |
| RAB5C | RNA | - | - | - |
| RAB6B | RNA | - | Immunity and Inflammation | Inflammation |
| RAB7A | RNA | - | Immunity and Inflammation | Inflammation |
| RAB7B | RNA | - | - | - |
| RAC1 | RNA | Cellular Differentiation RAS |
Immune Activation Status Immunity and Inflammation Transmitter Response and Reuptake Vesicle Trafficking |
Oncology Immuno-Oncology Inflammation CNS |
| RAC2 | RNA | Cell Proliferation Cellular Differentiation MAPK RAS Wnt Signaling |
Immunity and Inflammation | CNS Oncology Cardiovascular Inflammation |
| RAC3 | RNA | MAPK RAS Wnt Signaling |
Adhesion and Migration | Cardiovascular Oncology CNS |
| RACK1 | RNA | - | - | - |
| RAD1 | RNA | - | - | - |
| RAD17 | RNA | - | - | - |
| RAD21 | RNA | - | - | - |
| RAD23B | RNA | - | - | - |
| RAD50 | RNA | DNA Damage Repair Metabolism Stress Proliferation |
- | Epigenic and Nuclear Signaling Metabolic Diseases Oncology |
| RAD51 | RNA | Biosynthesis and Anabolic Pathways Cell Cycle Cell Stress DNA Damage Repair Proliferation |
- | CNS Oncology Epigenic and Nuclear Signaling Metabolic Diseases |
| RAD51AP1 | RNA | Cell Stress | - | CNS Oncology |
| RAD51B | RNA | - | - | - |
| RAD51C | RNA | DNA Damage Repair Proliferation |
- | Epigenic and Nuclear Signaling Oncology |
| RAD52 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| RAD54B | RNA | - | - | - |
| RAD54L | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| RAD9A | RNA | - | - | - |
| RAE1 | RNA | - | - | - |
| RAF1 | RNA | Cell Proliferation RAS TCR Signaling |
Adhesion and Migration Cellular Growth Factor Transmitter Release Transmitter Response and Reuptake |
CNS Oncology Immuno-Oncology |
| RAG1 | RNA | Epigenic and Transcriptional Regulation | B Cell Function Immune Activation Status |
Epigenic and Nuclear Signaling Immuno-Oncology |
| RAG2 | RNA | - | - | - |
| RAI1 | RNA | - | - | - |
| RALA | RNA | - | - | - |
| RALB | RNA | - | - | - |
| RAMP1 | RNA | Angiogenesis | - | Cardiovascular Oncology |
| RAMP2 | RNA | Angiogenesis Vasculogenesis |
Cellular Growth Factor | Cardiovascular Oncology |
| RAN | RNA | - | - | - |
| RANBP2 | RNA | Biosynthesis and Anabolic Pathways Signaling Affecting Cellular Metabolism |
- | CNS Metabolic Diseases |
| RAP1A | RNA | - | - | - |
| RAP1B | RNA | - | - | - |
| RAPGEF1 | RNA | - | - | - |
| RAPGEF2 | RNA | - | Neural Connectivity Vesicle Trafficking |
CNS |
| RAPGEF3 | RNA | - | Immunity and Inflammation | Inflammation |
| RARA | RNA | - | Immune Suppression | Immuno-Oncology |
| RARB | RNA | - | Immune Suppression | Immuno-Oncology |
| RARG | RNA | - | - | - |
| RARRES3 | RNA | - | - | - |
| RASA1 | RNA | PDGF Signaling | - | Oncology |
| RASA4 | RNA | RAS | - | Oncology |
| RASAL1 | RNA | MAPK RAS |
- | Cardiovascular Oncology CNS |
| RASGRF1 | RNA | MAPK RAS |
Immune Activation Status | Cardiovascular Oncology Immuno-Oncology CNS |
| RASGRF2 | RNA | MAPK RAS |
- | Cardiovascular Oncology CNS |
| RASGRP1 | RNA | MAPK RAS |
Immune Activation Status | Cardiovascular Oncology Immuno-Oncology CNS |
| RASGRP2 | RNA | RAS | - | Oncology |
| RASGRP3 | RNA | - | Immune Activation Status | Immuno-Oncology |
| RASGRP4 | RNA | - | - | - |
| RASSF5 | RNA | - | - | - |
| Rb IgG | Protein | - | Immune Cell Typing Neural Cell Typing |
Immuno-Oncology CNS |
| RB1 | RNA | Androgen Signaling Cell Cycle Metabolism Stress Proliferation |
- | Oncology Metabolic Diseases |
| RB1CC1 | RNA | Nutrient Capture and Catabolic Pathways | - | Metabolic Diseases |
| RBBP5 | RNA | Epigenic and Transcriptional Regulation Transcriptional Regulation |
- | Epigenic and Nuclear Signaling |
| RBCK1 | RNA | - | - | - |
| RBFOX3 | RNA | - | - | - |
| RBKS | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| RBL1 | RNA | Cell Cycle TGF Beta Signaling |
- | Oncology |
| RBL2 | RNA | Cytokine and Chemokine Signaling PI3K-AKT Proliferation TGF Beta Signaling |
Immune Activation Status | Immuno-Oncology Oncology |
| RBM45 | RNA | - | - | - |
| RBM47 | RNA | - | - | - |
| RBP4 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| RBPJ | RNA | Angiogenesis Cellular Differentiation |
- | Cardiovascular Oncology |
| RBX1 | RNA | Cell Cycle DNA Damage Repair HIF1 Signaling Proliferation TGF Beta Signaling Wnt Signaling |
Antigen Presentation Immune Activation Status Immune Suppression |
Oncology Epigenic and Nuclear Signaling Inflammation CNS Immuno-Oncology |
| RDH10 | RNA | - | - | - |
| RDH14 | RNA | - | - | - |
| RDH5 | RNA | - | - | - |
| RDX | RNA | - | Neuronal Cytoskeleton | CNS |
| REL | RNA | - | - | - |
| RELA | RNA | Costimulatory Signaling Cytokine and Chemokine Signaling Hypoxia MAPK Metabolism Stress NF-kappaB Signaling Oxydative Stress PI3K-AKT RAS Signaling Affecting Cellular Metabolism TCR Signaling Transcriptional Regulation |
Immune Activation Status Immunity and Inflammation Transmitter Response and Reuptake |
Immuno-Oncology Cardiovascular Metabolic Diseases CNS Inflammation Oncology Epigenic and Nuclear Signaling |
| RELB | RNA | MAPK NF-kappaB Signaling |
Immunity and Inflammation | Cardiovascular CNS Inflammation Oncology |
| RELN | RNA | Cellular Differentiation Matrix Remodeling and Metastases NF-kappaB Signaling PI3K-AKT |
Adhesion and Migration Immune Activation Status |
Oncology CNS Immuno-Oncology Inflammation |
| REN | RNA | - | - | - |
| REPS1 | RNA | - | - | - |
| REST | RNA | Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| RET | RNA | - | Axon and Dendrite Structure | CNS |
| RETN | RNA | - | - | - |
| RFC2 | RNA | Cell Cycle | - | Oncology |
| RFC3 | RNA | Cell Cycle DNA Damage Repair |
- | Oncology Epigenic and Nuclear Signaling |
| RFC4 | RNA | Cell Cycle DNA Damage Repair |
- | Oncology Epigenic and Nuclear Signaling |
| RGCC | RNA | - | - | - |
| RGL1 | RNA | - | Immunity and Inflammation | Inflammation |
| RGMA | RNA | - | - | - |
| RGMB | RNA | - | - | - |
| RGN | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| RGS16 | RNA | - | - | - |
| RGS2 | RNA | - | - | - |
| RGS7 | RNA | Adenosine Pathway | - | Immuno-Oncology |
| RHEB | RNA | - | Immune Activation Status | Immuno-Oncology |
| RHO | RNA | Adenosine Pathway | - | Immuno-Oncology |
| RHOA | RNA | Cellular Differentiation RAS |
Transmitter Response and Reuptake | Oncology CNS |
| RHOB | RNA | - | - | - |
| RHOG | RNA | - | - | - |
| RICTOR | RNA | Costimulatory Signaling Metabolism Stress mTOR Signaling Signaling Affecting Cellular Metabolism |
Immune Activation Status | Immuno-Oncology Metabolic Diseases Oncology |
| RIMKLA | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| RIMKLB | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| RIMS1 | RNA | Transmitter Synthesis | Neural Connectivity Transmitter Response and Reuptake Vesicle Trafficking |
CNS |
| RIN1 | RNA | RAS | - | Oncology |
| RING1 | RNA | - | - | - |
| RIPK1 | RNA | Apoptosis | Immunity and Inflammation | Oncology Inflammation |
| RIPK2 | RNA | Costimulatory Signaling | Immunity and Inflammation | Immuno-Oncology Inflammation |
| RIPK3 | RNA | Apoptosis | - | Oncology |
| RIT2 | RNA | - | Vesicle Trafficking | CNS |
| RNA | RNA | - | - | - |
| RNASE2 | RNA | Angiogenesis | - | Cardiovascular Oncology |
| RNASEH2A | RNA | - | - | - |
| RNASEL | RNA | - | - | - |
| RNF103 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| RNF111 | RNA | - | - | - |
| RNF114 | RNA | - | - | - |
| RNF126 | RNA | - | - | - |
| RNF135 | RNA | - | - | - |
| RNF152 | RNA | - | - | - |
| RNF31 | RNA | - | - | - |
| RNF43 | RNA | - | - | - |
| RNF8 | RNA | - | - | - |
| RNH1 | RNA | - | - | - |
| RNLS | RNA | - | - | - |
| ROBO4 | RNA | Angiogenesis | - | Cardiovascular Oncology |
| ROCK1 | RNA | Apoptosis Cellular Differentiation Cytokine and Chemokine Signaling TGF Beta Signaling |
Adhesion and Migration Immune Suppression |
Oncology Immuno-Oncology CNS |
| ROCK2 | RNA | TGF Beta Signaling | Adhesion and Migration | Oncology CNS |
| ROPN1 | RNA | - | - | - |
| ROR2 | RNA | - | - | - |
| RORA | RNA | Angiogenesis Transcriptional Misregulation |
Immune Activation Status | Cardiovascular Epigenic and Nuclear Signaling Immuno-Oncology Oncology |
| RORB | RNA | Cell Proliferation Transcriptional Misregulation |
- | CNS Epigenic and Nuclear Signaling Oncology |
| RORC | RNA | - | - | - |
| RORg | RNA | - | Immune Activation Status | Immuno-Oncology |
| RORgt | RNA | - | Immune Activation Status | Immuno-Oncology |
| RPA1 | RNA | - | - | - |
| RPA3 | RNA | Cell Cycle DNA Damage Repair |
- | Oncology Epigenic and Nuclear Signaling |
| RPIA | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| RPL23 | RNA | Signaling Affecting Cellular Metabolism | - | Metabolic Diseases |
| RPL28 | RNA | - | Immunity and Inflammation | Inflammation |
| RPL29 | RNA | - | Immunity and Inflammation | Inflammation |
| RPL3 | RNA | - | - | - |
| RPL36AL | RNA | - | Immunity and Inflammation | Inflammation |
| RPL4 | RNA | - | - | - |
| RPL7A | RNA | Angiogenesis | - | Cardiovascular Oncology |
| RPL9 | RNA | - | Immunity and Inflammation | Inflammation |
| RPLP0 | RNA | Signaling Affecting Cellular Metabolism | - | Metabolic Diseases |
| RPS10 | RNA | - | Immunity and Inflammation | Inflammation |
| RPS2 | RNA | - | Immunity and Inflammation | Inflammation |
| RPS21 | RNA | - | Immunity and Inflammation | Inflammation |
| RPS27A | RNA | Cellular Differentiation DNA Damage Repair |
- | Oncology Epigenic and Nuclear Signaling |
| RPS3 | RNA | - | Immunity and Inflammation | Inflammation |
| RPS6 | RNA | - | - | - |
| RPS6KA1 | RNA | Signaling Affecting Cellular Metabolism | - | Metabolic Diseases |
| RPS6KA2 | RNA | Adenosine Pathway | - | Immuno-Oncology |
| RPS6KA3 | RNA | - | - | - |
| RPS6KA5 | RNA | Chromatin Modification Epigenic and Transcriptional Regulation MAPK |
- | Epigenic and Nuclear Signaling Cardiovascular CNS Oncology |
| RPS6KA6 | RNA | - | - | - |
| RPS6KB1 | RNA | Autophagy Hypoxia Metabolism Stress Nutrient Capture and Catabolic Pathways PI3K-AKT Signaling Affecting Cellular Metabolism TGF Beta Signaling |
- | Cardiovascular Metabolic Diseases Oncology CNS Inflammation Oncology |
| RPS6KB2 | RNA | Nutrient Capture and Catabolic Pathways Proliferation Signaling Affecting Cellular Metabolism TGF Beta Signaling |
Cellular Growth Factor | Metabolic Diseases Oncology |
| RPS9 | RNA | - | Immunity and Inflammation | Inflammation |
| RPTOR | RNA | Autophagy Metabolism Stress mTOR Signaling Nutrient Capture and Catabolic Pathways PI3K-AKT Signaling Affecting Cellular Metabolism |
- | Cardiovascular Metabolic Diseases Oncology CNS Inflammation Oncology |
| RRAD | RNA | - | - | - |
| RRAGC | RNA | mTOR Signaling Nutrient Capture and Catabolic Pathways Signaling Affecting Cellular Metabolism |
Immune Activation Status | Oncology Metabolic Diseases Immuno-Oncology |
| RRAS | RNA | - | Immune Activation Status Transmitter Response and Reuptake |
Immuno-Oncology CNS |
| RRAS2 | RNA | RAS | - | Oncology |
| RRM1 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| RRM2 | RNA | Biosynthesis and Anabolic Pathways Cell Cycle DNA Damage Repair mTOR Signaling Proliferation |
Immunity and Inflammation | CNS Oncology Epigenic and Nuclear Signaling Inflammation Metabolic Diseases |
| RSAD2 | RNA | - | Immune Activation Status Immunity and Inflammation |
Immuno-Oncology Inflammation |
| RTN4 | RNA | Angiogenesis | - | Cardiovascular Oncology |
| RTN4RL1 | RNA | - | Immunity and Inflammation | Inflammation |
| RUNX1 | RNA | Epigenic and Transcriptional Regulation Transcriptional Regulation |
- | Epigenic and Nuclear Signaling |
| RUNX1T1 | RNA | - | - | - |
| RUNX2 | RNA | Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| RUNX3 | RNA | Transcriptional Misregulation | - | Epigenic and Nuclear Signaling |
| RUVBL1 | RNA | Cell Cycle | - | Oncology |
| RXRG | RNA | - | Immune Suppression | Immuno-Oncology |
| RYBP | RNA | - | - | - |
| RYR1 | RNA | - | Transmitter Release Transmitter Response and Reuptake |
CNS |
| RYR2 | RNA | - | Transmitter Release Transmitter Response and Reuptake |
CNS |
| RYR3 | RNA | - | Transmitter Release | CNS |
| S100A1 | RNA | Signaling Affecting Cellular Metabolism | - | Metabolic Diseases |
| S100A10 | RNA | - | - | - |
| S100A12 | RNA | Signaling Affecting Cellular Metabolism | Immune Activation Status Immune Cell Typing Immunity and Inflammation Myeloid Compartment |
Metabolic Diseases Immuno-Oncology Inflammation CNS |
| S100A14 | RNA | EMT | - | Oncology |
| S100A4 | RNA | - | - | - |
| S100A7 | RNA | Angiogenesis | Adhesion and Migration | Cardiovascular CNS Oncology |
| S100A8 | RNA | - | Myeloid Compartment | CNS |
| S100A9 | RNA | - | Myeloid Compartment | CNS |
| S100B | Protein | - | Astrocyte Immunity and Inflammation Inflammation Neural Cell Typing Pan-Tumor Vesicle Trafficking |
CNS Inflammation Oncology |
| S100B | RNA | - | Astrocyte Immunity and Inflammation Inflammation Neural Cell Typing Pan-Tumor Vesicle Trafficking |
CNS Inflammation Oncology |
| S1PR1 | RNA | Angiogenesis Cell Proliferation |
Adhesion and Migration Immune Activation Status |
Cardiovascular CNS Immuno-Oncology Oncology |
| S1PR3 | RNA | - | - | - |
| S1PR4 | RNA | - | - | - |
| S1PR5 | RNA | - | - | - |
| S6 | Protein | - | Immune Cell Typing Neural Cell Typing |
Immuno-Oncology CNS |
| SAA1 | RNA | Adenosine Pathway | - | Immuno-Oncology |
| SACS | RNA | - | - | - |
| SALL1 | RNA | - | - | - |
| SAMD9 | RNA | - | - | - |
| SAMHD1 | RNA | - | - | - |
| SAMSN1 | RNA | - | - | - |
| SAP130 | RNA | Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| SAR1B | RNA | - | - | - |
| SART1 | RNA | - | - | - |
| SAV1 | RNA | Hippo Signaling | - | CNS Oncology |
| SBNO2 | RNA | - | Macrophage Function | Immuno-Oncology |
| SCAMP2 | RNA | - | Activated Microglia | CNS |
| SCARA5 | RNA | - | - | - |
| SCARB2 | RNA | - | - | - |
| SCD | RNA | Biosynthesis and Anabolic Pathways Signaling Affecting Cellular Metabolism |
- | CNS Metabolic Diseases |
| SCG2 | RNA | Angiogenesis Cell Proliferation |
- | Cardiovascular CNS Oncology |
| Scillirosidin | Lipid | - | - | - |
| SCIN | RNA | - | - | - |
| SCN1A | RNA | - | Axon and Dendrite Structure Transmitter Release |
CNS |
| SCN2A | RNA | Myelination | Axon and Dendrite Structure Transmitter Release |
CNS |
| SCNN1A | RNA | - | - | - |
| SCP2 | RNA | - | - | - |
| sCTLA4 (soluble form) | RNA | TCR Signaling | - | Immuno-Oncology |
| SCUBE2 | RNA | ER Signaling | - | Oncology |
| SDC1 | RNA | ECM Remodeling Interleukin Signaling |
- | Metabolic Diseases Immuno-Oncology Oncology |
| SDC3 | RNA | Adenosine Pathway | - | Immuno-Oncology |
| SDC4 | RNA | - | - | - |
| SDHA | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| SDHB | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| SDHC | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| SDS | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| SDSL | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| SEC13 | RNA | Biosynthesis and Anabolic Pathways Signaling Affecting Cellular Metabolism |
- | CNS Metabolic Diseases |
| SEC22B | RNA | - | - | - |
| SEC23A | RNA | - | - | - |
| SEC24C | RNA | - | - | - |
| SEC61B | RNA | - | - | - |
| SEH1L | RNA | - | - | - |
| SEL1L | RNA | - | Immune Suppression | Immuno-Oncology |
| SELE | RNA | - | Adhesion and Migration Immune Activation Status |
CNS Immuno-Oncology |
| SELENBP1 | RNA | - | - | - |
| SELENOK | RNA | Cell Stress | - | CNS Oncology |
| SELENOS | RNA | - | - | - |
| SELL | RNA | - | Immune Activation Status Immune Suppression Immunity and Inflammation |
Immuno-Oncology Inflammation |
| SELP | RNA | - | - | - |
| SELPLG | RNA | - | - | - |
| SEM1 | RNA | Biosynthesis and Anabolic Pathways Cell Stress |
- | CNS Oncology Metabolic Diseases |
| SEMA3E | RNA | - | - | - |
| SEMA4D | RNA | - | Immune Activation Status | Immuno-Oncology |
| SEMG1 | RNA | - | - | - |
| SERBP1 | RNA | ER Signaling | - | Oncology |
| SERINC1 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| SERINC2 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| SERINC3 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| SERINC4 | RNA | - | - | - |
| SERINC5 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| Serine | Amino-acid & Metabolites | - | - | - |
| Serotonin | Amino-acid & Metabolites | - | - | - |
| Serotonin | Neuropeptide & Neurotransmitter | - | - | - |
| SERPINA1 | RNA | Matrix Remodeling and Metastases | Myeloid Compartment | CNS Oncology |
| SERPINA3 | RNA | - | - | - |
| SERPINB2 | RNA | - | - | - |
| SERPINB5 | RNA | Angiogenesis p53 Signaling |
- | Cardiovascular Oncology |
| SERPINB6 | RNA | - | Activated Microglia | CNS |
| SERPINB9 | RNA | - | - | - |
| SERPINE1 | RNA | Angiogenesis ECM Remodeling HIF1 Signaling Hippo Signaling Matrix Remodeling and Metastases |
- | Cardiovascular Metabolic Diseases Inflammation CNS Oncology |
| SERPINF1 | RNA | Cell Proliferation | Immunity and Inflammation | CNS Inflammation Oncology |
| SERPINF2 | RNA | - | - | - |
| SERPING1 | RNA | - | - | - |
| SERPINH1 | RNA | Angiogenesis Collagen Biosynthesis & Modification Matrix Remodeling and Metastases |
- | Cardiovascular CNS Oncology |
| SESN1 | RNA | - | - | - |
| SESN2 | RNA | - | Immune Activation Status | Immuno-Oncology |
| SESN3 | RNA | - | - | - |
| SET | RNA | Cell Proliferation | - | CNS Oncology |
| SETBP1 | RNA | - | - | - |
| SETD1A | RNA | - | - | - |
| SETD1B | RNA | - | - | - |
| SETD2 | RNA | Angiogenesis Epigenic and Transcriptional Regulation Vasculogenesis |
- | Cardiovascular Epigenic and Nuclear Signaling Oncology |
| SETD7 | RNA | - | - | - |
| SETDB1 | RNA | - | - | - |
| SF3A1 | RNA | - | - | - |
| SF3A2 | RNA | - | - | - |
| SF3A3 | RNA | - | - | - |
| SF3B1 | RNA | Epigenic and Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| SF3B2 | RNA | - | - | - |
| SF3B4 | RNA | - | - | - |
| SFN | RNA | Cell Cycle Proliferation |
Immune Activation Status | Oncology Immuno-Oncology |
| SFRP1 | RNA | Cell Proliferation EMT Vasculogenesis Wnt Signaling |
- | CNS Oncology Cardiovascular |
| SFRP2 | RNA | Cell Proliferation EMT Proliferation Vasculogenesis Wnt Signaling |
Cellular Growth Factor | CNS Oncology Cardiovascular |
| SFRP4 | RNA | Wnt Signaling | - | CNS Oncology |
| SFTPA1 | RNA | - | Immune Activation Status | Immuno-Oncology |
| SFTPD | RNA | - | Immunity and Inflammation | Inflammation |
| SFXN1 | RNA | - | - | - |
| SGK1 | RNA | Metabolism Stress PI3K-AKT |
- | Metabolic Diseases Oncology |
| SGK2 | RNA | - | - | - |
| SGK3 | RNA | - | - | - |
| SGO2 | RNA | - | - | - |
| SGPL1 | RNA | Lipid Metabolism | - | Metabolic Diseases |
| SH2B2 | RNA | - | - | - |
| SH2B3 | RNA | - | - | - |
| SH2D1A | RNA | - | Immune Activation Status Immune Cell Typing Immunity and Inflammation |
Immuno-Oncology Inflammation |
| SH2D1B | RNA | - | Leucocyte Function | Immuno-Oncology |
| SH2D3A | RNA | - | - | - |
| SH3BP2 | RNA | - | - | - |
| SH3PXD2A | RNA | - | - | - |
| SH3TC2 | RNA | Myelination | - | CNS |
| SH3YL1 | RNA | - | - | - |
| SHANK2 | RNA | - | Axon and Dendrite Structure Neural Connectivity Transmitter Release Vesicle Trafficking |
CNS |
| SHANK3 | RNA | - | - | - |
| SHB | RNA | Angiogenesis Cell Proliferation |
- | Cardiovascular CNS Oncology |
| SHC1 | RNA | RAS | - | Oncology |
| SHC2 | RNA | Cytokine and Chemokine Signaling MAPK RAS |
- | Immuno-Oncology Cardiovascular Oncology CNS |
| SHC3 | RNA | RAS | - | Oncology |
| SHC4 | RNA | MAPK RAS |
Immune Activation Status | Cardiovascular Oncology Immuno-Oncology CNS |
| SHE | RNA | Angiogenesis | - | Cardiovascular Oncology |
| SHH | RNA | - | - | - |
| SHMT1 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| SHMT2 | RNA | Biosynthesis and Anabolic Pathways ER Signaling |
- | CNS Oncology Metabolic Diseases |
| SIDT1 | RNA | - | - | - |
| SIGIRR | RNA | - | - | - |
| SIGLEC1 | RNA | - | Immune Activation Status Immunity and Inflammation |
Immuno-Oncology Inflammation |
| SIGLEC5 | RNA | - | Immune Cell Typing | Immuno-Oncology |
| SIGLEC6 | RNA | - | B Cell Exhaustion | Immuno-Oncology |
| SIGLEC8 | RNA | - | Immunity and Inflammation Myeloid Compartment |
Inflammation CNS |
| SIGLEC9 | RNA | - | - | - |
| SIK1 | RNA | - | - | - |
| SIL1 | RNA | - | - | - |
| SIN3A | RNA | Epigenic and Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| SIPA1 | RNA | - | - | - |
| SIRPA | RNA | Cytotoxicity | Myeloid Compartment | Oncology CNS |
| SIRPB2 | RNA | - | Myeloid Compartment | CNS |
| SIRT1 | RNA | Angiogenesis Carbohydrate Metabolism Oxydative Stress |
- | Cardiovascular CNS Inflammation Oncology Metabolic Diseases |
| SIRT2 | RNA | Myelination Oxydative Stress |
Axon and Dendrite Structure | CNS Inflammation |
| SIRT4 | RNA | Chromatin Modification | - | Epigenic and Nuclear Signaling |
| SIRT7 | RNA | - | - | - |
| SIX1 | RNA | Transcriptional Misregulation | - | Epigenic and Nuclear Signaling |
| SKA1 | RNA | Cell Cycle | - | Oncology |
| SKA3 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| SKI | RNA | - | - | - |
| SKIL | RNA | - | - | - |
| SKP1 | RNA | Proliferation TGF Beta Signaling Wnt Signaling |
- | Oncology CNS |
| SKP2 | RNA | Cell Cycle Proliferation |
- | Oncology |
| SLA | RNA | - | Activated Microglia | CNS |
| SLAMF1 | RNA | - | - | - |
| SLAMF6 | RNA | - | Immune Activation Status | Immuno-Oncology |
| SLAMF7 | RNA | - | Lymphoid Compartment | Immuno-Oncology |
| SLAMF8 | RNA | - | Immunity and Inflammation | Inflammation |
| SLAMF9 | RNA | - | Immunity and Inflammation | Inflammation |
| SLC10A6 | RNA | - | - | - |
| SLC11A1 | RNA | - | Macrophage Function Myeloid Compartment |
Immuno-Oncology CNS |
| SLC12A5 | RNA | - | Axon and Dendrite Structure Transmitter Release Vesicle Trafficking |
CNS |
| SLC12A6 | RNA | Angiogenesis | - | Cardiovascular Oncology |
| SLC16A1 | RNA | Biosynthesis and Anabolic Pathways Metabolism Stress |
- | CNS Metabolic Diseases |
| SLC16A11 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| SLC16A13 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| SLC16A2 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| SLC16A3 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| SLC16A6 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| SLC16A7 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| SLC16A8 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| SLC17A6 | RNA | Transmitter Synthesis | Neural Connectivity Transmitter Release Transmitter Response and Reuptake |
CNS |
| SLC17A7 | RNA | - | - | - |
| SLC18A2 | RNA | Transmitter Synthesis | Axon and Dendrite Structure Neural Connectivity Transmitter Release Vesicle Trafficking |
CNS |
| SLC18A3 | RNA | Transmitter Synthesis | Neural Connectivity Transmitter Release Vesicle Trafficking |
CNS |
| SLC1A1 | RNA | Carbohydrate Metabolism | Transmitter Release Vesicle Trafficking |
CNS Metabolic Diseases |
| SLC1A2 | RNA | Carbohydrate Metabolism | Axon and Dendrite Structure Transmitter Release Vesicle Trafficking |
CNS Metabolic Diseases |
| SLC1A3 | RNA | - | - | - |
| SLC1A5 | RNA | Metabolism Stress mTOR Signaling Nutrient Capture and Catabolic Pathways |
- | Metabolic Diseases Oncology |
| SLC25A1 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| SLC25A10 | RNA | - | - | - |
| SLC25A13 | RNA | - | - | - |
| SLC25A20 | RNA | - | - | - |
| SLC25A6 | RNA | - | - | - |
| SLC27A1 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| SLC27A3 | RNA | - | - | - |
| SLC2A1 | RNA | Biosynthesis and Anabolic Pathways HIF1 Signaling Hypoxia Metabolism Stress mTOR Signaling Nutrient Capture and Catabolic Pathways Tumor Metabolism |
Activated Microglia Immunity and Inflammation |
CNS Inflammation Cardiovascular Metabolic Diseases Oncology |
| SLC2A11 | RNA | - | - | - |
| SLC2A12 | RNA | - | - | - |
| SLC2A14 | RNA | Nutrient Capture and Catabolic Pathways | - | Metabolic Diseases |
| SLC2A2 | RNA | - | - | - |
| SLC2A3 | RNA | Biosynthesis and Anabolic Pathways Nutrient Capture and Catabolic Pathways |
- | CNS Metabolic Diseases |
| SLC2A3/14 | RNA | - | - | - |
| SLC2A5 | RNA | Nutrient Capture and Catabolic Pathways | Immunity and Inflammation | Metabolic Diseases Inflammation |
| SLC2A6 | RNA | Nutrient Capture and Catabolic Pathways | - | Metabolic Diseases |
| SLC2A8 | RNA | Nutrient Capture and Catabolic Pathways | - | Metabolic Diseases |
| SLC32A1 | RNA | Transmitter Synthesis | Axon and Dendrite Structure Neural Connectivity Transmitter Release Transmitter Response and Reuptake Vesicle Trafficking |
CNS |
| SLC35A3 | RNA | - | - | - |
| SLC37A1 | RNA | - | - | - |
| SLC37A4 | RNA | - | - | - |
| SLC39A6 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| SLC3A1 | RNA | Nutrient Capture and Catabolic Pathways | - | Metabolic Diseases |
| SLC3A2 | RNA | Nutrient Capture and Catabolic Pathways Signaling Affecting Cellular Metabolism |
- | Metabolic Diseases |
| SLC44A1 | RNA | - | Immunity and Inflammation | Inflammation |
| SLC44A4 | RNA | EMT | - | Oncology |
| SLC4A10 | RNA | - | Axon and Dendrite Structure | CNS |
| SLC4A1AP | RNA | - | - | - |
| SLC6A1 | RNA | - | - | - |
| SLC6A12 | RNA | Nutrient Capture and Catabolic Pathways | - | Metabolic Diseases |
| SLC6A18 | RNA | Nutrient Capture and Catabolic Pathways | - | Metabolic Diseases |
| SLC6A19 | RNA | Nutrient Capture and Catabolic Pathways | - | Metabolic Diseases |
| SLC6A3 | RNA | Transmitter Synthesis | Axon and Dendrite Structure Neural Connectivity Transmitter Release Vesicle Trafficking |
CNS |
| SLC6A4 | RNA | Transmitter Synthesis | Neural Connectivity Transmitter Release Vesicle Trafficking |
CNS |
| SLC7A11 | RNA | Cell Stress Nutrient Capture and Catabolic Pathways |
- | CNS Metabolic Diseases Oncology |
| SLC7A5 | RNA | Metabolism Stress mTOR Signaling Nutrient Capture and Catabolic Pathways Signaling Affecting Cellular Metabolism |
Immune Activation Status | Metabolic Diseases Oncology Immuno-Oncology |
| SLC7A9 | RNA | Nutrient Capture and Catabolic Pathways | - | Metabolic Diseases |
| SLC8A1 | RNA | Oxydative Stress | Axon and Dendrite Structure Neural Connectivity Transmitter Release Transmitter Response and Reuptake |
Inflammation CNS |
| SLC9A6 | RNA | - | Axon and Dendrite Structure Neural Connectivity |
CNS |
| SLCO2B1 | RNA | - | - | - |
| SLFN11 | RNA | - | - | - |
| SLIT2 | RNA | Hippo Signaling | Cellular Growth Factor | CNS Oncology |
| SLPI | RNA | EMT | - | Oncology |
| SLU7 | RNA | - | - | - |
| SM(d16:1/22:0) | Lipid | - | - | - |
| SM(d16:1/22:1) | Lipid | - | - | - |
| SM(d16:1/23:0) | Lipid | - | - | - |
| SM(d18:0/16:0) | Lipid | - | - | - |
| SM(d18:0/18:2) | Lipid | - | - | - |
| SM(d18:1/16:0) | Lipid | - | - | - |
| SM(d18:1/22:0) | Lipid | - | - | - |
| SM(d18:1/22:1) | Lipid | - | - | - |
| SM(d18:1/23:0) | Lipid | - | - | - |
| SM(d18:1/24:0) | Lipid | - | - | - |
| SM(d18:1/24:1(15Z)) | Lipid | - | - | - |
| SM(d18:2/15:0) | Lipid | - | - | - |
| SM(d18:2/21:0) | Lipid | - | - | - |
| SM(d18:2/23:0) | Lipid | - | - | - |
| SM(d18:2/24:1) | Lipid | - | - | - |
| SM(d19:1/18:0) | Lipid | - | - | - |
| SMA | Protein | - | Immune Cell Typing | Immuno-Oncology |
| SMAD1 | RNA | Cell Proliferation Proliferation TGF Beta Signaling |
Cellular Growth Factor | CNS Oncology |
| SMAD2 | RNA | Biosynthesis and Anabolic Pathways Cellular Differentiation Nutrient Capture and Catabolic Pathways |
Cellular Growth Factor Immune Suppression |
CNS Oncology Metabolic Diseases Immuno-Oncology |
| SMAD3 | RNA | Biosynthesis and Anabolic Pathways Nutrient Capture and Catabolic Pathways Proliferation Signaling Affecting Cellular Metabolism TGF Beta Signaling Wnt Signaling |
Cellular Growth Factor Immune Suppression |
CNS Metabolic Diseases Oncology Immuno-Oncology |
| SMAD4 | RNA | Biosynthesis and Anabolic Pathways Epigenic and Transcriptional Regulation Proliferation TGF Beta Signaling Wnt Signaling |
Cellular Growth Factor Immune Suppression |
CNS Epigenic and Nuclear Signaling Oncology Immuno-Oncology Metabolic Diseases |
| SMAD5 | RNA | Proliferation TGF Beta Signaling |
Cellular Growth Factor | Oncology |
| SMAD6 | RNA | - | - | - |
| SMAD7 | RNA | Hippo Signaling | - | CNS Oncology |
| SMAD9 | RNA | - | Cellular Growth Factor Immune Suppression |
Oncology Immuno-Oncology |
| SMAP1 | RNA | - | - | - |
| SMARCA4 | RNA | - | Immune Activation Status | Immuno-Oncology |
| SMARCA5 | RNA | - | - | - |
| SMARCB1 | RNA | - | - | - |
| SMARCC2 | RNA | - | - | - |
| SMARCD1 | RNA | - | - | - |
| SMC1A | RNA | - | - | - |
| SMC1B | RNA | Proliferation | - | Oncology |
| SMC2 | RNA | - | - | - |
| SMC3 | RNA | Cell Cycle | Immune Activation Status | Oncology Immuno-Oncology |
| SMN1 | RNA | - | - | - |
| SMO | RNA | Hedgehog | - | CNS Inflammation Oncology |
| SMOC1 | RNA | - | - | - |
| SMPD3 | RNA | - | - | - |
| SMPD4 | RNA | Lipid Metabolism | - | Metabolic Diseases |
| SMS | RNA | Androgen Signaling | - | Oncology |
| SMURF1 | RNA | - | Cellular Growth Factor | Oncology |
| SMURF2 | RNA | Proliferation TGF Beta Signaling |
Cellular Growth Factor | Oncology |
| SMYD1 | RNA | - | - | - |
| SNAI1 | RNA | Cellular Differentiation EMT |
- | Oncology |
| SNAI2 | RNA | Cellular Differentiation EMT Epigenic and Transcriptional Regulation Hippo Signaling |
Adhesion and Migration | Oncology Epigenic and Nuclear Signaling CNS |
| SNAI3 | RNA | - | - | - |
| SNAP91 | RNA | - | Vesicle Trafficking | CNS |
| SNCA | RNA | Oxydative Stress Transmitter Synthesis |
Activated Microglia Axon and Dendrite Structure Immunity and Inflammation Neural Connectivity Transmitter Release Transmitter Response and Reuptake Vesicle Trafficking |
Inflammation CNS |
| SNCAIP | RNA | Transmitter Synthesis | Neural Connectivity Vesicle Trafficking |
CNS |
| SNCB | RNA | Transmitter Synthesis | Axon and Dendrite Structure Neural Connectivity Vesicle Trafficking |
CNS |
| SNF8 | RNA | Nutrient Capture and Catabolic Pathways | - | Metabolic Diseases |
| SNRPA | RNA | - | - | - |
| SNRPF | RNA | - | - | - |
| SOCS1 | RNA | JAK-STAT | Antigen Presentation B Cell Function Immune Activation Status |
CNS Immuno-Oncology Inflammation Metabolic Diseases Oncology |
| SOCS2 | RNA | JAK-STAT | Immune Activation Status | CNS Immuno-Oncology Inflammation Metabolic Diseases Oncology |
| SOCS3 | RNA | JAK-STAT | Immune Activation Status Immunity and Inflammation |
CNS Immuno-Oncology Inflammation Metabolic Diseases Oncology |
| SOCS4 | RNA | - | - | - |
| SOCS5 | RNA | - | - | - |
| SOD1 | RNA | Carbohydrate Metabolism Cell Stress Myelination Oxydative Stress Signaling Affecting Cellular Metabolism |
Axon and Dendrite Structure | CNS Inflammation Metabolic Diseases Oncology |
| SOD2 | RNA | Biosynthesis and Anabolic Pathways Oxydative Stress Signaling Affecting Cellular Metabolism |
Activated Microglia Immunity and Inflammation |
CNS Inflammation Metabolic Diseases |
| SOD3 | RNA | Cell Stress | - | CNS Oncology |
| SORBS1 | RNA | - | - | - |
| SORCS3 | RNA | - | Vesicle Trafficking | CNS |
| SORD | RNA | Androgen Signaling mTOR Signaling Myc |
- | Oncology |
| SORL1 | RNA | - | - | - |
| SORT1 | RNA | - | - | - |
| SOS1 | RNA | EGFR Signaling ERBB2 Signaling FGFR Signaling Met Signaling PDGF Signaling RAS Signaling Affecting Cellular Metabolism |
Immune Activation Status | Oncology Cardiovascular Metabolic Diseases Immuno-Oncology CNS Inflammation |
| SOS2 | RNA | RAS Signaling Affecting Cellular Metabolism |
- | Oncology Metabolic Diseases |
| SOST | RNA | - | - | - |
| SOX10 | RNA | - | - | - |
| SOX11 | RNA | Wnt Signaling | - | CNS Oncology |
| SOX17 | RNA | Angiogenesis Proliferation Vasculogenesis Wnt Signaling |
Cellular Growth Factor | Cardiovascular Oncology CNS |
| SOX2 | RNA | Hippo Signaling Signaling Affecting Cellular Metabolism Transcriptional Misregulation Transcriptional Regulation Wnt Signaling |
- | CNS Metabolic Diseases Epigenic and Nuclear Signaling Oncology |
| SOX4 | RNA | - | Immunity and Inflammation | Inflammation |
| SOX7 | RNA | - | - | - |
| SOX9 | RNA | Cell Proliferation Cellular Differentiation EMT |
Transmitter Response and Reuptake | CNS Oncology |
| SP1 | RNA | TGF Beta Signaling Transcriptional Misregulation |
- | Oncology Epigenic and Nuclear Signaling |
| SP100 | RNA | - | Immune Activation Status | Immuno-Oncology |
| SP3 | RNA | - | - | - |
| SPA17 | RNA | - | - | - |
| SPACA3 | RNA | - | - | - |
| SPAG9 | RNA | AP1 Signaling | Immune Activation Status | Cardiovascular Immuno-Oncology CNS Inflammation Metabolic Diseases Oncology |
| SPANXB1 | RNA | - | - | - |
| SPARC | RNA | Cell Proliferation | Cellular Growth Factor | CNS Oncology |
| SPARCL1 | RNA | - | - | - |
| SPAST | RNA | - | Axon and Dendrite Structure | CNS |
| SPC25 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| SPDEF | RNA | Androgen Signaling EMT |
- | Oncology |
| Spermidine | Amino-acid & Metabolites | - | - | - |
| SPHK1 | RNA | - | - | - |
| SPHK2 | RNA | Cell Proliferation Vasculogenesis VEGFR Signaling |
- | CNS Cardiovascular Oncology |
| SPI1 | RNA | - | - | - |
| SPIB | RNA | Transcriptional Regulation | B Cell Function Immune Cell Typing |
Epigenic and Nuclear Signaling Immuno-Oncology |
| SPINK1 | RNA | - | - | - |
| SPINK5 | RNA | - | - | - |
| SPINT1 | RNA | Epigenic and Transcriptional Regulation Met Signaling Vasculogenesis |
Immunity and Inflammation | Epigenic and Nuclear Signaling Oncology Cardiovascular Inflammation |
| SPINT2 | RNA | Met Signaling | - | Oncology |
| SPN | RNA | - | - | - |
| SPO11 | RNA | - | - | - |
| SPOCK3 | RNA | - | - | - |
| SPOP | RNA | - | - | - |
| SPOPL | RNA | - | - | - |
| SPP1 | RNA | Costimulatory Signaling Matrix Remodeling and Metastases PI3K-AKT |
Adhesion and Migration Cytokines Immunity and Inflammation |
Immuno-Oncology CNS Oncology Inflammation |
| SPPL2B | RNA | - | - | - |
| SPRED1 | RNA | - | - | - |
| SPRY1 | RNA | JAK-STAT | - | CNS Inflammation Metabolic Diseases Oncology |
| SPRY2 | RNA | JAK-STAT | - | CNS Inflammation Metabolic Diseases Oncology |
| SPRY4 | RNA | Cytotoxicity JAK-STAT |
- | Oncology CNS Inflammation Metabolic Diseases Oncology |
| SPTAN1 | RNA | - | - | - |
| SPTBN2 | RNA | - | Neural Connectivity Neuronal Cytoskeleton |
CNS |
| SQLE | RNA | mTOR Signaling | - | Oncology |
| SQSTM1 | RNA | mTOR Signaling Signaling Affecting Cellular Metabolism |
Immunity and Inflammation | Oncology Metabolic Diseases Inflammation |
| SRC | RNA | Cell Proliferation EGFR Signaling ERBB2 Signaling Met Signaling Oxydative Stress PDGF Signaling |
Cellular Growth Factor Neural Connectivity Transmitter Release |
CNS Oncology Inflammation |
| SRD5A2 | RNA | - | - | - |
| SREBF1 | RNA | Lipid Metabolism Signaling Affecting Cellular Metabolism Transcriptional Regulation |
- | Metabolic Diseases Epigenic and Nuclear Signaling |
| SREBF2 | RNA | Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| SRF | RNA | Angiogenesis Cell Proliferation Vasculogenesis |
- | Cardiovascular CNS Oncology |
| SRGN | RNA | - | Immunity and Inflammation | Inflammation |
| SRI | RNA | - | Axon and Dendrite Structure Neural Connectivity |
CNS |
| SRM | RNA | Biosynthesis and Anabolic Pathways Myc Signaling Affecting Cellular Metabolism |
- | CNS Oncology Metabolic Diseases |
| SRP54 | RNA | - | - | - |
| SRPK2 | RNA | Angiogenesis Cell Proliferation |
- | Cardiovascular CNS Oncology |
| SRPX | RNA | - | - | - |
| SRPX2 | RNA | Angiogenesis Cellular Differentiation |
- | Cardiovascular Oncology |
| SRR | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| SRSF2 | RNA | - | - | - |
| SRSF4 | RNA | - | - | - |
| SRXN1 | RNA | - | - | - |
| SSR1 | RNA | - | - | - |
| SSR2 | RNA | - | - | - |
| SSR4 | RNA | - | - | - |
| SSRP1 | RNA | p53 Signaling | - | Oncology |
| SSTR2 | RNA | Cell Proliferation | - | CNS Oncology |
| SSX1 | RNA | - | - | - |
| SSX4 | RNA | - | - | - |
| ST14 | RNA | - | - | - |
| ST3GAL6 | RNA | - | Immune Suppression Immunity and Inflammation |
Immuno-Oncology Inflammation |
| ST6GAL1 | RNA | - | - | - |
| ST6GALNAC2 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| ST8SIA6 | RNA | - | Immunity and Inflammation | Inflammation |
| STAB1 | RNA | - | - | - |
| STAB2 | RNA | Angiogenesis Cellular Differentiation |
- | Cardiovascular Oncology |
| STAG2 | RNA | Cell Cycle | Immune Activation Status | Oncology Immuno-Oncology |
| STAM | RNA | - | - | - |
| STAM2 | RNA | Nutrient Capture and Catabolic Pathways Signaling Affecting Cellular Metabolism |
- | Metabolic Diseases |
| STAMBPL1 | RNA | - | Activated Microglia | CNS |
| STAT 3 | Protein | - | - | - |
| STAT1 | RNA | Cell Proliferation Cytokine and Chemokine Signaling Cytotoxicity JAK-STAT PDGF Signaling Signaling Affecting Cellular Metabolism Transcriptional Regulation |
Activated Microglia Axon and Dendrite Structure Chemokines Immune Activation Status Immune Suppression Immunity and Inflammation Lymphoid Compartment M1 Activation |
CNS Immuno-Oncology Oncology Metabolic Diseases Epigenic and Nuclear Signaling Inflammation Oncology |
| STAT2 | RNA | Cytokine and Chemokine Signaling Cytotoxicity JAK-STAT |
Chemokines Lymphoid Compartment |
Immuno-Oncology Oncology CNS Inflammation Metabolic Diseases Oncology |
| STAT3 | RNA | Cell Proliferation Cytokine and Chemokine Signaling Hypoxia JAK-STAT Met Signaling Metabolism Stress PDGF Signaling Signaling Affecting Cellular Metabolism Transcriptional Regulation |
Chemokines Immune Activation Status |
CNS Immuno-Oncology Cardiovascular Oncology Metabolic Diseases Epigenic and Nuclear Signaling Inflammation Oncology |
| STAT4 | RNA | Costimulatory Signaling JAK-STAT |
Chemokines Immune Activation Status |
Immuno-Oncology CNS Inflammation Metabolic Diseases Oncology |
| STAT5A | RNA | Signaling Affecting Cellular Metabolism Transcriptional Regulation |
Immune Activation Status | Metabolic Diseases Epigenic and Nuclear Signaling Immuno-Oncology |
| STAT5B | RNA | - | Chemokines Immune Activation Status |
Immuno-Oncology |
| STAT6 | RNA | Signaling Affecting Cellular Metabolism Transcriptional Regulation |
Chemokines | Metabolic Diseases Epigenic and Nuclear Signaling Immuno-Oncology |
| STC1 | RNA | Angiogenesis | - | Cardiovascular Oncology |
| STC2 | RNA | - | - | - |
| STEAP4 | RNA | - | - | - |
| STIM1 | Protein | - | Immune Activation Status | Immuno-Oncology |
| STIM1 | RNA | - | Immune Activation Status | Immuno-Oncology |
| STING | Protein | Interferon Signaling | - | Immuno-Oncology |
| STING1 | RNA | - | - | - |
| STIP1 | RNA | mTOR Signaling | - | Oncology |
| STK11 | RNA | Nutrient Capture and Catabolic Pathways Signaling Affecting Cellular Metabolism |
- | Metabolic Diseases |
| STK11IP | RNA | - | - | - |
| STK26 | RNA | - | - | - |
| STK3 | RNA | Hippo Signaling Signaling Affecting Cellular Metabolism |
- | CNS Metabolic Diseases Oncology |
| STK4 | RNA | Hippo Signaling | - | CNS Oncology |
| STMN1 | RNA | - | Immunity and Inflammation | Inflammation |
| STRADB | RNA | - | - | - |
| STRAP | RNA | - | - | - |
| STT3B | RNA | - | - | - |
| STX18 | RNA | - | - | - |
| STX1A | RNA | Transmitter Synthesis | Neural Connectivity Vesicle Trafficking |
CNS |
| STX1B | RNA | Transmitter Synthesis | Neural Connectivity Vesicle Trafficking |
CNS |
| STX2 | RNA | Oxydative Stress Transmitter Synthesis |
Neural Connectivity Vesicle Trafficking |
Inflammation CNS |
| SUCLA2 | RNA | Carbohydrate Metabolism | - | CNS Metabolic Diseases |
| SUFU | RNA | - | - | - |
| SUGT1 | RNA | - | - | - |
| SULF1 | RNA | Cell Proliferation | Cellular Growth Factor | CNS Oncology |
| SUMO1 | RNA | - | Immune Activation Status Immunity and Inflammation |
Immuno-Oncology Inflammation |
| SUPT16H | RNA | p53 Signaling | - | Oncology |
| SUV39H1 | RNA | - | - | - |
| SUV39H2 | RNA | Chromatin Modification Epigenic and Transcriptional Regulation |
- | Epigenic and Nuclear Signaling |
| SUZ12 | RNA | - | - | - |
| SV2B | RNA | Cellular Differentiation | - | Oncology |
| SYCP1 | RNA | - | - | - |
| SYK | RNA | Angiogenesis Cell Proliferation Interleukin Signaling PI3K-AKT |
Immune Activation Status Immunity and Inflammation Macrophage Function |
Cardiovascular CNS Immuno-Oncology Oncology Inflammation |
| SYN2 | RNA | - | - | - |
| Synaptophysin | Protein | - | Neural Cell Typing | CNS |
| SYNE1 | RNA | - | - | - |
| SYNJ1 | RNA | - | Axon and Dendrite Structure Neural Connectivity Vesicle Trafficking |
CNS |
| SYP | RNA | - | - | - |
| SYT1 | RNA | Transmitter Synthesis | Axon and Dendrite Structure Neural Connectivity Vesicle Trafficking |
CNS |
| SYT13 | RNA | - | Neural Connectivity Vesicle Trafficking |
CNS |
| SYT17 | RNA | - | - | - |
| SYT4 | RNA | - | Neural Connectivity Vesicle Trafficking |
CNS |
| SYT7 | RNA | - | Axon and Dendrite Structure Neural Connectivity Vesicle Trafficking |
CNS |
| SYTL4 | RNA | ER Signaling | - | Oncology |
| TAB1 | RNA | - | - | - |
| TAB2 | RNA | - | Immune Activation Status | Immuno-Oncology |
| TAB3 | RNA | - | - | - |
| TACSTD2 | RNA | Cell Proliferation | - | CNS Oncology |
| TAF10 | RNA | - | - | - |
| TAF3 | RNA | - | - | - |
| TAF4 | RNA | - | - | - |
| TAF4B | RNA | - | - | - |
| TAF6L | RNA | Epigenic and Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| TAF9 | RNA | - | - | - |
| TAGAP | RNA | - | - | - |
| TAL1 | RNA | Angiogenesis | - | Cardiovascular Oncology |
| TALDO1 | RNA | Biosynthesis and Anabolic Pathways Signaling Affecting Cellular Metabolism |
- | CNS Metabolic Diseases |
| TANK | RNA | - | - | - |
| TAOK2 | RNA | - | - | - |
| TAP1 | RNA | Antigen Processing DNA Damage Repair |
Antigen Presentation | Immuno-Oncology Epigenic and Nuclear Signaling |
| TAP2 | RNA | Antigen Processing | Antigen Presentation | Immuno-Oncology |
| TAPBP | RNA | Antigen Processing | Antigen Presentation Immune Activation Status |
Immuno-Oncology |
| TAPBPL | RNA | - | - | - |
| TARBP2 | RNA | - | - | - |
| TARDBP | RNA | - | - | - |
| TARP | RNA | - | - | - |
| TARP/TRGC1/2 | RNA | - | - | - |
| TATDN1 | RNA | - | - | - |
| Tau | Protein | - | AD Pathology Cytoskeleton |
CNS |
| Taurine | Amino-acid & Metabolites | - | - | - |
| TAX1BP1 | RNA | - | Immune Activation Status | Immuno-Oncology |
| TAZ | RNA | Hippo Signaling Lipid Metabolism |
- | CNS Metabolic Diseases Oncology |
| TBC1D10B | RNA | - | - | - |
| TBC1D4 | RNA | - | Immunity and Inflammation | Inflammation |
| TBC1D9 | RNA | ER Signaling | - | Oncology |
| Tbet | Protein | - | - | - |
| TBK1 | RNA | Signaling Affecting Cellular Metabolism | Immune Activation Status | Metabolic Diseases Immuno-Oncology |
| TBL1XR1 | RNA | Epigenic and Transcriptional Regulation | Immune Suppression | Epigenic and Nuclear Signaling Immuno-Oncology |
| TBP | RNA | Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| TBPL1 | RNA | - | - | - |
| TBR1 | RNA | - | - | - |
| TBRG4 | RNA | Myc | - | Oncology |
| TBX1 | RNA | Angiogenesis Cell Proliferation Transcriptional Misregulation Vasculogenesis |
- | Cardiovascular CNS Epigenic and Nuclear Signaling Oncology |
| TBX21 | RNA | Transcriptional Regulation | Immune Cell Typing Lymphoid Compartment T Cell Exhaustion |
Epigenic and Nuclear Signaling Immuno-Oncology |
| TBX4 | RNA | Angiogenesis | - | Cardiovascular Oncology |
| TBXA2R | RNA | - | - | - |
| TBXAS1 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| TCEAL1 | RNA | DNA Damage Repair ER Signaling |
- | Epigenic and Nuclear Signaling Oncology |
| TCEB1 | RNA | - | - | - |
| TCEB2 | RNA | - | - | - |
| TCERG1 | RNA | - | - | - |
| TCF20 | RNA | - | - | - |
| TCF3 | RNA | - | - | - |
| TCF4 | RNA | EMT | - | Oncology |
| TCF7 | RNA | - | Immune Activation Status T Cell Exhaustion |
Immuno-Oncology |
| TCF7L1 | RNA | Wnt Signaling | - | CNS Oncology |
| TCF7L2 | RNA | - | - | - |
| TCIRG1 | RNA | Transmitter Synthesis | - | CNS |
| TCL1A | RNA | PI3K-AKT Signaling Affecting Cellular Metabolism |
Immune Activation Status Immune Cell Typing |
Oncology Metabolic Diseases Immuno-Oncology |
| TCL1B | RNA | - | - | - |
| TCN2 | RNA | - | - | - |
| TCOF1 | RNA | Myc | - | Oncology |
| TDGF1 | RNA | Cell Proliferation Cellular Differentiation Vasculogenesis |
Cellular Growth Factor | CNS Oncology Cardiovascular |
| TDO2 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| Tdp-43 | Protein | - | AD Pathology | CNS |
| TDRD1 | RNA | Epigenic and Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| TEAD1 | RNA | Hippo Signaling | - | CNS Oncology |
| TEAD2 | RNA | Hippo Signaling | - | CNS Oncology |
| TECR | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| TEK | RNA | Angiogenesis Cell Proliferation HIF1 Signaling |
Adhesion and Migration | Cardiovascular CNS Inflammation Oncology |
| TELO2 | RNA | Signaling Affecting Cellular Metabolism | Immune Activation Status | Metabolic Diseases Immuno-Oncology |
| TENM2 | RNA | - | Axon and Dendrite Structure Neural Connectivity |
CNS |
| TERF2IP | RNA | - | - | - |
| TERT | RNA | Myc | - | Oncology |
| TET1 | RNA | - | - | - |
| TET2 | RNA | Biosynthesis and Anabolic Pathways Epigenic and Transcriptional Regulation |
- | CNS Epigenic and Nuclear Signaling Metabolic Diseases |
| Tetrahydrodeoxycorticosterone | Lipid | - | - | - |
| TF | RNA | Nutrient Capture and Catabolic Pathways | - | Metabolic Diseases |
| TFAM | RNA | Biosynthesis and Anabolic Pathways Carbohydrate Metabolism |
- | CNS Metabolic Diseases |
| TFB2M | RNA | - | - | - |
| TFDP1 | RNA | Cell Cycle Cell Proliferation Proliferation TGF Beta Signaling |
- | Oncology CNS |
| TFE3 | RNA | - | - | - |
| TFEB | Protein | Autophagy | - | Cardiovascular CNS Inflammation Metabolic Diseases Oncology |
| TFEB | RNA | Autophagy | - | Cardiovascular CNS Inflammation Metabolic Diseases Oncology |
| TFF1 | RNA | ER Signaling | - | Oncology |
| TFF3 | RNA | - | - | - |
| TFG | RNA | - | - | - |
| TFPI2 | RNA | - | - | - |
| TFRC | RNA | Hypoxia Nutrient Capture and Catabolic Pathways Signaling Affecting Cellular Metabolism |
- | Cardiovascular Metabolic Diseases Oncology |
| TG | RNA | - | - | - |
| TG(18:4(6Z.9Z.12Z.15Z)/18:4(6Z.9Z.12Z.15Z)/20:5(5Z.8Z.11Z.14Z.17Z))iso3 | Lipid | - | - | - |
| TG(18:4(6Z.9Z.12Z.15Z)/18:4(6Z.9Z.12Z.15Z)/22:6(4Z.7Z.10Z.13Z.16Z.19Z))iso3 | Lipid | - | - | - |
| TGFA | RNA | - | Immunity and Inflammation | Inflammation |
| TGFB1 | RNA | Cell Proliferation Cellular Differentiation ECM Remodeling Epigenic and Transcriptional Regulation MAPK Matrix Remodeling and Metastases Myelination Proliferation TGF Beta Signaling |
Activated Microglia Axon and Dendrite Structure Cellular Growth Factor Immune Suppression Immunity and Inflammation Interleukins |
CNS Oncology Metabolic Diseases Epigenic and Nuclear Signaling Cardiovascular Immuno-Oncology Inflammation |
| TGFB1I1 | RNA | - | - | - |
| TGFB2 | RNA | Angiogenesis Cell Proliferation Cellular Differentiation ECM Remodeling EMT Hippo Signaling MAPK Matrix Remodeling and Metastases Proliferation TGF Beta Signaling |
Cellular Growth Factor Immune Suppression Interleukins |
Cardiovascular CNS Oncology Metabolic Diseases Immuno-Oncology Inflammation |
| TGFB3 | RNA | ECM Remodeling HIF1 Signaling MAPK Matrix Remodeling and Metastases Proliferation TGF Beta Signaling |
- | Metabolic Diseases Inflammation Cardiovascular CNS Oncology |
| TGFBI | RNA | Angiogenesis Cell Proliferation |
- | Cardiovascular CNS Oncology |
| TGFBR1 | RNA | MAPK TGF Beta Signaling |
Immunity and Inflammation | Cardiovascular Oncology Inflammation CNS |
| TGFBR2 | RNA | Cell Proliferation MAPK Proliferation TGF Beta Signaling Transcriptional Misregulation Vasculogenesis |
Cellular Growth Factor | CNS Cardiovascular Oncology Epigenic and Nuclear Signaling |
| TGIF2 | RNA | - | - | - |
| TGM1 | RNA | - | - | - |
| TGM2 | RNA | Hippo Signaling | Immunity and Inflammation | CNS Inflammation Oncology |
| TH | RNA | Biosynthesis and Anabolic Pathways Transmitter Synthesis |
Axon and Dendrite Structure Neural Connectivity Transmitter Release Vesicle Trafficking |
CNS Metabolic Diseases |
| THBD | RNA | - | Antigen Presentation Leucocyte Function |
Immuno-Oncology |
| THBS1 | RNA | Angiogenesis Antigen Processing Cell Proliferation ECM Remodeling Hippo Signaling Matrix Remodeling and Metastases Myc PI3K-AKT PDGF Signaling Signaling Affecting Cellular Metabolism TGF Beta Signaling |
Adhesion and Migration Antigen Presentation |
Cardiovascular Immuno-Oncology CNS Metabolic Diseases Oncology |
| THBS2 | RNA | ECM Remodeling PDGF Signaling Signaling Affecting Cellular Metabolism TGF Beta Signaling |
Adhesion and Migration | Metabolic Diseases Oncology CNS |
| THBS3 | RNA | - | - | - |
| THBS4 | RNA | Cell Proliferation PI3K-AKT Proliferation TGF Beta Signaling |
Adhesion and Migration Cellular Growth Factor |
CNS Oncology |
| Theasinensin A | Lipid | - | - | - |
| THEM4 | RNA | - | - | - |
| Theronine | Amino-acid & Metabolites | - | - | - |
| THOP1 | RNA | - | - | - |
| THY1 | RNA | Angiogenesis | Adhesion and Migration Axon and Dendrite Structure |
Cardiovascular CNS Oncology |
| TIAM1 | RNA | RAS | - | Oncology |
| TICAM1 | RNA | Apoptosis | Immune Activation Status Macrophage Function |
Oncology Immuno-Oncology |
| TICAM2 | RNA | - | - | - |
| TIE1 | RNA | Angiogenesis | - | Cardiovascular Oncology |
| TIFA | RNA | - | - | - |
| TIGAR | RNA | Signaling Affecting Cellular Metabolism | - | Metabolic Diseases |
| TIGIT | RNA | Costimulatory Signaling Signaling Affecting Cellular Metabolism |
Immune Checkpoint Lymphoid Compartment T Cell Costimulation T Cell Exhaustion |
Immuno-Oncology Metabolic Diseases |
| TIM3 | Protein | - | - | - |
| Tim-3 | Protein | - | Immune Checkpoint T Cell Activation |
Immuno-Oncology |
| TIMELESS | RNA | Cell Stress | - | CNS Oncology |
| TIMM17A | RNA | - | - | - |
| TIMM23 | RNA | - | - | - |
| TIMP1 | RNA | Cell Proliferation Matrix Remodeling and Metastases |
Immune Activation Status Immune Suppression |
CNS Immuno-Oncology Oncology |
| TIMP2 | RNA | Cell Proliferation Matrix Remodeling and Metastases |
- | CNS Oncology |
| TIMP4 | RNA | Matrix Remodeling and Metastases | - | CNS Oncology |
| TIRAP | RNA | - | - | - |
| TJP1 | RNA | Hippo Signaling | - | CNS Oncology |
| TJP2 | RNA | - | - | - |
| TJP3 | RNA | - | - | - |
| TK1 | RNA | Biosynthesis and Anabolic Pathways Nutrient Capture and Catabolic Pathways |
- | CNS Metabolic Diseases |
| TK2 | RNA | Biosynthesis and Anabolic Pathways Nutrient Capture and Catabolic Pathways |
- | CNS Metabolic Diseases |
| TKT | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| TLE3 | RNA | ER Signaling | Immunity and Inflammation | Oncology Inflammation |
| TLE4 | RNA | - | Immune Suppression | Immuno-Oncology |
| TLK2 | RNA | - | - | - |
| TLN1 | RNA | - | - | - |
| TLR1 | RNA | - | Immune Activation Status Myeloid Compartment |
Immuno-Oncology CNS |
| TLR10 | RNA | Signaling Affecting Cellular Metabolism | Immune Activation Status | Metabolic Diseases Immuno-Oncology |
| TLR2 | RNA | PI3K-AKT Signaling Affecting Cellular Metabolism |
Activated Microglia Immune Activation Status Immunity and Inflammation Myeloid Compartment |
Oncology Metabolic Diseases CNS Immuno-Oncology Inflammation |
| TLR3 | RNA | Apoptosis | - | Oncology |
| TLR4 | RNA | Apoptosis Cellular Differentiation Hypoxia PI3K-AKT Signaling Affecting Cellular Metabolism |
Immunity and Inflammation Myeloid Compartment |
Oncology Cardiovascular Metabolic Diseases Inflammation CNS |
| TLR5 | RNA | - | - | - |
| TLR6 | RNA | - | - | - |
| TLR7 | RNA | Signaling Affecting Cellular Metabolism | Immune Activation Status Immunity and Inflammation |
Metabolic Diseases Immuno-Oncology Inflammation |
| TLR8 | RNA | - | Myeloid Compartment | CNS |
| TLR9 | RNA | - | - | - |
| TLX1 | RNA | Transcriptional Misregulation | - | Epigenic and Nuclear Signaling |
| TM4SF1 | RNA | - | - | - |
| TM6SF2 | RNA | - | - | - |
| TMC6 | RNA | - | - | - |
| TMC7 | RNA | - | Immunity and Inflammation | Inflammation |
| TMCC3 | RNA | - | Immunity and Inflammation | Inflammation |
| TMED2 | RNA | - | Immune Suppression | Immuno-Oncology |
| TMEFF2 | RNA | - | - | - |
| TMEM100 | RNA | Angiogenesis | Immunity and Inflammation | Cardiovascular Inflammation Oncology |
| TMEM119 | Protein | - | Activated Microglia Immunity and Inflammation Microglia Neural Cell Typing |
CNS Inflammation |
| TMEM119 | RNA | - | Activated Microglia Immunity and Inflammation Microglia Neural Cell Typing |
CNS Inflammation |
| TMEM140 | RNA | - | - | - |
| TMEM144 | RNA | - | Immunity and Inflammation | Inflammation |
| TMEM163 | RNA | - | - | - |
| TMEM173 | RNA | - | Immunity and Inflammation | Inflammation |
| TMEM176A | RNA | - | - | - |
| TMEM204 | RNA | - | Immunity and Inflammation | Inflammation |
| TMEM206 | RNA | - | Immunity and Inflammation | Inflammation |
| TMEM30B | RNA | Cellular Differentiation | - | Oncology |
| TMEM37 | RNA | - | Immunity and Inflammation | Inflammation |
| TMEM45B | RNA | - | - | - |
| TMEM64 | RNA | - | Immunity and Inflammation | Inflammation |
| TMEM88B | RNA | - | - | - |
| TMPRSS2 | RNA | Androgen Signaling EMT Epigenic and Transcriptional Regulation Matrix Remodeling and Metastases Transcriptional Misregulation |
- | Oncology Epigenic and Nuclear Signaling CNS |
| TMPRSS4 | RNA | EMT Matrix Remodeling and Metastases |
- | Oncology CNS |
| TMPRSS6 | RNA | Angiogenesis Matrix Remodeling and Metastases |
- | Cardiovascular CNS Oncology |
| TMUB2 | RNA | - | - | - |
| TNC | RNA | Cell Proliferation | - | CNS Oncology |
| TNF | RNA | Apoptosis Cellular Differentiation Cytokine and Chemokine Signaling MAPK Matrix Remodeling and Metastases Metabolism Stress NF-kappaB Signaling Oxydative Stress Signaling Affecting Cellular Metabolism TCR Signaling TGF Beta Signaling TNF Superfamily |
Activated Microglia Antigen Presentation Immune Activation Status Immune Suppression Immunity and Inflammation Interleukins M1 Activation |
Oncology Immuno-Oncology Cardiovascular CNS Metabolic Diseases Inflammation |
| TNFAIP3 | RNA | - | Immune Activation Status | Immuno-Oncology |
| TNFAIP6 | RNA | Angiogenesis | Myeloid Compartment | Cardiovascular CNS Oncology |
| TNFRSF10A | RNA | - | Immune Activation Status | Immuno-Oncology |
| TNFRSF10B | RNA | Apoptosis | Immunity and Inflammation | Oncology Inflammation |
| TNFRSF10C | RNA | - | - | - |
| TNFRSF10D | RNA | - | - | - |
| TNFRSF11A | RNA | NF-kappaB Signaling | - | CNS Inflammation Oncology |
| TNFRSF11B | RNA | NF-kappaB Signaling | Immunity and Inflammation | CNS Inflammation Oncology |
| TNFRSF12A | RNA | Angiogenesis | Immunity and Inflammation | Cardiovascular Inflammation Oncology |
| TNFRSF13B | RNA | - | Chemokines | Immuno-Oncology |
| TNFRSF13C | RNA | - | Immunity and Inflammation | Inflammation |
| TNFRSF14 | RNA | Costimulatory Signaling NF-kappaB Signaling |
B Cell Function Immune Checkpoint |
Immuno-Oncology CNS Inflammation Oncology |
| TNFRSF17 | RNA | NF-kappaB Signaling Signaling Affecting Cellular Metabolism TNF Superfamily |
Immune Cell Typing Immunity and Inflammation |
CNS Metabolic Diseases Oncology Immuno-Oncology Inflammation |
| TNFRSF18 | RNA | NF-kappaB Signaling TNF Superfamily |
Immune Checkpoint T Cell Costimulation |
CNS Oncology Immuno-Oncology Inflammation |
| TNFRSF1A | RNA | MAPK NF-kappaB Signaling |
Chemokines Immune Activation Status Immune Suppression Immunity and Inflammation |
Cardiovascular CNS Immuno-Oncology Inflammation Oncology |
| TNFRSF1B | RNA | NF-kappaB Signaling | Axon and Dendrite Structure Chemokines Immune Activation Status Immune Suppression Immunity and Inflammation |
CNS Immuno-Oncology Inflammation Oncology |
| TNFRSF25 | RNA | Costimulatory Signaling NF-kappaB Signaling |
Immunity and Inflammation Lymphoid Compartment |
Immuno-Oncology CNS Inflammation Oncology |
| TNFRSF4 | RNA | NF-kappaB Signaling Signaling Affecting Cellular Metabolism TNF Superfamily |
Immune Checkpoint Immunity and Inflammation T Cell Costimulation |
CNS Metabolic Diseases Oncology Immuno-Oncology Inflammation |
| TNFRSF8 | RNA | - | - | - |
| TNFRSF9 | RNA | TNF Superfamily | Immune Checkpoint T Cell Costimulation |
Oncology Immuno-Oncology |
| TNFSF10 | RNA | Apoptosis Cytotoxicity |
Cytokines Immune Activation Status Immunity and Inflammation |
Oncology Immuno-Oncology Inflammation |
| TNFSF11 | RNA | TNF Superfamily | - | Oncology |
| TNFSF12 | RNA | Angiogenesis Cell Proliferation Cellular Differentiation NF-kappaB Signaling |
Chemokines Immunity and Inflammation |
Cardiovascular CNS Oncology Immuno-Oncology Inflammation |
| TNFSF13 | RNA | Cell Proliferation NF-kappaB Signaling |
- | CNS Oncology Inflammation |
| TNFSF13B | RNA | NF-kappaB Signaling TNF Superfamily |
Immunity and Inflammation | CNS Oncology Inflammation |
| TNFSF14 | RNA | TNF Superfamily | Cytokines | Oncology Immuno-Oncology |
| TNFSF15 | RNA | - | Chemokines | Immuno-Oncology |
| TNFSF18 | RNA | NF-kappaB Signaling | B Cell Function Immune Checkpoint |
CNS Immuno-Oncology Inflammation Oncology |
| TNFSF4 | RNA | NF-kappaB Signaling | Chemokines Immune Checkpoint Immunity and Inflammation |
CNS Immuno-Oncology Inflammation Oncology |
| TNFSF8 | RNA | TNF Superfamily | Cytokines Immunity and Inflammation |
Oncology Immuno-Oncology Inflammation |
| TNFSF9 | RNA | Costimulatory Signaling | Immune Checkpoint | Immuno-Oncology |
| TNKS | RNA | Apoptosis DNA Damage Repair |
- | Oncology Epigenic and Nuclear Signaling |
| TNKS2 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| TNMD | RNA | Cell Proliferation Cellular Differentiation |
- | CNS Oncology |
| TNN | RNA | PI3K-AKT Proliferation |
Cellular Growth Factor | Oncology |
| TNR | RNA | - | Vesicle Trafficking | CNS |
| TNS1 | RNA | Hippo Signaling | - | CNS Oncology |
| TNS4 | RNA | Met Signaling | - | Oncology |
| TNXB | RNA | Cellular Differentiation | - | Oncology |
| TOLLIP | RNA | - | - | - |
| TOM1L1 | RNA | - | - | - |
| TOMM6 | RNA | - | - | - |
| TOP2A | RNA | Cell Cycle DNA Damage Repair Hippo Signaling |
- | Oncology Epigenic and Nuclear Signaling CNS |
| TOPBP1 | RNA | - | - | - |
| TOR1A | RNA | Oxydative Stress | Neural Connectivity Transmitter Release Vesicle Trafficking |
Inflammation CNS |
| TOX | RNA | - | Immune Activation Status T Cell Exhaustion |
Immuno-Oncology |
| TOX2 | RNA | - | T Cell Exhaustion | Immuno-Oncology |
| TOX3 | RNA | - | T Cell Exhaustion | Immuno-Oncology |
| TOX4 | RNA | - | T Cell Exhaustion | Immuno-Oncology |
| TP53 | RNA | Apoptosis Biosynthesis and Anabolic Pathways Cell Cycle Cell Proliferation Cell Stress DNA Damage Repair Epigenic and Transcriptional Regulation MAPK Metabolism Stress Notch Oxydative Stress PI3K-AKT Proliferation p53 Signaling Signaling Affecting Cellular Metabolism Transcriptional Misregulation Transcriptional Regulation Tumor Metabolism Wnt Signaling |
- | Oncology CNS Epigenic and Nuclear Signaling Cardiovascular Metabolic Diseases Immuno-Oncology Inflammation |
| TP53BP2 | RNA | - | - | - |
| TP53INP2 | RNA | - | - | - |
| TP63 | RNA | Signaling Affecting Cellular Metabolism Transcriptional Regulation |
- | Metabolic Diseases Epigenic and Nuclear Signaling |
| TP73 | RNA | Hippo Signaling p53 Signaling |
- | CNS Oncology |
| TPD52 | RNA | Androgen Signaling | Immunity and Inflammation | Oncology Inflammation |
| TPH1 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| TPI1 | RNA | HIF1 Signaling Metabolism Stress mTOR Signaling |
- | Inflammation Metabolic Diseases Oncology |
| TPM1 | RNA | Angiogenesis Oxydative Stress |
Neuronal Cytoskeleton | Cardiovascular Inflammation CNS Oncology |
| TPM2 | RNA | - | - | - |
| TPO | RNA | - | - | - |
| TPP1 | RNA | - | - | - |
| TPP2 | RNA | - | Antigen Presentation Immune Activation Status |
Immuno-Oncology |
| TPR | RNA | Biosynthesis and Anabolic Pathways Signaling Affecting Cellular Metabolism |
- | CNS Metabolic Diseases |
| TPSAB1 | RNA | - | - | - |
| TPSAB1/B2 | RNA | ECM Remodeling | Immune Cell Typing | Metabolic Diseases Immuno-Oncology Oncology |
| TPSB2 | RNA | Matrix Remodeling and Metastases | - | CNS Oncology |
| TPSD1 | RNA | Matrix Remodeling and Metastases | - | CNS Oncology |
| TPTE | RNA | - | - | - |
| TPX2 | RNA | Biosynthesis and Anabolic Pathways Cell Cycle |
- | CNS Oncology Metabolic Diseases |
| TRAC | RNA | - | Immune Activation Status Immune Checkpoint |
Immuno-Oncology |
| TRADD | RNA | - | Immunity and Inflammation | Inflammation |
| TRAF1 | RNA | Epigenic and Transcriptional Regulation Signaling Affecting Cellular Metabolism |
Immunity and Inflammation | Epigenic and Nuclear Signaling Metabolic Diseases Inflammation |
| TRAF2 | RNA | - | Immune Activation Status Immunity and Inflammation |
Immuno-Oncology Inflammation |
| TRAF3 | RNA | - | Immunity and Inflammation | Inflammation |
| TRAF4 | RNA | - | - | - |
| TRAF5 | RNA | - | - | - |
| TRAF6 | RNA | Nutrient Capture and Catabolic Pathways Signaling Affecting Cellular Metabolism TCR Signaling |
Immunity and Inflammation | Metabolic Diseases Immuno-Oncology Inflammation |
| TRAF7 | RNA | - | - | - |
| TRAM1 | RNA | - | - | - |
| trans-Hexadec-2-enoyl carnitine | Lipid | - | - | - |
| TRAT1 | RNA | Costimulatory Signaling TCR Signaling |
Immune Activation Status Immune Cell Typing Immunity and Inflammation |
Immuno-Oncology Inflammation |
| TRAV10 | RNA | - | - | - |
| TRAV11 | RNA | - | - | - |
| TRAV1-1 | RNA | - | - | - |
| TRAV1-2 | RNA | - | - | - |
| TRAV12-1 | RNA | - | - | - |
| TRAV12-2 | RNA | - | - | - |
| TRAV12-3 | RNA | - | - | - |
| TRAV13-1 | RNA | - | - | - |
| TRAV13-2 | RNA | - | - | - |
| TRAV14 | RNA | - | - | - |
| TRAV16 | RNA | - | - | - |
| TRAV17 | RNA | - | - | - |
| TRAV18 | RNA | - | - | - |
| TRAV19 | RNA | - | - | - |
| TRAV2 | RNA | - | - | - |
| TRAV20 | RNA | - | - | - |
| TRAV21 | RNA | - | - | - |
| TRAV22 | RNA | - | - | - |
| TRAV23 | RNA | - | - | - |
| TRAV24 | RNA | - | - | - |
| TRAV25 | RNA | - | - | - |
| TRAV26-1 | RNA | - | - | - |
| TRAV26-2 | RNA | - | - | - |
| TRAV27 | RNA | - | - | - |
| TRAV29 | RNA | - | - | - |
| TRAV3 | RNA | - | - | - |
| TRAV30 | RNA | - | - | - |
| TRAV34 | RNA | - | - | - |
| TRAV35 | RNA | - | - | - |
| TRAV36 | RNA | - | - | - |
| TRAV38-1 | RNA | - | - | - |
| TRAV38-2 | RNA | - | - | - |
| TRAV39 | RNA | - | - | - |
| TRAV4 | RNA | - | - | - |
| TRAV40 | RNA | - | - | - |
| TRAV41 | RNA | - | - | - |
| TRAV5 | RNA | - | - | - |
| TRAV6 | RNA | - | - | - |
| TRAV7 | RNA | - | - | - |
| TRAV8-1 | RNA | - | - | - |
| TRAV8-2 | RNA | - | - | - |
| TRAV8-3 | RNA | - | - | - |
| TRAV8-6 | RNA | - | - | - |
| TRAV9-1 | RNA | - | - | - |
| TRAV9-2 | RNA | - | - | - |
| TRBC1/2 | RNA | - | Immune Activation Status | Immuno-Oncology |
| TRBV10-1 | RNA | - | - | - |
| TRBV10-2 | RNA | - | - | - |
| TRBV10-3 | RNA | - | - | - |
| TRBV11-1 | RNA | - | - | - |
| TRBV11-2 | RNA | - | - | - |
| TRBV11-3 | RNA | - | - | - |
| TRBV12-3 | RNA | - | - | - |
| TRBV12-5 | RNA | - | - | - |
| TRBV13 | RNA | - | - | - |
| TRBV14 | RNA | - | - | - |
| TRBV15 | RNA | - | - | - |
| TRBV16 | RNA | - | - | - |
| TRBV18 | RNA | - | - | - |
| TRBV19 | RNA | - | - | - |
| TRBV2 | RNA | - | - | - |
| TRBV20-1 | RNA | - | - | - |
| TRBV24-1 | RNA | - | - | - |
| TRBV25-1 | RNA | - | - | - |
| TRBV27 | RNA | - | - | - |
| TRBV28 | RNA | - | - | - |
| TRBV29-1 | RNA | - | - | - |
| TRBV30 | RNA | - | - | - |
| TRBV3-1 | RNA | - | - | - |
| TRBV4-1 | RNA | - | - | - |
| TRBV4-2 | RNA | - | - | - |
| TRBV4-3 | RNA | - | - | - |
| TRBV5-1 | RNA | - | - | - |
| TRBV5-4 | RNA | - | - | - |
| TRBV5-5 | RNA | - | - | - |
| TRBV5-6 | RNA | - | - | - |
| TRBV5-8 | RNA | - | - | - |
| TRBV6-1 | RNA | - | - | - |
| TRBV6-2 | RNA | - | - | - |
| TRBV6-4 | RNA | - | - | - |
| TRBV6-5 | RNA | - | - | - |
| TRBV6-6 | RNA | - | - | - |
| TRBV6-8 | RNA | - | - | - |
| TRBV6-9 | RNA | - | - | - |
| TRBV7-2 | RNA | - | - | - |
| TRBV7-3 | RNA | - | - | - |
| TRBV7-4 | RNA | - | - | - |
| TRBV7-6 | RNA | - | - | - |
| TRBV7-7 | RNA | - | - | - |
| TRBV7-8 | RNA | - | - | - |
| TRBV7-9 | RNA | - | - | - |
| TRBV9 | RNA | - | - | - |
| TRDC | RNA | - | Immune Activation Status | Immuno-Oncology |
| TRDV1 | RNA | - | Immune Activation Status | Immuno-Oncology |
| TRDV2 | RNA | - | Immune Activation Status | Immuno-Oncology |
| TRDV3 | RNA | - | Immune Activation Status | Immuno-Oncology |
| TREM1 | RNA | - | Activated Microglia Immunity and Inflammation Myeloid Compartment |
CNS Inflammation |
| TREM2 | RNA | - | Activated Microglia Immune Activation Status Immunity and Inflammation Myeloid Compartment |
CNS Immuno-Oncology Inflammation |
| TREX1 | RNA | - | - | - |
| TRGC1 | RNA | - | Immune Activation Status | Immuno-Oncology |
| TRGC2 | RNA | - | Immune Activation Status | Immuno-Oncology |
| TRGV2 | RNA | - | Immune Activation Status | Immuno-Oncology |
| TRGV3/5 | RNA | - | Immune Activation Status | Immuno-Oncology |
| TRGV4 | RNA | - | Immune Activation Status | Immuno-Oncology |
| TRGV8 | RNA | - | Immune Activation Status | Immuno-Oncology |
| TRGV9 | RNA | - | Immune Activation Status | Immuno-Oncology |
| TRIB3 | RNA | - | - | - |
| Tricosanedioic acid | Lipid | - | - | - |
| TRIM10 | RNA | - | - | - |
| TRIM14 | RNA | - | - | - |
| TRIM2 | RNA | - | Immune Activation Status | Immuno-Oncology |
| TRIM21 | RNA | - | Antigen Presentation | Immuno-Oncology |
| TRIM22 | RNA | - | - | - |
| TRIM25 | RNA | - | - | - |
| TRIM26 | RNA | - | - | - |
| TRIM28 | RNA | - | - | - |
| TRIM29 | RNA | - | Immune Activation Status | Immuno-Oncology |
| TRIM31 | RNA | - | - | - |
| TRIM33 | RNA | - | Immune Suppression | Immuno-Oncology |
| TRIM34 | RNA | - | - | - |
| TRIM35 | RNA | - | Immune Activation Status | Immuno-Oncology |
| TRIM36 | RNA | - | Antigen Presentation Immune Activation Status |
Immuno-Oncology |
| TRIM37 | RNA | - | - | - |
| TRIM39 | RNA | - | - | - |
| TRIM46 | RNA | - | Immune Activation Status | Immuno-Oncology |
| TRIM47 | RNA | - | Immunity and Inflammation | Inflammation |
| TRIM48 | RNA | - | Immune Activation Status | Immuno-Oncology |
| TRIM5 | RNA | - | - | - |
| TRIM56 | RNA | - | - | - |
| TRIM6 | RNA | - | - | - |
| TRIM68 | RNA | - | - | - |
| TRIM8 | RNA | - | - | - |
| TRIM9 | RNA | - | Antigen Presentation Immune Activation Status |
Immuno-Oncology |
| TRIP13 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| TROVE2 | RNA | - | - | - |
| TRPA1 | RNA | - | Immunity and Inflammation | Inflammation |
| TRPC1 | RNA | - | Immune Activation Status | Immuno-Oncology |
| TRPC6 | RNA | - | - | - |
| TRPM2 | RNA | Oxydative Stress | Transmitter Release | Inflammation CNS |
| TRPM4 | RNA | - | Immunity and Inflammation | Inflammation |
| TRPM7 | RNA | - | - | - |
| TRPV1 | RNA | - | Neural Connectivity Transmitter Release Transmitter Response and Reuptake |
CNS |
| TRRAP | RNA | Epigenic and Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| Tryptamine | Amino-acid & Metabolites | - | - | - |
| Tryptophan | Amino-acid & Metabolites | - | - | - |
| TSC1 | RNA | - | - | - |
| TSC2 | RNA | - | - | - |
| TSHR | RNA | Cell Proliferation | - | CNS Oncology |
| TSLP | Protein | Costimulatory Signaling JAK-STAT |
Immune Activation Status | Immuno-Oncology CNS Inflammation Metabolic Diseases Oncology |
| TSLP | RNA | Costimulatory Signaling JAK-STAT |
Immune Activation Status | Immuno-Oncology CNS Inflammation Metabolic Diseases Oncology |
| TSPAN1 | RNA | EMT | - | Oncology |
| TSPAN18 | RNA | - | Immunity and Inflammation | Inflammation |
| TSPAN7 | RNA | Transcriptional Misregulation | - | Epigenic and Nuclear Signaling |
| TSPO | RNA | - | Neural Connectivity Transmitter Response and Reuptake Vesicle Trafficking |
CNS |
| TTC30A | RNA | - | - | - |
| TTC31 | RNA | - | - | - |
| TTK | RNA | Cell Cycle DNA Damage Repair |
Immune Activation Status | Oncology Epigenic and Nuclear Signaling Immuno-Oncology |
| TTN | RNA | - | - | - |
| TTPA | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| TTR | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| TTYH1 | RNA | - | - | - |
| TUBA4A | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| TUBB | RNA | - | - | - |
| TUBB3 | RNA | - | Immunity and Inflammation | Inflammation |
| TUBB4A | RNA | - | Immunity and Inflammation | Inflammation |
| TUBG1 | RNA | Cell Cycle mTOR Signaling |
- | Oncology |
| TUSC2 | RNA | - | Immune Activation Status | Immuno-Oncology |
| TWF1 | RNA | - | - | - |
| TWIST1 | RNA | Cellular Differentiation EMT Epigenic and Transcriptional Regulation |
Immune Activation Status | Oncology Epigenic and Nuclear Signaling Immuno-Oncology |
| TWIST2 | RNA | Cell Proliferation | - | CNS Oncology |
| TWISTNB | RNA | - | - | - |
| TXK | RNA | - | - | - |
| TXN | RNA | Signaling Affecting Cellular Metabolism | - | Metabolic Diseases |
| TXN2 | RNA | Cell Stress | - | CNS Oncology |
| TXNDC5 | RNA | - | - | - |
| TXNIP | RNA | Cell Proliferation | Cellular Growth Factor | CNS Oncology |
| TXNL1 | RNA | Oxydative Stress | - | Inflammation |
| TXNRD1 | RNA | Signaling Affecting Cellular Metabolism | - | Metabolic Diseases |
| TXNRD2 | RNA | - | - | - |
| TYK2 | RNA | - | Cytokines Immune Activation Status Immune Suppression |
Immuno-Oncology |
| TYMP | RNA | Angiogenesis Biosynthesis and Anabolic Pathways Nutrient Capture and Catabolic Pathways Proliferation |
Cellular Growth Factor | Cardiovascular CNS Metabolic Diseases Oncology |
| TYMS | RNA | Biosynthesis and Anabolic Pathways DNA Damage Repair Proliferation |
- | CNS Epigenic and Nuclear Signaling Oncology Metabolic Diseases |
| TYROBP | RNA | - | Immune Activation Status Immunity and Inflammation |
Immuno-Oncology Inflammation |
| Tyrosine | Neuropeptide & Neurotransmitter | - | - | - |
| Tyrosine Hydroxylase | Protein | - | PD Pathology | CNS |
| U2AF1 | RNA | - | - | - |
| U2AF2 | RNA | - | - | - |
| UBA5 | RNA | - | - | - |
| UBA52 | RNA | - | - | - |
| UBA7 | RNA | DNA Damage Repair | Antigen Presentation | Epigenic and Nuclear Signaling Immuno-Oncology |
| UBB | RNA | Apoptosis Biosynthesis and Anabolic Pathways Cell Stress Costimulatory Signaling DNA Damage Repair Hedgehog Metabolism Stress NF-kappaB Signaling Notch Nutrient Capture and Catabolic Pathways Proliferation Signaling Affecting Cellular Metabolism TGF Beta Signaling |
Antigen Presentation | Oncology CNS Immuno-Oncology Epigenic and Nuclear Signaling Metabolic Diseases Inflammation |
| UBC | RNA | - | - | - |
| UBE2C | RNA | Biosynthesis and Anabolic Pathways Cell Cycle DNA Damage Repair Metabolism Stress Proliferation Signaling Affecting Cellular Metabolism |
Antigen Presentation | CNS Oncology Epigenic and Nuclear Signaling Metabolic Diseases Immuno-Oncology |
| UBE2D1 | RNA | - | Antigen Presentation Immune Activation Status Immune Suppression |
Immuno-Oncology |
| UBE2D2 | RNA | - | - | - |
| UBE2F | RNA | - | - | - |
| UBE2I | RNA | - | Immune Activation Status | Immuno-Oncology |
| UBE2K | RNA | - | - | - |
| UBE2L3 | RNA | - | - | - |
| UBE2L6 | RNA | - | - | - |
| UBE2N | RNA | - | - | - |
| UBE2S | RNA | - | - | - |
| UBE2T | RNA | Cell Stress DNA Damage Repair |
- | CNS Epigenic and Nuclear Signaling Oncology |
| UBE2V1 | RNA | - | - | - |
| UBE3A | RNA | - | - | - |
| UBE4B | RNA | - | - | - |
| Ubiquitin | Protein | - | AD Pathology | CNS |
| UBQLN1 | RNA | Oxydative Stress | - | Inflammation |
| UCHL1 | RNA | - | Axon and Dendrite Structure | CNS |
| UCHL5 | RNA | mTOR Signaling | - | Oncology |
| UCK1 | RNA | Biosynthesis and Anabolic Pathways Nutrient Capture and Catabolic Pathways |
- | CNS Metabolic Diseases |
| UCK2 | RNA | Biosynthesis and Anabolic Pathways Nutrient Capture and Catabolic Pathways |
- | CNS Metabolic Diseases |
| UCKL1 | RNA | Biosynthesis and Anabolic Pathways Nutrient Capture and Catabolic Pathways |
- | CNS Metabolic Diseases |
| UCP1 | RNA | - | - | - |
| UGCG | RNA | Lipid Metabolism | - | Metabolic Diseases |
| UGDH | RNA | Androgen Signaling | - | Oncology |
| UGT8 | RNA | Lipid Metabolism Myelination |
- | Metabolic Diseases CNS |
| UHRF1 | RNA | Epigenic and Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| ULBP2 | RNA | - | Antigen Presentation Immune Activation Status |
Immuno-Oncology |
| ULBP3 | RNA | - | Immune Activation Status | Immuno-Oncology |
| ULK1 | RNA | - | - | - |
| ULK2 | RNA | - | - | - |
| UMPS | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| UNC13A | RNA | Transmitter Synthesis | Axon and Dendrite Structure Neural Connectivity Vesicle Trafficking |
CNS |
| UNC93B1 | RNA | - | - | - |
| UNG | RNA | - | - | - |
| UPP1 | RNA | Biosynthesis and Anabolic Pathways Nutrient Capture and Catabolic Pathways |
- | CNS Metabolic Diseases |
| UPP2 | RNA | Biosynthesis and Anabolic Pathways Nutrient Capture and Catabolic Pathways |
- | CNS Metabolic Diseases |
| UQCR10 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| UQCR11 | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| UQCRB | RNA | - | - | - |
| UQCRFS1 | RNA | - | - | - |
| UQCRH | RNA | - | - | - |
| UQCRQ | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| uric acid | Amino-acid & Metabolites | - | - | - |
| USP15 | RNA | Epigenic and Transcriptional Regulation | Immune Suppression | Epigenic and Nuclear Signaling Immuno-Oncology |
| USP18 | RNA | - | - | - |
| USP21 | RNA | - | - | - |
| USP30 | RNA | - | - | - |
| USP39 | RNA | - | - | - |
| USP8 | RNA | Nutrient Capture and Catabolic Pathways | - | Metabolic Diseases |
| USP9Y | RNA | - | - | - |
| UTS2 | RNA | - | - | - |
| UTY | RNA | - | - | - |
| Valine | Amino-acid & Metabolites | - | - | - |
| VAMP2 | RNA | - | - | - |
| VAMP3 | RNA | - | - | - |
| VAMP7 | RNA | - | - | - |
| VAMP8 | RNA | - | - | - |
| VASH1 | RNA | Angiogenesis Cell Proliferation |
- | Cardiovascular CNS Oncology |
| VAV1 | RNA | TCR Signaling | Immunity and Inflammation | Immuno-Oncology Inflammation |
| VAV2 | RNA | Angiogenesis | Cellular Growth Factor Immune Activation Status |
Cardiovascular Oncology Immuno-Oncology |
| VAV3 | RNA | Angiogenesis Cell Proliferation |
Cellular Growth Factor Immune Activation Status |
Cardiovascular CNS Oncology Immuno-Oncology |
| VCAM1 | RNA | Cell Proliferation Matrix Remodeling and Metastases Vasculogenesis |
Immune Activation Status | CNS Cardiovascular Immuno-Oncology Oncology |
| VCAN | RNA | Angiogenesis Cell Proliferation Cellular Differentiation EMT Matrix Remodeling and Metastases |
Adhesion and Migration | Cardiovascular CNS Oncology |
| VCL | RNA | - | - | - |
| VCP | RNA | - | - | - |
| VDAC1 | RNA | - | - | - |
| VEGA | - | Cytokine and Chemokine Signaling | - | Immuno-Oncology |
| VEGFA | RNA | Angiogenesis Cell Proliferation Cell Stress Hypoxia MAPK Matrix Remodeling and Metastases Metabolism Stress PI3K-AKT Proliferation RAS Signaling Affecting Cellular Metabolism Vasculogenesis VEGFR Signaling |
Cellular Growth Factor Cytokines Immune Activation Status Immunity and Inflammation Leucocyte Function |
Cardiovascular CNS Metabolic Diseases Oncology Immuno-Oncology Inflammation |
| VEGFB | RNA | Angiogenesis Cell Proliferation MAPK Matrix Remodeling and Metastases PI3K-AKT Vasculogenesis VEGFR Signaling |
Cellular Growth Factor | Cardiovascular CNS Oncology |
| VEGFC | RNA | Angiogenesis Cell Proliferation Cellular Differentiation MAPK PI3K-AKT RAS Vasculogenesis VEGFR Signaling |
Cellular Growth Factor | Cardiovascular CNS Oncology |
| VEGFD | RNA | MAPK PI3K-AKT Proliferation VEGFR Signaling |
- | Cardiovascular Oncology CNS |
| VEZF1 | RNA | Angiogenesis | - | Cardiovascular Oncology |
| VHL | RNA | Cell Proliferation Cell Stress Cellular Differentiation Hypoxia Metabolism Stress Signaling Affecting Cellular Metabolism |
Antigen Presentation | CNS Oncology Cardiovascular Metabolic Diseases Immuno-Oncology |
| VIM | RNA | EMT | - | Oncology |
| Vimentin | Protein | - | Astrocyte Glial Cell Subtyping |
CNS |
| VIP | RNA | Carbohydrate Metabolism Transmitter Synthesis |
- | CNS Metabolic Diseases |
| VISTA | Protein | - | Immune Checkpoint Myeloid Compartment |
Immuno-Oncology CNS |
| VIT | RNA | EMT | - | Oncology |
| VPS13A | RNA | - | - | - |
| VPS28 | RNA | Nutrient Capture and Catabolic Pathways | - | Metabolic Diseases |
| VPS33B | RNA | - | - | - |
| VPS35 | Protein | Autophagy | - | Cardiovascular CNS Inflammation Metabolic Diseases Oncology |
| VPS4A | RNA | - | - | - |
| VPS4B | RNA | - | - | - |
| VRK3 | RNA | - | - | - |
| VSIG4 | RNA | Cell Proliferation Cellular Differentiation |
- | CNS Oncology |
| VSIR | RNA | - | Immune Checkpoint | Immuno-Oncology |
| VTCN1 | RNA | Costimulatory Signaling | Immune Checkpoint | Immuno-Oncology |
| VTN | RNA | - | - | - |
| VWA1 | RNA | - | - | - |
| VWA2 | RNA | - | - | - |
| VWF | RNA | ECM Remodeling | - | Metabolic Diseases Oncology |
| WARS | RNA | Angiogenesis | - | Cardiovascular Oncology |
| WAS | RNA | - | Immunity and Inflammation | Inflammation |
| WASF2 | RNA | VEGFR Signaling | - | Cardiovascular Oncology |
| WASHC4 | RNA | Nutrient Capture and Catabolic Pathways | - | Metabolic Diseases |
| WDR45 | RNA | Nutrient Capture and Catabolic Pathways | - | Metabolic Diseases |
| WDR5 | RNA | - | - | - |
| WDR76 | RNA | - | - | - |
| WDR77 | RNA | ER Signaling | - | Oncology |
| WEE1 | RNA | Cell Cycle Proliferation |
- | Oncology |
| WFS1 | RNA | - | Axon and Dendrite Structure | CNS |
| WHSC1 | RNA | - | - | - |
| WHSC1L1 | RNA | Chromatin Modification | - | Epigenic and Nuclear Signaling |
| WIF1 | RNA | Wnt Signaling | - | CNS Oncology |
| WIPF1 | RNA | Cellular Differentiation | - | Oncology |
| WIPI1 | RNA | - | - | - |
| WNT1 | RNA | Signaling Affecting Cellular Metabolism | - | Metabolic Diseases |
| WNT10A | RNA | Hedgehog Wnt Signaling |
- | CNS Oncology Inflammation |
| WNT10B | RNA | - | - | - |
| WNT11 | RNA | Hedgehog Wnt Signaling |
Immune Activation Status | CNS Immuno-Oncology Oncology Inflammation |
| WNT16 | RNA | - | - | - |
| WNT2 | RNA | Hedgehog Signaling Affecting Cellular Metabolism Wnt Signaling |
Immune Activation Status | CNS Metabolic Diseases Immuno-Oncology Oncology Inflammation |
| WNT2B | RNA | Hedgehog Wnt Signaling |
- | CNS Oncology Inflammation |
| WNT3 | RNA | - | Immune Activation Status | Immuno-Oncology |
| WNT3A | RNA | Hedgehog Wnt Signaling |
Immune Activation Status | CNS Immuno-Oncology Oncology Inflammation |
| WNT4 | RNA | Hedgehog Wnt Signaling |
Immune Activation Status | CNS Immuno-Oncology Oncology Inflammation |
| WNT5A | RNA | Cell Proliferation Cellular Differentiation EMT Hedgehog Wnt Signaling |
- | CNS Oncology Inflammation |
| WNT5B | RNA | Cellular Differentiation Hedgehog Wnt Signaling |
- | Oncology CNS Inflammation |
| WNT6 | RNA | Hedgehog Wnt Signaling |
Immune Activation Status | CNS Immuno-Oncology Oncology Inflammation |
| WNT7A | RNA | - | - | - |
| WNT7B | RNA | Hedgehog Wnt Signaling |
- | CNS Oncology Inflammation |
| WRAP53 | RNA | Cell Cycle | - | Oncology |
| WRN | RNA | Biosynthesis and Anabolic Pathways Cell Stress DNA Damage Repair |
- | CNS Epigenic and Nuclear Signaling Oncology Metabolic Diseases |
| WT1 | RNA | Transcriptional Misregulation | - | Epigenic and Nuclear Signaling |
| WWC1 | RNA | Hippo Signaling | - | CNS Oncology |
| WWTR1 | RNA | Hippo Signaling | - | CNS Oncology |
| XAB2 | RNA | - | - | - |
| XAF1 | RNA | - | Immune Activation Status | Immuno-Oncology |
| xanthine | Amino-acid & Metabolites | - | - | - |
| XBP1 | RNA | mTOR Signaling Oxydative Stress |
Activated Microglia | Oncology Inflammation CNS |
| XCL1 | RNA | - | Immunity and Inflammation | Inflammation |
| XCL1/2 | RNA | Adenosine Pathway DNA Damage Repair |
Immune Activation Status Immune Cell Typing |
Immuno-Oncology Epigenic and Nuclear Signaling |
| XCL2 | RNA | - | Chemokines | Immuno-Oncology |
| XCR1 | RNA | - | Chemokines | Immuno-Oncology |
| XDH | RNA | Biosynthesis and Anabolic Pathways | - | CNS Metabolic Diseases |
| XIAP | RNA | - | Immune Activation Status Immunity and Inflammation |
Immuno-Oncology Inflammation |
| XK | RNA | Myelination | - | CNS |
| XPA | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| XRCC2 | RNA | Cell Stress DNA Damage Repair |
- | CNS Epigenic and Nuclear Signaling Oncology |
| XRCC3 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| XRCC4 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| XRCC6 | RNA | - | Immunity and Inflammation | Inflammation |
| YAP1 | RNA | Hippo Signaling | - | CNS Oncology |
| YES1 | RNA | - | Immune Activation Status Immune Checkpoint |
Immuno-Oncology |
| YTHDF2 | RNA | - | - | - |
| YWHAB | RNA | - | - | - |
| YWHAE | RNA | - | - | - |
| YWHAG | RNA | - | - | - |
| YWHAQ | RNA | - | - | - |
| YWHAZ | RNA | Biosynthesis and Anabolic Pathways Signaling Affecting Cellular Metabolism |
Immune Activation Status Immune Suppression |
CNS Metabolic Diseases Immuno-Oncology |
| YY1 | RNA | Epigenic and Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| ZAK | RNA | - | - | - |
| ZAP70 | RNA | Costimulatory Signaling MAPK Signaling Affecting Cellular Metabolism TCR Signaling |
Immune Activation Status Lymphoid Compartment |
Immuno-Oncology Cardiovascular Metabolic Diseases CNS Oncology |
| ZBP1 | RNA | - | Immunity and Inflammation | Inflammation |
| ZBTB16 | RNA | Transcriptional Misregulation | Antigen Presentation Immune Activation Status |
Epigenic and Nuclear Signaling Immuno-Oncology |
| ZBTB20 | RNA | - | - | - |
| ZBTB32 | RNA | DNA Damage Repair | - | Epigenic and Nuclear Signaling |
| ZC3H12A | RNA | Angiogenesis | - | Cardiovascular Oncology |
| ZC3H14 | RNA | - | - | - |
| ZCCHC24 | RNA | - | - | - |
| ZDHHC2 | RNA | - | - | - |
| ZEB1 | RNA | Cell Proliferation EMT Epigenic and Transcriptional Regulation |
- | CNS Oncology Epigenic and Nuclear Signaling |
| ZEB2 | RNA | Cell Proliferation EMT |
- | CNS Oncology |
| ZFP36L2 | RNA | - | - | - |
| ZFPM2 | RNA | EMT Vasculogenesis |
- | Oncology Cardiovascular |
| ZFYVE16 | RNA | - | - | - |
| ZFYVE9 | RNA | Proliferation TGF Beta Signaling |
Cellular Growth Factor | Oncology |
| ZIC2 | RNA | Hedgehog | - | CNS Inflammation Oncology |
| ZKSCAN5 | RNA | - | - | - |
| ZMYM2 | RNA | Epigenic and Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| ZNF100 | RNA | Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| ZNF136 | RNA | Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| ZNF143 | RNA | - | - | - |
| ZNF205 | RNA | - | - | - |
| ZNF24 | RNA | Myelination | - | CNS |
| ZNF253 | RNA | Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| ZNF254 | RNA | Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| ZNF346 | RNA | - | - | - |
| ZNF367 | RNA | - | Immunity and Inflammation | Inflammation |
| ZNF384 | RNA | - | - | - |
| ZNF385A | RNA | - | - | - |
| ZNF43 | RNA | Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| ZNF610 | RNA | Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| ZNF675 | RNA | Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| ZNF682 | RNA | Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| ZNF683 | RNA | - | Immune Activation Status | Immuno-Oncology |
| ZNF708 | RNA | Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| ZNF85 | RNA | Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| ZNF91 | RNA | Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| ZNF93 | RNA | Transcriptional Regulation | - | Epigenic and Nuclear Signaling |
| Target | Pathway | Phenotype | Area |